1	y	NN	O	y	_	0	SENT_1	[p1l382t96r856b203],
2	+	CC	O	+	_	0	SENT_1	[p1l382t96r856b203],
3	Original	NNP	O	Original	conj_+	1	SENT_1	[p1l1538t138r1794b219],
4	Research	NNP	O	Research	dep	1	SENT_1	[p1l1819t138r2110b202],

1	CYSTIC	JJ	MISC	cystic	amod	2	SENT_2	[p1l1859t257r1967b285],
2	FIBROSIS	NNS	O	fibrosis	_	0	SENT_2	[p1l1978t257r2114b285],

1	lvacaftor	NN	O	lvacaftor	_	0	SENT_3	[p1l403t346r724b403],
2	in	IN	O	in	_	0	SENT_3	[p1l749t346r807b402],
3	Subjects	NNS	O	subject	prep_in	1	SENT_3	[p1l834t345r1151b416],
4	With	IN	O	with	dep	1	SENT_3	[p1l1175t346r1336b402],
5	Cystic	JJ	MISC	cystic	amod	6	SENT_3	[p1l1364t345r1590b416],
6	Fibrosis	NNP	MISC	Fibrosis	pobj	4	SENT_3	[p1l403t430r687b486],
7	Who	WP	MISC	who	nsubj	9	SENT_3	[p1l711t430r873b486],
8	Are	VBP	MISC	be	cop	9	SENT_3	[p1l897t430r1021b486],
9	Homozygous	NNP	MISC	Homozygous	rcmod	6	SENT_3	[p1l1050t430r1525b500],
10	for	IN	O	for	_	0	SENT_3	[p1l1548t430r1651b486],
11	the	DT	O	the	det	13	SENT_3	[p1l1673t430r1788b486],
12	F508deI-CFTR	NN	O	f508dei-cftr	nn	13	SENT_3	[p1l398t512r919b570],
13	Mutation	NN	O	mutation	prep_for	9	SENT_3	[p1l947t513r1265b570],

1	Patrick	NNP	PERSON	Patrick	nn	5	SENT_4	[p1l400t645r526b679],
2	A.	NNP	PERSON	A.	nn	5	SENT_4	[p1l538t648r573b679],
3	Flume	NNP	PERSON	Flume	nn	5	SENT_4	[p1l590t645r710b685],
4	,	,	O	,	_	0	SENT_4	[p1l590t645r710b685],
5	MD	NNP	O	MD	_	0	SENT_4	[p1l725t648r803b685],
6	,	,	O	,	_	0	SENT_4	[p1l725t648r803b685],
7	F	NN	O	f	nn	8	SENT_4	[p1l819t648r844b679],
8	CCP	NN	O	ccp	appos	5	SENT_4	[p1l846t648r939b685],
9	;	:	O	;	_	0	SENT_4	[p1l846t648r939b685],
10	Theodore	NNP	PERSON	Theodore	nn	12	SENT_4	[p1l954t645r1120b679],
11	G.	NNP	PERSON	G.	nn	12	SENT_4	[p1l1135t648r1171b679],
12	Liou	NNP	PERSON	Liou	dep	5	SENT_4	[p1l1188t648r1279b685],
13	,	,	O	,	_	0	SENT_4	[p1l1188t648r1279b685],
14	MD	NNP	O	MD	appos	12	SENT_4	[p1l1295t648r1372b685],
15	,	,	O	,	_	0	SENT_4	[p1l1295t648r1372b685],
16	F	NN	O	f	nn	17	SENT_4	[p1l1388t648r1413b679],
17	CCP	NN	O	ccp	appos	12	SENT_4	[p1l1415t648r1508b685],
18	;	:	O	;	_	0	SENT_4	[p1l1415t648r1508b685],
19	Drucy	NNP	PERSON	Drucy	nn	21	SENT_4	[p1l1521t648r1634b691],
20	S.	NNP	PERSON	S.	nn	21	SENT_4	[p1l1649t648r1676b679],
21	Borowitz	NNP	PERSON	Borowitz	dep	12	SENT_4	[p1l1693t648r1863b685],
22	,	,	O	,	_	0	SENT_4	[p1l1693t648r1863b685],
23	MD	NN	O	md	appos	21	SENT_4	[p1l1879t648r1959b685],
24	;	:	O	;	_	0	SENT_4	[p1l1879t648r1959b685],
25	Haihong	NNP	PERSON	Haihong	nn	26	SENT_4	[p1l400t701r554b747],
26	Li	NNP	PERSON	Li	conj_and	21	SENT_4	[p1l566t704r613b741],
27	,	,	O	,	_	0	SENT_4	[p1l566t704r613b741],
28	PhD	NN	O	phd	appos	26	SENT_4	[p1l628t701r718b741],
29	;	:	O	;	_	0	SENT_4	[p1l628t701r718b741],
30	Karl	NNP	PERSON	Karl	nn	31	SENT_4	[p1l731t701r809b735],
31	Yen	NNP	PERSON	Yen	dep	12	SENT_4	[p1l822t704r893b741],
32	,	,	O	,	_	0	SENT_4	[p1l822t704r893b741],
33	MD	NN	O	md	appos	31	SENT_4	[p1l909t704r989b741],
34	;	:	O	;	_	0	SENT_4	[p1l909t704r989b741],
35	Claudia	NNP	PERSON	Claudia	nn	37	SENT_4	[p1l1003t701r1143b735],
36	L.	NNP	PERSON	L.	nn	37	SENT_4	[p1l1156t704r1189b735],
37	Orcloﬁez	NNP	PERSON	Orcloﬁez	conj_and	21	SENT_4	[p1l1207t701r1368b741],
38	,	,	O	,	_	0	SENT_4	[p1l1207t701r1368b741],
39	MD	NN	O	md	appos	37	SENT_4	[p1l1384t704r1464b741],
40	;	:	O	;	_	0	SENT_4	[p1l1384t704r1464b741],
41	and	CC	O	and	_	0	SENT_4	[p1l1477t701r1544b735],
42	David	NNP	PERSON	David	nn	44	SENT_4	[p1l1556t701r1666b735],
43	E.	NNP	PERSON	E.	nn	44	SENT_4	[p1l1678t704r1711b735],
44	Geller	NNP	PERSON	Geller	dep	12	SENT_4	[p1l1730t701r1842b741],
45	,	,	O	,	_	0	SENT_4	[p1l1730t701r1842b741],
46	MD	NN	O	md	appos	44	SENT_4	[p1l1858t704r1937b741],
47	;	:	O	;	_	0	SENT_4	[p1l1858t704r1937b741],
48	for	IN	O	for	_	0	SENT_4	[p1l392t757r453b802],
49	the	DT	O	the	det	50	SENT_4	[p1l462t757r517b791],
50	VX08	NN	O	vx08	prep_for	44	SENT_4	[p1l530t760r640b791],
51	-	:	O	-	_	0	SENT_4	[p1l530t760r640b791],
52	770-104	CD	NUMBER	770-104	num	54	SENT_4	[p1l646t759r787b791],
53	Study	NNP	O	Study	nn	54	SENT_4	[p1l802t757r903b803],
54	Group	NNP	O	Group	dep	12	SENT_4	[p1l918t760r1053b803],
55	*	IN	O	*	amod	54	SENT_4	[p1l918t760r1053b803],

1	Background	NN	O	background	_	0	SENT_5	[p1l221t904r447b945],
2	:	:	O	:	_	0	SENT_5	[p1l221t904r447b945],
3	Ivacaftor	NNP	O	Ivacaftor	dep	1	SENT_5	[p1l460t904r623b934],
4	(	CD	NUMBER	(	num	6	SENT_5	[p1l634t904r788b940],
5	VX-770	NN	O	vx-770	nn	6	SENT_5	[p1l634t904r788b940],
6	)	NN	O	)	nsubj	12	SENT_5	[p1l634t904r788b940],
7	is	VBZ	O	be	cop	12	SENT_5	[p1l800t907r826b934],
8	a	DT	O	a	det	12	SENT_5	[p1l837t916r857b934],
9	cystic	JJ	O	cystic	amod	12	SENT_5	[p1l867t907r965b945],
10	ﬁbrosis	NN	O	ﬁbrosis	nn	12	SENT_5	[p1l976t904r1104b934],
11	transmembrane	NN	O	transmembrane	nn	12	SENT_5	[p1l1115t904r1402b934],
12	conductance	NN	O	conductance	rcmod	3	SENT_5	[p1l1413t904r1640b934],
13	regulator	NN	O	regulator	nn	15	SENT_5	[p1l1651t904r1820b945],
14	(	CD	NUMBER	(	num	15	SENT_5	[p1l1832t904r1964b940],
15	CFTR	NNP	ORGANIZATION	CFTR	dep	12	SENT_5	[p1l1832t904r1964b940],
16	)	CD	NUMBER	)	num	17	SENT_5	[p1l1832t904r1964b940],
17	potentiator	NN	O	potentiator	dep	12	SENT_5	[p1l221t952r434b991],
18	that	WDT	O	that	nsubjpass	20	SENT_5	[p1l445t950r519b980],
19	was	VBD	O	be	auxpass	20	SENT_5	[p1l531t962r598b980],
20	approved	VBN	O	approve	rcmod	12	SENT_5	[p1l612t950r788b991],
21	in	IN	O	in	_	0	SENT_5	[p1l801t952r836b979],
22	the	DT	O	the	det	24	SENT_5	[p1l848t950r907b980],
23	United	NNP	LOCATION	United	nn	24	SENT_5	[p1l921t950r1048b980],
24	States	NNPS	LOCATION	States	prep_in	20	SENT_5	[p1l1063t952r1171b980],
25	for	IN	O	for	_	0	SENT_5	[p1l1185t950r1240b980],
26	the	DT	O	the	det	27	SENT_5	[p1l1252t950r1310b980],
27	treatment	NN	O	treatment	prep_for	20	SENT_5	[p1l1324t956r1510b980],
28	of	IN	O	of	_	0	SENT_5	[p1l1523t950r1562b980],
29	cystic	JJ	O	cystic	amod	33	SENT_5	[p1l1572t952r1674b991],
30	ﬁbrosis	NN	O	ﬁbrosis	nn	33	SENT_5	[p1l1687t950r1820b980],
31	(	NN	O	(	nn	33	SENT_5	[p1l1836t950r1916b986],
32	CF	NN	O	cf	nn	33	SENT_5	[p1l1836t950r1916b986],
33	)	NN	O	)	prep_of	27	SENT_5	[p1l1836t950r1916b986],
34	in	IN	O	in	_	0	SENT_5	[p1l1931t952r1966b979],
35	patients	NNS	O	patient	prep_in	33	SENT_5	[p1l221t998r370b1037],
36	2	CD	NUMBER	2	number	37	SENT_5	[p1l388t1002r415b1022],
37	6	CD	DURATION	6	num	38	SENT_5	[p1l426t998r445b1026],
38	years	NNS	NUMBER	year	npadvmod	35	SENT_5	[p1l459t1008r556b1037],
39	of	IN	O	of	_	0	SENT_5	[p1l572t996r612b1026],
40	age	NN	O	age	prep_of	35	SENT_5	[p1l622t1006r686b1037],
41	who	WP	O	who	nsubj	42	SENT_5	[p1l700t996r776b1026],
42	have	VBP	O	have	rcmod	27	SENT_5	[p1l790t996r876b1026],
43	a	DT	O	a	det	45	SENT_5	[p1l892t1008r911b1026],
44	G55lD	NN	O	g55ld	nn	45	SENT_5	[p1l926t997r1058b1026],
45	mutation	NN	O	mutation	dobj	42	SENT_5	[p1l1073t998r1252b1032],
46	;	:	O	;	_	0	SENT_5	[p1l1073t998r1252b1032],
47	however	RB	O	however	advmod	60	SENT_5	[p1l1267t996r1434b1032],
48	,	,	O	,	_	0	SENT_5	[p1l1267t996r1434b1032],
49	the	DT	O	the	det	55	SENT_5	[p1l1449t996r1508b1026],
50	most	RBS	O	most	advmod	51	SENT_5	[p1l1523t1002r1611b1026],
51	prevalent	JJ	O	prevalent	amod	55	SENT_5	[p1l1625t996r1804b1037],
52	diseasecausing	VBG	O	diseasecause	dep	51	SENT_5	[p1l1818t996r1965b1026, p1l222t1044r362b1082],
53	CF	NN	O	cf	nn	54	SENT_5	[p1l377t1044r430b1072],
54	TR	NN	O	tr	dobj	52	SENT_5	[p1l433t1044r485b1071],
55	mutation	NN	O	mutation	nsubj	60	SENT_5	[p1l499t1044r678b1078],
56	,	,	O	,	_	0	SENT_5	[p1l499t1044r678b1078],
57	F	NN	O	f	nn	58	SENT_5	[p1l693t1044r718b1071],
58	508del	NN	O	508del	appos	55	SENT_5	[p1l721t1041r857b1078],
59	,	,	O	,	_	0	SENT_5	[p1l721t1041r857b1078],
60	causes	VBZ	O	cause	parataxis	12	SENT_5	[p1l872t1053r990b1072],
61	a	DT	O	a	det	64	SENT_5	[p1l1005t1053r1025b1072],
62	different	JJ	O	different	amod	63	SENT_5	[p1l1039t1041r1205b1072],
63	functional	JJ	O	functional	amod	64	SENT_5	[p1l1218t1041r1408b1072],
64	defect	NN	O	defect	dobj	60	SENT_5	[p1l1422t1041r1548b1072],
65	.	.	O	.	_	0	SENT_5	[p1l1422t1041r1548b1072],

1	The	DT	O	the	det	2	SENT_6	[p1l1563t1041r1634b1072],
2	objectives	NNS	O	objective	nsubj	6	SENT_6	[p1l1650t1041r1835b1083],
3	of	IN	O	of	_	0	SENT_6	[p1l1850t1041r1889b1072],
4	this	DT	O	this	det	5	SENT_6	[p1l1899t1041r1965b1072],
5	study	NN	O	study	prep_of	2	SENT_6	[p1l223t1087r319b1128],
6	were	VBD	O	be	_	0	SENT_6	[p1l329t1099r417b1118],
7	to	TO	O	to	aux	8	SENT_6	[p1l430t1093r465b1118],
8	evaluate	VB	O	evaluate	ccomp	6	SENT_6	[p1l478t1087r628b1117],
9	the	DT	O	the	det	10	SENT_6	[p1l641t1087r698b1117],
10	safety	NN	O	safety	dobj	8	SENT_6	[p1l711t1087r816b1129],
11	of	IN	O	of	_	0	SENT_6	[p1l828t1087r866b1117],
12	ivacaftor	NN	O	ivacaftor	prep_of	10	SENT_6	[p1l874t1087r1033b1118],
13	in	IN	O	in	_	0	SENT_6	[p1l1044t1090r1079b1117],
14	a	DT	O	a	det	16	SENT_6	[p1l1091t1099r1111b1117],
15	larger	JJR	O	larger	amod	16	SENT_6	[p1l1122t1087r1233b1128],
16	population	NN	O	population	prep_in	8	SENT_6	[p1l1244t1087r1439b1129],
17	and	CC	O	and	_	0	SENT_6	[p1l1451t1087r1518b1117],
18	for	IN	O	for	_	0	SENT_6	[p1l1530t1087r1583b1117],
19	a	DT	O	a	det	22	SENT_6	[p1l1595t1099r1614b1117],
20	longer	JJR	O	longer	amod	22	SENT_6	[p1l1626t1087r1744b1128],
21	time	NN	O	time	nn	22	SENT_6	[p1l1755t1090r1835b1117],
22	period	NN	O	period	prep_for	8	SENT_6	[p1l1847t1087r1966b1129],
23	than	IN	O	than	advmod	24	SENT_6	[p1l222t1133r302b1163],
24	tested	VBN	O	test	partmod	22	SENT_6	[p1l313t1133r423b1163],
25	previously	RB	DATE	previously	advmod	24	SENT_6	[p1l433t1133r621b1174],
26	and	CC	O	and	_	0	SENT_6	[p1l631t1133r698b1163],
27	to	TO	O	to	aux	28	SENT_6	[p1l708t1139r743b1163],
28	assess	VB	O	assess	conj_and	8	SENT_6	[p1l755t1145r859b1163],
29	the	DT	O	the	det	30	SENT_6	[p1l871t1133r928b1163],
30	efficacy	NN	O	efficacy	dobj	28	SENT_6	[p1l941t1133r1077b1174],
31	of	IN	O	of	_	0	SENT_6	[p1l1088t1133r1126b1163],
32	ivacaftor	NN	O	ivacaftor	prep_of	30	SENT_6	[p1l1134t1133r1293b1163],
33	in	IN	O	in	_	0	SENT_6	[p1l1303t1136r1337b1163],
34	subjects	NNS	O	subject	prep_in	28	SENT_6	[p1l1349t1133r1491b1174],
35	with	IN	O	with	_	0	SENT_6	[p1l1503t1133r1581b1163],
36	CF	NN	O	cf	prep_with	34	SENT_6	[p1l1593t1136r1647b1163],
37	who	WP	O	who	nsubj	39	SENT_6	[p1l1658t1133r1732b1163],
38	are	VBP	O	be	cop	39	SENT_6	[p1l1744t1145r1801b1163],
39	homozygous	JJ	O	homozygous	rcmod	34	SENT_6	[p1l1813t1133r1965b1174, p1l223t1189r303b1220],
40	for	IN	O	for	_	0	SENT_6	[p1l317t1179r370b1209],
41	F508del-CFTR	NN	O	f508del-cftr	prep_for	39	SENT_6	[p1l380t1179r655b1209],
42	.	.	O	.	_	0	SENT_6	[p1l380t1179r655b1209],

1	Methods	NNS	O	method	_	0	SENT_7	[p1l220t1225r376b1255],
2	:	:	O	:	_	0	SENT_7	[p1l220t1225r376b1255],
3	This	DT	O	this	nsubj	8	SENT_7	[p1l387t1225r460b1255],
4	was	VBD	O	be	cop	8	SENT_7	[p1l470t1237r533b1255],
5	a	DT	O	a	det	8	SENT_7	[p1l543t1237r563b1255],
6	phase	NN	O	phase	nn	8	SENT_7	[p1l572t1225r672b1266],
7	2	CD	NUMBER	2	num	8	SENT_7	[p1l682t1227r702b1254],
8	study	NN	O	study	dep	1	SENT_7	[p1l713t1225r806b1266],
9	with	IN	O	with	_	0	SENT_7	[p1l814t1225r890b1255],
10	a	DT	O	a	det	11	SENT_7	[p1l899t1237r919b1255],
11	16-week	JJ	DURATION	16-week	prep_with	8	SENT_7	[p1l931t1225r1074b1255],
12	randomized	VBN	O	randomize	partmod	11	SENT_7	[p1l1082t1225r1292b1255],
13	(	NN	O	(	dep	22	SENT_7	[p1l1302t1225r1387b1261],
14	4:1	CD	NUMBER	4:1	dep	13	SENT_7	[p1l1302t1225r1387b1261],
15	)	NN	O	)	nn	20	SENT_7	[p1l1302t1225r1387b1261],
16	,	,	O	,	_	0	SENT_7	[p1l1302t1225r1387b1261],
17	double-blind	JJ	O	double-blind	amod	20	SENT_7	[p1l1398t1225r1629b1262],
18	,	,	O	,	_	0	SENT_7	[p1l1398t1225r1629b1262],
19	placebo-controlled	JJ	O	placebo-controlled	amod	20	SENT_7	[p1l1639t1225r1966b1266],
20	period	NN	O	period	dep	22	SENT_7	[p1l221t1271r341b1312],
21	(	CD	NUMBER	(	num	22	SENT_7	[p1l354t1271r440b1312],
22	part	NN	O	part	dep	32	SENT_7	[p1l354t1271r440b1312],
23	A	DT	O	a	det	24	SENT_7	[p1l451t1271r489b1307],
24	)	NN	O	)	dep	22	SENT_7	[p1l451t1271r489b1307],
25	and	CC	O	and	_	0	SENT_7	[p1l503t1271r570b1301],
26	an	DT	O	a	det	28	SENT_7	[p1l582t1283r624b1301],
27	open-label	JJ	O	open-label	amod	28	SENT_7	[p1l637t1271r828b1312],
28	extension	NN	O	extension	dep	22	SENT_7	[p1l840t1273r1010b1301],
29	(	CD	NUMBER	(	num	32	SENT_7	[p1l1024t1271r1110b1312],
30	part	NN	O	part	nn	32	SENT_7	[p1l1024t1271r1110b1312],
31	B	NN	O	b	nn	32	SENT_7	[p1l1122t1271r1160b1307],
32	)	NN	O	)	dep	12	SENT_7	[p1l1122t1271r1160b1307],
33	for	IN	O	for	_	0	SENT_7	[p1l1174t1271r1227b1301],
34	subjects	NNS	O	subject	prep_for	32	SENT_7	[p1l1239t1271r1381b1312],
35	who	WP	O	who	nsubj	36	SENT_7	[p1l1394t1271r1468b1301],
36	met	VBD	O	meet	rcmod	32	SENT_7	[p1l1480t1277r1549b1301],
37	prespeciﬁed	JJ	O	prespeciﬁed	amod	38	SENT_7	[p1l1560t1271r1782b1312],
38	criteria	NNS	O	criterion	dobj	36	SENT_7	[p1l1794t1273r1935b1301],
39	.	.	O	.	_	0	SENT_7	[p1l1794t1273r1935b1301],

1	Results	NNS	O	result	_	0	SENT_8	[p1l221t1316r364b1347],
2	:	:	O	:	_	0	SENT_8	[p1l221t1316r364b1347],
3	Part	NNP	O	Part	nn	4	SENT_8	[p1l383t1319r462b1347],
4	A	NNP	O	A	dep	1	SENT_8	[p1l478t1319r514b1347],
5	:	:	O	:	_	0	SENT_8	[p1l478t1319r514b1347],
6	The	DT	O	the	det	8	SENT_8	[p1l534t1316r605b1347],
7	safety	NN	O	safety	nn	8	SENT_8	[p1l624t1316r732b1358],
8	proﬁle	NN	O	proﬁle	nsubj	12	SENT_8	[p1l748t1316r871b1358],
9	of	IN	O	of	_	0	SENT_8	[p1l889t1316r928b1347],
10	ivacaftor	NN	O	ivacaftor	prep_of	8	SENT_8	[p1l942t1316r1107b1347],
11	was	VBD	O	be	cop	12	SENT_8	[p1l1123t1328r1190b1347],
12	comparable	JJ	O	comparable	dep	1	SENT_8	[p1l1208t1316r1428b1358],
13	to	TO	O	to	_	0	SENT_8	[p1l1445t1322r1481b1347],
14	that	DT	O	that	prep_to	12	SENT_8	[p1l1499t1316r1573b1347],
15	of	IN	O	of	_	0	SENT_8	[p1l1590t1316r1629b1347],
16	the	DT	O	the	det	17	SENT_8	[p1l1643t1316r1702b1347],
17	placebo	NN	O	placebo	prep_of	14	SENT_8	[p1l1719t1316r1875b1358],
18	.	.	O	.	_	0	SENT_8	[p1l1719t1316r1875b1358],

1	The	DT	O	the	det	5	SENT_9	[p1l1894t1316r1965b1347],
2	overall	JJ	O	overall	amod	5	SENT_9	[p1l222t1362r346b1392],
3	adverse	JJ	O	adverse	amod	5	SENT_9	[p1l358t1362r496b1393],
4	event	NN	O	event	nn	5	SENT_9	[p1l509t1368r608b1392],
5	frequency	NN	O	frequency	nsubj	7	SENT_9	[p1l620t1362r803b1404],
6	was	VBD	O	be	cop	7	SENT_9	[p1l813t1374r878b1393],
7	similar	JJ	O	similar	_	0	SENT_9	[p1l892t1362r1014b1392],
8	in	IN	O	in	_	0	SENT_9	[p1l1026t1365r1060b1392],
9	the	DT	O	the	det	11	SENT_9	[p1l1072t1362r1129b1393],
10	ivacaftor	NN	O	ivacaftor	nn	11	SENT_9	[p1l1142t1362r1301b1393],
11	(	NN	O	(	prep_in	7	SENT_9	[p1l1314t1362r1448b1398],
12	87.5	CD	PERCENT	87.5	num	13	SENT_9	[p1l1314t1362r1448b1398],
13	%	NN	PERCENT	%	dep	11	SENT_9	[p1l1314t1362r1448b1398],
14	)	CD	NUMBER	)	dep	13	SENT_9	[p1l1314t1362r1448b1398],
15	and	CC	O	and	_	0	SENT_9	[p1l1462t1362r1528b1392],
16	placebo	NN	O	placebo	conj_and	7	SENT_9	[p1l1540t1362r1680b1404],
17	(	CD	PERCENT	(	num	16	SENT_9	[p1l1695t1362r1828b1398],
18	89.3	CD	PERCENT	89.3	num	19	SENT_9	[p1l1695t1362r1828b1398],
19	%	NN	PERCENT	%	dep	16	SENT_9	[p1l1695t1362r1828b1398],
20	)	CD	NUMBER	)	num	21	SENT_9	[p1l1695t1362r1828b1398],
21	groups	NNS	O	group	dep	7	SENT_9	[p1l1843t1373r1965b1403],
22	through	IN	O	through	_	0	SENT_9	[p1l222t1408r372b1449],
23	16	CD	DURATION	16	num	24	SENT_9	[p1l389t1411r429b1438],
24	weeks	NNS	NUMBER	week	prep_through	7	SENT_9	[p1l443t1408r566b1438],
25	.	.	O	.	_	0	SENT_9	[p1l443t1408r566b1438],

1	The	DT	O	the	det	2	SENT_10	[p1l581t1408r652b1438],
2	difference	NN	O	difference	nsubj	33	SENT_10	[p1l668t1408r859b1438],
3	in	IN	O	in	_	0	SENT_10	[p1l874t1411r909b1438],
4	the	DT	O	the	det	5	SENT_10	[p1l923t1408r982b1438],
5	change	NN	O	change	prep_in	2	SENT_10	[p1l997t1408r1128b1449],
6	of	IN	O	of	_	0	SENT_10	[p1l1143t1408r1183b1438],
7	FEV1	NN	PERCENT	fev1	nn	8	SENT_10	[p1l1193t1411r1287b1448],
8	%	NN	PERCENT	%	prep_of	5	SENT_10	[p1l1304t1411r1334b1438],
9	predicted	VBN	O	predict	partmod	8	SENT_10	[p1l1350t1408r1531b1449],
10	from	IN	O	from	_	0	SENT_10	[p1l1545t1408r1634b1438],
11	baseline	NN	O	baseline	prep_from	9	SENT_10	[p1l1648t1408r1801b1438],
12	through	IN	O	through	_	0	SENT_10	[p1l1816t1408r1966b1449],
13	week	NN	DURATION	week	prep_through	9	SENT_10	[p1l221t1454r318b1484],
14	16	CD	NUMBER	16	number	15	SENT_10	[p1l333t1457r372b1484],
15	(	CD	NUMBER	(	dep	13	SENT_10	[p1l386t1454r542b1495],
16	primary	JJ	O	primary	amod	19	SENT_10	[p1l386t1454r542b1495],
17	end	NN	O	end	nn	19	SENT_10	[p1l553t1454r620b1484],
18	point	NN	O	point	nn	19	SENT_10	[p1l630t1454r735b1495],
19	)	NN	O	)	dep	15	SENT_10	[p1l630t1454r735b1495],
20	between	IN	O	between	_	0	SENT_10	[p1l748t1454r901b1484],
21	the	DT	O	the	det	25	SENT_10	[p1l912t1454r969b1484],
22	ivacaftor	NN	O	ivacaftor	nn	25	SENT_10	[p1l981t1454r1140b1484],
23	and	CC	O	and	_	0	SENT_10	[p1l1151t1454r1217b1484],
24	placebo	NN	O	placebo	nn	25	SENT_10	[p1l1227t1454r1368b1495],
25	groups	NNS	O	group	prep_between	9	SENT_10	[p1l1380t1464r1502b1495],
26	was	VBD	O	be	cop	33	SENT_10	[p1l1513t1466r1578b1484],
27	1.7	CD	PERCENT	1.7	num	28	SENT_10	[p1l1593t1455r1677b1484],
28	%	NN	PERCENT	%	nn	33	SENT_10	[p1l1593t1455r1677b1484],
29	(	CD	NUMBER	(	num	30	SENT_10	[p1l1692t1454r1727b1490],
30	P	NN	O	p	dep	28	SENT_10	[p1l1692t1454r1727b1490],
31	=	JJ	O	=	amod	33	SENT_10	[p1l1737t1466r1761b1475],
32	.15	CD	NUMBER	.15	tmod	31	SENT_10	[p1l1772t1454r1847b1490],
33	)	NN	O	)	_	0	SENT_10	[p1l1772t1454r1847b1490],
34	.	.	O	.	_	0	SENT_10	[p1l1772t1454r1847b1490],

1	Sweat	NN	O	sweat	nn	2	SENT_11	[p1l1861t1457r1966b1484],
2	chloride	NN	O	chloride	nsubj	10	SENT_11	[p1l222t1500r388b1537],
3	,	,	O	,	_	0	SENT_11	[p1l222t1500r388b1537],
4	a	DT	O	a	det	5	SENT_11	[p1l403t1512r422b1530],
5	biomarker	NN	O	biomarker	appos	2	SENT_11	[p1l436t1500r633b1530],
6	of	IN	O	of	_	0	SENT_11	[p1l646t1500r685b1530],
7	CFTR	NN	O	cftr	nn	8	SENT_11	[p1l696t1502r807b1530],
8	activity	NN	O	activity	prep_of	5	SENT_11	[p1l822t1502r964b1541],
9	,	,	O	,	_	0	SENT_11	[p1l822t1502r964b1541],
10	showed	VBD	O	show	_	0	SENT_11	[p1l980t1500r1118b1530],
11	a	DT	O	a	det	13	SENT_11	[p1l1132t1512r1151b1530],
12	small	JJ	O	small	amod	13	SENT_11	[p1l1166t1500r1262b1530],
13	reduction	NN	O	reduction	dobj	10	SENT_11	[p1l1276t1500r1457b1530],
14	in	IN	O	in	_	0	SENT_11	[p1l1471t1502r1506b1529],
15	the	DT	O	the	det	16	SENT_11	[p1l1519t1500r1578b1530],
16	ivacaftor	NN	O	ivacaftor	prep_in	13	SENT_11	[p1l1593t1500r1758b1530],
17	vs	CC	O	vs	_	0	SENT_11	[p1l1770t1512r1806b1530],
18	placebo	NN	O	placebo	nn	19	SENT_11	[p1l1820t1500r1966b1541],
19	groups	NNS	O	group	dobj	10	SENT_11	[p1l223t1556r348b1587],
20	of	IN	O	of	_	0	SENT_11	[p1l361t1546r401b1576],
21	-2.9	CD	NUMBER	-2.9	num	22	SENT_11	[p1l412t1548r497b1576],
22	mmol/L	NN	O	mmol/l	prep_of	19	SENT_11	[p1l509t1546r653b1576],
23	(	CD	NUMBER	(	num	24	SENT_11	[p1l666t1546r702b1582],
24	P	NN	O	p	npadvmod	25	SENT_11	[p1l666t1546r702b1582],
25	=	JJ	O	=	amod	22	SENT_11	[p1l713t1558r737b1567],
26	.04	CD	NUMBER	.04	number	27	SENT_11	[p1l750t1546r816b1582],
27	)	CD	NUMBER	)	npadvmod	10	SENT_11	[p1l750t1546r816b1582],
28	from	IN	O	from	_	0	SENT_11	[p1l829t1546r919b1576],
29	baseline	NN	O	baseline	prep_from	10	SENT_11	[p1l930t1546r1083b1576],
30	through	IN	O	through	_	0	SENT_11	[p1l1095t1546r1245b1587],
31	week	NN	DURATION	week	prep_through	10	SENT_11	[p1l1256t1546r1353b1576],
32	16	CD	NUMBER	16	num	31	SENT_11	[p1l1367t1548r1417b1576],
33	.	.	O	.	_	0	SENT_11	[p1l1367t1548r1417b1576],

1	Part	NN	O	part	nn	2	SENT_12	[p1l1431t1548r1509b1576],
2	B	NN	O	b	_	0	SENT_12	[p1l1521t1548r1557b1576],
3	:	:	O	:	_	0	SENT_12	[p1l1521t1548r1557b1576],
4	No	DT	O	no	det	7	SENT_12	[p1l1571t1548r1623b1576],
5	new	JJ	O	new	amod	7	SENT_12	[p1l1635t1558r1710b1576],
6	safety	NN	O	safety	nn	7	SENT_12	[p1l1721t1546r1830b1587],
7	signals	NNS	O	signal	nsubjpass	9	SENT_12	[p1l1841t1546r1965b1587],
8	were	VBD	O	be	auxpass	9	SENT_12	[p1l221t1603r307b1622],
9	identiﬁed	VBN	O	identiﬁed	dep	2	SENT_12	[p1l321t1591r496b1622],
10	.	.	O	.	_	0	SENT_12	[p1l321t1591r496b1622],

1	The	DT	O	the	det	2	SENT_13	[p1l510t1591r578b1622],
2	changes	NNS	O	change	nsubjpass	14	SENT_13	[p1l592t1591r731b1632],
3	in	IN	O	in	_	0	SENT_13	[p1l745t1594r778b1621],
4	F	NN	O	f	nn	5	SENT_13	[p1l791t1594r816b1621],
5	EV1	NN	O	ev1	prep_in	2	SENT_13	[p1l817t1594r881b1631],
6	or	CC	O	or	_	0	SENT_13	[p1l896t1603r934b1622],
7	sweat	NN	O	sweat	nn	8	SENT_13	[p1l947t1597r1043b1622],
8	chloride	NN	O	chloride	prep_in	2	SENT_13	[p1l1056t1591r1199b1622],
9	in	IN	O	in	_	0	SENT_13	[p1l1212t1594r1246b1621],
10	part	NN	O	part	nn	11	SENT_13	[p1l1258t1597r1331b1633],
11	A	NN	O	a	prep_in	5	SENT_13	[p1l1343t1594r1370b1621],
12	were	VBD	O	be	auxpass	14	SENT_13	[p1l1381t1603r1467b1622],
13	not	RB	O	not	neg	14	SENT_13	[p1l1481t1597r1538b1622],
14	sustained	VBN	O	sustain	_	0	SENT_13	[p1l1551t1591r1714b1622],
15	with	IN	O	with	_	0	SENT_13	[p1l1725t1591r1801b1622],
16	ivacaftor	NN	O	ivacaftor	nn	17	SENT_13	[p1l1814t1591r1967b1622],
17	treatment	NN	O	treatment	prep_with	14	SENT_13	[p1l222t1643r402b1667],
18	from	IN	O	from	_	0	SENT_13	[p1l413t1637r500b1667],
19	week	NN	DURATION	week	prep_from	14	SENT_13	[p1l511t1637r606b1667],
20	16	CD	NUMBER	16	num	19	SENT_13	[p1l620t1640r660b1667],
21	to	TO	O	to	_	0	SENT_13	[p1l672t1643r707b1668],
22	week	NN	DURATION	week	prep_to	14	SENT_13	[p1l718t1637r813b1668],
23	40	CD	NUMBER	40	num	22	SENT_13	[p1l824t1640r876b1667],
24	.	.	O	.	_	0	SENT_13	[p1l824t1640r876b1667],

1	Conclusions	NNS	O	conclusion	_	0	SENT_14	[p1l223t1683r447b1713],
2	:	:	O	:	_	0	SENT_14	[p1l223t1683r447b1713],
3	These	DT	O	these	det	4	SENT_14	[p1l461t1683r568b1713],
4	results	NNS	O	result	nsubj	12	SENT_14	[p1l581t1683r699b1713],
5	expand	VBP	O	expand	dep	1	SENT_14	[p1l713t1683r842b1724],
6	the	DT	O	the	det	8	SENT_14	[p1l854t1683r911b1713],
7	safety	NN	O	safety	nn	8	SENT_14	[p1l925t1683r1030b1724],
8	information	NN	O	information	dobj	5	SENT_14	[p1l1041t1683r1255b1713],
9	for	IN	O	for	_	0	SENT_14	[p1l1267t1683r1320b1713],
10	ivacaftor	NN	O	ivacaftor	prep_for	8	SENT_14	[p1l1332t1683r1491b1713],
11	and	CC	O	and	_	0	SENT_14	[p1l1502t1683r1569b1713],
12	support	VB	O	support	conj_and	5	SENT_14	[p1l1582t1689r1720b1724],
13	its	PRP$	O	its	poss	15	SENT_14	[p1l1732t1686r1772b1713],
14	continued	JJ	O	continued	amod	15	SENT_14	[p1l1785t1683r1966b1713],
15	evaluation	NN	O	evaluation	dobj	12	SENT_14	[p1l222t1729r426b1759],
16	.	.	O	.	_	0	SENT_14	[p1l222t1729r426b1759],

1	Lack	NN	O	lack	nsubj	6	SENT_15	[p1l441t1729r532b1759],
2	of	IN	O	of	_	0	SENT_15	[p1l544t1729r583b1759],
3	a	DT	O	a	det	5	SENT_15	[p1l592t1741r611b1759],
4	clinical	JJ	O	clinical	amod	5	SENT_15	[p1l624t1729r757b1759],
5	effect	NN	O	effect	prep_of	1	SENT_15	[p1l770t1729r876b1759],
6	suggests	VBZ	O	suggest	_	0	SENT_15	[p1l889t1735r1043b1770],
7	that	IN	O	that	complm	17	SENT_15	[p1l1056t1729r1130b1759],
8	a	DT	O	a	det	10	SENT_15	[p1l1143t1741r1162b1759],
9	CFTR	NNP	O	CFTR	nn	10	SENT_15	[p1l1175t1732r1286b1759],
10	potentiator	NN	O	potentiator	nsubj	17	SENT_15	[p1l1298t1732r1510b1770],
11	alone	RB	O	alone	advmod	17	SENT_15	[p1l1522t1729r1622b1759],
12	is	VBZ	O	be	cop	17	SENT_15	[p1l1636t1732r1662b1759],
13	not	RB	O	not	neg	17	SENT_15	[p1l1676t1735r1736b1759],
14	an	DT	O	a	det	17	SENT_15	[p1l1749t1741r1792b1759],
15	effective	JJ	O	effective	amod	17	SENT_15	[p1l1805t1729r1965b1759],
16	therapeutic	JJ	O	therapeutic	amod	17	SENT_15	[p1l222t1775r431b1816],
17	approach	NN	O	approach	ccomp	6	SENT_15	[p1l443t1775r612b1816],
18	for	IN	O	for	_	0	SENT_15	[p1l624t1775r677b1805],
19	patients	NNS	O	patient	prep_for	17	SENT_15	[p1l688t1777r831b1816],
20	who	WP	O	who	nsubj	21	SENT_15	[p1l843t1775r917b1805],
21	have	VBP	O	have	rcmod	17	SENT_15	[p1l929t1775r1013b1805],
22	CF	NN	O	cf	dobj	21	SENT_15	[p1l1026t1777r1080b1805],
23	and	CC	O	and	_	0	SENT_15	[p1l1093t1775r1159b1805],
24	are	VBP	O	be	cop	25	SENT_15	[p1l1171t1787r1229b1805],
25	homozygous	JJ	O	homozygous	ccomp	6	SENT_15	[p1l1241t1775r1464b1816],
26	for	IN	O	for	_	0	SENT_15	[p1l1477t1775r1530b1805],
27	F508del-CF	NN	O	f508del-cf	nn	28	SENT_15	[p1l1540t1775r1753b1805],
28	TR	NN	O	tr	prep_for	25	SENT_15	[p1l1755t1777r1815b1805],
29	.	.	O	.	_	0	SENT_15	[p1l1755t1777r1815b1805],

1	Trial	NN	O	trial	nn	2	SENT_16	[p1l223t1821r307b1851],
2	registry	NN	O	registry	_	0	SENT_16	[p1l319t1822r468b1861],
3	:	:	O	:	_	0	SENT_16	[p1l319t1822r468b1861],
4	ClinicalTrials	NNS	O	clinicaltrial	dep	2	SENT_16	[p1l482t1821r806b1862],
5	.	.	O	.	_	0	SENT_16	[p1l482t1821r806b1862],

1	gov	NN	O	gov	_	0	SENT_17	[p1l482t1821r806b1862],
2	;	:	O	;	_	0	SENT_17	[p1l482t1821r806b1862],
3	No.	NN	O	no.	dep	1	SENT_17	[p1l819t1823r891b1851],
4	:	:	O	:	_	0	SENT_17	[p1l819t1823r891b1851],
5	NCT00953706	NN	O	nct00953706	dep	3	SENT_17	[p1l905t1822r1176b1857],
6	;	:	O	;	_	0	SENT_17	[p1l905t1822r1176b1857],
7	URL	NN	O	url	dep	1	SENT_17	[p1l1189t1823r1283b1851],
8	:	:	O	:	_	0	SENT_17	[p1l1189t1823r1283b1851],
9	wvvw	NN	O	wvvw	dep	7	SENT_17	[p1l1296t1821r1693b1862],
10	.	.	O	.	_	0	SENT_17	[p1l1296t1821r1693b1862],

1	clinicaltrials	NNS	O	clinicaltrial	_	0	SENT_18	[p1l1296t1821r1693b1862],
2	.	.	O	.	_	0	SENT_18	[p1l1296t1821r1693b1862],

1	gov.	NN	O	gov.	_	0	SENT_19	[p1l1296t1821r1693b1862],

1	CHEST	NN	O	chest	_	0	SENT_20	[p1l1430t1869r1565b1897],
2	2012	CD	DATE	2012	num	1	SENT_20	[p1l1576t1869r1674b1903],
3	;	:	O	;	_	0	SENT_20	[p1l1576t1869r1674b1903],
4	142	CD	NUMBER	142	number	5	SENT_20	[p1l1687t1867r1964b1903],
5	(	CD	NUMBER	(	dep	1	SENT_20	[p1l1687t1867r1964b1903],
6	3	CD	NUMBER	3	num	7	SENT_20	[p1l1687t1867r1964b1903],
7	)	NN	O	)	dep	5	SENT_20	[p1l1687t1867r1964b1903],
8	:718	CD	NUMBER	:718	num	9	SENT_20	[p1l1687t1867r1964b1903],
9	—	NN	O	—	dep	5	SENT_20	[p1l1687t1867r1964b1903],
10	724	CD	NUMBER	724	dep	9	SENT_20	[p1l1687t1867r1964b1903],

1	Abbreviations	NNS	O	abbreviation	nsubjpass	44	SENT_21	[p1l221t1957r450b1984],
2	:	:	O	:	_	0	SENT_21	[p1l221t1957r450b1984],
3	ALT	NN	O	alt	dep	1	SENT_21	[p1l466t1960r533b1984],
4	=	JJ	O	=	amod	6	SENT_21	[p1l541t1968r562b1976],
5	alanine	NN	O	alanine	nn	6	SENT_21	[p1l571t1957r671b1984],
6	aminotransferase	NN	O	aminotransferase	dep	3	SENT_21	[p1l686t1957r936b1989],
7	;	:	O	;	_	0	SENT_21	[p1l686t1957r936b1989],
8	AST	NNP	O	AST	dep	3	SENT_21	[p1l952t1959r1015b1984],
9	=	JJ	O	=	amod	11	SENT_21	[p1l1023t1968r1044b1976],
10	aspartate	NN	O	aspartate	nn	11	SENT_21	[p1l1053t1963r1180b1994],
11	aminotransferase	NN	O	aminotransferase	dep	8	SENT_21	[p1l1195t1957r1444b1989],
12	;	:	O	;	_	0	SENT_21	[p1l1195t1957r1444b1989],
13	CF	NN	O	cf	dep	3	SENT_21	[p1l1460t1959r1505b1984],
14	=	JJ	O	=	amod	16	SENT_21	[p1l1514t1968r1535b1976],
15	cystic	JJ	O	cystic	amod	16	SENT_21	[p1l1544t1961r1621b1994],
16	ﬁbrosis	NN	O	ﬁbrosis	dep	13	SENT_21	[p1l1635t1957r1743b1989],
17	;	:	O	;	_	0	SENT_21	[p1l1635t1957r1743b1989],
18	CFTR	NNP	O	CFTR	nn	21	SENT_21	[p1l1758t1959r1850b1984],
19	=	JJ	O	=	amod	21	SENT_21	[p1l1858t1968r1880b1976],
20	cystic	JJ	O	cystic	amod	21	SENT_21	[p1l1888t1961r1966b1994],
21	ﬁbrosis	NN	O	ﬁbrosis	dep	3	SENT_21	[p1l222t1999r324b2026],
22	transmembrane	NN	O	transmembrane	nn	24	SENT_21	[p1l335t1999r564b2026],
23	conductance	NN	O	conductance	nn	24	SENT_21	[p1l575t1999r758b2026],
24	regulator	NN	O	regulator	dep	21	SENT_21	[p1l769t1999r908b2036],
25	;	:	O	;	_	0	SENT_21	[p1l769t1999r908b2036],
26	HBE	NN	O	hbe	dep	3	SENT_21	[p1l920t2001r994b2026],
27	=	JJ	O	=	amod	30	SENT_21	[p1l1005t2009r1026b2018],
28	human	JJ	O	human	amod	30	SENT_21	[p1l1035t1999r1135b2026],
29	bronchial	JJ	O	bronchial	amod	30	SENT_21	[p1l1145t1999r1282b2026],
30	epithelial	NN	O	epithelial	dep	26	SENT_21	[p1l1292t1999r1434b2036],
31	;	:	O	;	_	0	SENT_21	[p1l1292t1999r1434b2036],
32	ULN	NN	O	uln	nn	35	SENT_21	[p1l1446t2001r1520b2026],
33	=	JJ	O	=	amod	35	SENT_21	[p1l1531t2009r1552b2018],
34	upper	JJ	O	upper	amod	35	SENT_21	[p1l1561t2009r1648b2036],
35	limit	NN	O	limit	dep	3	SENT_21	[p1l1657t1999r1724b2026],
36	of	IN	O	of	_	0	SENT_21	[p1l1734t1999r1765b2026],
37	normal	JJ	O	normal	amod	39	SENT_21	[p1l1771t1999r1874b2026],
38	ystic	JJ	O	ystic	amod	39	SENT_21	[p1l157t2244r345b2337],
39	ﬁbrosis	NN	O	ﬁbrosis	prep_of	35	SENT_21	[p1l376t2234r672b2309],
40	(	NN	O	(	nn	42	SENT_21	[p1l709t2234r901b2324],
41	CF	NN	O	cf	nn	42	SENT_21	[p1l709t2234r901b2324],
42	)	NN	O	)	dep	1	SENT_21	[p1l709t2234r901b2324],
43	is	VBZ	O	be	auxpass	44	SENT_21	[p1l936t2244r994b2309],
44	caused	VBN	O	cause	_	0	SENT_21	[p1l1027t2234r1312b2309],
45	by	IN	O	by	_	0	SENT_21	[p1l1340t2234r1440b2337],
46	mutations	NNS	O	mutation	agent	44	SENT_21	[p1l1468t2244r1881b2309],
47	in	IN	O	in	_	0	SENT_21	[p1l1912t2245r1990b2308],
48	the	DT	O	the	det	58	SENT_21	[p1l2020t2234r2151b2309],
49	cystic	JJ	O	cystic	amod	56	SENT_21	[p1l160t2357r378b2450],
50	ﬁbrosis	NN	O	ﬁbrosis	nn	56	SENT_21	[p1l413t2347r694b2422],
51	transmembrane	NN	O	transmembrane	nn	56	SENT_21	[p1l730t2347r1363b2423],
52	conductance	NN	O	conductance	nn	56	SENT_21	[p1l1400t2347r1905b2422],
53	regulator	NN	O	regulator	nn	56	SENT_21	[p1l1941t2374r2150b2450, p1l9t2460r187b2535],
54	(	CD	NUMBER	(	num	56	SENT_21	[p1l218t2460r369b2549],
55	CF	NN	O	cf	nn	56	SENT_21	[p1l218t2460r369b2549],
56	TR	NN	O	tr	nn	58	SENT_21	[p1l372t2460r512b2549],
57	)	NN	O	)	nn	58	SENT_21	[p1l372t2460r512b2549],
58	gene	NN	O	gene	prep_in	46	SENT_21	[p1l548t2487r751b2563],
59	.	.	O	.	_	0	SENT_21	[p1l548t2487r751b2563],

1	The	DT	O	the	nsubj	12	SENT_22	[p1l786t2460r940b2535],
2	encoded	VBN	O	encode	partmod	1	SENT_22	[p1l972t2460r1305b2535],
3	protein	NN	O	protein	dobj	2	SENT_22	[p1l1332t2470r1633b2563],
4	,	,	O	,	_	0	SENT_22	[p1l1332t2470r1633b2563],
5	CF	NN	O	cf	nn	6	SENT_22	[p1l1669t2466r1794b2535],
6	TB	NN	O	tb	appos	1	SENT_22	[p1l1797t2467r1940b2549],
7	,	,	O	,	_	0	SENT_22	[p1l1797t2467r1940b2549],
8	is	VBZ	O	be	cop	12	SENT_22	[p1l1974t2470r2029b2535],
9	an	DT	O	a	det	12	SENT_22	[p1l2062t2489r2152b2535],
10	epithelial	JJ	O	epithelial	amod	12	SENT_22	[p1l10t2572r394b2675],
11	chloride	NN	O	chloride	nn	12	SENT_22	[p1l423t2572r759b2647],
12	channel	NN	O	channel	_	0	SENT_22	[p1l791t2572r1113b2647],
13	that	WDT	O	that	nsubj	14	SENT_22	[p1l1142t2572r1302b2647],
14	maintains	VBZ	O	maintain	rcmod	12	SENT_22	[p1l1332t2582r1726b2647],
15	hydration	NN	O	hydration	dobj	14	SENT_22	[p1l1757t2572r2152b2675],
16	of	IN	O	of	_	0	SENT_22	[p1l10t2685r98b2760],
17	lung	NN	O	lung	nn	18	SENT_22	[p1l124t2685r306b2788],
18	secretions	NNS	O	secretion	prep_of	15	SENT_22	[p1l344t2695r757b2760],
19	by	IN	O	by	_	0	SENT_22	[p1l796t2685r895b2788],
20	regulating	VBG	O	regulate	prepc_by	14	SENT_22	[p1l930t2685r1352b2788],
21	water	NN	O	water	nn	22	SENT_22	[p1l1384t2701r1619b2760],
22	absorption	NN	O	absorption	dobj	20	SENT_22	[p1l1656t2685r2151b2788],
23	}	CD	NUMBER	}	num	26	SENT_22	[p1l1656t2685r2151b2788],
24	Inadequate	NNP	O	Inadequate	nn	26	SENT_22	[p1l11t2797r486b2900],
25	airway	NN	O	airway	nn	26	SENT_22	[p1l522t2807r792b2900],
26	hydration	NN	O	hydration	nsubj	27	SENT_22	[p1l820t2797r1223b2900],
27	results	VBZ	O	result	rcmod	22	SENT_22	[p1l1257t2797r1528b2872],
28	in	IN	O	in	_	0	SENT_22	[p1l1563t2807r1640b2871],
29	obstruction	NN	O	obstruction	prep_in	27	SENT_22	[p1l1674t2797r2152b2872],
30	of	IN	O	of	_	0	SENT_22	[p1l9t2909r97b2984],
31	the	DT	O	the	det	32	SENT_22	[p1l123t2909r252b2984],
32	airways	NNS	O	airway	prep_of	29	SENT_22	[p1l292t2919r588b3012],
33	with	IN	O	with	_	0	SENT_22	[p1l625t2909r805b2984],
34	thick	JJ	O	thick	amod	35	SENT_22	[p1l841t2908r1046b2984],
35	mucus	NN	O	mucus	prep_with	27	SENT_22	[p1l1082t2938r1370b2998],
36	,	,	O	,	_	0	SENT_22	[p1l1082t2938r1370b2998],
37	rendering	VBG	O	render	dep	20	SENT_22	[p1l1412t2909r1817b3012],
38	the	DT	O	the	det	39	SENT_22	[p1l1852t2909r1981b2984],
39	airways	NNS	O	airway	nsubj	40	SENT_22	[p1l2021t2919r2150b2984, p1l6t3050r198b3124],
40	Vulnerable	JJ	O	vulnerable	xcomp	37	SENT_22	[p1l231t3021r667b3096],
41	to	TO	O	to	_	0	SENT_22	[p1l702t3037r779b3096],
42	chronic	JJ	O	chronic	amod	43	SENT_22	[p1l815t3021r1121b3096],
43	infection	NN	O	infection	prep_to	40	SENT_22	[p1l1155t3021r1520b3096],
44	and	CC	O	and	_	0	SENT_22	[p1l1555t3021r1703b3096],
45	inﬂammation	NN	O	inﬂammation	conj_and	43	SENT_22	[p1l1735t3020r2150b3096, p1l8t3143r189b3222],
46	,	,	O	,	_	0	SENT_22	[p1l1735t3020r2150b3096, p1l8t3143r189b3222],
47	leading	VBG	O	lead	dep	20	SENT_22	[p1l233t3133r534b3236],
48	to	TO	O	to	_	0	SENT_22	[p1l571t3149r649b3208],
49	irreversible	JJ	O	irreversible	amod	51	SENT_22	[p1l689t3133r1158b3209],
50	structural	JJ	O	structural	amod	51	SENT_22	[p1l1201t3133r1597b3208],
51	changes	NNS	O	change	prep_to	20	SENT_22	[p1l1637t3133r1961b3236],
52	and	CC	O	and	_	0	SENT_22	[p1l2005t3133r2153b3208],
53	respiratory	JJ	O	respiratory	amod	54	SENT_22	[p1l10t3256r450b3349],
54	failure	NN	O	failure	prep_to	20	SENT_22	[p1l475t3246r753b3321],
55	.	.	O	.	_	0	SENT_22	[p1l475t3246r753b3321],

1	CF	NN	O	cf	_	0	SENT_23	[p1l104t3364r233b3433],
2	—	CD	NUMBER	—	num	1	SENT_23	[p1l243t3368r589b3461],
3	causing	VBG	O	cause	partmod	1	SENT_23	[p1l243t3368r589b3461],
4	CF	NN	O	cf	nn	5	SENT_23	[p1l618t3364r744b3433],
5	T	NN	O	t	dobj	3	SENT_23	[p1l750t3364r807b3433],
6	R	NN	O	r	nn	7	SENT_23	[p1l806t3365r868b3433],
7	mutations	NNS	O	mutation	nsubj	8	SENT_23	[p1l899t3368r1311b3433],
8	cause	VBP	O	cause	rcmod	5	SENT_23	[p1l1343t3387r1569b3433],
9	either	CC	O	either	dep	8	SENT_23	[p1l1600t3358r1849b3433],
10	diminished	VBN	O	diminish	conj	8	SENT_23	[p1l1876t3358r2150b3433, p1l8t3470r222b3545],
11	or	CC	O	or	_	0	SENT_23	[p1l254t3499r337b3545],
12	defective	JJ	O	defective	amod	15	SENT_23	[p1l369t3470r733b3545],
13	CF	NN	O	cf	nn	15	SENT_23	[p1l768t3476r895b3545],
14	TR	NN	O	tr	nn	15	SENT_23	[p1l900t3477r1027b3544],
15	protein	NN	O	protein	dobj	3	SENT_23	[p1l1057t3480r1351b3573],
16	in	IN	O	in	_	0	SENT_23	[p1l1383t3480r1458b3544],
17	the	DT	O	the	det	19	SENT_23	[p1l1490t3470r1616b3545],
18	apical	JJ	O	apical	amod	19	SENT_23	[p1l1652t3470r1883b3573],
19	membrane	NN	O	membrane	prep_in	15	SENT_23	[p1l1916t3499r2150b3545, p1l7t3582r275b3671],
20	,	,	O	,	_	0	SENT_23	[p1l1916t3499r2150b3545, p1l7t3582r275b3671],
21	resulting	VBG	O	result	dobj	3	SENT_23	[p1l317t3582r694b3685],
22	in	IN	O	in	_	0	SENT_23	[p1l729t3592r808b3656],
23	decreased	VBN	O	decrease	amod	25	SENT_23	[p1l847t3582r1276b3657],
24	chloride	NN	O	chloride	nn	25	SENT_23	[p1l1313t3582r1662b3657],
25	transport	NN	O	transport	prep_in	21	SENT_23	[p1l1701t3591r2152b3685],
26	?	.	O	?	_	0	SENT_23	[p1l1701t3591r2152b3685],

1	718	CD	NUMBER	718	nsubj	26	SENT_24	[p2l10t74r132b129],
2	The	DT	O	the	det	7	SENT_24	[p2l6t166r167b241],
3	most	RBS	O	most	advmod	4	SENT_24	[p2l218t182r417b241],
4	prevalent	JJ	O	prevalent	amod	7	SENT_24	[p2l461t166r857b269],
5	disease-causing	JJ	O	disease-causing	amod	7	SENT_24	[p2l904t166r1554b269],
6	CFTR	NN	O	cftr	nn	7	SENT_24	[p2l1601t172r1851b241],
7	mutation	NN	O	mutation	nsubj	8	SENT_24	[p2l1899t182r2141b241, p2l6t288r167b353],
8	is	VBZ	O	be	rcmod	1	SENT_24	[p2l210t288r268b353],
9	F508del	NN	O	f508del	nn	12	SENT_24	[p2l315t277r659b353],
10	(	CD	NUMBER	(	num	12	SENT_24	[p2l705t278r1737b367],
11	c.	NN	O	c.	nn	12	SENT_24	[p2l705t278r1737b367],
12	1521_1523delCTT	NN	O	1521_1523delctt	dep	18	SENT_24	[p2l705t278r1737b367],
13	)	CD	NUMBER	)	dep	12	SENT_24	[p2l705t278r1737b367],
14	.3	NN	NUMBER	.3	dep	18	SENT_24	[p2l705t278r1737b367],
15	-5	CD	NUMBER	-5	num	14	SENT_24	[p2l705t278r1737b367],
16	Approximately	RB	O	approximately	quantmod	17	SENT_24	[p2l1778t285r2141b381, p2l8t390r269b493],
17	90	CD	PERCENT	90	num	18	SENT_24	[p2l290t396r458b465],
18	%	NN	PERCENT	%	dep	8	SENT_24	[p2l290t396r458b465],
19	of	IN	O	of	_	0	SENT_24	[p2l488t390r572b465],
20	patients	NNS	O	patient	prep_of	18	SENT_24	[p2l585t400r887b493],
21	with	IN	O	with	_	0	SENT_24	[p2l911t390r1082b465],
22	CF	NN	O	cf	prep_with	8	SENT_24	[p2l1108t396r1232b465],
23	in	IN	O	in	_	0	SENT_24	[p2l1258t400r1331b464],
24	North	NNP	LOCATION	North	nn	25	SENT_24	[p2l1359t390r1590b465],
25	America	NNP	LOCATION	America	prep_in	22	SENT_24	[p2l1613t396r1943b465],
26	have	VBP	O	have	_	0	SENT_24	[p2l1964t390r2142b465],
27	F	NN	O	f	nn	28	SENT_24	[p2l8t509r65b576],
28	508del	NN	O	508del	dobj	26	SENT_24	[p2l72t502r353b577],
29	on	IN	O	on	_	0	SENT_24	[p2l388t531r487b577],
30	at	IN	O	at	quantmod	32	SENT_24	[p2l524t518r597b577],
31	least	JJS	O	least	mwe	30	SENT_24	[p2l630t502r821b577],
32	one	CD	NUMBER	one	num	33	SENT_24	[p2l855t531r1002b577],
33	allele	NN	O	allele	prep_on	28	SENT_24	[p2l1040t502r1283b591],
34	,	,	O	,	_	0	SENT_24	[p2l1040t502r1283b591],
35	and	CC	O	and	_	0	SENT_24	[p2l1323t502r1473b577],
36	nearly	RB	O	nearly	quantmod	38	SENT_24	[p2l1506t502r1766b605],
37	one	CD	NUMBER	one	number	38	SENT_24	[p2l1798t502r2153b577],
38	—	CD	NUMBER	—	num	39	SENT_24	[p2l1798t502r2153b577],
39	half	NN	O	half	nsubj	41	SENT_24	[p2l1798t502r2153b577],
40	are	VBP	O	be	cop	41	SENT_24	[p2l8t643r133b689],
41	homozygousf	NN	O	homozygousf	conj_and	26	SENT_24	[p2l168t614r701b717],
42	‘	CD	NUMBER	‘	num	41	SENT_24	[p2l168t614r701b717],
43	The	DT	O	the	det	47	SENT_24	[p2l727t614r881b689],
44	F	NN	O	f	nn	47	SENT_24	[p2l908t621r966b688],
45	508del-CF	NN	O	508del-cf	nn	47	SENT_24	[p2l965t614r1377b689],
46	TR	NN	O	tr	nn	47	SENT_24	[p2l1379t621r1493b689],
47	mutation	NN	O	mutation	nsubj	48	SENT_24	[p2l1521t624r1869b689],
48	causes	VBZ	O	cause	rcmod	41	SENT_24	[p2l1897t643r2141b689],
49	improper	JJ	O	improper	amod	50	SENT_24	[p2l6t737r400b830],
50	protein	NN	O	protein	nsubj	73	SENT_24	[p2l440t738r744b830],
51	folding	JJ	O	folding	amod	50	SENT_24	[p2l789t727r1103b830],
52	,	,	O	,	_	0	SENT_24	[p2l789t727r1103b830],
53	resulting	VBG	O	result	partmod	50	SENT_24	[p2l1151t727r1520b830],
54	in	IN	O	in	_	0	SENT_24	[p2l1560t737r1637b801],
55	little	JJ	O	little	prep_in	53	SENT_24	[p2l1681t727r1871b802],
56	or	CC	O	or	_	0	SENT_24	[p2l1917t756r2002b802],
57	no	DT	O	no	det	59	SENT_24	[p2l2043t756r2142b802],
58	CFTR	NN	O	cftr	nn	59	SENT_24	[p2l8t845r269b914],
59	protein	NN	O	protein	prep_in	53	SENT_24	[p2l302t849r601b942],
60	reaching	VBG	O	reach	xcomp	53	SENT_24	[p2l637t839r991b942],
61	the	DT	O	the	det	64	SENT_24	[p2l1023t839r1152b914],
62	cell	NN	O	cell	nn	64	SENT_24	[p2l1189t839r1330b914],
63	surface	NN	O	surface	nn	64	SENT_24	[p2l1365t839r1757b914],
64	.7	NN	NUMBER	.7	nsubj	65	SENT_24	[p2l1365t839r1757b914],
65	=	JJ	O	=	xcomp	60	SENT_24	[p2l1365t839r1757b914],
66	8	CD	NUMBER	8	num	68	SENT_24	[p2l1365t839r1757b914],
67	F	NN	O	f	nn	68	SENT_24	[p2l1793t846r1850b913],
68	urther	NN	O	urther	tmod	60	SENT_24	[p2l1857t839r2141b914],
69	—	CD	NUMBER	—	npadvmod	70	SENT_24	[p2l1857t839r2141b914],
70	more	JJR	O	more	advmod	68	SENT_24	[p2l8t980r237b1040],
71	,	,	O	,	_	0	SENT_24	[p2l8t980r237b1040],
72	any	DT	O	any	det	73	SENT_24	[p2l281t980r420b1054],
73	F508del	NN	O	f508del	xcomp	48	SENT_24	[p2l457t950r1084b1026],
74	.	.	O	.	_	0	SENT_24	[p2l457t950r1084b1026],

1	—	NN	O	—	_	0	SENT_25	[p2l457t950r1084b1026],
2	.	.	O	.	_	0	SENT_25	[p2l457t950r1084b1026],

1	CFTR	NNP	ORGANIZATION	CFTR	nn	2	SENT_26	[p2l457t950r1084b1026],
2	protein	NN	O	protein	nsubj	9	SENT_26	[p2l1122t961r1415b1054],
3	reaching	VBG	O	reach	partmod	2	SENT_26	[p2l1454t951r1802b1054],
4	the	DT	O	the	det	6	SENT_26	[p2l1838t951r1964b1026],
5	cell	NN	O	cell	nn	6	SENT_26	[p2l2005t951r2144b1026],
6	surface	NN	O	surface	dobj	3	SENT_26	[p2l8t1063r305b1138],
7	may	MD	O	may	aux	9	SENT_26	[p2l344t1092r515b1166],
8	also	RB	O	also	advmod	9	SENT_26	[p2l549t1063r703b1138],
9	have	VB	O	have	_	0	SENT_26	[p2l740t1063r929b1138],
10	a	DT	O	a	det	11	SENT_26	[p2l969t1092r1010b1138],
11	defect	NN	O	defect	dobj	9	SENT_26	[p2l1045t1063r1305b1138],
12	in	IN	O	in	_	0	SENT_26	[p2l1339t1073r1416b1137],
13	the	DT	O	the	det	14	SENT_26	[p2l1452t1063r1582b1138],
14	opening	NN	O	opening	prep_in	11	SENT_26	[p2l1621t1073r1959b1166],
15	and	CC	O	and	_	0	SENT_26	[p2l1995t1063r2144b1138],
16	closing	NN	O	closing	conj_and	14	SENT_26	[p2l7t1175r285b1278],
17	of	IN	O	of	_	0	SENT_26	[p2l313t1175r399b1250],
18	the	DT	O	the	det	19	SENT_26	[p2l417t1175r543b1250],
19	channel	NN	O	channel	prep_of	14	SENT_26	[p2l574t1175r909b1264],
20	,	,	O	,	_	0	SENT_26	[p2l574t1175r909b1264],
21	known	VBN	O	know	partmod	19	SENT_26	[p2l941t1175r1208b1250],
22	as	IN	O	as	_	0	SENT_26	[p2l1238t1204r1310b1250],
23	a	DT	O	a	det	26	SENT_26	[p2l1343t1204r1384b1250],
24	gating	VBG	O	gate	amod	26	SENT_26	[p2l1410t1186r1655b1278],
25	defect	NN	O	defect	nn	26	SENT_26	[p2l1684t1174r1986b1250],
26	.9	NN	NUMBER	.9	prep_as	21	SENT_26	[p2l1684t1174r1986b1250],

1	Compounds	NNS	O	compound	nsubj	14	SENT_27	[p2l102t1286r599b1390],
2	designed	VBN	O	design	partmod	1	SENT_27	[p2l638t1287r1004b1390],
3	to	TO	O	to	aux	4	SENT_27	[p2l1038t1303r1115b1362],
4	increase	VB	O	increase	xcomp	2	SENT_27	[p2l1151t1297r1487b1362],
5	CFTR	NNP	O	CFTR	nn	7	SENT_27	[p2l1525t1293r1786b1362],
6	channel	NN	O	channel	nn	7	SENT_27	[p2l1823t1287r2144b1362],
7	opening	NN	O	opening	dobj	4	SENT_27	[p2l7t1410r352b1503],
8	,	,	O	,	_	0	SENT_27	[p2l7t1410r352b1503],
9	CF	NN	O	cf	nn	11	SENT_27	[p2l389t1406r516b1475],
10	TR	NN	O	tr	nn	11	SENT_27	[p2l520t1407r647b1474],
11	potentiators	NNS	O	potentiator	appos	7	SENT_27	[p2l677t1410r1182b1503],
12	,	,	O	,	_	0	SENT_27	[p2l677t1410r1182b1503],
13	can	MD	O	can	aux	14	SENT_27	[p2l1219t1429r1355b1475],
14	prevent	VB	O	prevent	_	0	SENT_27	[p2l1385t1416r1697b1503],
15	the	DT	O	the	det	16	SENT_27	[p2l1726t1400r1852b1475],
16	hyperabsorption	NN	O	hyperabsorption	dobj	14	SENT_27	[p2l1885t1400r2141b1503, p2l8t1512r451b1615],
17	of	IN	O	of	_	0	SENT_27	[p2l494t1512r582b1587],
18	water	NN	O	water	prep_of	16	SENT_27	[p2l610t1528r846b1587],
19	across	IN	O	across	_	0	SENT_27	[p2l887t1541r1135b1587],
20	the	DT	O	the	det	23	SENT_27	[p2l1179t1512r1309b1587],
21	epithelial	JJ	O	epithelial	amod	23	SENT_27	[p2l1354t1512r1744b1615],
22	surface	NN	O	surface	nn	23	SENT_27	[p2l1788t1512r2143b1587],
23	.9	NN	NUMBER	.9	prep_across	14	SENT_27	[p2l1788t1512r2143b1587],

1	Original	NNP	O	Original	nn	2	SENT_28	[p2l1628t1755r1847b1817],
2	Research	NNP	O	Research	_	0	SENT_28	[p2l1874t1756r2141b1804],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_29	[p2l302t1893r479b1917],
2	From	IN	O	from	dep	1	SENT_29	[p2l488t1893r576b1917],
3	:	:	O	:	_	0	SENT_29	[p2l488t1893r576b1917],
4	http://journal.puhlications.chestnet.org/	NN	O	http://journal.puhlications.chestnet.org/	dep	1	SENT_29	[p2l587t1892r1156b1923],
5	by	IN	O	by	dep	4	SENT_29	[p2l1163t1893r1198b1923],
6	a	DT	O	a	det	10	SENT_29	[p2l1207t1900r1223b1916],
7	University	NNP	ORGANIZATION	University	dep	10	SENT_29	[p2l1232t1892r1379b1923],
8	of	IN	ORGANIZATION	of	_	0	SENT_29	[p2l1389t1892r1418b1916],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_29	[p2l1425t1892r1570b1917],
10	User	NN	ORGANIZATION	user	pobj	5	SENT_29	[p2l1579t1893r1645b1917],
11	on	IN	O	on	_	0	SENT_29	[p2l1663t1900r1697b1916],
12	01/05/2014	CD	DATE	01/05/2014	prep_on	10	SENT_29	[p2l1706t1892r1857b1917],

1	Ivacaftor	NNP	O	Ivacaftor	dep	110	SENT_30	[p2l12t2092r385b2167],
2	is	VBZ	O	be	dep	110	SENT_30	[p2l418t2103r475b2167],
3	a	DT	O	a	dep	110	SENT_30	[p2l515t2122r555b2167],
4	CF	NN	O	cf	dep	110	SENT_30	[p2l590t2099r718b2167],
5	TR	NN	O	tr	dep	110	SENT_30	[p2l725t2099r853b2166],
6	potentiator	NN	O	potentiator	dep	110	SENT_30	[p2l887t2103r1356b2194],
7	shown	VBN	O	show	dep	110	SENT_30	[p2l1391t2092r1652b2167],
8	to	TO	O	to	dep	110	SENT_30	[p2l1687t2108r1765b2167],
9	increase	VB	O	increase	dep	110	SENT_30	[p2l1800t2103r2143b2167],
10	chloride	NN	O	chloride	dep	110	SENT_30	[p2l11t2203r325b2278],
11	transport	NN	O	transport	dep	110	SENT_30	[p2l361t2219r714b2305],
12	by	IN	O	by	dep	110	SENT_30	[p2l747t2203r843b2305],
13	activated	VBN	O	activate	dep	110	SENT_30	[p2l876t2203r1219b2278],
14	CFTR	NN	ORGANIZATION	cftr	dep	110	SENT_30	[p2l1255t2210r1506b2278],
15	channels	NNS	O	channel	dep	110	SENT_30	[p2l1543t2203r1877b2278],
16	at	IN	O	at	dep	110	SENT_30	[p2l1917t2219r1986b2278],
17	the	DT	O	the	dep	110	SENT_30	[p2l2020t2203r2143b2278],
18	cell	NN	O	cell	dep	110	SENT_30	[p2l11t2315r149b2390],
19	surface	NN	O	surface	dep	110	SENT_30	[p2l177t2315r462b2390],
20	in	FW	O	in	dep	110	SENT_30	[p2l490t2326r565b2389],
21	vitro	FW	O	vitro	dep	110	SENT_30	[p2l589t2324r857b2390],
22	.10	CD	NUMBER	.10	dep	110	SENT_30	[p2l589t2324r857b2390],
23	G551	NN	O	g551	dep	110	SENT_30	[p2l886t2319r1092b2390],
24	D-C	NN	O	d-c	dep	110	SENT_30	[p2l1104t2322r1276b2390],
25	F	NN	O	f	dep	110	SENT_30	[p2l1282t2322r1339b2389],
26	TR	NN	O	tr	dep	110	SENT_30	[p2l1344t2322r1460b2390],
27	(	CD	NUMBER	(	dep	110	SENT_30	[p2l1491t2315r1855b2404],
28	c.	NN	O	c.	dep	110	SENT_30	[p2l1491t2315r1855b2404],
29	1652G	NN	O	1652g	dep	110	SENT_30	[p2l1491t2315r1855b2404],
30	>	JJR	O	>	dep	110	SENT_30	[p2l1878t2328r1944b2385],
31	A	DT	O	a	dep	110	SENT_30	[p2l1965t2315r2054b2404],
32	)	NN	O	)	dep	110	SENT_30	[p2l1965t2315r2054b2404],
33	is	VBZ	O	be	dep	110	SENT_30	[p2l2085t2326r2142b2390],
34	the	DT	O	the	dep	110	SENT_30	[p2l10t2426r132b2501],
35	most	RBS	O	most	dep	110	SENT_30	[p2l166t2442r353b2501],
36	common	JJ	O	common	dep	110	SENT_30	[p2l383t2456r724b2501],
37	gating	NN	O	gating	dep	110	SENT_30	[p2l756t2437r991b2528],
38	mutation	NN	O	mutation	dep	110	SENT_30	[p2l1021t2437r1369b2501],
39	associated	VBN	O	associate	dep	110	SENT_30	[p2l1401t2426r1790b2501],
40	with	IN	O	with	dep	110	SENT_30	[p2l1815t2426r1986b2501],
41	CF	NN	O	cf	dep	110	SENT_30	[p2l2018t2433r2143b2501],
42	disease	NN	O	disease	dep	110	SENT_30	[p2l11t2538r317b2626],
43	,	,	O	,	_	0	SENT_30	[p2l11t2538r317b2626],
44	having	VBG	O	have	dep	110	SENT_30	[p2l357t2538r621b2640],
45	an	DT	O	a	dep	110	SENT_30	[p2l658t2568r749b2613],
46	allelic	JJ	O	allelic	dep	110	SENT_30	[p2l787t2538r1019b2613],
47	frequency	NN	O	frequency	dep	110	SENT_30	[p2l1056t2538r1464b2640],
48	of	IN	O	of	dep	110	SENT_30	[p2l1498t2538r1584b2613],
49	only	RB	O	only	dep	110	SENT_30	[p2l1611t2538r1782b2640],
50	approximately	RB	O	approximately	dep	110	SENT_30	[p2l1816t2549r2142b2640, p2l12t2649r277b2751],
51	2.2	CD	PERCENT	2.2	dep	110	SENT_30	[p2l305t2656r582b2723],
52	%	NN	PERCENT	%	dep	110	SENT_30	[p2l305t2656r582b2723],
53	.11	CD	NUMBER	.11	dep	110	SENT_30	[p2l305t2656r582b2723],
54	Ivacaftor	NNP	O	Ivacaftor	dep	110	SENT_30	[p2l618t2649r968b2724],
55	was	VBD	O	be	dep	110	SENT_30	[p2l995t2679r1138b2724],
56	tested	VBN	O	test	dep	110	SENT_30	[p2l1173t2649r1411b2724],
57	for	IN	O	for	dep	110	SENT_30	[p2l1443t2649r1556b2724],
58	up	RB	DURATION	up	dep	110	SENT_30	[p2l1586t2679r1686b2751],
59	to	TO	DURATION	to	dep	110	SENT_30	[p2l1719t2665r1794b2724],
60	4	CD	DURATION	4	dep	110	SENT_30	[p2l1827t2656r1873b2723],
61	weeks	NNS	NUMBER	week	dep	110	SENT_30	[p2l1903t2649r2142b2724],
62	in	IN	O	in	dep	110	SENT_30	[p2l9t2771r85b2833],
63	a	DT	O	a	dep	110	SENT_30	[p2l122t2790r162b2835],
64	small	JJ	O	small	dep	110	SENT_30	[p2l197t2760r403b2835],
65	number	NN	O	number	dep	110	SENT_30	[p2l438t2760r759b2835],
66	of	IN	O	of	dep	110	SENT_30	[p2l793t2760r879b2835],
67	subjects	NNS	O	subject	dep	110	SENT_30	[p2l906t2760r1224b2862],
68	with	IN	O	with	dep	110	SENT_30	[p2l1258t2760r1435b2835],
69	CF	NN	O	cf	dep	110	SENT_30	[p2l1471t2767r1598b2835],
70	who	WP	O	who	dep	110	SENT_30	[p2l1631t2760r1800b2835],
71	had	VBD	O	have	dep	110	SENT_30	[p2l1835t2760r1983b2835],
72	the	DT	O	the	dep	110	SENT_30	[p2l2017t2760r2143b2835],
73	G551D-CFTR	NN	O	g551d-cftr	dep	110	SENT_30	[p2l12t2875r577b2946],
74	mutation	NN	O	mutation	dep	110	SENT_30	[p2l610t2882r964b2946],
75	on	IN	O	on	dep	110	SENT_30	[p2l996t2901r1093b2946],
76	at	IN	O	at	dep	110	SENT_30	[p2l1125t2887r1195b2946],
77	least	JJS	O	least	dep	110	SENT_30	[p2l1225t2871r1403b2946],
78	one	CD	NUMBER	one	dep	110	SENT_30	[p2l1434t2901r1575b2946],
79	C	NN	O	c	dep	110	SENT_30	[p2l1610t2878r1670b2946],
80	F	NN	O	f	dep	110	SENT_30	[p2l1675t2878r1732b2945],
81	TR	NN	O	tr	dep	110	SENT_30	[p2l1736t2878r1851b2945],
82	allele	NN	O	allele	dep	110	SENT_30	[p2l1884t2871r2144b2946],
83	”	NN	O	”	dep	110	SENT_30	[p2l1884t2871r2144b2946],
84	and	CC	O	and	dep	110	SENT_30	[p2l11t2982r161b3057],
85	has	VBZ	O	have	dep	110	SENT_30	[p2l188t2982r320b3057],
86	been	VBN	O	be	dep	110	SENT_30	[p2l350t2982r554b3057],
87	approved	VBN	O	approve	dep	110	SENT_30	[p2l585t2982r974b3084],
88	in	IN	O	in	dep	110	SENT_30	[p2l1002t2993r1079b3055],
89	the	DT	O	the	dep	110	SENT_30	[p2l1108t2982r1238b3057],
90	United	NNP	LOCATION	United	dep	110	SENT_30	[p2l1271t2982r1561b3057],
91	States	NNPS	LOCATION	States	dep	110	SENT_30	[p2l1593t2989r1835b3057],
92	for	IN	O	for	dep	110	SENT_30	[p2l1867t2982r1985b3057],
93	the	DT	O	the	dep	110	SENT_30	[p2l2012t2982r2143b3057],
94	treatment	NN	O	treatment	dep	110	SENT_30	[p2l9t3109r409b3168],
95	of	IN	O	of	dep	110	SENT_30	[p2l438t3093r524b3168],
96	CF	NN	O	cf	dep	110	SENT_30	[p2l544t3100r671b3168],
97	in	IN	O	in	dep	110	SENT_30	[p2l701t3104r776b3166],
98	patients	NNS	O	patient	dep	110	SENT_30	[p2l805t3104r1120b3195],
99	who	WP	O	who	dep	110	SENT_30	[p2l1149t3093r1317b3168],
100	are	VBP	O	be	dep	110	SENT_30	[p2l1349t3123r1470b3168],
101	2	CD	NUMBER	2	dep	110	SENT_30	[p2l1507t3108r1573b3159],
102	6	CD	DURATION	6	dep	110	SENT_30	[p2l1596t3100r1640b3167],
103	years	NNS	NUMBER	year	dep	110	SENT_30	[p2l1668t3123r1872b3195],
104	of	IN	O	of	dep	110	SENT_30	[p2l1904t3093r1990b3168],
105	age	NN	O	age	dep	110	SENT_30	[p2l2011t3120r2143b3195],
106	and	CC	O	and	dep	110	SENT_30	[p2l11t3204r157b3279],
107	have	VBP	O	have	dep	110	SENT_30	[p2l184t3204r366b3279],
108	a	DT	O	a	dep	110	SENT_30	[p2l398t3234r438b3279],
109	G551D	NN	O	g551d	dep	110	SENT_30	[p2l468t3207r760b3279],
110	mutation	NN	O	mutation	_	0	SENT_30	[p2l793t3215r1174b3279],
111	.	.	O	.	_	0	SENT_30	[p2l793t3215r1174b3279],

1	This	DT	O	this	det	2	SENT_31	[p3l103t25r280b100],
2	study	NN	O	study	nsubj	3	SENT_31	[p3l315t25r538b127],
3	aimed	VBN	O	aim	_	0	SENT_31	[p3l566t25r820b100],
4	to	TO	O	to	aux	5	SENT_31	[p3l849t41r926b100],
5	evaluate	VB	O	evaluate	xcomp	3	SENT_31	[p3l959t25r1301b100],
6	the	DT	O	the	det	8	SENT_31	[p3l1333t25r1463b100],
7	safety	NN	O	safety	nn	8	SENT_31	[p3l1497t25r1738b127],
8	proﬁle	NN	O	proﬁle	dobj	5	SENT_31	[p3l1763t25r2034b127],
9	of	IN	O	of	_	0	SENT_31	[p3l2066t25r2154b100],
10	ivacaftor	NN	O	ivacaftor	prep_of	8	SENT_31	[p3l9t136r341b211],
11	in	IN	O	in	_	0	SENT_31	[p3l369t147r442b209],
12	a	DT	O	a	det	15	SENT_31	[p3l474t166r515b211],
13	larger	JJR	O	larger	amod	15	SENT_31	[p3l543t136r769b238],
14	CF	NN	O	cf	nn	15	SENT_31	[p3l799t143r923b211],
15	population	NN	O	population	prep_in	5	SENT_31	[p3l954t136r1370b238],
16	(	CD	NUMBER	(	num	19	SENT_31	[p3l1405t136r1517b225],
17	ie	FW	O	ie	nn	19	SENT_31	[p3l1405t136r1517b225],
18	,	,	O	,	_	0	SENT_31	[p3l1405t136r1517b225],
19	subjects	NNS	O	subject	dep	15	SENT_31	[p3l1554t136r1858b238],
20	homozygous	JJ	O	homozygous	amod	19	SENT_31	[p3l1891t136r2142b211, p3l10t274r265b349],
21	for	IN	O	for	_	0	SENT_31	[p3l305t247r416b322],
22	the	DT	O	the	det	27	SENT_31	[p3l450t247r573b322],
23	F	NN	O	f	nn	27	SENT_31	[p3l610t254r668b321],
24	508del-CF	NN	O	508del-cf	nn	27	SENT_31	[p3l667t247r1078b322],
25	TR	NN	O	tr	nn	27	SENT_31	[p3l1081t254r1195b321],
26	mutation	NN	O	mutation	nn	27	SENT_31	[p3l1233t247r1629b336],
27	)	NN	O	)	prep_for	20	SENT_31	[p3l1233t247r1629b336],
28	.	.	O	.	_	0	SENT_31	[p3l1233t247r1629b336],

1	This	DT	O	this	det	3	SENT_32	[p3l1670t247r1836b322],
2	patient	NN	O	patient	nn	3	SENT_32	[p3l1874t258r2145b349],
3	population	NN	O	population	nsubjpass	5	SENT_32	[p3l8t357r435b459],
4	was	VBD	O	be	auxpass	5	SENT_32	[p3l467t387r610b432],
5	chosen	VBN	O	choose	_	0	SENT_32	[p3l649t357r923b432],
6	(	NN	O	(	nn	8	SENT_32	[p3l963t357r1063b446],
7	1	CD	NUMBER	1	num	8	SENT_32	[p3l963t357r1063b446],
8	)	NN	O	)	dobj	5	SENT_32	[p3l963t357r1063b446],
9	because	IN	O	because	mark	16	SENT_32	[p3l1102t357r1417b432],
10	F508del-CFTR	NN	O	f508del-cftr	nsubj	16	SENT_32	[p3l1454t357r2051b432],
11	is	VBZ	O	be	cop	16	SENT_32	[p3l2086t368r2142b432],
12	the	DT	O	the	det	16	SENT_32	[p3l9t469r133b544],
13	most	RBS	O	most	advmod	14	SENT_32	[p3l169t485r358b544],
14	common	JJ	O	common	amod	16	SENT_32	[p3l391t499r734b544],
15	CF	NN	O	cf	nn	16	SENT_32	[p3l769t476r894b544],
16	—	NN	O	—	advcl	5	SENT_32	[p3l900t480r1221b571],
17	causing	VBG	O	cause	partmod	16	SENT_32	[p3l900t480r1221b571],
18	mutation	NN	O	mutation	dobj	17	SENT_32	[p3l1254t480r1624b557],
19	,	,	O	,	_	0	SENT_32	[p3l1254t480r1624b557],
20	and	CC	O	and	_	0	SENT_32	[p3l1663t469r1805b544],
21	patients	NNS	O	patient	nsubj	27	SENT_32	[p3l1836t480r2142b571],
22	with	IN	O	with	_	0	SENT_32	[p3l7t580r183b655],
23	F508del	NN	O	f508del	prep_with	21	SENT_32	[p3l219t580r551b655],
24	on	IN	O	on	_	0	SENT_32	[p3l585t610r682b655],
25	both	DT	O	both	det	26	SENT_32	[p3l715t580r898b655],
26	alleles	NNS	O	allele	prep_on	23	SENT_32	[p3l934t580r1177b655],
27	account	VBP	O	account	conj_and	5	SENT_32	[p3l1215t596r1528b655],
28	for	IN	O	for	_	0	SENT_32	[p3l1562t580r1676b655],
29	about	RB	O	about	quantmod	30	SENT_32	[p3l1709t580r1935b655],
30	50	CD	PERCENT	50	num	31	SENT_32	[p3l1967t583r2140b654],
31	%	NN	PERCENT	%	prep_for	27	SENT_32	[p3l1967t583r2140b654],

1	of	IN	O	of	_	0	SENT_33	[p3l11t691r98b766],
2	the	DT	O	the	det	3	SENT_33	[p3l125t691r253b766],
3	population	NN	O	population	prep_of	19	SENT_33	[p3l291t691r733b793],
4	with	IN	O	with	_	0	SENT_33	[p3l767t691r946b766],
5	CF	NN	O	cf	prep_with	3	SENT_33	[p3l985t698r1136b779],
6	;	:	O	;	_	0	SENT_33	[p3l985t698r1136b779],
7	(	CD	NUMBER	(	number	8	SENT_33	[p3l1182t691r1286b780],
8	2	CD	NUMBER	2	num	9	SENT_33	[p3l1182t691r1286b780],
9	)	NN	O	)	dep	5	SENT_33	[p3l1182t691r1286b780],
10	to	TO	O	to	aux	11	SENT_33	[p3l1327t707r1404b766],
11	explore	VB	O	explore	infmod	3	SENT_33	[p3l1444t691r1742b793],
12	potential	JJ	O	potential	amod	13	SENT_33	[p3l1779t691r2145b793],
13	efficacy	NN	O	efficacy	dobj	11	SENT_33	[p3l11t801r316b903],
14	because	IN	O	because	mark	16	SENT_33	[p3l346t801r666b876],
15	in	FW	O	in	nn	16	SENT_33	[p3l701t812r777b874],
16	vitro	FW	O	vitro	advcl	11	SENT_33	[p3l808t812r993b876],
17	studies	NNS	O	study	nsubj	19	SENT_33	[p3l1030t801r1304b876],
18	have	VBP	O	have	aux	19	SENT_33	[p3l1340t801r1523b876],
19	suggested	VBN	O	suggest	_	0	SENT_33	[p3l1561t801r1956b903],
20	that	IN	O	that	_	0	SENT_33	[p3l1989t801r2145b876],
21	a	DT	O	a	det	23	SENT_33	[p3l11t943r52b988],
22	small	JJ	O	small	amod	23	SENT_33	[p3l95t913r310b988],
23	amount	NN	O	amount	prep_that	19	SENT_33	[p3l355t929r670b988],
24	of	IN	O	of	_	0	SENT_33	[p3l714t913r802b988],
25	F508del	NN	O	f508del	prep_of	23	SENT_33	[p3l837t913r1486b988],
26	.	.	O	.	_	0	SENT_33	[p3l837t913r1486b988],

1	—	NN	O	—	_	0	SENT_34	[p3l837t913r1486b988],
2	.	.	O	.	_	0	SENT_34	[p3l837t913r1486b988],

1	CFTR	NNP	ORGANIZATION	CFTR	nsubj	3	SENT_35	[p3l837t913r1486b988],
2	may	MD	O	may	aux	3	SENT_35	[p3l1531t943r1701b1015],
3	reach	VB	O	reach	_	0	SENT_35	[p3l1742t913r1969b988],
4	the	DT	O	the	det	6	SENT_35	[p3l2012t913r2143b988],
5	cell	NN	O	cell	nn	6	SENT_35	[p3l11t1024r146b1099],
6	surface	NN	O	surface	dobj	3	SENT_35	[p3l181t1024r460b1099],
7	in	IN	O	in	_	0	SENT_35	[p3l494t1035r569b1097],
8	some	DT	O	some	det	9	SENT_35	[p3l604t1054r807b1099],
9	patients	NNS	O	patient	prep_in	3	SENT_35	[p3l841t1035r1150b1126],
10	with	IN	O	with	_	0	SENT_35	[p3l1183t1024r1356b1099],
11	the	DT	O	the	det	13	SENT_35	[p3l1390t1024r1514b1099],
12	F508del	NN	O	f508del	nn	13	SENT_35	[p3l1552t1024r1878b1099],
13	mutation	NN	O	mutation	prep_with	9	SENT_35	[p3l1913t1040r2142b1099, p3l9t1146r193b1223],
14	,	,	O	,	_	0	SENT_35	[p3l1913t1040r2142b1099, p3l9t1146r193b1223],
15	and	CC	O	and	_	0	SENT_35	[p3l235t1135r384b1210],
16	tissues	NNS	O	tissue	nsubj	21	SENT_35	[p3l419t1146r690b1210],
17	derived	VBN	O	derive	partmod	16	SENT_35	[p3l730t1135r1045b1210],
18	from	IN	O	from	_	0	SENT_35	[p3l1080t1135r1277b1210],
19	these	DT	O	these	det	20	SENT_35	[p3l1314t1135r1532b1210],
20	patients	NNS	O	patient	prep_from	17	SENT_35	[p3l1568t1146r1898b1237],
21	show	VBP	O	show	conj_and	3	SENT_35	[p3l1938t1135r2147b1210],
22	a	DT	O	a	det	24	SENT_35	[p3l11t1276r52b1321],
23	limited	JJ	O	limited	amod	24	SENT_35	[p3l87t1246r384b1321],
24	response	NN	O	response	dobj	21	SENT_35	[p3l420t1276r786b1348],
25	to	TO	O	to	_	0	SENT_35	[p3l824t1262r902b1321],
26	CFTR	NNP	ORGANIZATION	CFTR	nn	27	SENT_35	[p3l941t1253r1204b1321],
27	potentiation9	NN	O	potentiation9	prep_to	21	SENT_35	[p3l1240t1255r1954b1348],
28	=	JJ	O	=	amod	27	SENT_35	[p3l1240t1255r1954b1348],
29	13	CD	NUMBER	13	tmod	28	SENT_35	[p3l1240t1255r1954b1348],
30	=	JJ	O	=	amod	27	SENT_35	[p3l1240t1255r1954b1348],
31	14	CD	NUMBER	14	tmod	30	SENT_35	[p3l1240t1255r1954b1348],
32	;	:	O	;	_	0	SENT_35	[p3l1240t1255r1954b1348],
33	and	CC	O	and	_	0	SENT_35	[p3l1996t1246r2145b1321],
34	(	NN	O	(	dep	36	SENT_35	[p3l15t1357r114b1446],
35	3	CD	NUMBER	3	num	36	SENT_35	[p3l15t1357r114b1446],
36	)	NN	O	)	conj_and	3	SENT_35	[p3l15t1357r114b1446],
37	because	IN	O	because	_	0	SENT_35	[p3l153t1357r464b1432],
38	F	NN	O	f	nn	39	SENT_35	[p3l504t1364r561b1431],
39	508del	NN	O	508del	prep_because	36	SENT_35	[p3l565t1357r1115b1432],
40	.	.	O	.	_	0	SENT_35	[p3l565t1357r1115b1432],

1	—	NN	O	—	_	0	SENT_36	[p3l565t1357r1115b1432],
2	.	.	O	.	_	0	SENT_36	[p3l565t1357r1115b1432],

1	CFTR	NNP	ORGANIZATION	CFTR	nsubj	3	SENT_37	[p3l565t1357r1115b1432],
2	may	MD	O	may	aux	3	SENT_37	[p3l1153t1387r1316b1459],
3	respond	VB	O	respond	dep	18	SENT_37	[p3l1349t1357r1666b1459],
4	to	TO	O	to	aux	5	SENT_37	[p3l1700t1373r1775b1432],
5	ivacaftor	VB	O	ivacaftor	xcomp	3	SENT_37	[p3l1811t1357r2146b1432],
6	in	IN	O	in	_	0	SENT_37	[p3l9t1479r85b1541],
7	some	DT	O	some	det	8	SENT_37	[p3l125t1498r331b1543],
8	subjects	NNS	O	subject	prep_in	5	SENT_37	[p3l373t1468r714b1570],
9	,	,	O	,	_	0	SENT_37	[p3l373t1468r714b1570],
10	and	CC	O	and	_	0	SENT_37	[p3l757t1468r903b1543],
11	most	JJS	O	most	amod	12	SENT_37	[p3l941t1484r1134b1543],
12	subjects	NNS	O	subject	nsubj	13	SENT_37	[p3l1173t1468r1491b1570],
13	enrolled	VBD	O	enrol	dep	18	SENT_37	[p3l1533t1468r1867b1543],
14	in	IN	O	in	_	0	SENT_37	[p3l1903t1479r1978b1541],
15	the	DT	O	the	det	17	SENT_37	[p3l2016t1468r2143b1543],
16	G551D	NN	O	g551d	nn	17	SENT_37	[p3l13t1582r302b1654],
17	study	NN	O	study	prep_in	13	SENT_37	[p3l338t1579r550b1681],
18	had	VBD	O	have	_	0	SENT_37	[p3l577t1579r723b1654],
19	F508del	NN	O	f508del	dobj	18	SENT_37	[p3l755t1579r1081b1654],
20	on	IN	O	on	_	0	SENT_37	[p3l1113t1609r1210b1654],
21	the	DT	O	the	det	23	SENT_37	[p3l1241t1579r1365b1654],
22	other	JJ	O	other	amod	23	SENT_37	[p3l1399t1579r1610b1654],
23	CF	NN	MISC	cf	prep_on	19	SENT_37	[p3l1642t1586r1764b1654],
24	TR	NN	MISC	tr	nn	25	SENT_37	[p3l1768t1586r1883b1653],
25	allele	NN	O	allele	nsubj	18	SENT_37	[p3l1916t1579r2140b1668],
26	,	,	O	,	_	0	SENT_37	[p3l1916t1579r2140b1668],
27	a	DT	O	a	det	28	SENT_37	[p3l11t1720r52b1765],
28	study	NN	O	study	appos	25	SENT_37	[p3l92t1690r307b1792],
29	of	IN	O	of	_	0	SENT_37	[p3l344t1690r430b1765],
30	ivacaftor	NN	O	ivacaftor	prep_of	28	SENT_37	[p3l459t1690r806b1765],
31	in	IN	O	in	_	0	SENT_37	[p3l843t1701r918b1763],
32	subjects	NNS	O	subject	prep_in	30	SENT_37	[p3l960t1690r1278b1792],
33	homozygous	JJ	O	homozygous	amod	32	SENT_37	[p3l1320t1690r1818b1792],
34	for	IN	O	for	_	0	SENT_37	[p3l1860t1690r1975b1765],
35	the	DT	O	the	det	36	SENT_37	[p3l2012t1690r2143b1765],
36	F508clel	NN	O	f508clel	prep_for	33	SENT_37	[p3l9t1801r637b1876],
37	.	.	O	.	_	0	SENT_37	[p3l9t1801r637b1876],

1	—	NN	O	—	_	0	SENT_38	[p3l9t1801r637b1876],
2	.	.	O	.	_	0	SENT_38	[p3l9t1801r637b1876],

1	CFTR	NN	ORGANIZATION	cftr	nn	2	SENT_39	[p3l9t1801r637b1876],
2	mutation	NN	O	mutation	nsubj	4	SENT_39	[p3l677t1812r1052b1876],
3	may	MD	O	may	aux	4	SENT_39	[p3l1092t1831r1262b1903],
4	help	VB	O	help	_	0	SENT_39	[p3l1295t1801r1475b1903],
5	isolate	VB	O	isolate	dep	4	SENT_39	[p3l1514t1801r1780b1876],
6	possible	JJ	O	possible	amod	7	SENT_39	[p3l1818t1801r2143b1903],
7	potentiation	NN	O	potentiation	dobj	4	SENT_39	[p3l8t1923r509b2014],
8	of	IN	O	of	_	0	SENT_39	[p3l546t1912r633b1987],
9	F508del	NN	O	f508del	prep_of	7	SENT_39	[p3l660t1912r998b1987],
10	without	IN	O	without	_	0	SENT_39	[p3l1029t1912r1346b1987],
11	a	DT	DURATION	a	det	13	SENT_39	[p3l1381t1942r1422b1987],
12	second	JJ	DURATION	second	amod	13	SENT_39	[p3l1457t1912r1740b1987],
13	mutation	NN	O	mutation	prep_without	4	SENT_39	[p3l1776t1923r2144b1987],
14	confounding	VBG	O	confound	partmod	13	SENT_39	[p3l10t2023r518b2125],
15	the	DT	O	the	det	16	SENT_39	[p3l545t2023r671b2098],
16	results	NNS	O	result	dobj	14	SENT_39	[p3l702t2023r982b2098],
17	.	.	O	.	_	0	SENT_39	[p3l702t2023r982b2098],

1	MATERIALS	NNS	O	material	_	0	SENT_40	[p3l511t2294r990b2362],
2	AND	CC	O	and	_	0	SENT_40	[p3l1021t2311r1192b2361],
3	METHODS	NNS	O	method	conj_and	1	SENT_40	[p3l1226t2294r1645b2362],

1	Study	NNP	O	Study	nn	2	SENT_41	[p3l13t2526r197b2609],
2	Design	NNP	O	Design	_	0	SENT_41	[p3l222t2532r445b2609],

1	This	DT	O	this	nsubj	6	SENT_42	[p3l103t2628r246b2689],
2	was	VBD	O	be	cop	6	SENT_42	[p3l269t2652r390b2689],
3	a	DT	O	a	det	6	SENT_42	[p3l418t2652r451b2689],
4	two	CD	NUMBER	two	number	5	SENT_42	[p3l473t2641r778b2711],
5	—	CD	NUMBER	—	num	6	SENT_42	[p3l473t2641r778b2711],
6	part	NN	O	part	_	0	SENT_42	[p3l473t2641r778b2711],
7	,	,	O	,	_	0	SENT_42	[p3l473t2641r778b2711],
8	phase	NN	O	phase	appos	6	SENT_42	[p3l804t2628r996b2711],
9	2	CD	NUMBER	2	num	8	SENT_42	[p3l1022t2633r1077b2700],
10	,	,	O	,	_	0	SENT_42	[p3l1022t2633r1077b2700],
11	multicenter	NN	O	multicenter	appos	6	SENT_42	[p3l1105t2628r1513b2700],
12	,	,	O	,	_	0	SENT_42	[p3l1105t2628r1513b2700],
13	randomized	VBN	O	randomize	partmod	6	SENT_42	[p3l1541t2628r1944b2689],
14	(	CD	NUMBER	(	number	15	SENT_42	[p3l1970t2628r2142b2700],
15	4:1	CD	NUMBER	4:1	num	16	SENT_42	[p3l1970t2628r2142b2700],
16	)	NN	O	)	dobj	13	SENT_42	[p3l1970t2628r2142b2700],
17	,	,	O	,	_	0	SENT_42	[p3l1970t2628r2142b2700],
18	placebo	NN	O	placebo	nn	19	SENT_42	[p3l8t2721r661b2803],
19	—	NN	O	—	appos	16	SENT_42	[p3l8t2721r661b2803],
20	controlled	VBN	O	control	partmod	19	SENT_42	[p3l8t2721r661b2803],
21	,	,	O	,	_	0	SENT_42	[p3l8t2721r661b2803],
22	double	JJ	O	double	amod	25	SENT_42	[p3l698t2720r1131b2782],
23	—	RB	O	—	advmod	24	SENT_42	[p3l698t2720r1131b2782],
24	blind	JJ	O	blind	amod	25	SENT_42	[p3l698t2720r1131b2782],
25	study	NN	O	study	appos	19	SENT_42	[p3l1164t2721r1343b2803],
26	of	IN	O	of	_	0	SENT_42	[p3l1372t2720r1443b2781],
27	ivacaftor	NN	O	ivacaftor	prep_of	25	SENT_42	[p3l1466t2721r1757b2781],
28	(	CD	NUMBER	(	num	27	SENT_42	[p3l1790t2720r2142b2803],
29	Kalydeco	NNP	PERSON	Kalydeco	dep	25	SENT_42	[p3l1790t2720r2142b2803],
30	,	,	O	,	_	0	SENT_42	[p3l1790t2720r2142b2803],

1	Manuscript	NN	O	manuscript	nsubj	2	SENT_43	[p3l13t2929r364b3006],
2	received	VBD	O	receive	_	0	SENT_43	[p3l385t2923r645b2984],
3	October	NNP	DATE	October	tmod	2	SENT_43	[p3l667t2923r921b2984],
4	19	CD	DATE	19	num	3	SENT_43	[p3l946t2928r1030b2995],
5	,	,	DATE	,	_	0	SENT_43	[p3l946t2928r1030b2995],
6	2011	CD	DATE	2011	num	3	SENT_43	[p3l1055t2928r1218b2995],
7	;	:	O	;	_	0	SENT_43	[p3l1055t2928r1218b2995],
8	revision	NN	O	revision	nsubj	9	SENT_43	[p3l1244t2932r1480b2984],
9	accepted	VBD	O	accept	parataxis	2	SENT_43	[p3l1503t2923r1777b3006],
10	january	JJ	DATE	january	amod	11	SENT_43	[p3l1796t2929r2034b3006],
11	30	CD	DATE	30	dobj	9	SENT_43	[p3l2053t2928r2142b2994],
12	,	,	DATE	,	_	0	SENT_43	[p3l2053t2928r2142b2994],
13	2012	CD	DATE	2012	appos	11	SENT_43	[p3l10t3013r178b3068],
14	.	.	O	.	_	0	SENT_43	[p3l10t3013r178b3068],

1	Afﬁliations	NNP	O	Afﬁliations	dep	100	SENT_44	[p3l7t3092r418b3153],
2	:	:	O	:	_	0	SENT_44	[p3l7t3092r418b3153],
3	From	IN	O	from	dep	100	SENT_44	[p3l450t3097r631b3153],
4	the	DT	O	the	dep	100	SENT_44	[p3l659t3092r761b3153],
5	Departments	NNP	O	Departments	dep	100	SENT_44	[p3l792t3098r1222b3175],
6	of	IN	O	of	dep	100	SENT_44	[p3l1252t3092r1321b3153],
7	Medicine	NNP	O	Medicine	dep	100	SENT_44	[p3l1344t3092r1649b3153],
8	and	CC	O	and	dep	100	SENT_44	[p3l1679t3092r1797b3153],
9	Pediatrics	NNP	O	Pediatrics	dep	100	SENT_44	[p3l1824t3092r2143b3153],
10	(	CD	NUMBER	(	dep	100	SENT_44	[p3l14t3176r126b3249],
11	Dr	NNP	O	Dr	dep	100	SENT_44	[p3l14t3176r126b3249],
12	Flume	NNP	O	Flume	dep	100	SENT_44	[p3l150t3176r397b3249],
13	)	NNP	O	)	dep	100	SENT_44	[p3l150t3176r397b3249],
14	,	,	O	,	_	0	SENT_44	[p3l150t3176r397b3249],
15	Medical	NNP	ORGANIZATION	Medical	dep	100	SENT_44	[p3l428t3176r679b3237],
16	University	NNP	ORGANIZATION	University	dep	100	SENT_44	[p3l705t3182r1026b3260],
17	of	IN	ORGANIZATION	of	dep	100	SENT_44	[p3l1048t3176r1116b3237],
18	South	NNP	ORGANIZATION	South	dep	100	SENT_44	[p3l1134t3176r1315b3237],
19	Carolina	NNP	ORGANIZATION	Carolina	dep	100	SENT_44	[p3l1340t3176r1620b3248],
20	,	,	O	,	_	0	SENT_44	[p3l1340t3176r1620b3248],
21	Charleston	NNP	LOCATION	Charleston	dep	100	SENT_44	[p3l1648t3176r2005b3248],
22	,	,	O	,	_	0	SENT_44	[p3l1648t3176r2005b3248],
23	SC	NNP	O	SC	dep	100	SENT_44	[p3l2036t3182r2142b3248],
24	;	:	O	;	_	0	SENT_44	[p3l2036t3182r2142b3248],
25	the	DT	O	the	dep	100	SENT_44	[p3l9t3261r112b3322],
26	University	NNP	ORGANIZATION	University	dep	100	SENT_44	[p3l137t3267r473b3344],
27	of	IN	ORGANIZATION	of	dep	100	SENT_44	[p3l492t3261r562b3322],
28	Utah	NNP	ORGANIZATION	Utah	dep	100	SENT_44	[p3l578t3261r737b3322],
29	(	CD	NUMBER	(	dep	100	SENT_44	[p3l762t3261r878b3333],
30	Dr	NNP	O	Dr	dep	100	SENT_44	[p3l762t3261r878b3333],
31	Liou	NNP	PERSON	Liou	dep	100	SENT_44	[p3l901t3261r1094b3333],
32	)	NNP	O	)	dep	100	SENT_44	[p3l901t3261r1094b3333],
33	,	,	O	,	_	0	SENT_44	[p3l901t3261r1094b3333],
34	Salt	NNP	LOCATION	Salt	dep	100	SENT_44	[p3l1123t3261r1241b3322],
35	Lake	NNP	LOCATION	Lake	dep	100	SENT_44	[p3l1265t3261r1422b3322],
36	City	NNP	LOCATION	City	dep	100	SENT_44	[p3l1446t3266r1590b3344],
37	,	,	O	,	_	0	SENT_44	[p3l1446t3266r1590b3344],
38	UT	NNP	ORGANIZATION	UT	dep	100	SENT_44	[p3l1617t3267r1734b3333],
39	;	:	O	;	_	0	SENT_44	[p3l1617t3267r1734b3333],
40	the	DT	O	the	dep	100	SENT_44	[p3l1759t3261r1861b3322],
41	Department	NNP	ORGANIZATION	Department	dep	100	SENT_44	[p3l1887t3267r2143b3344, p3l11t3359r184b3407],
42	of	IN	ORGANIZATION	of	dep	100	SENT_44	[p3l205t3345r276b3407],
43	Pediatrics	NNP	ORGANIZATION	Pediatrics	dep	100	SENT_44	[p3l291t3345r624b3407],
44	(	CD	NUMBER	(	dep	100	SENT_44	[p3l652t3346r771b3418],
45	Dr	NNP	O	Dr	dep	100	SENT_44	[p3l652t3346r771b3418],
46	Borowitz	NNP	PERSON	Borowitz	dep	100	SENT_44	[p3l793t3346r1143b3418],
47	)	NNP	O	)	dep	100	SENT_44	[p3l793t3346r1143b3418],
48	,	,	O	,	_	0	SENT_44	[p3l793t3346r1143b3418],
49	State	NNP	ORGANIZATION	State	dep	100	SENT_44	[p3l1171t3351r1336b3407],
50	University	NNP	ORGANIZATION	University	dep	100	SENT_44	[p3l1362t3351r1712b3429],
51	of	IN	ORGANIZATION	of	dep	100	SENT_44	[p3l1732t3345r1803b3407],
52	New	NNP	ORGANIZATION	New	dep	100	SENT_44	[p3l1819t3351r1974b3407],
53	York	NNP	ORGANIZATION	York	dep	100	SENT_44	[p3l1992t3345r2146b3407],
54	at	IN	O	at	dep	100	SENT_44	[p3l11t3523r70b3571],
55	Buffalo	NNP	LOCATION	Buffalo	dep	100	SENT_44	[p3l103t3510r368b3582],
56	,	,	O	,	_	0	SENT_44	[p3l103t3510r368b3582],
57	Buffalo	NNP	LOCATION	Buffalo	dep	100	SENT_44	[p3l405t3510r670b3582],
58	,	,	O	,	_	0	SENT_44	[p3l405t3510r670b3582],
59	NY	NNP	O	NY	dep	100	SENT_44	[p3l708t3516r826b3582],
60	;	:	O	;	_	0	SENT_44	[p3l708t3516r826b3582],
61	Vertex	NNP	ORGANIZATION	Vertex	dep	100	SENT_44	[p3l859t3516r1077b3571],
62	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	dep	100	SENT_44	[p3l1109t3510r1664b3571],
63	Incorporated	NNP	ORGANIZATION	Incorporated	dep	100	SENT_44	[p3l1699t3510r2145b3593],
64	(	NNP	O	(	dep	100	SENT_44	[p3l14t3595r155b3667],
65	Drs	NNP	O	Drs	dep	100	SENT_44	[p3l14t3595r155b3667],
66	Li	NNP	O	Li	dep	100	SENT_44	[p3l188t3600r272b3666],
67	,	,	O	,	_	0	SENT_44	[p3l188t3600r272b3666],
68	Yen	NNP	O	Yen	dep	100	SENT_44	[p3l302t3600r440b3667],
69	,	,	O	,	_	0	SENT_44	[p3l302t3600r440b3667],
70	and	CC	O	and	dep	100	SENT_44	[p3l473t3594r591b3656],
71	Ordoﬁez	NNP	LOCATION	Ordoﬁez	dep	100	SENT_44	[p3l620t3594r947b3667],
72	)	CD	NUMBER	)	dep	100	SENT_44	[p3l620t3594r947b3667],
73	,	,	O	,	_	0	SENT_44	[p3l620t3594r947b3667],
74	Cambridge	NNP	LOCATION	Cambridge	dep	100	SENT_44	[p3l980t3594r1362b3678],
75	,	,	O	,	_	0	SENT_44	[p3l980t3594r1362b3678],
76	MA	NNP	LOCATION	MA	dep	100	SENT_44	[p3l1397t3600r1533b3667],
77	;	:	O	;	_	0	SENT_44	[p3l1397t3600r1533b3667],
78	and	CC	O	and	dep	100	SENT_44	[p3l1566t3594r1684b3656],
79	the	DT	O	the	dep	100	SENT_44	[p3l1711t3594r1813b3655],
80	Divisions	NNS	ORGANIZATION	division	dep	100	SENT_44	[p3l1846t3600r2143b3656],
81	of	IN	ORGANIZATION	of	dep	100	SENT_44	[p4l10t47r81b108],
82	Biomedical	NNP	ORGANIZATION	Biomedical	dep	100	SENT_44	[p4l97t47r472b108],
83	Research	NNP	ORGANIZATION	Research	dep	100	SENT_44	[p4l496t47r800b108],
84	and	CC	O	and	dep	100	SENT_44	[p4l824t47r943b108],
85	Pediatric	NNP	ORGANIZATION	Pediatric	dep	100	SENT_44	[p4l966t47r1263b108],
86	Pulmonology	NNP	ORGANIZATION	Pulmonology	dep	100	SENT_44	[p4l1286t47r1726b130],
87	(	CD	NUMBER	(	dep	100	SENT_44	[p4l1749t47r1867b119],
88	Dr	NNP	O	Dr	dep	100	SENT_44	[p4l1749t47r1867b119],
89	Geller	NNP	PERSON	Geller	dep	100	SENT_44	[p4l1890t47r2142b119],
90	)	NNP	O	)	dep	100	SENT_44	[p4l1890t47r2142b119],
91	,	,	O	,	_	0	SENT_44	[p4l1890t47r2142b119],
92	N	NNP	O	N	dep	100	SENT_44	[p4l12t137r66b191],
93	emours	VBZ	O	emour	dep	100	SENT_44	[p4l72t155r311b192],
94	Children	NNP	O	Children	dep	100	SENT_44	[p4l338t131r672b192],
95	’s	POS	O	’s	dep	100	SENT_44	[p4l338t131r672b192],
96	Clinic	NNP	O	Clinic	dep	100	SENT_44	[p4l698t131r907b203],
97	,	,	O	,	_	0	SENT_44	[p4l698t131r907b203],
98	Orlando	NNP	LOCATION	Orlando	dep	100	SENT_44	[p4l935t131r1218b203],
99	,	,	O	,	_	0	SENT_44	[p4l935t131r1218b203],
100	FL	NN	LOCATION	fl	_	0	SENT_44	[p4l1246t137r1360b192],
101	.	.	O	.	_	0	SENT_44	[p4l1246t137r1360b192],

1	*	NN	O	*	nn	2	SENT_45	[p4l15t219r97b275],
2	A	NN	O	a	nn	4	SENT_45	[p4l15t219r97b275],
3	complete	JJ	O	complete	amod	4	SENT_45	[p4l120t215r420b298],
4	list	NN	O	list	nsubj	9	SENT_45	[p4l444t215r538b276],
5	of	IN	O	of	_	0	SENT_45	[p4l561t215r631b276],
6	study	NN	O	study	nn	7	SENT_45	[p4l647t215r821b298],
7	participants	NNS	O	participant	prep_of	4	SENT_45	[p4l840t224r1221b298],
8	is	VBZ	O	be	cop	9	SENT_45	[p4l1245t224r1291b276],
9	located	JJ	O	located	_	0	SENT_45	[p4l1316t215r1551b276],
10	in	IN	O	in	_	0	SENT_45	[p4l1573t224r1633b275],
11	e-Appendix	NN	O	e-appendix	prep_in	9	SENT_45	[p4l1658t215r2034b298],
12	1	CD	NUMBER	1	num	11	SENT_45	[p4l2060t220r2108b276],
13	.	.	O	.	_	0	SENT_45	[p4l2060t220r2108b276],

1	Funding/Support	NNP	O	Funding/Support	_	0	SENT_46	[p4l10t299r676b382],
2	:	:	O	:	_	0	SENT_46	[p4l10t299r676b382],
3	The	DT	O	the	det	5	SENT_46	[p4l722t299r852b360],
4	DISCOVER	NNP	O	DISCOVER	nn	5	SENT_46	[p4l899t305r1322b360],
5	study	NN	O	study	nsubjpass	7	SENT_46	[p4l1366t299r1547b382],
6	is	VBZ	O	be	auxpass	7	SENT_46	[p4l1587t308r1634b360],
7	sponsored	VBN	O	sponsor	dep	1	SENT_46	[p4l1681t299r2026b382],
8	by	IN	O	by	_	0	SENT_46	[p4l2067t299r2147b382],
9	Vertex	NNP	ORGANIZATION	Vertex	nn	11	SENT_46	[p4l7t389r210b444],
10	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	11	SENT_46	[p4l236t383r747b444],
11	Incorporated	NNP	ORGANIZATION	Incorporated	agent	7	SENT_46	[p4l777t383r1201b467],
12	.	.	O	.	_	0	SENT_46	[p4l777t383r1201b467],

1	This	DT	O	this	det	2	SENT_47	[p4l1232t383r1366b444],
2	research	NN	O	research	nsubjpass	4	SENT_47	[p4l1396t383r1659b444],
3	was	VBD	O	be	auxpass	4	SENT_47	[p4l1684t407r1798b444],
4	supported	VBN	O	support	_	0	SENT_47	[p4l1829t383r2145b467],
5	by	IN	O	by	_	0	SENT_47	[p4l8t468r88b551],
6	the	DT	O	the	det	9	SENT_47	[p4l112t468r213b529],
7	Cystic	JJ	MISC	cystic	amod	9	SENT_47	[p4l243t473r440b551],
8	Fibrosis	NNP	MISC	Fibrosis	nn	9	SENT_47	[p4l469t468r726b529],
9	Foundation	NNP	MISC	Foundation	agent	4	SENT_47	[p4l757t468r1136b529],
10	to	TO	O	to	_	0	SENT_47	[p4l1162t481r1224b529],
11	the	DT	O	the	det	12	SENT_47	[p4l1251t468r1353b529],
12	Women	NNS	O	woman	prep_to	4	SENT_47	[p4l1379t473r1635b529],
13	and	CC	O	and	_	0	SENT_47	[p4l1663t468r1781b529],
14	Children	NNS	O	child	poss	16	SENT_47	[p4l1808t468r2143b529],
15	’s	POS	O	’s	_	0	SENT_47	[p4l1808t468r2143b529],
16	Hospital	NN	O	hospital	conj_and	12	SENT_47	[p4l12t552r286b635],
17	of	IN	O	of	_	0	SENT_47	[p4l313t552r383b613],
18	Buffalo	NNP	LOCATION	Buffalo	nn	22	SENT_47	[p4l404t552r640b613],
19	[	NNP	O	[	nn	22	SENT_47	[p4l673t552r886b624],
20	Grant	NNP	O	Grant	nn	22	SENT_47	[p4l673t552r886b624],
21	BOROWIOBCSO	NNP	O	BOROWIOBCSO	nn	22	SENT_47	[p4l914t552r1484b624],
22	]	NN	O	]	prep_of	16	SENT_47	[p4l914t552r1484b624],
23	and	CC	O	and	_	0	SENT_47	[p4l1517t552r1635b613],
24	to	TO	O	to	_	0	SENT_47	[p4l1661t565r1722b613],
25	the	DT	O	the	det	27	SENT_47	[p4l1750t552r1852b613],
26	Medical	NNP	ORGANIZATION	Medical	nn	27	SENT_47	[p4l1884t552r2145b613],
27	University	NNP	ORGANIZATION	University	conj_and	12	SENT_47	[p4l12t642r347b720],
28	of	IN	ORGANIZATION	of	_	0	SENT_47	[p4l368t636r437b698],
29	South	NNP	ORGANIZATION	South	nn	34	SENT_47	[p4l456t636r643b698],
30	Carolina	NNP	ORGANIZATION	Carolina	nn	34	SENT_47	[p4l667t636r945b698],
31	[	NNP	O	[	nn	34	SENT_47	[p4l971t636r1183b709],
32	Grant	NNP	O	Grant	nn	34	SENT_47	[p4l971t636r1183b709],
33	C104-TDCIOY	NN	O	c104-tdcioy	nn	34	SENT_47	[p4l1206t636r1743b709],
34	]	NN	O	]	prep_of	27	SENT_47	[p4l1206t636r1743b709],
35	.	.	O	.	_	0	SENT_47	[p4l1206t636r1743b709],

1	Correspondence	NN	O	correspondence	_	0	SENT_48	[p4l11t721r633b804],
2	to	TO	O	to	dep	1	SENT_48	[p4l665t733r758b782],
3	:	:	O	:	_	0	SENT_48	[p4l665t733r758b782],
4	Patrick	NNP	PERSON	Patrick	nn	12	SENT_48	[p4l792t721r1031b782],
5	A.	NNP	PERSON	A.	nn	12	SENT_48	[p4l1058t726r1125b782],
6	Flume	NNP	PERSON	Flume	nn	12	SENT_48	[p4l1161t721r1399b793],
7	,	,	O	,	_	0	SENT_48	[p4l1161t721r1399b793],
8	MD	NNP	O	MD	appos	12	SENT_48	[p4l1436t727r1588b793],
9	,	,	O	,	_	0	SENT_48	[p4l1436t727r1588b793],
10	FCCP	NNP	O	FCCP	appos	12	SENT_48	[p4l1623t726r1842b793],
11	,	,	O	,	_	0	SENT_48	[p4l1623t726r1842b793],
12	Departments	NNP	O	Departments	dep	27	SENT_48	[p4l1878t727r2143b804, p4l10t819r209b867],
13	of	IN	O	of	_	0	SENT_48	[p4l239t805r309b866],
14	Medicine	NNP	O	Medicine	prep_of	12	SENT_48	[p4l332t805r642b867],
15	and	CC	O	and	_	0	SENT_48	[p4l672t805r792b867],
16	Pediatrics	NNP	O	Pediatrics	conj_and	14	SENT_48	[p4l819t805r1164b878],
17	,	,	O	,	_	0	SENT_48	[p4l819t805r1164b878],
18	Medical	NNP	ORGANIZATION	Medical	nn	19	SENT_48	[p4l1199t805r1464b867],
19	University	NNP	ORGANIZATION	University	appos	14	SENT_48	[p4l1493t811r1836b889],
20	of	IN	ORGANIZATION	of	_	0	SENT_48	[p4l1861t805r1932b867],
21	South	NNP	ORGANIZATION	South	nn	22	SENT_48	[p4l1955t805r2145b867],
22	Carolina	NNP	ORGANIZATION	Carolina	prep_of	19	SENT_48	[p4l11t890r299b962],
23	,	,	O	,	_	0	SENT_48	[p4l11t890r299b962],
24	96	CD	NUMBER	96	num	25	SENT_48	[p4l327t895r401b950],
25	jonathan	NN	O	jonathan	dep	27	SENT_48	[p4l425t890r713b973],
26	Lucas	NNP	PERSON	Lucas	nn	27	SENT_48	[p4l739t896r924b951],
27	St	NNP	O	St	dep	39	SENT_48	[p4l953t895r1030b962],
28	,	,	O	,	_	0	SENT_48	[p4l953t895r1030b962],
29	Room	NNP	O	Room	appos	27	SENT_48	[p4l1060t896r1251b951],
30	812	CD	NUMBER	812	num	29	SENT_48	[p4l1277t895r1408b962],
31	,	,	O	,	_	0	SENT_48	[p4l1277t895r1408b962],
32	Clinical	JJ	O	clinical	amod	34	SENT_48	[p4l1436t890r1680b951],
33	Science	NNP	O	Science	nn	34	SENT_48	[p4l1707t895r1949b951],
34	Bldg	NNP	O	Bldg	appos	27	SENT_48	[p4l1977t890r2142b973],
35	,	,	O	,	_	0	SENT_48	[p4l1977t890r2142b973],
36	Charleston	NNP	LOCATION	Charleston	appos	27	SENT_48	[p4l11t974r383b1046],
37	,	,	O	,	_	0	SENT_48	[p4l11t974r383b1046],
38	SC	NNP	O	SC	appos	27	SENT_48	[p4l413t980r503b1035],
39	29425	CD	NUMBER	29425	dep	1	SENT_48	[p4l528t977r741b1046],
40	;	:	O	;	_	0	SENT_48	[p4l528t977r741b1046],
41	e	SYM	O	e	dep	43	SENT_48	[p4l768t974r986b1035],
42	—	CD	NUMBER	—	num	43	SENT_48	[p4l768t974r986b1035],
43	mail	NN	O	mail	dep	39	SENT_48	[p4l768t974r986b1035],
44	:	:	O	:	_	0	SENT_48	[p4l768t974r986b1035],
45	ﬂumepa@musc.edu	FW	O	ﬂumepa@musc.edu	nn	46	SENT_48	[p4l1014t974r1658b1058],
46	©	FW	O	©	dep	47	SENT_48	[p4l13t1064r67b1120],
47	2012	CD	DATE	2012	dep	49	SENT_48	[p4l93t1064r264b1119],
48	American	NNP	ORGANIZATION	American	nn	49	SENT_48	[p4l286t1064r637b1120],
49	College	NNP	ORGANIZATION	College	dep	52	SENT_48	[p4l660t1059r935b1141],
50	of	IN	ORGANIZATION	of	_	0	SENT_48	[p4l958t1059r1036b1120],
51	Chest	NN	ORGANIZATION	chest	prep_of	49	SENT_48	[p4l1050t1059r1257b1120],
52	Physicians	NNP	ORGANIZATION	Physicians	dep	43	SENT_48	[p4l1278t1059r1670b1142],
53	.	.	O	.	_	0	SENT_48	[p4l1278t1059r1670b1142],

1	Reproduction	NNP	O	Reproduction	nsubjpass	6	SENT_49	[p4l1695t1059r2144b1142],
2	of	IN	O	of	_	0	SENT_49	[p4l10t1143r80b1204],
3	this	DT	O	this	det	4	SENT_49	[p4l101t1143r215b1204],
4	article	NN	O	article	prep_of	1	SENT_49	[p4l248t1143r447b1204],
5	is	VBZ	O	be	auxpass	6	SENT_49	[p4l478t1152r524b1204],
6	prohibited	VBN	O	prohibit	_	0	SENT_49	[p4l555t1143r899b1227],
7	without	IN	O	without	_	0	SENT_49	[p4l925t1143r1177b1204],
8	written	VBN	O	write	amod	9	SENT_49	[p4l1203t1152r1439b1204],
9	permission	NN	O	permission	prep_without	6	SENT_49	[p4l1468t1152r1825b1227],
10	from	IN	O	from	_	0	SENT_49	[p4l1856t1143r2010b1204],
11	the	DT	O	the	det	13	SENT_49	[p4l2041t1143r2143b1204],
12	American	NNP	ORGANIZATION	American	nn	13	SENT_49	[p4l8t1233r320b1289],
13	College	NNP	ORGANIZATION	College	prep_from	9	SENT_49	[p4l342t1228r584b1311],
14	of	IN	ORGANIZATION	of	_	0	SENT_49	[p4l608t1228r676b1289],
15	Chest	NN	ORGANIZATION	chest	nn	16	SENT_49	[p4l690t1228r876b1289],
16	Physicians	NNP	ORGANIZATION	Physicians	prep_of	13	SENT_49	[p4l897t1228r1240b1311],
17	.	.	O	.	_	0	SENT_49	[p4l897t1228r1240b1311],

1	See	VB	O	see	_	0	SENT_50	[p4l1269t1233r1379b1289],
2	online	NN	O	online	dep	1	SENT_50	[p4l1402t1228r1598b1289],
3	for	IN	O	for	_	0	SENT_50	[p4l1622t1228r1713b1289],
4	more	JJR	O	more	amod	5	SENT_50	[p4l1733t1252r1898b1289],
5	details	NNS	O	detail	prep_for	1	SENT_50	[p4l1922t1228r2140b1289],
6	.	.	O	.	_	0	SENT_50	[p4l1922t1228r2140b1289],

1	DOI	NNP	O	DOI	_	0	SENT_51	[p4l10t1318r191b1373],
2	:	:	O	:	_	0	SENT_51	[p4l10t1318r191b1373],
3	10.1378	CD	NUMBER	10.1378	dep	1	SENT_51	[p4l243t1312r1046b1373],
4	/	:	O	/	punct	5	SENT_51	[p4l243t1312r1046b1373],
5	chest.l1-2672	NN	O	chest.l1-2672	dep	3	SENT_51	[p4l243t1312r1046b1373],

1	journal.publications.chestnet.org	NN	O	journal.publications.chestnet.org	nsubj	3	SENT_52	[p4l6t1542r960b1603],
2	formerly	RB	O	formerly	advmod	3	SENT_52	[p4l14t1622r307b1704],
3	known	VBN	O	know	_	0	SENT_52	[p4l339t1622r561b1683],
4	as	IN	O	as	_	0	SENT_52	[p4l599t1646r659b1682],
5	VX-770	NN	O	vx-770	prep_as	3	SENT_52	[p4l694t1624r967b1693],
6	;	:	O	;	_	0	SENT_52	[p4l694t1624r967b1693],
7	Vertex	NNP	ORGANIZATION	Vertex	nn	10	SENT_52	[p4l1003t1627r1222b1682],
8	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	10	SENT_52	[p4l1257t1622r1811b1682],
9	Incorporated	NNP	ORGANIZATION	Incorporated	nn	10	SENT_52	[p4l1851t1628r2143b1705, p4l14t1714r219b1786],
10	)	NN	O	)	nsubj	22	SENT_52	[p4l1851t1628r2143b1705, p4l14t1714r219b1786],
11	,	,	O	,	_	0	SENT_52	[p4l1851t1628r2143b1705, p4l14t1714r219b1786],
12	150	CD	NUMBER	150	num	14	SENT_52	[p4l254t1716r363b1774],
13	mg	NN	O	mg	nn	14	SENT_52	[p4l391t1736r491b1797],
14	po	NN	O	po	appos	10	SENT_52	[p4l516t1738r595b1797],
15	administered	VBN	O	administer	partmod	14	SENT_52	[p4l624t1714r1042b1775],
16	every	DT	O	every	det	18	SENT_52	[p4l1068t1738r1241b1797],
17	12	CD	NUMBER	12	num	18	SENT_52	[p4l1269t1719r1339b1774],
18	h	NN	O	h	dobj	15	SENT_52	[p4l1366t1714r1407b1773],
19	for	IN	O	for	_	0	SENT_52	[p4l1434t1714r1525b1775],
20	16	CD	DURATION	16	num	21	SENT_52	[p4l1555t1719r1625b1774],
21	weeks	NNS	NUMBER	week	prep_for	18	SENT_52	[p4l1649t1714r1843b1775],
22	(	VBD	O	(	parataxis	3	SENT_52	[p4l1875t1714r2026b1797],
23	part	NN	O	part	dobj	22	SENT_52	[p4l1875t1714r2026b1797],
24	A	DT	O	a	det	25	SENT_52	[p4l2050t1714r2142b1786],
25	)	NN	O	)	dep	23	SENT_52	[p4l2050t1714r2142b1786],
26	,	,	O	,	_	0	SENT_52	[p4l2050t1714r2142b1786],
27	followed	VBN	O	follow	partmod	23	SENT_52	[p4l14t1806r298b1867],
28	by	IN	O	by	_	0	SENT_52	[p4l328t1806r408b1889],
29	an	DT	O	a	det	32	SENT_52	[p4l439t1830r514b1867],
30	open	JJ	O	open	amod	32	SENT_52	[p4l547t1806r898b1889],
31	—	NN	O	—	nn	32	SENT_52	[p4l547t1806r898b1889],
32	label	NN	O	label	agent	27	SENT_52	[p4l547t1806r898b1889],
33	96-week	JJ	DURATION	96-week	amod	34	SENT_52	[p4l931t1806r1209b1867],
34	extension	NN	O	extension	dobj	27	SENT_52	[p4l1241t1815r1552b1867],
35	for	IN	O	for	_	0	SENT_52	[p4l1585t1806r1680b1867],
36	subjects	NNS	O	subject	prep_for	34	SENT_52	[p4l1712t1806r1975b1889],
37	who	WP	O	who	nsubj	38	SENT_52	[p4l2006t1806r2144b1867],
38	met	VBD	O	meet	rcmod	36	SENT_52	[p4l14t1911r143b1958],
39	prespecified	JJ	O	prespecified	amod	41	SENT_52	[p4l171t1898r587b1981],
40	eligibility	NN	O	eligibility	nn	41	SENT_52	[p4l617t1898r936b1981],
41	criteria	NNS	O	criterion	nsubj	42	SENT_52	[p4l964t1907r1207b1958],
42	(	VBD	O	(	ccomp	38	SENT_52	[p4l1240t1898r1400b1980],
43	part	NN	O	part	nn	45	SENT_52	[p4l1240t1898r1400b1980],
44	B	NN	O	b	nn	45	SENT_52	[p4l1432t1898r1525b1970],
45	)	NN	O	)	dobj	42	SENT_52	[p4l1432t1898r1525b1970],
46	.	.	O	.	_	0	SENT_52	[p4l1432t1898r1525b1970],

1	The	DT	O	the	det	2	SENT_53	[p4l1560t1898r1690b1958],
2	rationale	NN	O	rationale	nsubj	12	SENT_53	[p4l1723t1898r2018b1958],
3	for	IN	O	for	_	0	SENT_53	[p4l2051t1898r2147b1958],
4	selecting	VBG	O	select	prepc_for	2	SENT_53	[p4l15t1990r300b2073],
5	subjects	NNS	O	subject	dobj	4	SENT_53	[p4l328t1990r586b2073],
6	for	IN	O	for	_	0	SENT_53	[p4l616t1990r708b2051],
7	the	DT	O	the	det	11	SENT_53	[p4l735t1990r836b2051],
8	open	JJ	O	open	amod	11	SENT_53	[p4l867t1990r1211b2073],
9	—	NN	O	—	nn	11	SENT_53	[p4l867t1990r1211b2073],
10	label	NN	O	label	nn	11	SENT_53	[p4l867t1990r1211b2073],
11	extension	NN	O	extension	prep_for	4	SENT_53	[p4l1239t1999r1545b2051],
12	was	VBD	O	be	_	0	SENT_53	[p4l1570t2014r1687b2051],
13	to	TO	O	to	aux	14	SENT_53	[p4l1717t2003r1779b2051],
14	determine	VB	O	determine	xcomp	12	SENT_53	[p4l1808t1990r2143b2051],
15	whether	IN	O	whether	complm	27	SENT_53	[p4l10t2082r273b2143],
16	the	DT	O	the	det	17	SENT_53	[p4l297t2082r395b2143],
17	changes	NNS	O	change	nsubj	27	SENT_53	[p4l423t2082r670b2165],
18	from	IN	O	from	_	0	SENT_53	[p4l697t2082r847b2143],
19	baseline	NN	O	baseline	prep_from	17	SENT_53	[p4l872t2082r1126b2143],
20	observed	VBN	O	observe	partmod	19	SENT_53	[p4l1153t2082r1436b2143],
21	in	IN	O	in	_	0	SENT_53	[p4l1460t2091r1519b2142],
22	part	NN	O	part	nn	23	SENT_53	[p4l1543t2095r1670b2165],
23	A	NN	O	a	prep_in	20	SENT_53	[p4l1693t2088r1744b2142],
24	of	IN	O	of	_	0	SENT_53	[p4l1769t2082r1836b2143],
25	the	DT	O	the	det	26	SENT_53	[p4l1853t2082r1952b2143],
26	study	NN	O	study	prep_of	23	SENT_53	[p4l1980t2082r2148b2165],
27	persisted	VBD	O	persist	ccomp	14	SENT_53	[p4l12t2174r314b2257],
28	.	.	O	.	_	0	SENT_53	[p4l12t2174r314b2257],

1	Prespeciﬁed	JJ	O	prespeciﬁed	amod	3	SENT_54	[p4l349t2174r743b2257],
2	eligibility	NN	O	eligibility	nn	3	SENT_54	[p4l772t2174r1067b2257],
3	criteria	NNS	O	criterion	nsubj	9	SENT_54	[p4l1094t2183r1321b2234],
4	for	IN	O	for	_	0	SENT_54	[p4l1348t2174r1440b2234],
5	enrollment	NN	O	enrollment	prep_for	3	SENT_54	[p4l1468t2174r1821b2234],
6	in	IN	O	in	_	0	SENT_54	[p4l1848t2183r1908b2234],
7	part	NN	O	part	nn	8	SENT_54	[p4l1937t2187r2066b2256],
8	B	NN	O	b	prep_in	5	SENT_54	[p4l2097t2179r2141b2234],
9	included	VBD	O	include	_	0	SENT_54	[p4l13t2266r291b2327],
10	either	CC	O	either	prep	9	SENT_54	[p4l315t2266r504b2327],
11	2	CD	PERCENT	2	number	13	SENT_54	[p4l530t2278r584b2320],
12	10	CD	PERCENT	10	number	13	SENT_54	[p4l605t2271r738b2326],
13	%	NN	PERCENT	%	amod	14	SENT_54	[p4l605t2271r738b2326],
14	change	NN	O	change	dep	10	SENT_54	[p4l766t2266r990b2349],
15	relative	JJ	O	relative	amod	14	SENT_54	[p4l1016t2266r1248b2327],
16	to	TO	O	to	_	0	SENT_54	[p4l1273t2279r1334b2327],
17	baseline	NN	O	baseline	prep_to	15	SENT_54	[p4l1358t2266r1617b2327],
18	in	IN	O	in	_	0	SENT_54	[p4l1642t2275r1702b2326],
19	F	NN	O	f	prep_in	17	SENT_54	[p4l1727t2272r1773b2326],
20	EV1	CD	PERCENT	ev1	num	21	SENT_54	[p4l1779t2272r1900b2346],
21	%	NN	PERCENT	%	dep	15	SENT_54	[p4l1929t2271r1986b2326],
22	predicted	VBN	O	predict	partmod	14	SENT_54	[p4l2012t2290r2143b2349, p4l14t2358r220b2419],
23	at	IN	O	at	_	0	SENT_54	[p4l252t2371r310b2419],
24	any	DT	O	any	det	26	SENT_54	[p4l342t2382r456b2441],
25	time	NN	O	time	nn	26	SENT_54	[p4l485t2367r632b2419],
26	point	NN	O	point	prep_at	22	SENT_54	[p4l664t2367r837b2441],
27	through	IN	O	through	_	0	SENT_54	[p4l868t2358r1131b2441],
28	week	NN	DURATION	week	prep_through	22	SENT_54	[p4l1161t2358r1334b2419],
29	16	CD	NUMBER	16	num	28	SENT_54	[p4l1369t2364r1459b2430],
30	,	,	O	,	_	0	SENT_54	[p4l1369t2364r1459b2430],
31	or	CC	O	or	_	0	SENT_54	[p4l1495t2383r1563b2419],
32	a	DT	O	a	det	36	SENT_54	[p4l1594t2382r1627b2419],
33	sweat	NN	O	sweat	nn	36	SENT_54	[p4l1659t2371r1842b2419],
34	chloride	NN	O	chloride	nn	36	SENT_54	[p4l1873t2358r2143b2419],
35	concentration	NN	O	concentration	nn	36	SENT_54	[p4l13t2459r462b2511],
36	reduction	NN	O	reduction	conj_or	14	SENT_54	[p4l491t2450r804b2511],
37	from	IN	O	from	_	0	SENT_54	[p4l833t2450r988b2511],
38	baseline	NN	O	baseline	prep_from	36	SENT_54	[p4l1016t2450r1280b2511],
39	2	CD	NUMBER	2	number	40	SENT_54	[p4l1315t2462r1369b2504],
40	15	CD	NUMBER	15	num	41	SENT_54	[p4l1391t2452r1462b2510],
41	mmol/L	NN	O	mmol/l	npadvmod	42	SENT_54	[p4l1492t2450r1753b2511],
42	at	IN	O	at	advmod	38	SENT_54	[p4l1781t2463r1838b2511],
43	both	CC	O	both	preconj	36	SENT_54	[p4l1865t2450r2013b2511],
44	the	DT	DATE	the	det	45	SENT_54	[p4l2041t2450r2143b2511],
45	day	NN	DATE	day	conj_and	36	SENT_54	[p4l14t2543r126b2626],
46	15	CD	NUMBER	15	dep	45	SENT_54	[p4l153t2546r223b2603],
47	and	CC	O	and	_	0	SENT_54	[p4l251t2543r369b2604],
48	week	NN	DURATION	week	conj_and	36	SENT_54	[p4l389t2543r560b2604],
49	8	CD	NUMBER	8	num	50	SENT_54	[p4l584t2548r619b2603],
50	visits	NNS	O	visit	dep	48	SENT_54	[p4l642t2552r818b2604],
51	.	.	O	.	_	0	SENT_54	[p4l642t2552r818b2604],

1	Interim	JJ	O	interim	amod	2	SENT_55	[p4l848t2549r1095b2604],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_55	[p4l1122t2543r1382b2626],
3	were	VBD	O	be	auxpass	4	SENT_55	[p4l1407t2567r1565b2604],
4	planned	VBN	O	plan	_	0	SENT_55	[p4l1590t2543r1855b2626],
5	to	TO	O	to	aux	6	SENT_55	[p4l1878t2556r1940b2604],
6	occur	VB	O	occur	xcomp	4	SENT_55	[p4l1966t2567r2146b2604],
7	every	DT	SET	every	det	9	SENT_55	[p4l14t2659r196b2718],
8	6	CD	SET	6	num	9	SENT_55	[p4l225t2641r260b2696],
9	months	NNS	NUMBER	month	dobj	6	SENT_55	[p4l292t2635r559b2707],
10	,	,	O	,	_	0	SENT_55	[p4l292t2635r559b2707],
11	the	DT	O	the	det	12	SENT_55	[p4l592t2635r698b2696],
12	first	JJ	ORDINAL	first	nsubjpass	16	SENT_55	[p4l730t2635r859b2696],
13	of	IN	O	of	_	0	SENT_55	[p4l889t2635r960b2696],
14	which	WDT	O	which	prep_of	12	SENT_55	[p4l980t2635r1182b2696],
15	was	VBD	O	be	auxpass	16	SENT_55	[p4l1210t2660r1330b2696],
16	performed	VBN	O	perform	rcmod	9	SENT_55	[p4l1362t2635r1724b2718],
17	at	IN	O	at	_	0	SENT_55	[p4l1755t2648r1814b2696],
18	week	NN	DURATION	week	prep_at	16	SENT_55	[p4l1840t2635r2017b2696],
19	40	CD	NUMBER	40	num	18	SENT_55	[p4l2044t2641r2140b2696],
20	.	.	O	.	_	0	SENT_55	[p4l2044t2641r2140b2696],

1	The	DT	O	the	det	2	SENT_56	[p4l12t2727r143b2787],
2	protocol	NN	O	protocol	nsubjpass	4	SENT_56	[p4l176t2727r458b2810],
3	was	VBD	O	be	auxpass	4	SENT_56	[p4l488t2751r608b2787],
4	approved	VBN	O	approve	_	0	SENT_56	[p4l644t2727r959b2810],
5	by	IN	O	by	_	0	SENT_56	[p4l989t2727r1070b2809],
6	each	DT	O	each	det	7	SENT_56	[p4l1100t2727r1253b2787],
7	site	NN	O	site	poss	11	SENT_56	[p4l1287t2732r1449b2787],
8	’s	POS	O	’s	_	0	SENT_56	[p4l1287t2732r1449b2787],
9	institutional	JJ	O	institutional	amod	11	SENT_56	[p4l1483t2727r1891b2787],
10	review	NN	O	review	nn	11	SENT_56	[p4l1924t2736r2148b2787],
11	board	NN	O	board	agent	4	SENT_56	[p4l12t2819r213b2891],
12	,	,	O	,	_	0	SENT_56	[p4l12t2819r213b2891],
13	and	CC	O	and	_	0	SENT_56	[p4l242t2819r358b2880],
14	subjects	NNS	O	subject	nsubj	15	SENT_56	[p4l382t2819r634b2902],
15	provided	VBD	O	provide	conj_and	4	SENT_56	[p4l660t2819r945b2902],
16	written	VBN	O	write	dep	15	SENT_56	[p4l966t2828r1196b2880],
17	informed	VBN	O	inform	amod	18	SENT_56	[p4l1220t2819r1517b2880],
18	consent	NN	O	consent	dobj	16	SENT_56	[p4l1541t2832r1787b2880],
19	and	CC	O	and	_	0	SENT_56	[p4l1812t2819r1928b2880],
20	assent	NN	O	assent	conj_and	18	SENT_56	[p4l1953t2832r2146b2880],
21	as	IN	O	as	_	0	SENT_56	[p4l14t2936r73b2973],
22	applicable	JJ	O	applicable	prep_as	18	SENT_56	[p4l99t2912r444b2995],
23	.	.	O	.	_	0	SENT_56	[p4l99t2912r444b2995],

1	The	DT	O	the	det	2	SENT_57	[p4l106t3005r233b3065],
2	study	NN	O	study	nsubj	3	SENT_57	[p4l268t3005r442b3087],
3	included	VBD	O	include	_	0	SENT_57	[p4l470t3005r754b3065],
4	clinically	RB	O	clinically	advmod	5	SENT_57	[p4l785t3005r1071b3087],
5	stable	JJ	O	stable	amod	6	SENT_57	[p4l1101t3005r1287b3066],
6	subjects	NNS	O	subject	dobj	3	SENT_57	[p4l1321t3005r1579b3088],
7	aged	JJ	O	aged	amod	6	SENT_57	[p4l1614t3005r1765b3088],
8	2	CD	NUMBER	2	tmod	7	SENT_57	[p4l1800t3017r1854b3058],
9	12	CD	DURATION	12	num	10	SENT_57	[p4l1876t3010r1947b3065],
10	years	NNS	NUMBER	year	tmod	6	SENT_57	[p4l1978t3029r2143b3087],
11	with	IN	O	with	_	0	SENT_57	[p4l10t3097r158b3158],
12	CF	NN	O	cf	prep_with	3	SENT_57	[p4l183t3102r298b3169],
13	,	,	O	,	_	0	SENT_57	[p4l183t3102r298b3169],
14	homozygous	JJ	O	homozygous	dep	3	SENT_57	[p4l325t3097r741b3180],
15	for	IN	O	for	_	0	SENT_57	[p4l768t3097r864b3158],
16	the	DT	O	the	det	18	SENT_57	[p4l887t3097r992b3158],
17	F	NN	O	f	nn	18	SENT_57	[p4l1017t3102r1063b3157],
18	508del	NN	O	508del	prep_for	14	SENT_57	[p4l1066t3097r1424b3158],
19	.	.	O	.	_	0	SENT_57	[p4l1066t3097r1424b3158],

1	—	NN	O	—	_	0	SENT_58	[p4l1066t3097r1424b3158],
2	.	.	O	.	_	0	SENT_58	[p4l1066t3097r1424b3158],

1	CF	NN	O	cf	nn	3	SENT_59	[p4l1066t3097r1424b3158],
2	TR	NN	O	tr	nn	3	SENT_59	[p4l1429t3102r1524b3157],
3	mutation	NN	O	mutation	nsubj	11	SENT_59	[p4l1550t3106r1871b3169],
4	,	,	O	,	_	0	SENT_59	[p4l1550t3106r1871b3169],
5	with	IN	O	with	_	0	SENT_59	[p4l1896t3097r2043b3158],
6	an	DT	O	a	det	7	SENT_59	[p4l2069t3121r2144b3158],
7	FEVI	NN	O	fevus	prep_with	3	SENT_59	[p4l15t3195r189b3269],
8	2	CD	PERCENT	2	number	10	SENT_59	[p4l223t3202r276b3243],
9	40	CD	PERCENT	40	number	10	SENT_59	[p4l293t3195r434b3250],
10	%	NN	PERCENT	%	amod	7	SENT_59	[p4l293t3195r434b3250],
11	predicted	VBN	O	predict	_	0	SENT_59	[p4l463t3189r778b3272],
12	at	IN	O	at	_	0	SENT_59	[p4l805t3202r862b3250],
13	screening	NN	O	screening	prep_at	11	SENT_59	[p4l889t3198r1216b3272],
14	.	.	O	.	_	0	SENT_59	[p4l889t3198r1216b3272],

1	Subjects	NNS	O	subject	nsubj	2	SENT_60	[p4l1251t3189r1519b3272],
2	remained	VBD	O	remain	_	0	SENT_60	[p4l1549t3189r1859b3250],
3	on	IN	O	on	_	0	SENT_60	[p4l1885t3214r1964b3250],
4	their	PRP$	O	they	poss	8	SENT_60	[p4l1991t3189r2147b3250],
5	prestudy	JJ	O	prestudy	amod	8	SENT_60	[p4l11t3281r288b3363],
6	stable	JJ	O	stable	amod	8	SENT_60	[p4l314t3281r491b3342],
7	medication	NN	O	medication	nn	8	SENT_60	[p4l521t3281r868b3341],
8	regimens	NNS	O	regimen	prep_on	2	SENT_60	[p4l897t3290r1181b3363],
9	throughout	IN	O	throughout	_	0	SENT_60	[p4l1210t3281r1563b3364],
10	the	DT	O	the	det	11	SENT_60	[p4l1589t3281r1688b3341],
11	study	NN	O	study	prep_throughout	2	SENT_60	[p4l1718t3281r1892b3363],
12	,	,	O	,	_	0	SENT_60	[p4l1718t3281r1892b3363],
13	including	VBG	O	include	_	0	SENT_60	[p4l1922t3281r2143b3341, p4l12t3382r114b3456],
14	cycling	NN	O	cycling	prep_including	2	SENT_60	[p4l141t3373r372b3456],
15	inhaled	VBD	O	inhale	partmod	14	SENT_60	[p4l398t3373r644b3434],
16	antibiotics	NNS	O	antibiotic	dobj	15	SENT_60	[p4l671t3373r1029b3434],
17	.	.	O	.	_	0	SENT_60	[p4l671t3373r1029b3434],

1	Use	NN	O	use	nsubjpass	17	SENT_61	[p4l1063t3379r1186b3434],
2	of	IN	O	of	_	0	SENT_61	[p4l1216t3373r1286b3434],
3	inhaled	VBN	O	inhale	prepc_of	1	SENT_61	[p4l1304t3373r1551b3434],
4	hypertonic	JJ	O	hypertonic	amod	5	SENT_61	[p4l1576t3373r1933b3456],
5	saline	NN	O	saline	dobj	3	SENT_61	[p4l1962t3373r2143b3434],
6	or	CC	O	or	_	0	SENT_61	[p4l14t3490r80b3526],
7	known	VBN	O	know	conj_or	3	SENT_61	[p4l105t3465r317b3526],
8	inhibitors	NNS	O	inhibitor	dobj	7	SENT_61	[p4l344t3465r646b3526],
9	or	CC	O	or	_	0	SENT_61	[p4l675t3490r742b3526],
10	inducers	NNS	O	inducer	dobj	7	SENT_61	[p4l767t3465r1038b3526],
11	of	IN	O	of	_	0	SENT_61	[p4l1068t3465r1136b3526],
12	cytochrome	NN	O	cytochrome	nn	14	SENT_61	[p4l1156t3465r1530b3548],
13	P450	NN	O	p450	nn	14	SENT_61	[p4l1559t3468r1719b3526],
14	3A4	NN	O	3a4	prep_of	8	SENT_61	[p4l1747t3471r1872b3526],
15	was	VBD	O	be	auxpass	17	SENT_61	[p4l1897t3489r2013b3526],
16	not	RB	O	not	neg	17	SENT_61	[p4l2042t3478r2146b3526],
17	allowed	VBN	O	allow	_	0	SENT_61	[p4l14t3557r277b3618],
18	.	.	O	.	_	0	SENT_61	[p4l14t3557r277b3618],

1	End	NN	O	end	nn	2	SENT_62	[p5l11t91r148b152],
2	Points	NNS	O	point	_	0	SENT_62	[p5l169t98r366b152],

1	The	DT	O	the	det	4	SENT_63	[p5l106t241r233b302],
2	primary	JJ	O	primary	amod	4	SENT_63	[p5l253t250r512b324],
3	end	NN	O	end	nn	4	SENT_63	[p5l529t241r651b302],
4	point	NN	O	point	nsubjpass	8	SENT_63	[p5l668t250r838b324],
5	of	IN	O	of	_	0	SENT_63	[p5l857t241r926b302],
6	safety	NN	O	safety	prep_of	4	SENT_63	[p5l939t241r1126b324],
7	was	VBD	O	be	auxpass	8	SENT_63	[p5l1140t265r1258b302],
8	evaluated	VBN	O	evaluate	_	0	SENT_63	[p5l1280t241r1591b302],
9	by	IN	O	by	_	0	SENT_63	[p5l1608t241r1688b324],
10	assessment	NN	O	assessment	agent	8	SENT_63	[p5l1705t254r2064b302],
11	of	IN	O	of	_	0	SENT_63	[p5l2083t241r2153b302],
12	adverse	JJ	O	adverse	amod	13	SENT_63	[p5l14t333r258b394],
13	events	NNS	O	event	prep_of	10	SENT_63	[p5l289t346r511b405],
14	,	,	O	,	_	0	SENT_63	[p5l289t346r511b405],
15	clinical	JJ	O	clinical	amod	17	SENT_63	[p5l544t333r772b394],
16	laboratory	NN	O	laboratory	nn	17	SENT_63	[p5l801t333r1134b416],
17	values	NNS	O	value	conj_and	13	SENT_63	[p5l1158t333r1376b405],
18	,	,	O	,	_	0	SENT_63	[p5l1158t333r1376b405],
19	ECGS	NNS	O	ecg	conj_and	13	SENT_63	[p5l1410t338r1624b405],
20	,	,	O	,	_	0	SENT_63	[p5l1410t338r1624b405],
21	vital	JJ	O	vital	amod	22	SENT_63	[p5l1654t333r1791b394],
22	signs	NNS	O	sign	conj_and	13	SENT_63	[p5l1821t342r1994b416],
23	,	,	O	,	_	0	SENT_63	[p5l1821t342r1994b416],
24	and	CC	O	and	_	0	SENT_63	[p5l2028t333r2146b394],
25	physical	JJ	O	physical	amod	26	SENT_63	[p5l11t426r262b508],
26	examinations	NNS	O	examination	conj_and	13	SENT_63	[p5l291t434r713b486],
27	.	.	O	.	_	0	SENT_63	[p5l291t434r713b486],

1	ECG	NN	O	ecg	nn	2	SENT_64	[p5l747t431r911b486],
2	monitoring	NN	O	monitoring	nsubj	3	SENT_64	[p5l940t434r1288b508],
3	included	VBD	O	include	_	0	SENT_64	[p5l1315t425r1589b486],
4	standard	JJ	O	standard	amod	6	SENT_64	[p5l1617t425r1887b486],
5	12	CD	NUMBER	12	number	6	SENT_64	[p5l1918t425r2146b486],
6	—	CD	NUMBER	—	dobj	3	SENT_64	[p5l1918t425r2146b486],
7	lead	NN	O	lead	dep	6	SENT_64	[p5l1918t425r2146b486],
8	digital	JJ	O	digital	amod	7	SENT_64	[p5l14t517r223b600],
9	and	CC	O	and	_	0	SENT_64	[p5l262t517r382b578],
10	24-h	JJ	O	24-h	amod	13	SENT_64	[p5l419t517r570b577],
11	ambulatory	JJ	O	ambulatory	amod	13	SENT_64	[p5l609t517r994b600],
12	ECG	NN	O	ecg	nn	13	SENT_64	[p5l1030t522r1200b578],
13	(	NN	O	(	dobj	3	SENT_64	[p5l1243t517r1623b589],
14	conducted	VBN	O	conduct	partmod	13	SENT_64	[p5l1243t517r1623b589],
15	at	IN	O	at	_	0	SENT_64	[p5l1661t530r1719b578],
16	day	NN	DURATION	day	prep_at	14	SENT_64	[p5l1757t517r1873b600],
17	14	CD	NUMBER	14	num	16	SENT_64	[p5l1912t522r1985b577],
18	and	CC	O	and	_	0	SENT_64	[p5l2025t517r2146b578],
19	week	NN	DURATION	week	advmod	6	SENT_64	[p5l10t609r186b670],
20	16	CD	NUMBER	16	num	21	SENT_64	[p5l220t614r293b669],
21	visits	NNS	O	visit	conj_and	6	SENT_64	[p5l322t609r537b681],
22	)	CD	NUMBER	)	dep	21	SENT_64	[p5l322t609r537b681],
23	;	:	O	;	_	0	SENT_64	[p5l322t609r537b681],
24	data	NNS	O	datum	nsubjpass	26	SENT_64	[p5l572t609r714b670],
25	were	VBD	O	be	auxpass	26	SENT_64	[p5l740t633r904b670],
26	interpreted	VBN	O	interpret	parataxis	3	SENT_64	[p5l936t609r1323b692],
27	by	IN	O	by	_	0	SENT_64	[p5l1353t609r1433b692],
28	a	DT	O	a	det	29	SENT_64	[p5l1463t633r1496b670],
29	cardiologist	NN	O	cardiologist	agent	26	SENT_64	[p5l1526t609r1918b692],
30	at	IN	O	at	_	0	SENT_64	[p5l1949t622r2008b670],
31	the	DT	O	the	det	34	SENT_64	[p5l2038t609r2143b670],
32	Central	NNP	O	Central	nn	34	SENT_64	[p5l14t700r258b761],
33	ECG	NNP	O	ECG	nn	34	SENT_64	[p5l282t706r450b761],
34	laboratory	NN	O	laboratory	prep_at	29	SENT_64	[p5l472t701r812b783],
35	.	.	O	.	_	0	SENT_64	[p5l472t701r812b783],

1	The	DT	O	the	det	5	SENT_65	[p5l106t793r238b854],
2	primary	JJ	O	primary	amod	5	SENT_65	[p5l277t802r551b876],
3	efficacy	NN	O	efficacy	nn	5	SENT_65	[p5l587t793r853b876],
4	end	NN	O	end	nn	5	SENT_65	[p5l890t793r1016b854],
5	point	NN	O	point	nsubj	9	SENT_65	[p5l1052t802r1232b876],
6	was	VBD	O	be	cop	9	SENT_65	[p5l1267t817r1389b854],
7	the	DT	O	the	det	9	SENT_65	[p5l1429t793r1536b854],
8	absolute	JJ	O	absolute	amod	9	SENT_65	[p5l1578t793r1863b854],
9	change	NN	O	change	_	0	SENT_65	[p5l1904t793r2143b876],
10	in	IN	O	in	_	0	SENT_65	[p5l12t894r75b945],
11	FEV1	NN	PERCENT	fev1	nn	12	SENT_65	[p5l104t891r284b965],
12	%	NN	PERCENT	%	prep_in	9	SENT_65	[p5l316t890r372b945],
13	predicted	VBN	O	predict	partmod	12	SENT_65	[p5l402t885r730b968],
14	from	IN	O	from	_	0	SENT_65	[p5l756t885r916b946],
15	baseline	NN	O	baseline	prep_from	13	SENT_65	[p5l944t885r1220b946],
16	through	IN	O	through	_	0	SENT_65	[p5l1248t885r1516b968],
17	week	NN	DURATION	week	prep_through	13	SENT_65	[p5l1541t885r1717b946],
18	16	CD	NUMBER	16	num	17	SENT_65	[p5l1747t890r1838b946],
19	.	.	O	.	_	0	SENT_65	[p5l1747t890r1838b946],

1	Secondary	JJ	O	secondary	amod	4	SENT_66	[p5l1873t885r2143b946, p5l14t1002r116b1060],
2	efﬁcacy	NN	O	efﬁcacy	nn	4	SENT_66	[p5l157t977r413b1060],
3	end	NN	O	end	nn	4	SENT_66	[p5l454t977r578b1038],
4	points	NNS	O	point	nsubj	6	SENT_66	[p5l619t986r824b1060],
5	were	VBD	O	be	cop	6	SENT_66	[p5l865t1002r1030b1038],
6	change	NN	O	change	dep	24	SENT_66	[p5l1074t978r1310b1060],
7	from	IN	O	from	_	0	SENT_66	[p5l1355t978r1514b1038],
8	baseline	NN	O	baseline	prep_from	6	SENT_66	[p5l1557t978r1833b1039],
9	through	IN	O	through	_	0	SENT_66	[p5l1877t977r2145b1060],
10	week	NN	DURATION	week	prep_through	6	SENT_66	[p5l10t1069r181b1130],
11	16	CD	NUMBER	16	num	10	SENT_66	[p5l214t1074r285b1129],
12	in	IN	O	in	_	0	SENT_66	[p5l315t1078r376b1129],
13	sweat	NN	O	sweat	nn	15	SENT_66	[p5l407t1082r586b1130],
14	chloride	NN	O	chloride	nn	15	SENT_66	[p5l616t1069r880b1130],
15	concentration	NN	O	concentration	prep_in	10	SENT_66	[p5l912t1078r1378b1141],
16	,	,	O	,	_	0	SENT_66	[p5l912t1078r1378b1141],
17	change	NN	O	change	conj_and	15	SENT_66	[p5l1411t1069r1639b1152],
18	in	IN	O	in	_	0	SENT_66	[p5l1670t1078r1731b1129],
19	weight	NN	O	weight	prep_in	17	SENT_66	[p5l1758t1069r1994b1152],
20	,	,	O	,	_	0	SENT_66	[p5l1758t1069r1994b1152],
21	and	CC	O	and	_	0	SENT_66	[p5l2028t1069r2146b1130],
22	patient	NN	O	patient	prep_in	10	SENT_66	[p5l11t1161r541b1244],
23	—	RB	O	—	advmod	24	SENT_66	[p5l11t1161r541b1244],
24	reported	VBD	O	report	_	0	SENT_66	[p5l11t1161r541b1244],
25	health	NN	O	health	dobj	24	SENT_66	[p5l572t1161r771b1222],
26	using	VBG	O	use	xcomp	24	SENT_66	[p5l803t1170r972b1244],
27	the	DT	O	the	det	30	SENT_66	[p5l1004t1161r1104b1222],
28	disease	NN	O	disease	nn	30	SENT_66	[p5l1139t1161r1629b1244],
29	—	NN	O	—	nn	30	SENT_66	[p5l1139t1161r1629b1244],
30	speciﬁc	NN	O	speciﬁc	dobj	26	SENT_66	[p5l1139t1161r1629b1244],
31	Cystic	JJ	MISC	cystic	amod	33	SENT_66	[p5l1663t1166r1857b1244],
32	Fibrosis	NNP	MISC	Fibrosis	nn	33	SENT_66	[p5l1891t1161r2143b1222],
33	Questionnaire	NNP	MISC	Questionnaire	nsubj	24	SENT_66	[p5l15t1252r863b1330],
34	.	.	O	.	_	0	SENT_66	[p5l15t1252r863b1330],

1	—	NN	O	—	_	0	SENT_67	[p5l15t1252r863b1330],
2	.	.	O	.	_	0	SENT_67	[p5l15t1252r863b1330],

1	Revised	VBN	O	revise	dep	5	SENT_68	[p5l15t1252r863b1330],
2	.15	CD	NUMBER	.15	num	3	SENT_68	[p5l15t1252r863b1330],
3	Spirometry	NN	O	spirometry	nsubjpass	5	SENT_68	[p5l889t1258r1269b1335],
4	was	VBD	O	be	auxpass	5	SENT_68	[p5l1286t1277r1406b1313],
5	performed	VBN	O	perform	_	0	SENT_68	[p5l1430t1253r1793b1335],
6	according	VBG	O	accord	_	0	SENT_68	[p5l1817t1252r2146b1335],
7	to	TO	O	to	prepc_according_to	5	SENT_68	[p5l12t1358r76b1406],
8	American	NNP	ORGANIZATION	American	nn	11	SENT_68	[p5l101t1350r429b1406],
9	Thoracic	NNP	ORGANIZATION	Thoracic	nn	11	SENT_68	[p5l455t1345r752b1406],
10	Society	NNP	ORGANIZATION	Society	nn	11	SENT_68	[p5l782t1350r1026b1428],
11	guidelines	NNS	O	guideline	pobj	5	SENT_68	[p5l1050t1345r1465b1428],
12	.	.	O	.	_	0	SENT_68	[p5l1050t1345r1465b1428],

1	”	NN	O	”	nn	2	SENT_69	[p5l1050t1345r1465b1428],
2	Sweat	NN	O	sweat	nsubjpass	25	SENT_69	[p5l1494t1350r1691b1406],
3	chloride	NN	O	chloride	nn	4	SENT_69	[p5l1717t1345r1993b1406],
4	collection	NN	O	collection	dep	2	SENT_69	[p5l2021t1345r2143b1406, p5l13t1438r227b1499],
5	was	VBD	O	be	auxpass	6	SENT_69	[p5l252t1462r368b1499],
6	performed	VBN	O	perform	_	0	SENT_69	[p5l396t1438r740b1521],
7	according	VBG	O	accord	_	0	SENT_69	[p5l767t1438r1077b1521],
8	to	TO	O	to	prepc_according_to	6	SENT_69	[p5l1103t1451r1164b1499],
9	a	DT	O	a	det	11	SENT_69	[p5l1193t1462r1226b1499],
10	standardized	JJ	O	standardized	amod	11	SENT_69	[p5l1253t1438r1660b1499],
11	protocol	NN	O	protocol	pobj	6	SENT_69	[p5l1684t1438r1950b1521],
12	using	VBG	O	use	partmod	11	SENT_69	[p5l1977t1447r2146b1521],
13	the	DT	O	the	det	15	SENT_69	[p5l13t1529r118b1589],
14	Macroduct	NN	O	macroduct	nn	15	SENT_69	[p5l146t1528r513b1589],
15	(	NN	O	(	dobj	12	SENT_69	[p5l539t1529r825b1601],
16	Wescor	NNP	O	Wescor	nn	18	SENT_69	[p5l539t1529r825b1601],
17	,	,	O	,	_	0	SENT_69	[p5l539t1529r825b1601],
18	Inc	NNP	ORGANIZATION	Inc	tmod	12	SENT_69	[p5l853t1529r985b1601],
19	)	CD	NUMBER	)	num	18	SENT_69	[p5l853t1529r985b1601],
20	collection	NN	O	collection	nn	22	SENT_69	[p5l1013t1528r1342b1589],
21	device	NN	O	device	nn	22	SENT_69	[p5l1366t1528r1631b1589],
22	”	NN	O	”	dep	18	SENT_69	[p5l1366t1528r1631b1589],
23	and	CC	O	and	_	0	SENT_69	[p5l1654t1529r1775b1589],
24	was	VBD	O	be	auxpass	25	SENT_69	[p5l1795t1553r1915b1589],
25	evaluated	VBN	O	evaluate	conj_and	6	SENT_69	[p5l1942t1529r2143b1589, p5l14t1622r152b1683],
26	centrally	RB	O	centrally	advmod	25	SENT_69	[p5l175t1622r463b1705],
27	.	.	O	.	_	0	SENT_69	[p5l175t1622r463b1705],

1	Analyses	NNS	O	analysis	_	0	SENT_70	[p5l105t1714r385b1797],
2	of	IN	O	of	_	0	SENT_70	[p5l417t1714r487b1775],
3	other	JJ	O	other	amod	6	SENT_70	[p5l509t1714r683b1775],
4	clinically	RB	O	clinically	advmod	5	SENT_70	[p5l711t1714r998b1797],
5	relevant	JJ	O	relevant	amod	6	SENT_70	[p5l1026t1714r1288b1775],
6	events	NNS	O	event	prep_of	1	SENT_70	[p5l1318t1727r1540b1786],
7	,	,	O	,	_	0	SENT_70	[p5l1318t1727r1540b1786],
8	including	VBG	O	include	_	0	SENT_70	[p5l1573t1714r1878b1797],
9	time	NN	O	time	prep_including	6	SENT_70	[p5l1907t1723r2051b1775],
10	to	TO	O	to	_	0	SENT_70	[p5l2082t1727r2144b1775],
11	first	JJ	ORDINAL	first	amod	13	SENT_70	[p5l14t1806r143b1867],
12	pulmonary	JJ	O	pulmonary	amod	13	SENT_70	[p5l170t1807r537b1889],
13	exacerbation	NN	O	exacerbation	prep_to	9	SENT_70	[p5l564t1807r1012b1878],
14	,	,	O	,	_	0	SENT_70	[p5l564t1807r1012b1878],
15	duration	NN	O	duration	nsubj	20	SENT_70	[p5l1046t1806r1331b1867],
16	and	CC	O	and	_	0	SENT_70	[p5l1362t1807r1483b1867],
17	frequency	NN	O	frequency	nsubj	20	SENT_70	[p5l1512t1807r1854b1889],
18	of	IN	O	of	_	0	SENT_70	[p5l1881t1806r1952b1867],
19	exacerbations	NNS	O	exacerbation	prep_of	15	SENT_70	[p5l1974t1831r2143b1867, p5l14t1898r324b1959],
20	using	VBG	O	use	rcmod	6	SENT_70	[p5l353t1907r532b1981],
21	a	DT	O	a	det	24	SENT_70	[p5l560t1922r593b1959],
22	modiﬁed	JJ	O	modiﬁed	amod	24	SENT_70	[p5l619t1898r917b1959],
23	Fuchs	NNP	PERSON	Fuchs	nn	24	SENT_70	[p5l945t1898r1147b1959],
24	deﬁnition	NN	O	deﬁnition	dobj	20	SENT_70	[p5l1178t1898r1571b1969],
25	,	,	O	,	_	0	SENT_70	[p5l1178t1898r1571b1969],
26	“	CD	NUMBER	“	num	27	SENT_70	[p5l1178t1898r1571b1969],
27	hospitalizations	NNS	O	hospitalization	dobj	20	SENT_70	[p5l1598t1898r2142b1981],
28	,	,	O	,	_	0	SENT_70	[p5l1598t1898r2142b1981],
29	and	CC	O	and	_	0	SENT_70	[p5l14t1991r135b2052],
30	use	NN	O	use	dobj	20	SENT_70	[p5l164t2015r274b2052],
31	of	IN	O	of	_	0	SENT_70	[p5l306t1991r377b2052],
32	antibiotics	NNS	O	antibiotic	prep_of	30	SENT_70	[p5l400t1991r748b2052],
33	for	IN	O	for	_	0	SENT_70	[p5l781t1991r877b2052],
34	sinopulmonary	JJ	O	sinopulmonary	amod	35	SENT_70	[p5l907t1991r1410b2074],
35	signs	NNS	O	sign	prep_for	32	SENT_70	[p5l1439t2000r1600b2074],
36	and	CC	O	and	_	0	SENT_70	[p5l1633t1991r1754b2052],
37	symptoms	NNS	O	symptom	prep_for	32	SENT_70	[p5l1785t2004r2142b2074],
38	,	,	O	,	_	0	SENT_70	[p5l1785t2004r2142b2074],

1	were	VBD	O	be	cop	5	SENT_71	[p5l10t2140r169b2176],
2	prespecified	JJ	O	prespecified	amod	5	SENT_71	[p5l199t2115r599b2198],
3	tertiary	JJ	O	tertiary	amod	5	SENT_71	[p5l627t2124r866b2198],
4	end	NN	O	end	nn	5	SENT_71	[p5l893t2116r1015b2176],
5	points	NNS	O	point	_	0	SENT_71	[p5l1042t2124r1256b2198],
6	.	.	O	.	_	0	SENT_71	[p5l1042t2124r1256b2198],

1	Investigator	NN	O	investigator	nn	2	SENT_72	[p5l1292t2115r1987b2198],
2	—	NN	O	—	nsubj	3	SENT_72	[p5l1292t2115r1987b2198],
3	reported	VBD	O	report	_	0	SENT_72	[p5l1292t2115r1987b2198],
4	pulmonary	JJ	O	pulmonary	amod	5	SENT_72	[p5l2014t2116r2143b2198, p5l14t2232r261b2291],
5	exacerbations	NNS	O	exacerbation	nsubjpass	8	SENT_72	[p5l281t2208r720b2269],
6	were	VBD	O	be	auxpass	8	SENT_72	[p5l742t2232r901b2269],
7	also	RB	O	also	advmod	8	SENT_72	[p5l927t2208r1047b2269],
8	captured	VBN	O	capture	ccomp	3	SENT_72	[p5l1071t2208r1360b2291],
9	as	IN	O	as	_	0	SENT_72	[p5l1383t2232r1442b2269],
10	adverse	JJ	O	adverse	amod	11	SENT_72	[p5l1468t2208r1711b2269],
11	events	NNS	O	event	prep_as	8	SENT_72	[p5l1736t2221r1957b2269],
12	.	.	O	.	_	0	SENT_72	[p5l1736t2221r1957b2269],

1	Statistical	JJ	O	statistical	amod	2	SENT_73	[p5l16t2441r333b2502],
2	Analyses	NNS	O	analysis	_	0	SENT_73	[p5l351t2441r636b2524],

1	Because	IN	O	because	mark	7	SENT_74	[p5l109t2597r365b2651],
2	the	DT	O	the	det	5	SENT_74	[p5l390t2590r488b2651],
3	primary	JJ	O	primary	amod	5	SENT_74	[p5l512t2599r761b2673],
4	end	NN	O	end	nn	5	SENT_74	[p5l782t2590r900b2651],
5	point	NN	O	point	nsubj	7	SENT_74	[p5l921t2599r1086b2673],
6	was	VBD	O	be	cop	7	SENT_74	[p5l1105t2615r1219b2651],
7	safety	NN	O	safety	advcl	15	SENT_74	[p5l1246t2590r1431b2673],
8	,	,	O	,	_	0	SENT_74	[p5l1246t2590r1431b2673],
9	no	DT	O	no	det	13	SENT_74	[p5l1458t2615r1535b2651],
10	formal	JJ	O	formal	amod	13	SENT_74	[p5l1560t2590r1763b2651],
11	sample	NN	O	sample	nn	13	SENT_74	[p5l1788t2591r2006b2673],
12	size	NN	O	size	nn	13	SENT_74	[p5l2032t2599r2143b2651],
13	calculations	NNS	O	calculation	nsubjpass	15	SENT_74	[p5l13t2683r408b2744],
14	were	VBD	O	be	auxpass	15	SENT_74	[p5l434t2707r597b2744],
15	performed	VBN	O	perform	_	0	SENT_74	[p5l624t2683r1003b2766],
16	.	.	O	.	_	0	SENT_74	[p5l624t2683r1003b2766],

1	Based	VBN	O	base	_	0	SENT_75	[p5l1035t2683r1236b2744],
2	on	IN	O	on	prepc_based_on	13	SENT_75	[p5l1262t2707r1343b2744],
3	clinical	JJ	O	clinical	amod	4	SENT_75	[p5l1369t2683r1608b2744],
4	considerations	NNS	O	consideration	pobj	13	SENT_75	[p5l1635t2683r2142b2755],
5	,	,	O	,	_	0	SENT_75	[p5l1635t2683r2142b2755],
6	a	DT	O	a	det	8	SENT_75	[p5l14t2799r47b2836],
7	sample	NN	O	sample	nn	8	SENT_75	[p5l77t2775r302b2858],
8	size	NN	O	size	nsubjpass	13	SENT_75	[p5l335t2784r452b2836],
9	of	IN	O	of	_	0	SENT_75	[p5l484t2775r553b2836],
10	120	CD	NUMBER	120	num	11	SENT_75	[p5l580t2780r691b2835],
11	subjects	NNS	O	subject	prep_of	8	SENT_75	[p5l723t2775r980b2858],
12	was	VBD	O	be	auxpass	13	SENT_75	[p5l1010t2799r1127b2836],
13	selected	VBN	O	select	_	0	SENT_75	[p5l1160t2775r1425b2836],
14	to	TO	O	to	aux	15	SENT_75	[p5l1454t2788r1515b2836],
15	provide	VB	O	provide	xcomp	13	SENT_75	[p5l1545t2775r1791b2858],
16	additional	JJ	O	additional	amod	18	SENT_75	[p5l1824t2775r2145b2836],
17	safety	NN	O	safety	nn	18	SENT_75	[p5l14t2868r210b2950],
18	data	NNS	O	datum	dobj	15	SENT_75	[p5l236t2867r377b2928],
19	on	IN	O	on	_	0	SENT_75	[p5l404t2892r484b2928],
20	ivacaftor	NN	O	ivacaftor	prep_on	15	SENT_75	[p5l512t2867r806b2928],
21	in	IN	O	in	_	0	SENT_75	[p5l832t2876r894b2927],
22	this	DT	O	this	det	23	SENT_75	[p5l922t2867r1040b2928],
23	population	NN	O	population	prep_in	20	SENT_75	[p5l1069t2868r1451b2950],
24	.	.	O	.	_	0	SENT_75	[p5l1069t2868r1451b2950],

1	With	IN	O	with	_	0	SENT_76	[p5l1481t2868r1648b2928],
2	96	CD	NUMBER	96	num	3	SENT_76	[p5l1677t2873r1753b2928],
3	subjects	NNS	O	subject	prep_with	25	SENT_76	[p5l1784t2868r2052b2950],
4	in	IN	O	in	_	0	SENT_76	[p5l2082t2876r2144b2927],
5	the	DT	O	the	det	7	SENT_76	[p5l12t2959r115b3020],
6	ivacaftor	NN	O	ivacaftor	nn	7	SENT_76	[p5l149t2959r430b3020],
7	group	NN	O	group	prep_in	3	SENT_76	[p5l462t2981r668b3042],
8	,	,	O	,	_	0	SENT_76	[p5l462t2981r668b3042],
9	the	DT	O	the	det	13	SENT_76	[p5l704t2959r806b3020],
10	90	CD	PERCENT	90	number	11	SENT_76	[p5l842t2964r980b3019],
11	%	NN	PERCENT	%	amod	13	SENT_76	[p5l842t2964r980b3019],
12	CI	NN	O	ci	nn	13	SENT_76	[p5l1018t2964r1100b3020],
13	estimates	NNS	O	estimate	nsubj	25	SENT_76	[p5l1136t2968r1436b3020],
14	for	IN	O	for	_	0	SENT_76	[p5l1472t2959r1565b3020],
15	the	DT	O	the	det	19	SENT_76	[p5l1596t2959r1698b3020],
16	true	JJ	O	true	amod	19	SENT_76	[p5l1733t2972r1864b3020],
17	adverse	JJ	O	adverse	amod	19	SENT_76	[p5l1900t2959r2143b3020],
18	event	NN	O	event	nn	19	SENT_76	[p5l14t3064r194b3112],
19	rate	NN	O	rate	prep_for	13	SENT_76	[p5l225t3064r350b3112],
20	were	VBD	O	be	cop	25	SENT_76	[p5l380t3075r541b3112],
21	7.4	CD	PERCENT	7.4	number	25	SENT_76	[p5l575t3054r735b3112],
22	%	NN	PERCENT	%	dep	25	SENT_76	[p5l575t3054r735b3112],
23	and	CC	O	and	_	0	SENT_76	[p5l771t3051r890b3112],
24	19.5	CD	PERCENT	19.5	conj_and	25	SENT_76	[p5l925t3054r1122b3112],
25	%	NN	PERCENT	%	_	0	SENT_76	[p5l925t3054r1122b3112],
26	if	IN	O	if	mark	30	SENT_76	[p5l1156t3051r1208b3111],
27	12	CD	NUMBER	12	num	28	SENT_76	[p5l1236t3056r1307b3111],
28	subjects	NNS	O	subject	nsubj	30	SENT_76	[p5l1341t3051r1604b3134],
29	should	MD	O	should	aux	30	SENT_76	[p5l1638t3051r1857b3112],
30	have	VB	O	have	dep	25	SENT_76	[p5l1886t3051r2036b3112],
31	an	DT	O	a	det	33	SENT_76	[p5l2070t3075r2144b3112],
32	adverse	JJ	O	adverse	amod	33	SENT_76	[p5l14t3142r258b3203],
33	event	NN	O	event	dobj	30	SENT_76	[p5l283t3156r477b3214],
34	,	,	O	,	_	0	SENT_76	[p5l283t3156r477b3214],
35	2.8	CD	PERCENT	2.8	num	36	SENT_76	[p5l503t3148r663b3203],
36	%	NN	PERCENT	%	dobj	30	SENT_76	[p5l503t3148r663b3203],
37	and	CC	O	and	_	0	SENT_76	[p5l692t3143r809b3203],
38	12	CD	PERCENT	12	num	39	SENT_76	[p5l837t3148r972b3203],
39	%	NN	PERCENT	%	dobj	30	SENT_76	[p5l837t3148r972b3203],
40	should	MD	O	should	dep	43	SENT_76	[p5l1001t3143r1216b3203],
41	six	CD	NUMBER	six	num	42	SENT_76	[p5l1240t3151r1319b3203],
42	subjects	NNS	O	subject	nsubj	43	SENT_76	[p5l1344t3142r1601b3225],
43	have	VBP	O	have	dep	30	SENT_76	[p5l1626t3143r1774b3203],
44	an	DT	O	a	det	46	SENT_76	[p5l1801t3167r1875b3203],
45	adverse	JJ	O	adverse	amod	46	SENT_76	[p5l1900t3143r2143b3203],
46	event	NN	O	event	dobj	43	SENT_76	[p5l14t3248r210b3307],
47	,	,	O	,	_	0	SENT_76	[p5l14t3248r210b3307],
48	and	CC	O	and	_	0	SENT_76	[p5l243t3235r362b3296],
49	0.4	CD	PERCENT	0.4	num	50	SENT_76	[p5l390t3240r551b3295],
50	%	NN	PERCENT	%	conj_and	25	SENT_76	[p5l390t3240r551b3295],
51	and	CC	O	and	_	0	SENT_76	[p5l583t3235r703b3296],
52	64	CD	PERCENT	64	num	53	SENT_76	[p5l731t3240r892b3295],
53	%	NN	PERCENT	%	conj_and	50	SENT_76	[p5l731t3240r892b3295],
54	should	MD	O	should	dep	57	SENT_76	[p5l925t3235r1143b3296],
55	two	CD	NUMBER	two	num	56	SENT_76	[p5l1170t3248r1288b3296],
56	subjects	NNS	O	subject	nsubj	57	SENT_76	[p5l1318t3235r1581b3318],
57	have	VBP	O	have	dep	25	SENT_76	[p5l1610t3235r1761b3296],
58	an	DT	O	a	det	60	SENT_76	[p5l1791t3259r1866b3296],
59	adverse	JJ	O	adverse	amod	60	SENT_76	[p5l1895t3235r2143b3296],
60	event	NN	O	event	dobj	57	SENT_76	[p5l14t3341r213b3389],
61	.	.	O	.	_	0	SENT_76	[p5l14t3341r213b3389],

1	The	DT	O	the	det	2	SENT_77	[p5l242t3328r372b3389],
2	analysis	NN	O	analysis	nsubj	3	SENT_77	[p5l399t3328r653b3411],
3	suggests	VBZ	O	suggest	_	0	SENT_77	[p5l681t3341r957b3411],
4	that	IN	O	that	complm	9	SENT_77	[p5l983t3328r1115b3389],
5	this	DT	O	this	det	7	SENT_77	[p5l1138t3328r1256b3389],
6	sample	NN	O	sample	nn	7	SENT_77	[p5l1284t3328r1517b3411],
7	size	NN	O	size	nsubj	9	SENT_77	[p5l1545t3337r1666b3389],
8	was	VBD	O	be	cop	9	SENT_77	[p5l1689t3352r1809b3389],
9	adequate	JJ	O	adequate	ccomp	3	SENT_77	[p5l1837t3328r2143b3411],
10	to	TO	O	to	aux	11	SENT_77	[p5l12t3433r74b3480],
11	evaluate	VB	O	evaluate	xcomp	9	SENT_77	[p5l99t3420r364b3480],
12	the	DT	O	the	det	13	SENT_77	[p5l388t3419r490b3480],
13	safety	NN	O	safety	dobj	11	SENT_77	[p5l516t3419r704b3502],
14	of	IN	O	of	_	0	SENT_77	[p5l724t3420r793b3480],
15	this	DT	O	this	det	16	SENT_77	[p5l808t3420r921b3480],
16	drug	NN	O	drug	prep_of	13	SENT_77	[p5l946t3420r1097b3502],
17	in	IN	O	in	_	0	SENT_77	[p5l1118t3428r1179b3479],
18	this	DT	O	this	det	19	SENT_77	[p5l1201t3420r1315b3480],
19	population	NN	O	population	prep_in	16	SENT_77	[p5l1338t3420r1704b3502],
20	.	.	O	.	_	0	SENT_77	[p5l1338t3420r1704b3502],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_78	[p5l105t3512r396b3595],
2	were	VBD	O	be	auxpass	3	SENT_78	[p5l431t3536r595b3573],
3	performed	VBN	O	perform	_	0	SENT_78	[p5l632t3512r995b3595],
4	on	IN	O	on	_	0	SENT_78	[p5l1030t3536r1111b3573],
5	all	DT	O	all	det	7	SENT_78	[p5l1148t3512r1225b3573],
6	randomized	JJ	O	randomized	amod	7	SENT_78	[p5l1262t3512r1664b3573],
7	subjects	NNS	O	subject	prep_on	3	SENT_78	[p5l1700t3512r1969b3595],
8	who	WP	O	who	nsubj	9	SENT_78	[p5l2005t3512r2144b3573],
9	received	VBD	O	receive	rcmod	7	SENT_78	[p5l14t3604r289b3665],
10	at	IN	O	at	quantmod	12	SENT_78	[p5l319t3617r376b3665],
11	least	JJS	O	least	mwe	10	SENT_78	[p5l404t3604r552b3665],
12	one	CD	NUMBER	one	num	13	SENT_78	[p5l580t3628r696b3665],
13	dose	NN	O	dose	dobj	9	SENT_78	[p5l728t3604r873b3665],
14	of	IN	O	of	_	0	SENT_78	[p5l905t3604r974b3665],
15	the	DT	O	the	det	17	SENT_78	[p5l995t3604r1097b3665],
16	study	NN	O	study	nn	17	SENT_78	[p5l1129t3604r1304b3687],
17	drug	NN	O	drug	prep_of	13	SENT_78	[p5l1331t3604r1495b3687],
18	.	.	O	.	_	0	SENT_78	[p5l1331t3604r1495b3687],

1	Analyses	NNS	O	analysis	nsubjpass	5	SENT_79	[p5l1528t3604r1807b3687],
2	for	IN	O	for	_	0	SENT_79	[p5l1839t3604r1932b3665],
3	safety	NN	O	safety	prep_for	1	SENT_79	[p5l1961t3604r2148b3687],
4	are	VBP	O	be	auxpass	5	SENT_79	[p5l14t3722r112b3758],
5	presented	VBN	O	present	_	0	SENT_79	[p5l140t3697r467b3780],
6	using	VBG	O	use	xcomp	5	SENT_79	[p5l494t3706r666b3780],
7	descriptive	JJ	O	descriptive	amod	8	SENT_79	[p5l694t3697r1046b3780],
8	statistics	NNS	O	statistics	dobj	6	SENT_79	[p5l1078t3706r1347b3758],
9	only	RB	O	only	advmod	6	SENT_79	[p5l1378t3697r1516b3780],
10	and	CC	O	and	_	0	SENT_79	[p5l1542t3697r1660b3758],
11	were	VBD	O	be	auxpass	13	SENT_79	[p5l1684t3722r1843b3758],
12	not	RB	O	not	neg	13	SENT_79	[p5l1873t3711r1979b3758],
13	subjected	VBN	O	subject	conj_and	5	SENT_79	[p5l2008t3697r2143b3759, p6l7t12r215b95],

1	to	TO	O	to	_	0	SENT_80	[p6l248t25r311b73],
2	hypothesis	NN	O	hypothesis	nn	3	SENT_80	[p6l346t12r695b95],
3	testing	NN	O	testing	pobj	1	SENT_80	[p6l731t21r969b95],
4	.	.	O	.	_	0	SENT_80	[p6l731t21r969b95],

1	Primary	JJ	O	primary	amod	2	SENT_81	[p6l1009t18r1276b95],
2	analyses	NNS	O	analysis	nsubjpass	8	SENT_81	[p6l1308t12r1574b95],
3	for	IN	O	for	_	0	SENT_81	[p6l1611t12r1706b73],
4	efficacy	NN	O	efficacy	nn	6	SENT_81	[p6l1739t12r1990b95],
5	end	NN	O	end	nn	6	SENT_81	[p6l2023t12r2146b73],
6	points	NNS	O	point	prep_for	2	SENT_81	[p6l11t113r216b187],
7	were	VBD	O	be	auxpass	8	SENT_81	[p6l245t128r408b165],
8	based	VBN	O	base	_	0	SENT_81	[p6l438t104r632b165],
9	on	IN	O	on	_	0	SENT_81	[p6l661t128r741b165],
10	miXed	JJ	O	mixed	amod	13	SENT_81	[p6l771t104r1226b165],
11	—	JJ	O	—	amod	13	SENT_81	[p6l771t104r1226b165],
12	effects	NNS	O	effect	nn	13	SENT_81	[p6l771t104r1226b165],
13	models	NNS	O	model	prep_on	8	SENT_81	[p6l1258t104r1496b165],
14	for	IN	O	for	_	0	SENT_81	[p6l1527t104r1623b165],
15	repeated	VBN	O	repeat	amod	16	SENT_81	[p6l1651t104r1950b187],
16	measures	NNS	O	measure	prep_for	8	SENT_81	[p6l1979t128r2143b165, p6l14t220r177b256],
17	with	IN	O	with	_	0	SENT_81	[p6l211t196r353b256],
18	adjustments	NNS	O	adjustment	prep_with	16	SENT_81	[p6l389t196r779b278],
19	for	IN	O	for	_	0	SENT_81	[p6l816t195r909b256],
20	age	NN	O	age	nn	23	SENT_81	[p6l943t217r1049b278],
21	and	CC	O	and	_	0	SENT_81	[p6l1086t195r1204b256],
22	baseline	NN	O	baseline	nn	23	SENT_81	[p6l1236t196r1500b257],
23	FEV1	NN	O	fev1	prep_for	18	SENT_81	[p6l1538t201r1730b275],
24	.	.	O	.	_	0	SENT_81	[p6l1538t201r1730b275],

1	Analyses	NNS	O	analysis	_	0	SENT_82	[p6l1767t196r2046b278],
2	of	IN	O	of	_	0	SENT_82	[p6l2083t196r2153b256],
3	individual	JJ	O	individual	amod	5	SENT_82	[p6l12t288r342b349],
4	subject	JJ	O	subject	amod	5	SENT_82	[p6l370t288r606b371],
5	responses	NNS	O	response	prep_of	1	SENT_82	[p6l633t312r953b371],
6	based	VBN	O	base	_	0	SENT_82	[p6l982t288r1173b349],
7	on	IN	O	on	prepc_based_on	1	SENT_82	[p6l1200t312r1280b349],
8	FEV1	NN	O	fev1	nn	11	SENT_82	[p6l1309t293r1486b368],
9	and	CC	O	and	_	0	SENT_82	[p6l1516t288r1635b349],
10	sweat	NN	O	sweat	nn	11	SENT_82	[p6l1663t301r1846b349],
11	chloride	NN	O	chloride	pobj	1	SENT_82	[p6l1873t288r2143b349],

1	CHEST	NN	O	chest	_	0	SENT_83	[p6l804t516r1057b566],
2	/	:	O	/	punct	7	SENT_83	[p6l804t516r1057b566],
3	142	CD	NUMBER	142	dep	7	SENT_83	[p6l1080t518r1180b565],
4	/	:	O	/	punct	5	SENT_83	[p6l1200t516r1225b566],
5	3	CD	NUMBER	3	dep	3	SENT_83	[p6l1244t518r1276b566],
6	/	:	O	/	punct	5	SENT_83	[p6l1295t516r1320b566],
7	SEPTEMBER	NNP	DATE	SEPTEMBER	dep	1	SENT_83	[p6l1339t516r1724b566],
8	2012	CD	DATE	2012	num	9	SENT_83	[p6l1746t518r1886b566],
9	719	CD	NUMBER	719	dep	1	SENT_83	[p6l2024t511r2145b566],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_84	[p6l302t642r479b666],
2	From	IN	O	from	dep	1	SENT_84	[p6l488t642r576b665],
3	:	:	O	:	_	0	SENT_84	[p6l488t642r576b665],
4	http://journal.puhlications.chestnet.org/	NN	O	http://journal.puhlications.chestnet.org/	dep	1	SENT_84	[p6l587t641r1156b672],
5	by	IN	O	by	dep	4	SENT_84	[p6l1163t642r1198b672],
6	a	DT	O	a	det	10	SENT_84	[p6l1207t649r1223b665],
7	University	NNP	ORGANIZATION	University	dep	10	SENT_84	[p6l1232t641r1379b672],
8	of	IN	ORGANIZATION	of	_	0	SENT_84	[p6l1389t641r1418b665],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_84	[p6l1425t641r1570b666],
10	User	NN	ORGANIZATION	user	pobj	5	SENT_84	[p6l1579t642r1645b666],
11	on	IN	O	on	_	0	SENT_84	[p6l1663t649r1697b665],
12	01/05/2014	CD	DATE	01/05/2014	prep_on	10	SENT_84	[p6l1706t641r1857b666],

1	were	VBD	O	be	auxpass	2	SENT_85	[p6l9t865r168b901],
2	performed	VBN	O	perform	_	0	SENT_85	[p6l194t841r545b923],
3	using	VBG	O	use	xcomp	2	SENT_85	[p6l570t850r743b923],
4	the	DT	O	the	det	6	SENT_85	[p6l767t841r869b901],
5	predetermined	JJ	O	predetermined	amod	6	SENT_85	[p6l895t841r1389b924],
6	criteria	NNS	O	criterion	dobj	3	SENT_85	[p6l1415t850r1647b901],
7	for	IN	O	for	_	0	SENT_85	[p6l1672t841r1765b901],
8	enrollment	NN	O	enrollment	prep_for	6	SENT_85	[p6l1790t841r2150b901],
9	in	IN	O	in	_	0	SENT_85	[p6l12t942r74b993],
10	part	NN	O	part	nn	11	SENT_85	[p6l103t946r240b1016],
11	B	NN	O	b	prep_in	3	SENT_85	[p6l271t939r316b993],
12	and	CC	O	and	_	0	SENT_85	[p6l350t933r471b994],
13	two	CD	NUMBER	two	num	15	SENT_85	[p6l499t946r619b994],
14	additional	JJ	O	additional	amod	15	SENT_85	[p6l651t933r988b994],
15	criteria	NNS	O	criterion	conj_and	11	SENT_85	[p6l1018t942r1279b1005],
16	,	,	O	,	_	0	SENT_85	[p6l1018t942r1279b1005],
17	for	IN	O	for	_	0	SENT_85	[p6l1312t933r1408b994],
18	a	DT	O	a	det	20	SENT_85	[p6l1438t957r1471b994],
19	threshold	NN	O	threshold	nn	20	SENT_85	[p6l1498t933r1821b994],
20	response	NN	O	response	prep_for	2	SENT_85	[p6l1851t957r2148b1016],
21	predetermined	VBN	O	predetermine	amod	20	SENT_85	[p6l11t1025r505b1108],
22	in	IN	O	in	_	0	SENT_85	[p6l525t1034r586b1085],
23	the	DT	O	the	det	26	SENT_85	[p6l608t1025r710b1086],
24	statistical	JJ	O	statistical	amod	26	SENT_85	[p6l735t1025r1034b1086],
25	analysis	NN	O	analysis	nn	26	SENT_85	[p6l1057t1025r1300b1108],
26	plan	NN	O	plan	prep_in	20	SENT_85	[p6l1323t1025r1463b1108],
27	(	CD	NUMBER	(	dep	20	SENT_85	[p6l1488t1026r1584b1098],
28	ie	FW	O	ie	nsubjpass	2	SENT_85	[p6l1488t1026r1584b1098],
29	,	,	O	,	_	0	SENT_85	[p6l1488t1026r1584b1098],
30	a	DT	O	a	det	32	SENT_85	[p6l1610t1050r1644b1086],
31	mean	JJ	O	mean	amod	32	SENT_85	[p6l1665t1050r1842b1086],
32	decrease	NN	O	decrease	appos	28	SENT_85	[p6l1866t1025r2148b1086],
33	in	IN	O	in	_	0	SENT_85	[p6l12t1126r73b1177],
34	sweat	NN	O	sweat	nn	35	SENT_85	[p6l101t1130r283b1178],
35	chloride	NN	O	chloride	prep_in	32	SENT_85	[p6l310t1117r581b1178],
36	of	IN	O	of	_	0	SENT_85	[p6l609t1117r679b1178],
37	Z	NN	O	z	nn	39	SENT_85	[p6l702t1129r756b1171],
38	10	CD	NUMBER	10	num	39	SENT_85	[p6l781t1122r852b1177],
39	mmol/L	NN	O	mmol/l	prep_of	35	SENT_85	[p6l880t1117r1146b1178],
40	and	CC	O	and	_	0	SENT_85	[p6l1172t1117r1292b1178],
41	2	CD	NUMBER	2	number	42	SENT_85	[p6l1322t1129r1376b1171],
42	15	CD	NUMBER	15	num	43	SENT_85	[p6l1400t1119r1472b1177],
43	mmol/L	NN	O	mmol/l	prep_in	32	SENT_85	[p6l1500t1117r1766b1178],
44	from	IN	O	from	_	0	SENT_85	[p6l1791t1117r1949b1178],
45	baseline	NN	O	baseline	nn	46	SENT_85	[p6l1975t1117r2148b1178, p6l12t1211r175b1283],
46	)	NN	O	)	prep_from	43	SENT_85	[p6l1975t1117r2148b1178, p6l12t1211r175b1283],
47	,	,	O	,	_	0	SENT_85	[p6l1975t1117r2148b1178, p6l12t1211r175b1283],
48	and	CC	O	and	_	0	SENT_85	[p6l208t1211r326b1272],
49	differences	NNS	O	difference	nsubjpass	53	SENT_85	[p6l355t1211r716b1272],
50	between	IN	O	between	_	0	SENT_85	[p6l746t1211r1024b1272],
51	groups	NNS	O	group	prep_between	49	SENT_85	[p6l1054t1233r1271b1294],
52	were	VBD	O	be	auxpass	53	SENT_85	[p6l1300t1235r1459b1272],
53	compared	VBN	O	compare	conj_and	2	SENT_85	[p6l1490t1211r1817b1294],
54	using	VBG	O	use	xcomp	53	SENT_85	[p6l1845t1220r2018b1294],
55	the	DT	O	the	det	58	SENT_85	[p6l2046t1211r2148b1272],
56	Pearson	NNP	O	Pearson	nn	58	SENT_85	[p6l13t1309r272b1364],
57	X2	NN	O	x2	nn	58	SENT_85	[p6l304t1311r369b1379],
58	test	NN	O	test	dobj	54	SENT_85	[p6l400t1316r517b1364],
59	or	CC	O	or	_	0	SENT_85	[p6l549t1327r616b1364],
60	Fisher	NNP	O	Fisher	nn	62	SENT_85	[p6l648t1303r858b1364],
61	exact	JJ	O	exact	amod	62	SENT_85	[p6l889t1316r1053b1364],
62	test	NN	O	test	conj_or	58	SENT_85	[p6l1084t1316r1215b1364],
63	.	.	O	.	_	0	SENT_85	[p6l1084t1316r1215b1364],

1	Additional	JJ	O	additional	amod	2	SENT_86	[p6l1250t1303r1591b1364],
2	details	NNS	O	detail	nsubjpass	8	SENT_86	[p6l1624t1303r1831b1364],
3	on	IN	O	on	_	0	SENT_86	[p6l1865t1328r1944b1364],
4	study	NN	O	study	nn	5	SENT_86	[p6l1978t1303r2152b1386],
5	methodology	NN	O	methodology	prep_on	2	SENT_86	[p6l13t1395r441b1478],
6	can	MD	O	can	aux	8	SENT_86	[p6l461t1419r571b1455],
7	be	VB	O	be	auxpass	8	SENT_86	[p6l593t1395r671b1456],
8	found	VBN	O	find	_	0	SENT_86	[p6l695t1395r887b1455],
9	in	IN	O	in	_	0	SENT_86	[p6l908t1404r969b1454],
10	e-Appendix	NN	O	e-appendix	prep_in	8	SENT_86	[p6l993t1395r1370b1478],
11	2	CD	NUMBER	2	num	10	SENT_86	[p6l1391t1400r1444b1455],
12	.	.	O	.	_	0	SENT_86	[p6l1391t1400r1444b1455],

1	RESULTS	NNS	O	result	_	0	SENT_87	[p6l898t1647r1263b1715],

1	Subjects	NNS	O	subject	_	0	SENT_88	[p6l16t1790r339b1893],

1	The	DT	O	the	det	2	SENT_89	[p6l105t1916r259b1991],
2	study	NN	O	study	nsubjpass	4	SENT_89	[p6l294t1916r502b2019],
3	was	VBD	O	be	auxpass	4	SENT_89	[p6l525t1945r666b1991],
4	conducted	VBN	O	conduct	_	0	SENT_89	[p6l701t1916r1109b1991],
5	between	IN	O	between	_	0	SENT_89	[p6l1137t1916r1469b1992],
6	September	NNP	DATE	September	prep_between	4	SENT_89	[p6l1505t1916r1932b2019],
7	2009	CD	DATE	2009	num	6	SENT_89	[p6l1961t1922r2148b1991],
8	and	CC	O	and	_	0	SENT_89	[p6l14t2028r162b2103],
9	july	RB	DATE	july	advmod	10	SENT_89	[p6l191t2028r355b2131],
10	2010	CD	DATE	2010	conj_and	4	SENT_89	[p6l384t2034r600b2103],
11	.	.	O	.	_	0	SENT_89	[p6l384t2034r600b2103],

1	Thirty	CD	NUMBER	thirty	number	2	SENT_90	[p6l638t2028r1101b2131],
2	—	CD	NUMBER	—	num	5	SENT_90	[p6l638t2028r1101b2131],
3	four	CD	NUMBER	four	num	5	SENT_90	[p6l638t2028r1101b2131],
4	study	NN	O	study	nn	5	SENT_90	[p6l1133t2028r1353b2131],
5	sites	NNS	O	site	npadvmod	10	SENT_90	[p6l1384t2038r1556b2103],
6	in	IN	O	in	_	0	SENT_90	[p6l1592t2039r1668b2102],
7	the	DT	O	the	det	9	SENT_90	[p6l1700t2028r1829b2103],
8	United	NNP	LOCATION	United	nn	9	SENT_90	[p6l1866t2028r2150b2103],
9	States	NNPS	LOCATION	States	prep_in	10	SENT_90	[p6l16t2146r236b2215],
10	enrolled	VBD	O	enrol	_	0	SENT_90	[p6l270t2140r587b2215],
11	and	CC	O	and	_	0	SENT_90	[p6l617t2140r758b2215],
12	randomized	VBD	O	randomize	conj_and	10	SENT_90	[p6l787t2140r1245b2215],
13	140	CD	NUMBER	140	num	14	SENT_90	[p6l1280t2146r1412b2215],
14	subjects	NNS	O	subject	dobj	10	SENT_90	[p6l1445t2140r1746b2243],
15	(	JJ	O	(	amod	16	SENT_90	[p6l1783t2140r2145b2229],
16	ivacaftor	NN	O	ivacaftor	nsubj	12	SENT_90	[p6l1783t2140r2145b2229],
17	,	,	O	,	_	0	SENT_90	[p6l1783t2140r2145b2229],
18	n	NN	O	n	appos	16	SENT_90	[p6l12t2282r61b2326],
19	=	JJ	O	=	amod	18	SENT_90	[p6l87t2282r146b2305],
20	112	CD	NUMBER	112	tmod	19	SENT_90	[p6l178t2259r336b2341],
21	;	:	O	;	_	0	SENT_90	[p6l178t2259r336b2341],
22	placebo	NN	O	placebo	dep	18	SENT_90	[p6l367t2252r701b2355],
23	,	,	O	,	_	0	SENT_90	[p6l367t2252r701b2355],
24	n	NN	O	n	appos	22	SENT_90	[p6l733t2282r782b2326],
25	=	JJ	O	=	amod	27	SENT_90	[p6l808t2282r867b2305],
26	28	CD	NUMBER	28	tmod	25	SENT_90	[p6l893t2252r1039b2342],
27	)	NN	O	)	dep	24	SENT_90	[p6l893t2252r1039b2342],
28	.	.	O	.	_	0	SENT_90	[p6l893t2252r1039b2342],

1	The	DT	O	the	det	2	SENT_91	[p6l1073t2252r1230b2327],
2	groups	NNS	O	group	nsubj	5	SENT_91	[p6l1261t2279r1529b2355],
3	were	VBD	O	be	cop	5	SENT_91	[p6l1556t2282r1752b2327],
4	generally	RB	O	generally	advmod	5	SENT_91	[p6l1783t2252r2153b2355],
5	similar	JJ	O	similar	_	0	SENT_91	[p6l14t2364r284b2439],
6	at	IN	O	at	_	0	SENT_91	[p6l312t2380r383b2439],
7	baseline	NN	O	baseline	nn	9	SENT_91	[p6l409t2364r736b2439],
8	(	CD	NUMBER	(	num	9	SENT_91	[p6l771t2364r1019b2453],
9	Table	NNP	O	Table	prep_at	5	SENT_91	[p6l771t2364r1019b2453],
10	1	CD	NUMBER	1	number	11	SENT_91	[p6l1055t2364r1146b2453],
11	)	CD	NUMBER	)	dep	9	SENT_91	[p6l1055t2364r1146b2453],
12	.	.	O	.	_	0	SENT_91	[p6l1055t2364r1146b2453],

1	A	DT	O	a	det	2	SENT_92	[p6l105t2483r168b2550],
2	total	NN	O	total	nsubj	24	SENT_92	[p6l210t2476r394b2551],
3	of	IN	O	of	_	0	SENT_92	[p6l438t2476r525b2551],
4	104	CD	NUMBER	104	num	5	SENT_92	[p6l566t2482r706b2551],
5	subjects	NNS	O	subject	prep_of	2	SENT_92	[p6l753t2476r1081b2579],
6	(	JJ	O	(	amod	5	SENT_92	[p6l1132t2476r1449b2566],
7	92.9	CD	PERCENT	92.9	dep	8	SENT_92	[p6l1132t2476r1449b2566],
8	%	NN	PERCENT	%	advmod	6	SENT_92	[p6l1132t2476r1449b2566],
9	)	CD	NUMBER	)	tmod	6	SENT_92	[p6l1132t2476r1449b2566],
10	in	IN	O	in	_	0	SENT_92	[p6l1497t2487r1573b2550],
11	the	DT	O	the	det	13	SENT_92	[p6l1617t2476r1746b2551],
12	ivacaftor	NN	O	ivacaftor	nn	13	SENT_92	[p6l1792t2476r2151b2551],
13	group	NN	O	group	prep_in	5	SENT_92	[p6l13t2615r254b2691],
14	and	CC	O	and	_	0	SENT_92	[p6l299t2588r449b2663],
15	26	CD	PERCENT	26	conj_and	2	SENT_92	[p6l489t2595r585b2663],
16	(	CD	PERCENT	(	number	17	SENT_92	[p6l632t2588r951b2678],
17	92.9	CD	PERCENT	92.9	num	18	SENT_92	[p6l632t2588r951b2678],
18	%	NN	PERCENT	%	dep	15	SENT_92	[p6l632t2588r951b2678],
19	)	CD	NUMBER	)	dep	15	SENT_92	[p6l632t2588r951b2678],
20	in	IN	O	in	_	0	SENT_92	[p6l997t2599r1074b2662],
21	the	DT	O	the	det	23	SENT_92	[p6l1116t2588r1246b2663],
22	placebo	NN	O	placebo	nn	23	SENT_92	[p6l1289t2588r1613b2691],
23	group	NN	O	group	prep_in	19	SENT_92	[p6l1656t2615r1897b2691],
24	completed	VBD	O	complete	_	0	SENT_92	[p6l1941t2618r2147b2663, p6l11t2700r274b2803],
25	dosing	NN	O	dosing	nsubj	32	SENT_92	[p6l309t2700r577b2803],
26	in	IN	O	in	_	0	SENT_92	[p6l610t2711r687b2774],
27	part	NN	O	part	prep_in	25	SENT_92	[p6l720t2716r888b2803],
28	A	DT	O	a	det	32	SENT_92	[p6l919t2707r983b2774],
29	(	CD	NUMBER	(	num	32	SENT_92	[p6l1020t2700r1188b2803],
30	Fig	NN	O	fig	nn	32	SENT_92	[p6l1020t2700r1188b2803],
31	1	CD	NUMBER	1	num	32	SENT_92	[p6l1227t2700r1321b2790],
32	)	NN	O	)	xcomp	24	SENT_92	[p6l1227t2700r1321b2790],
33	.	.	O	.	_	0	SENT_92	[p6l1227t2700r1321b2790],

1	The	DT	O	the	det	4	SENT_93	[p6l1361t2700r1521b2775],
2	most	RBS	O	most	advmod	3	SENT_93	[p6l1559t2716r1757b2775],
3	frequent	JJ	O	frequent	amod	4	SENT_93	[p6l1791t2700r2150b2803],
4	reason	NN	O	reason	nsubj	10	SENT_93	[p6l14t2840r284b2885],
5	for	IN	O	for	_	0	SENT_93	[p6l337t2811r456b2885],
6	discontinuation	NN	O	discontinuation	prep_for	4	SENT_93	[p6l507t2811r1155b2885],
7	was	VBD	O	be	cop	10	SENT_93	[p6l1204t2840r1353b2885],
8	an	DT	O	a	det	10	SENT_93	[p6l1408t2840r1502b2885],
9	adverse	JJ	O	adverse	amod	10	SENT_93	[p6l1555t2811r1869b2885],
10	event	NN	O	event	_	0	SENT_93	[p6l1923t2827r2150b2885],
11	(	CD	NUMBER	(	number	12	SENT_93	[p6l17t2923r270b3013],
12	three	CD	NUMBER	three	num	13	SENT_93	[p6l17t2923r270b3013],
13	subjects	NNS	O	subject	npadvmod	14	SENT_93	[p6l312t2923r652b3026],
14	[	JJ	O	[	amod	10	SENT_93	[p6l700t2923r969b3013],
15	2.7	CD	PERCENT	2.7	num	16	SENT_93	[p6l700t2923r969b3013],
16	%	NN	PERCENT	%	dep	28	SENT_93	[p6l700t2923r969b3013],
17	]	CD	NUMBER	]	dep	16	SENT_93	[p6l700t2923r969b3013],
18	in	IN	O	in	_	0	SENT_93	[p6l1014t2934r1092b2997],
19	the	DT	O	the	det	21	SENT_93	[p6l1131t2923r1263b2998],
20	ivacaftor	NN	O	ivacaftor	nn	21	SENT_93	[p6l1303t2923r1674b2998],
21	group	NN	O	group	prep_in	17	SENT_93	[p6l1711t2950r1957b3026],
22	and	CC	O	and	_	0	SENT_93	[p6l1999t2923r2150b2998],
23	two	CD	NUMBER	two	num	24	SENT_93	[p6l12t3051r158b3110],
24	subjects	NNS	O	subject	prep_in	17	SENT_93	[p6l203t3035r532b3138],
25	[	JJ	O	[	amod	24	SENT_93	[p6l582t3035r844b3125],
26	7.1	CD	PERCENT	7.1	num	27	SENT_93	[p6l582t3035r844b3125],
27	%	NN	PERCENT	%	dep	28	SENT_93	[p6l582t3035r844b3125],
28	]	CD	NUMBER	]	dep	32	SENT_93	[p6l582t3035r844b3125],
29	in	IN	O	in	_	0	SENT_93	[p6l892t3046r968b3109],
30	the	DT	O	the	det	31	SENT_93	[p6l1010t3035r1139b3110],
31	placebo	NN	O	placebo	prep_in	28	SENT_93	[p6l1181t3035r1502b3138],
32	group	NN	O	group	dep	10	SENT_93	[p6l1545t3035r1841b3138],
33	)	CD	NUMBER	)	num	32	SENT_93	[p6l1545t3035r1841b3138],
34	.	.	O	.	_	0	SENT_93	[p6l1545t3035r1841b3138],

1	Fortytwo	NN	O	fortytwo	nn	3	SENT_94	[p6l1890t3042r2147b3138, p6l12t3161r158b3220],
2	ivacaftor	NN	O	ivacaftor	nn	3	SENT_94	[p6l192t3145r551b3220],
3	subjects	NNS	O	subject	_	0	SENT_94	[p6l583t3145r912b3248],
4	(	JJ	O	(	amod	11	SENT_94	[p6l951t3145r1268b3235],
5	37.5	CD	PERCENT	37.5	dep	6	SENT_94	[p6l951t3145r1268b3235],
6	%	NN	PERCENT	%	advmod	4	SENT_94	[p6l951t3145r1268b3235],
7	)	CD	NUMBER	)	tmod	4	SENT_94	[p6l951t3145r1268b3235],
8	and	CC	O	and	_	0	SENT_94	[p6l1306t3145r1455b3220],
9	six	CD	NUMBER	six	conj_and	7	SENT_94	[p6l1487t3156r1590b3220],
10	placebo	NN	O	placebo	nn	11	SENT_94	[p6l1618t3145r1939b3248],
11	subjects	NNS	O	subject	dobj	16	SENT_94	[p6l1975t3145r2147b3221, p6l6t3270r202b3362],
12	(	JJ	O	(	amod	11	SENT_94	[p6l249t3259r575b3349],
13	21.4	CD	PERCENT	21.4	dep	14	SENT_94	[p6l249t3259r575b3349],
14	%	NN	PERCENT	%	advmod	12	SENT_94	[p6l249t3259r575b3349],
15	)	CD	NUMBER	)	tmod	12	SENT_94	[p6l249t3259r575b3349],
16	qualified	VBN	O	qualify	dep	3	SENT_94	[p6l621t3259r998b3362],
17	for	IN	O	for	_	0	SENT_94	[p6l1038t3259r1159b3334],
18	part	NN	O	part	nn	19	SENT_94	[p6l1195t3275r1368b3362],
19	B	NN	O	b	prep_for	16	SENT_94	[p6l1409t3266r1492b3348],
20	;	:	O	;	_	0	SENT_94	[p6l1409t3266r1492b3348],
21	the	DT	O	the	det	22	SENT_94	[p6l1536t3259r1668b3334],
22	difference	NN	O	difference	nsubj	28	SENT_94	[p6l1711t3259r2147b3334],
23	was	VBD	O	be	cop	28	SENT_94	[p6l9t3401r157b3446],
24	not	RB	O	not	neg	28	SENT_94	[p6l191t3387r325b3446],
25	statistically	RB	O	statistically	advmod	26	SENT_94	[p6l356t3371r816b3474],
26	signiﬁcant	JJ	O	signiﬁcant	amod	28	SENT_94	[p6l845t3371r1266b3474],
27	(	NN	O	(	nn	28	SENT_94	[p6l1300t3371r1383b3461],
28	P	NN	O	p	dep	3	SENT_94	[p6l1300t3371r1383b3461],
29	=	JJ	O	=	amod	28	SENT_94	[p6l1410t3401r1469b3424],
30	.11	CD	NUMBER	.11	num	31	SENT_94	[p6l1503t3371r1675b3461],
31	)	NN	O	)	dep	29	SENT_94	[p6l1503t3371r1675b3461],
32	.	.	O	.	_	0	SENT_94	[p6l1503t3371r1675b3461],

1	Safety	NNP	O	Safety	nn	2	SENT_95	[p6l16t3596r257b3699],
2	Proﬁle	NNP	O	Proﬁle	_	0	SENT_95	[p6l287t3596r546b3697],

1	The	DT	O	the	det	3	SENT_96	[p7l105t40r267b115],
2	overall	JJ	O	overall	amod	3	SENT_96	[p7l303t40r583b115],
3	proportion	NN	O	proportion	nsubj	11	SENT_96	[p7l615t51r1066b143],
4	of	IN	O	of	_	0	SENT_96	[p7l1101t40r1189b115],
5	subjects	NNS	O	subject	prep_of	3	SENT_96	[p7l1214t40r1547b143],
6	reporting	VBG	O	report	partmod	5	SENT_96	[p7l1584t51r1976b143],
7	any	DT	O	any	det	9	SENT_96	[p7l2010t70r2153b143],
8	adverse	JJ	O	adverse	amod	9	SENT_96	[p7l14t152r321b227],
9	event	NN	O	event	dobj	6	SENT_96	[p7l360t168r583b227],
10	was	VBD	O	be	cop	11	SENT_96	[p7l614t182r761b227],
11	similar	JJ	O	similar	_	0	SENT_96	[p7l801t152r1078b227],
12	between	IN	O	between	_	0	SENT_96	[p7l1111t152r1460b228],
13	the	DT	O	the	det	14	SENT_96	[p7l1496t152r1625b227],
14	groups	NNS	O	group	prep_between	11	SENT_96	[p7l1663t179r1961b255],
15	,	,	O	,	_	0	SENT_96	[p7l1663t179r1961b255],
16	and	CC	O	and	_	0	SENT_96	[p7l2003t152r2150b227],
17	the	DT	O	the	det	20	SENT_96	[p7l12t265r142b340],
18	most	RBS	O	most	advmod	20	SENT_96	[p7l184t281r383b340],
19	common	JJ	O	common	amod	20	SENT_96	[p7l420t295r781b340],
20	events	NNS	O	event	nsubj	24	SENT_96	[p7l821t281r1083b340],
21	were	VBD	O	be	cop	24	SENT_96	[p7l1120t295r1323b340],
22	respiratory	JJ	O	respiratory	amod	24	SENT_96	[p7l1363t276r1822b368],
23	related	JJ	O	related	amod	24	SENT_96	[p7l1857t265r2150b340],
24	(	NN	O	(	conj_and	11	SENT_96	[p7l17t377r269b466],
25	Table	NNP	O	Table	prep	24	SENT_96	[p7l17t377r269b466],
26	2	CD	NUMBER	2	num	27	SENT_96	[p7l302t377r402b466],
27	)	CD	NUMBER	)	dep	25	SENT_96	[p7l302t377r402b466],
28	.	.	O	.	_	0	SENT_96	[p7l302t377r402b466],

1	Adverse	JJ	O	adverse	amod	2	SENT_97	[p7l437t377r768b452],
2	events	NNS	O	event	_	0	SENT_97	[p7l802t393r1058b452],
3	that	WDT	O	that	nsubj	4	SENT_97	[p7l1092t377r1252b452],
4	occurred	VBD	O	occur	rcmod	2	SENT_97	[p7l1283t377r1650b452],
5	2	CD	PERCENT	2	number	7	SENT_97	[p7l1686t392r1752b443],
6	5	CD	PERCENT	5	number	7	SENT_97	[p7l1776t380r1901b451],
7	%	NN	PERCENT	%	amod	8	SENT_97	[p7l1776t380r1901b451],
8	more	JJR	O	more	dobj	4	SENT_97	[p7l1938t406r2147b452],

1	Table	NNP	O	Table	_	0	SENT_98	[p7l18t635r229b700],
2	1	CD	NUMBER	1	dep	1	SENT_98	[p7l263t635r702b700],
3	.	.	O	.	_	0	SENT_98	[p7l263t635r702b700],

1	—	NN	O	—	_	0	SENT_99	[p7l263t635r702b700],
2	.	.	O	.	_	0	SENT_99	[p7l263t635r702b700],

1	Baseline	NN	O	baseline	nn	2	SENT_100	[p7l263t635r702b700],
2	Characteristics	NNS	O	characteristic	_	0	SENT_100	[p7l734t635r1306b700],
3	of	IN	O	of	_	0	SENT_100	[p7l1335t635r1420b722],
4	Study	NNP	O	Study	nn	5	SENT_100	[p7l1435t635r1652b722],
5	Participants	NNS	O	participant	prep_of	2	SENT_100	[p7l1676t639r2139b722],

1	Characteristic	JJ	O	characteristic	amod	4	SENT_101	[p7l13t812r441b870],
2	Placebo	NN	O	placebo	nn	4	SENT_101	[p7l915t812r1154b870],
3	(	NN	O	(	nn	4	SENT_101	[p7l1180t812r1239b881],
4	n	NN	O	n	_	0	SENT_101	[p7l1180t812r1239b881],
5	=	JJ	O	=	quantmod	7	SENT_101	[p7l1259t835r1304b853],
6	28	CD	NUMBER	28	number	7	SENT_101	[p7l1324t812r1417b881],
7	)	CD	NUMBER	)	num	10	SENT_101	[p7l1324t812r1417b881],
8	Ivacaftor	NNP	O	Ivacaftor	nn	10	SENT_101	[p7l1577t812r1850b870],
9	(	CD	NUMBER	(	num	10	SENT_101	[p7l1871t812r1930b881],
10	n	NN	O	n	dep	4	SENT_101	[p7l1871t812r1930b881],
11	=	JJ	O	=	amod	10	SENT_101	[p7l1950t835r1995b853],
12	112	CD	NUMBER	112	tmod	11	SENT_101	[p7l2019t813r2146b880],
13	)	NN	O	)	dep	4	SENT_101	[p7l2019t813r2146b880],

1	Female	JJ	O	female	_	0	SENT_102	[p7l14t958r260b1026],
2	,	,	O	,	_	0	SENT_102	[p7l14t958r260b1026],
3	No.	NN	O	no.	appos	1	SENT_102	[p7l287t963r392b1015],
4	(	CD	PERCENT	(	num	5	SENT_102	[p7l421t958r524b1026],
5	%	NN	PERCENT	%	dep	3	SENT_102	[p7l421t958r524b1026],
6	)	CD	NUMBER	)	number	7	SENT_102	[p7l421t958r524b1026],
7	12	CD	NUMBER	12	num	5	SENT_102	[p7l1083t962r1149b1015],
8	(	NN	O	(	dep	1	SENT_102	[p7l1175t958r1290b1026],
9	43	CD	NUMBER	43	num	8	SENT_102	[p7l1175t958r1290b1026],
10	)	CD	NUMBER	)	number	11	SENT_102	[p7l1175t958r1290b1026],
11	54	CD	NUMBER	54	num	12	SENT_102	[p7l1772t960r1843b1015],
12	(	NN	O	(	dep	8	SENT_102	[p7l1869t958r1984b1026],
13	48	CD	NUMBER	48	number	14	SENT_102	[p7l1869t958r1984b1026],
14	)	CD	NUMBER	)	dep	8	SENT_102	[p7l1869t958r1984b1026],
15	Age	NNP	O	Age	dep	14	SENT_102	[p7l11t1056r146b1129],
16	,	,	O	,	_	0	SENT_102	[p7l11t1056r146b1129],
17	y	IN	O	y	amod	14	SENT_102	[p7l168t1075r204b1129],

1	Mean	NN	O	mean	dep	10	SENT_103	[p7l90t1151r263b1204],
2	(	CD	NUMBER	(	num	3	SENT_103	[p7l289t1146r431b1215],
3	SD	NN	O	sd	dep	1	SENT_103	[p7l289t1146r431b1215],
4	)	CD	NUMBER	)	number	5	SENT_103	[p7l289t1146r431b1215],
5	25.0	CD	NUMBER	25.0	num	6	SENT_103	[p7l1021t1148r1148b1204],
6	(	NN	O	(	dep	3	SENT_103	[p7l1174t1146r1308b1214],
7	8.4	CD	NUMBER	8.4	num	8	SENT_103	[p7l1174t1146r1308b1214],
8	)	NN	O	)	dep	10	SENT_103	[p7l1174t1146r1308b1214],
9	22.8	CD	NUMBER	22.8	num	10	SENT_103	[p7l1715t1151r1842b1203],
10	(	NN	O	(	dep	18	SENT_103	[p7l1869t1146r2040b1214],
11	10.3	CD	NUMBER	10.3	number	12	SENT_103	[p7l1869t1146r2040b1214],
12	)	CD	NUMBER	)	num	13	SENT_103	[p7l1869t1146r2040b1214],
13	Median	JJ	MISC	median	dep	10	SENT_103	[p7l90t1240r323b1296],
14	24.0	CD	NUMBER	24.0	number	15	SENT_103	[p7l1118t1244r1246b1296],
15	19.5	CD	NUMBER	19.5	num	13	SENT_103	[p7l1818t1242r1941b1296],
16	Range	NNP	O	Range	dep	13	SENT_103	[p7l89t1338r280b1411],
17	12-39	CD	NUMBER	12-39	num	18	SENT_103	[p7l1081t1338r1248b1390],
18	12-52	CD	NUMBER	12-52	_	0	SENT_103	[p7l1778t1336r1945b1390],

1	Height	NN	O	height	_	0	SENT_104	[p7l14t1426r242b1504],
2	,	,	O	,	_	0	SENT_104	[p7l14t1426r242b1504],
3	cm	NN	O	cm	appos	1	SENT_104	[p7l267t1449r357b1484],

1	Median	JJ	MISC	median	amod	2	SENT_105	[p7l90t1519r323b1575],
2	170.7	CD	NUMBER	170.7	_	0	SENT_105	[p7l1085t1521r1247b1575],
3	164.0	CD	NUMBER	164.0	num	4	SENT_105	[p7l1780t1523r1941b1575],
4	Range	NNP	O	Range	dep	2	SENT_105	[p7l89t1618r280b1691],
5	145.6-184	CD	NUMBER	145.6-184	num	4	SENT_105	[p7l987t1616r1342b1670],
6	.0	CD	NUMBER	.0	dep	4	SENT_105	[p7l987t1616r1342b1670],
7	139.0-189	CD	NUMBER	139.0-189	num	8	SENT_105	[p7l1684t1618r2039b1670],
8	.6	CD	NUMBER	.6	dep	2	SENT_105	[p7l1684t1618r2039b1670],

1	Weight	NNP	O	Weight	_	0	SENT_106	[p7l9t1706r247b1784],
2	,	,	O	,	_	0	SENT_106	[p7l9t1706r247b1784],
3	kg	NN	O	kg	appos	1	SENT_106	[p7l271t1706r343b1784],

1	Median	JJ	MISC	median	_	0	SENT_107	[p7l90t1800r323b1856],
2	64.9	CD	NUMBER	64.9	number	3	SENT_107	[p7l1119t1804r1245b1856],
3	55.9	CD	NUMBER	55.9	num	6	SENT_107	[p7l1814t1802r1941b1856],
4	Range	NNP	O	Range	nn	6	SENT_107	[p7l89t1898r280b1972],
5	44.2-100	CD	NUMBER	44.2-100	num	6	SENT_107	[p7l1020t1898r1342b1951],
6	.3	NN	NUMBER	.3	dep	1	SENT_107	[p7l1020t1898r1342b1951],
7	35.1-99	CD	NUMBER	35.1-99	num	8	SENT_107	[p7l1717t1895r2001b1951],
8	.8	CD	NUMBER	.8	dep	6	SENT_107	[p7l1717t1895r2001b1951],

1	BMI	NNP	O	BMI	_	0	SENT_108	[p7l14t1992r174b2055],
2	,	,	O	,	_	0	SENT_108	[p7l14t1992r174b2055],
3	kg/m2	NN	O	kg/m2	appos	1	SENT_108	[p7l197t1987r372b2065],

1	Median	JJ	MISC	median	amod	3	SENT_109	[p7l90t2080r323b2137],
2	21.5	CD	NUMBER	21.5	number	3	SENT_109	[p7l1118t2083r1245b2137],
3	20.4	CD	NUMBER	20.4	_	0	SENT_109	[p7l1814t2085r1941b2137],
4	Range	NNP	O	Range	dep	3	SENT_109	[p7l89t2179r280b2253],
5	17.9-40	CD	NUMBER	17.9-40	num	4	SENT_109	[p7l1025t2177r1304b2232],
6	.8	CD	NUMBER	.8	number	7	SENT_109	[p7l1025t2177r1304b2232],
7	15.7-31	CD	NUMBER	15.7-31	dep	3	SENT_109	[p7l1721t2176r2001b2232],
8	.6	CD	NUMBER	.6	dep	7	SENT_109	[p7l1721t2176r2001b2232],

1	Sweat	NN	O	sweat	nn	2	SENT_110	[p7l15t2272r194b2325],
2	chloride	NN	O	chloride	_	0	SENT_110	[p7l216t2267r483b2335],
3	,	,	O	,	_	0	SENT_110	[p7l216t2267r483b2335],
4	mmol/L	NN	O	mmol/l	appos	2	SENT_110	[p7l508t2267r754b2325],

1	Mean	NN	O	mean	dep	7	SENT_111	[p7l90t2368r263b2420],
2	(	CD	NUMBER	(	num	1	SENT_111	[p7l288t2363r431b2431],
3	SD	NN	O	sd	dep	1	SENT_111	[p7l288t2363r431b2431],
4	)	CD	NUMBER	)	num	3	SENT_111	[p7l288t2363r431b2431],
5	102.4	CD	NUMBER	102.4	num	6	SENT_111	[p7l987t2367r1148b2420],
6	(	NN	O	(	dep	7	SENT_111	[p7l1174t2363r1308b2431],
7	7.9	CD	NUMBER	7.9	dep	16	SENT_111	[p7l1174t2363r1308b2431],
8	)	CD	NUMBER	)	number	9	SENT_111	[p7l1174t2363r1308b2431],
9	101.4	CD	NUMBER	101.4	num	10	SENT_111	[p7l1683t2367r1843b2420],
10	(	NN	O	(	dep	7	SENT_111	[p7l1869t2363r2041b2431],
11	10.3	CD	NUMBER	10.3	number	12	SENT_111	[p7l1869t2363r2041b2431],
12	)	CD	NUMBER	)	num	13	SENT_111	[p7l1869t2363r2041b2431],
13	Median	JJ	MISC	median	dep	10	SENT_111	[p7l90t2455r323b2512],
14	101.5	CD	NUMBER	101.5	number	15	SENT_111	[p7l1085t2457r1245b2512],
15	101.0	CD	NUMBER	101.0	num	13	SENT_111	[p7l1780t2460r1941b2512],
16	Range	NNP	O	Range	dep	21	SENT_111	[p7l89t2553r280b2625],
17	91.0	CD	NUMBER	91.0	num	16	SENT_111	[p7l1021t2552r1342b2604],
18	—	CD	NUMBER	—	num	19	SENT_111	[p7l1021t2552r1342b2604],
19	122.0	CD	NUMBER	122.0	dep	16	SENT_111	[p7l1021t2552r1342b2604],
20	79.5-135	CD	NUMBER	79.5-135	num	21	SENT_111	[p7l1719t2550r2038b2604],
21	.5	CD	NUMBER	.5	_	0	SENT_111	[p7l1719t2550r2038b2604],

1	FEV1	NN	PERCENT	fev1	nn	2	SENT_112	[p7l14t2648r178b2718],
2	%	NN	PERCENT	%	nsubj	3	SENT_112	[p7l204t2647r258b2700],
3	predicted	VBD	O	predict	_	0	SENT_112	[p7l282t2642r578b2721],

1	Mean	NN	O	mean	dep	10	SENT_113	[p7l90t2740r263b2793],
2	(	CD	NUMBER	(	num	3	SENT_113	[p7l288t2735r431b2803],
3	SD	NN	O	sd	dep	1	SENT_113	[p7l288t2735r431b2803],
4	)	CD	NUMBER	)	number	5	SENT_113	[p7l288t2735r431b2803],
5	74.8	CD	NUMBER	74.8	dep	3	SENT_113	[p7l1022t2738r1148b2793],
6	(	NN	O	(	dep	10	SENT_113	[p7l1174t2735r1346b2803],
7	24.1	CD	NUMBER	24.1	num	6	SENT_113	[p7l1174t2735r1346b2803],
8	)	CD	NUMBER	)	num	10	SENT_113	[p7l1174t2735r1346b2803],
9	79.7	CD	NUMBER	79.7	num	10	SENT_113	[p7l1717t2738r1845b2793],
10	(	NN	O	(	dep	18	SENT_113	[p7l1869t2735r2041b2803],
11	22.7	CD	NUMBER	22.7	number	12	SENT_113	[p7l1869t2735r2041b2803],
12	)	CD	NUMBER	)	num	13	SENT_113	[p7l1869t2735r2041b2803],
13	Median	JJ	MISC	median	dep	10	SENT_113	[p7l90t2830r323b2886],
14	67.0	CD	NUMBER	67.0	number	15	SENT_113	[p7l1119t2832r1246b2886],
15	79.0	CD	NUMBER	79.0	num	13	SENT_113	[p7l1816t2832r1941b2886],
16	Range	NNP	O	Range	dep	13	SENT_113	[p7l89t2927r280b2999],
17	43-127	CD	NUMBER	43-127	num	18	SENT_113	[p7l1076t2924r1287b2978],
18	40-129	CD	NUMBER	40-129	_	0	SENT_113	[p7l1772t2926r1982b2978],

1	None	NN	O	none	nsubj	5	SENT_114	[p7l14t3056r180b3108],
2	of	IN	O	of	_	0	SENT_114	[p7l207t3051r273b3108],
3	the	DT	O	the	det	4	SENT_114	[p7l290t3051r386b3108],
4	characteristics	NNS	O	characteristic	prep_of	1	SENT_114	[p7l413t3051r848b3108],
5	differed	VBD	O	differ	_	0	SENT_114	[p7l876t3051r1120b3108],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_114	[p7l1146t3051r1512b3129],
7	between	IN	O	between	_	0	SENT_114	[p7l1532t3051r1795b3109],
8	the	DT	O	the	det	9	SENT_114	[p7l1819t3051r1916b3108],
9	groups	NNS	O	group	prep_between	5	SENT_114	[p7l1943t3071r2147b3129],
10	(	VBP	O	(	rcmod	9	SENT_114	[p7l15t3144r76b3212],
11	P	NN	O	p	npadvmod	12	SENT_114	[p7l15t3144r76b3212],
12	>	JJR	O	>	acomp	10	SENT_114	[p7l93t3154r143b3197],
13	.05	CD	NUMBER	.05	tmod	12	SENT_114	[p7l164t3146r250b3201],
14	for	IN	O	for	mark	17	SENT_114	[p7l273t3144r360b3202],
15	all	DT	O	all	det	16	SENT_114	[p7l381t3144r450b3202],
16	comparisons	NNS	O	comparison	nsubj	17	SENT_114	[p7l472t3144r894b3222],
17	)	VBP	O	)	ccomp	12	SENT_114	[p7l472t3144r894b3222],
18	.	.	O	.	_	0	SENT_114	[p7l472t3144r894b3222],

1	Enrolled	VBN	O	enrol	_	0	SENT_115	[p8l1218t116r1401b158],
2	,	,	O	,	_	0	SENT_115	[p8l1218t116r1401b158],
3	randomized	VBN	O	randomize	dep	1	SENT_115	[p8l1421t116r1680b158],
4	,	,	O	,	_	0	SENT_115	[p8l1421t116r1680b158],

1	and	CC	O	and	dep	2	SENT_116	[p8l1338t170r1415b206],
2	dosed	VBN	O	dose	_	0	SENT_116	[p8l1432t170r1560b206],

1	N	NN	O	n	_	0	SENT_117	[p8l1367t230r1396b267],
2	=	JJ	O	=	dep	1	SENT_117	[p8l1415t240r1440b257],
3	140	CD	NUMBER	140	tmod	2	SENT_117	[p8l1458t230r1533b267],

1	Ivacaftor	NNP	O	Ivacaftor	nn	2	SENT_118	[p8l874t425r1056b461],
2	Placebo	NNP	O	Placebo	_	0	SENT_118	[p8l1811t426r1981b461],
3	150	CD	NUMBER	150	num	5	SENT_118	[p8l826t486r901b522],
4	mg	NN	O	mg	nn	5	SENT_118	[p8l918t495r980b531],
5	q12h	NN	O	q12h	dep	2	SENT_118	[p8l997t486r1100b531],

1	Discontinued	VBN	O	discontinue	_	0	SENT_119	[p8l38t550r311b586],
2	due	JJ	O	due	_	0	SENT_119	[p8l329t550r407b586],
3	to	TO	O	to	_	0	SENT_119	[p8l422t551r460b586],
4	N	NN	O	n	prep_due_to	25	SENT_119	[p8l880t545r909b582],
5	=	JJ	O	=	amod	7	SENT_119	[p8l927t556r952b573],
6	112	CD	NUMBER	112	tmod	5	SENT_119	[p8l971t545r1046b582],
7	N	NN	O	n	dep	4	SENT_119	[p8l1826t545r1855b582],
8	=	JJ	O	=	amod	7	SENT_119	[p8l1874t556r1898b573],
9	28	CD	NUMBER	28	tmod	8	SENT_119	[p8l1914t545r1966b583],
10	-	:	O	-	_	0	SENT_119	[p8l68t618r79b630],
11	Adverse	JJ	O	adverse	amod	12	SENT_119	[p8l96t608r247b639],
12	event	NN	O	event	dep	7	SENT_119	[p8l261t610r361b639],
13	3	CD	NUMBER	3	num	14	SENT_119	[p8l432t608r453b639],
14	(	NN	O	(	rcmod	12	SENT_119	[p8l468t608r587b648],
15	2.7	CD	PERCENT	2.7	num	16	SENT_119	[p8l468t608r587b648],
16	%	NN	PERCENT	%	dep	14	SENT_119	[p8l468t608r587b648],
17	)	SYM	O	)	dep	14	SENT_119	[p8l468t608r587b648],
18	-	:	O	-	_	0	SENT_119	[p8l68t671r79b682],
19	Noncompliance	NN	O	noncompliance	dep	7	SENT_119	[p8l99t661r380b700],
20	2	CD	PERCENT	2	num	19	SENT_119	[p8l429t661r449b691],
21	(	CD	PERCENT	(	number	22	SENT_119	[p8l465t660r585b700],
22	1.8	CD	PERCENT	1.8	num	23	SENT_119	[p8l465t660r585b700],
23	%	NN	PERCENT	%	dep	19	SENT_119	[p8l465t660r585b700],
24	)	CD	NUMBER	)	tmod	4	SENT_119	[p8l465t660r585b700],
25	Discontinued	NNP	O	Discontinued	nsubj	26	SENT_119	[p8l1220t657r1493b692],
26	due	JJ	O	due	xcomp	1	SENT_119	[p8l1511t657r1588b692],
27	to	TO	O	to	_	0	SENT_119	[p8l1604t658r1642b692],
28	-	:	O	-	_	0	SENT_119	[p8l68t723r79b734],
29	Prohibited	VBN	O	prohibit	prep_to	1	SENT_119	[p8l99t713r281b744],
30	med	VBN	O	med	dep	29	SENT_119	[p8l296t713r372b744],
31	1	CD	PERCENT	1	number	32	SENT_119	[p8l438t713r449b743],
32	(	CD	PERCENT	(	dobj	30	SENT_119	[p8l471t712r589b752],
33	0.9	CD	PERCENT	0.9	num	34	SENT_119	[p8l471t712r589b752],
34	%	NN	PERCENT	%	dep	32	SENT_119	[p8l471t712r589b752],
35	)	SYM	O	)	dep	32	SENT_119	[p8l471t712r589b752],
36	-	:	O	-	_	0	SENT_119	[p8l1249t725r1261b736],
37	Adverse	JJ	O	adverse	amod	38	SENT_119	[p8l1278t715r1429b746],
38	event	NN	O	event	nsubj	45	SENT_119	[p8l1443t716r1542b746],
39	2	CD	PERCENT	2	number	40	SENT_119	[p8l1567t715r1587b746],
40	(	CD	PERCENT	(	amod	38	SENT_119	[p8l1603t715r1722b754],
41	7.1	CD	PERCENT	7.1	num	42	SENT_119	[p8l1603t715r1722b754],
42	%	NN	PERCENT	%	dep	40	SENT_119	[p8l1603t715r1722b754],
43	)	SYM	O	)	dep	45	SENT_119	[p8l1603t715r1722b754],
44	-	:	O	-	_	0	SENT_119	[p8l68t775r79b786],
45	Lost	VBN	O	lose	parataxis	30	SENT_119	[p8l99t765r175b796],
46	to	TO	O	to	_	0	SENT_119	[p8l187t766r220b796],
47	follow-up	NN	O	follow-up	num	51	SENT_119	[p8l232t765r397b803],
48	1	CD	PERCENT	1	number	47	SENT_119	[p8l437t765r448b795],
49	(	CD	PERCENT	(	number	47	SENT_119	[p8l470t765r588b804],
50	0.9	CD	PERCENT	0.9	number	47	SENT_119	[p8l470t765r588b804],
51	%	NN	PERCENT	%	prep_to	45	SENT_119	[p8l470t765r588b804],
52	)	NN	O	)	dobj	45	SENT_119	[p8l470t765r588b804],
53	'	''	O	'	_	0	SENT_119	[p8l68t827r79b838],
54	Other	JJ	O	other	amod	56	SENT_119	[p8l98t816r201b848],
55	1	CD	NUMBER	1	number	56	SENT_119	[p8l439t817r451b847],
56	(	CD	NUMBER	(	nsubj	62	SENT_119	[p8l472t816r591b856],
57	0-9	CD	NUMBER	0-9	num	58	SENT_119	[p8l472t816r591b856],
58	°	NN	O	°	dep	56	SENT_119	[p8l472t816r591b856],
59	/	:	O	/	punct	60	SENT_119	[p8l472t816r591b856],
60	o	NN	O	o	dep	56	SENT_119	[p8l472t816r591b856],
61	)	CD	NUMBER	)	num	60	SENT_119	[p8l472t816r591b856],
62	Completed	VBN	O	complete	rcmod	52	SENT_119	[p8l770t818r998b864],
63	dosing	NN	O	dosing	dobj	62	SENT_119	[p8l1015t819r1154b864],
64	Completed	VBN	O	complete	partmod	63	SENT_119	[p8l1703t818r1931b864],
65	dosing	NN	O	dosing	dobj	64	SENT_119	[p8l1949t819r2087b864],

1	Eligible	JJ	O	eligible	_	0	SENT_120	[p8l779t1026r930b1071],
2	for	IN	O	for	_	0	SENT_120	[p8l945t1025r1003b1061],
3	Part	NN	O	part	nn	4	SENT_120	[p8l1018t1026r1103b1061],
4	B	NN	O	b	prep_for	1	SENT_120	[p8l1120t1026r1147b1061],
5	Eligible	JJ	O	eligible	dep	1	SENT_120	[p8l1712t1022r1863b1068],
6	for	IN	O	for	_	0	SENT_120	[p8l1878t1021r1935b1058],
7	Part	NN	O	part	nn	8	SENT_120	[p8l1951t1022r2036b1058],
8	B	NN	O	b	prep_for	5	SENT_120	[p8l2053t1022r2080b1057],

1	Discontinued	VBN	O	discontinue	_	0	SENT_121	[p8l38t1259r311b1295],
2	due	JJ	O	due	dobj	1	SENT_121	[p8l329t1259r407b1295],
3	to	TO	O	to	aux	4	SENT_121	[p8l422t1260r460b1295],
4	Enr	NN	O	enr	infmod	2	SENT_121	[p8l778t1228r1104b1326],
5	:	:	O	:	_	0	SENT_121	[p8l778t1228r1104b1326],
6	p	NN	O	p	dep	4	SENT_121	[p8l778t1228r1104b1326],
7	:	:	O	:	_	0	SENT_121	[p8l778t1228r1104b1326],
8	|	CD	NUMBER	|	number	9	SENT_121	[p8l778t1228r1104b1326],
9	3	CD	NUMBER	3	num	11	SENT_121	[p8l778t1228r1104b1326],
10	|	NN	O	|	nn	11	SENT_121	[p8l778t1228r1104b1326],
11	ec2lSi	NN	O	ec2lsus	dep	4	SENT_121	[p8l778t1228r1104b1326],
12	,	,	O	,	_	0	SENT_121	[p8l778t1228r1104b1326],
13	n5l	NN	O	n5l	appos	11	SENT_121	[p8l778t1228r1104b1326],
14	;	:	O	;	_	0	SENT_121	[p8l778t1228r1104b1326],
15	art	NN	O	art	nn	17	SENT_121	[p8l778t1228r1104b1326],
16	B	NN	O	b	nn	17	SENT_121	[p8l1121t1228r1148b1264],
17	Enr	NN	O	enr	dep	4	SENT_121	[p8l1711t1228r2037b1326],
18	<	JJR	O	<	dep	17	SENT_121	[p8l1711t1228r2037b1326],
19	:	:	O	:	_	0	SENT_121	[p8l1711t1228r2037b1326],
20	|	NN	O	|	nn	21	SENT_121	[p8l1711t1228r2037b1326],
21	e1cl7ig	NN	O	e1cl7ig	dep	4	SENT_121	[p8l1711t1228r2037b1326],
22	;	:	O	;	_	0	SENT_121	[p8l1711t1228r2037b1326],
23	art	NN	O	art	nn	24	SENT_121	[p8l1711t1228r2037b1326],
24	B	NN	O	b	dep	4	SENT_121	[p8l2054t1228r2081b1264],
25	-	:	O	-	_	0	SENT_121	[p8l68t1327r79b1339],
26	Adverse	JJ	O	adverse	amod	27	SENT_121	[p8l96t1317r247b1348],
27	event	NN	O	event	dep	4	SENT_121	[p8l261t1318r361b1348],
28	1	CD	PERCENT	1	number	29	SENT_121	[p8l401t1317r412b1348],
29	(	CD	PERCENT	(	amod	27	SENT_121	[p8l433t1317r552b1357],
30	3.0	CD	PERCENT	3.0	num	31	SENT_121	[p8l433t1317r552b1357],
31	%	NN	PERCENT	%	dep	29	SENT_121	[p8l433t1317r552b1357],
32	)	CD	NUMBER	)	num	33	SENT_121	[p8l433t1317r552b1357],
33	(	NN	O	(	dep	27	SENT_121	[p8l914t1288r927b1335],
34	'	''	O	'	_	0	SENT_121	[p8l984t1318r991b1325],
35	°	CD	NUMBER	°	num	36	SENT_121	[p8l1047t1288r1079b1335],
36	)	CD	NUMBER	)	dep	4	SENT_121	[p8l1047t1288r1079b1335],
37	(	NN	O	(	rcmod	36	SENT_121	[p8l1833t1288r1846b1335],
38	'	''	O	'	_	0	SENT_121	[p8l1904t1318r1911b1325],
39	°	CD	NUMBER	°	dep	37	SENT_121	[p8l1966t1288r1999b1335],
40	)	SYM	O	)	dep	37	SENT_121	[p8l1966t1288r1999b1335],
41	-	:	O	-	_	0	SENT_121	[p8l68t1380r79b1391],
42	Noncompliance	NN	O	noncompliance	dep	4	SENT_121	[p8l99t1370r380b1408],
43	1	CD	PERCENT	1	number	44	SENT_121	[p8l397t1370r409b1400],
44	(	CD	PERCENT	(	amod	47	SENT_121	[p8l430t1369r549b1409],
45	3.0	CD	PERCENT	3.0	num	46	SENT_121	[p8l430t1369r549b1409],
46	%	NN	PERCENT	%	dep	44	SENT_121	[p8l430t1369r549b1409],
47	)	NN	O	)	dep	42	SENT_121	[p8l430t1369r549b1409],
48	'	''	O	'	_	0	SENT_121	[p8l68t1432r79b1443],
49	"	``	O	"	punct	51	SENT_121	[p8l97t1422r299b1452],
50	"	``	O	"	punct	51	SENT_121	[p8l97t1422r299b1452],
51	‘“	CD	NUMBER	‘“	dep	4	SENT_121	[p8l97t1422r299b1452],
52	“	CD	NUMBER	“	dep	51	SENT_121	[p8l97t1422r299b1452],
53	"	``	O	"	punct	52	SENT_121	[p8l97t1422r299b1452],
54	"	``	O	"	punct	55	SENT_121	[p8l97t1422r299b1452],
55	=	JJ	O	=	dep	52	SENT_121	[p8l97t1422r299b1452],
56	“’	CD	NUMBER	“’	tmod	51	SENT_121	[p8l97t1422r299b1452],
57	V	NN	O	v	prep	51	SENT_121	[p8l97t1422r299b1452],
58	“	CD	NUMBER	“	dep	57	SENT_121	[p8l97t1422r299b1452],
59	"	``	O	"	punct	60	SENT_121	[p8l97t1422r299b1452],
60	2	CD	NUMBER	2	dep	51	SENT_121	[p8l395t1422r416b1452],
61	(	CD	NUMBER	(	num	62	SENT_121	[p8l431t1421r550b1461],
62	6	CD	NUMBER	6	xcomp	4	SENT_121	[p8l431t1421r550b1461],
63	-	:	O	-	_	0	SENT_121	[p8l431t1421r550b1461],
64	‘	CD	PERCENT	‘	num	65	SENT_121	[p8l431t1421r550b1461],
65	%	NN	PERCENT	%	nsubj	68	SENT_121	[p8l431t1421r550b1461],
66	)	CD	NUMBER	)	num	67	SENT_121	[p8l431t1421r550b1461],
67	Com	NNP	O	Com	dep	65	SENT_121	[p8l745t1441r843b1477],
68	leted	VBD	O	lete	dep	62	SENT_121	[p8l876t1441r974b1477],
69	Week	NN	DURATION	week	dobj	68	SENT_121	[p8l991t1441r1114b1477],
70	40	CD	NUMBER	40	num	69	SENT_121	[p8l1128t1441r1179b1477],
71	Com	NNP	O	Com	nsubj	72	SENT_121	[p8l1679t1441r1776b1477],
72	leted	VBD	O	lete	rcmod	69	SENT_121	[p8l1808t1441r1907b1477],
73	Week	NN	DURATION	week	dobj	72	SENT_121	[p8l1923t1441r2047b1477],
74	40	CD	NUMBER	40	num	73	SENT_121	[p8l2061t1441r2112b1477],
75	°	NN	O	°	dep	73	SENT_121	[p8l68t1484r79b1495],
76	°	CD	NUMBER	°	num	75	SENT_121	[p8l98t1473r201b1504],
77	"	``	O	"	punct	75	SENT_121	[p8l98t1473r201b1504],
78	“	CD	NUMBER	“	dep	75	SENT_121	[p8l98t1473r201b1504],
79	"	``	O	"	punct	62	SENT_121	[p8l98t1473r201b1504],
80	'	''	O	'	_	0	SENT_121	[p8l98t1473r201b1504],
81	1	CD	PERCENT	1	number	82	SENT_121	[p8l404t1474r416b1504],
82	(	CD	PERCENT	(	amod	2	SENT_121	[p8l437t1473r556b1513],
83	30	CD	PERCENT	30	num	84	SENT_121	[p8l437t1473r556b1513],
84	%	NN	PERCENT	%	dep	82	SENT_121	[p8l437t1473r556b1513],
85	)	CD	NUMBER	)	number	86	SENT_121	[p8l437t1473r556b1513],
86	33	CD	NUMBER	33	num	87	SENT_121	[p8l845t1450r897b1538],
87	(	NN	O	(	dep	2	SENT_121	[p8l914t1500r1079b1548],
88	25.0	CD	PERCENT	25.0	num	89	SENT_121	[p8l914t1500r1079b1548],
89	%	NN	PERCENT	%	dep	87	SENT_121	[p8l914t1500r1079b1548],
90	)	CD	NUMBER	)	num	91	SENT_121	[p8l914t1500r1079b1548],
91	F	NN	O	f	dep	87	SENT_121	[p8l1781t1450r1817b1538],
92	;	:	O	;	_	0	SENT_121	[p8l1781t1450r1817b1538],
93	(	CD	PERCENT	(	number	94	SENT_121	[p8l1833t1500r1999b1548],
94	17.9	CD	PERCENT	17.9	num	95	SENT_121	[p8l1833t1500r1999b1548],
95	%	NN	PERCENT	%	dep	87	SENT_121	[p8l1833t1500r1999b1548],
96	)	CD	NUMBER	)	dep	95	SENT_121	[p8l1833t1500r1999b1548],

1	FIGURE	NN	O	figure	_	0	SENT_122	[p8l10t1684r273b1739],
2	1	CD	NUMBER	1	dep	1	SENT_122	[p8l305t1684r354b1739],
3	.	.	O	.	_	0	SENT_122	[p8l305t1684r354b1739],

1	Subject	NNP	O	Subject	dep	4	SENT_123	[p8l388t1678r640b1762],
2	How	WRB	O	how	advmod	4	SENT_123	[p8l664t1678r805b1739],
3	diagram	NN	O	diagram	nn	4	SENT_123	[p8l829t1678r1101b1762],
4	(	NN	O	(	_	0	SENT_123	[p8l1131t1678r1469b1762],
5	following	VBG	O	follow	dep	4	SENT_123	[p8l1131t1678r1469b1762],
6	Consolidated	NNP	O	Consolidated	nn	7	SENT_123	[p8l1495t1678r1943b1739],
7	Standards	NNPS	O	Standards	pobj	5	SENT_123	[p8l1971t1684r2142b1739, p8l10t1763r184b1824],
8	of	IN	O	of	_	0	SENT_123	[p8l209t1763r279b1824],
9	Reporting	NNP	O	Reporting	nn	11	SENT_123	[p8l295t1768r624b1846],
10	Trials	NNP	O	Trials	nn	11	SENT_123	[p8l645t1763r820b1824],
11	guidelines	NNS	O	guideline	prep_of	7	SENT_123	[p8l846t1763r1219b1846],
12	)	CD	NUMBER	)	tmod	7	SENT_123	[p8l846t1763r1219b1846],
13	.	.	O	.	_	0	SENT_123	[p8l846t1763r1219b1846],

1	often	RB	O	often	advmod	12	SENT_124	[p8l10t2005r209b2080],
2	in	IN	O	in	_	0	SENT_124	[p8l240t2015r313b2079],
3	the	DT	O	the	det	5	SENT_124	[p8l345t2005r467b2080],
4	ivacaftor	NN	O	ivacaftor	nn	5	SENT_124	[p8l501t2005r832b2080],
5	group	NN	O	group	prep_in	12	SENT_124	[p8l862t2032r1087b2108],
6	than	IN	O	than	advmod	12	SENT_124	[p8l1121t2005r1292b2080],
7	in	IN	O	in	_	0	SENT_124	[p8l1324t2015r1396b2079],
8	the	DT	O	the	det	10	SENT_124	[p8l1428t2005r1550b2080],
9	placebo	NN	O	placebo	nn	10	SENT_124	[p8l1583t2005r1883b2108],
10	group	NN	O	group	prep_in	6	SENT_124	[p8l1917t2032r2142b2108],
11	were	VBD	O	be	cop	12	SENT_124	[p8l6t2146r211b2192],
12	cough	NN	O	cough	_	0	SENT_124	[p8l248t2117r525b2220],
13	,	,	O	,	_	0	SENT_124	[p8l248t2117r525b2220],
14	nausea	NN	O	nausea	conj_and	12	SENT_124	[p8l564t2146r876b2206],
15	,	,	O	,	_	0	SENT_124	[p8l564t2146r876b2206],
16	rash	NN	O	rash	conj_and	12	SENT_124	[p8l916t2117r1113b2206],
17	,	,	O	,	_	0	SENT_124	[p8l916t2117r1113b2206],
18	and	CC	O	and	_	0	SENT_124	[p8l1154t2117r1305b2192],
19	contact	NN	O	contact	nn	20	SENT_124	[p8l1339t2133r1649b2192],
20	dermatitis	NN	O	dermatitis	conj_and	12	SENT_124	[p8l1684t2117r2137b2192],
21	.	.	O	.	_	0	SENT_124	[p8l1684t2117r2137b2192],

1	None	NN	O	none	nsubjpass	8	SENT_125	[p8l12t2236r223b2304],
2	of	IN	O	of	_	0	SENT_125	[p8l259t2229r343b2304],
3	these	DT	O	these	det	4	SENT_125	[p8l365t2229r567b2304],
4	events	NNS	O	event	prep_of	1	SENT_125	[p8l603t2245r844b2304],
5	was	VBD	O	be	auxpass	6	SENT_125	[p8l877t2258r1018b2304],
6	serious	JJ	O	serious	_	0	SENT_125	[p8l1054t2240r1319b2304],
7	or	CC	O	or	_	0	SENT_125	[p8l1355t2258r1436b2304],
8	led	VBN	O	lead	conj_or	6	SENT_125	[p8l1467t2228r1586b2304],
9	to	TO	O	to	aux	10	SENT_125	[p8l1617t2245r1692b2304],
10	study	VB	O	study	xcomp	8	SENT_125	[p8l1727t2229r1934b2332],
11	drug	NN	O	drug	nn	12	SENT_125	[p8l1965t2229r2145b2332],
12	discontinuation	NN	O	discontinuation	dobj	10	SENT_125	[p8l10t2340r671b2416],
13	.	.	O	.	_	0	SENT_125	[p8l10t2340r671b2416],

1	Conversely	RB	O	conversely	advmod	8	SENT_126	[p8l715t2341r1190b2444],
2	,	,	O	,	_	0	SENT_126	[p8l715t2341r1190b2444],
3	investigator	NN	O	investigator	nn	4	SENT_126	[p8l1230t2341r2144b2444],
4	—	NN	O	—	nsubj	8	SENT_126	[p8l1230t2341r2144b2444],
5	identiﬁed	VBN	O	identiﬁed	partmod	4	SENT_126	[p8l1230t2341r2144b2444],
6	pulmonary	JJ	O	pulmonary	amod	7	SENT_126	[p8l7t2454r446b2556],
7	exacerbations	NNS	O	exacerbation	dobj	5	SENT_126	[p8l470t2454r1013b2529],
8	occurred	VBD	O	occur	_	0	SENT_126	[p8l1042t2454r1402b2528],
9	in	IN	O	in	_	0	SENT_126	[p8l1426t2464r1501b2527],
10	a	DT	O	a	det	12	SENT_126	[p8l1529t2483r1570b2528],
11	lower	JJR	O	lower	amod	12	SENT_126	[p8l1594t2454r1819b2528],
12	proportion	NN	O	proportion	prep_in	8	SENT_126	[p8l1841t2483r2141b2556, p8l8t2576r164b2641],
13	of	IN	O	of	_	0	SENT_126	[p8l193t2566r279b2641],
14	subjects	NNS	O	subject	prep_of	12	SENT_126	[p8l300t2566r618b2669],
15	treated	VBN	O	treat	partmod	14	SENT_126	[p8l649t2566r936b2641],
16	with	IN	O	with	_	0	SENT_126	[p8l960t2566r1137b2641],
17	ivacaftor	NN	O	ivacaftor	prep_with	15	SENT_126	[p8l1165t2566r1513b2641],
18	compared	VBN	O	compare	_	0	SENT_126	[p8l1540t2566r1943b2669],
19	with	IN	O	with	prepc_compared_with	15	SENT_126	[p8l1967t2566r2143b2641],
20	placebo	NN	O	placebo	pobj	15	SENT_126	[p8l7t2679r339b2781],
21	.	.	O	.	_	0	SENT_126	[p8l7t2679r339b2781],

1	Adverse	JJ	O	adverse	amod	2	SENT_127	[p8l101t2791r431b2866],
2	events	NNS	O	event	nsubj	6	SENT_127	[p8l471t2807r727b2866],
3	were	VBD	O	be	cop	6	SENT_127	[p8l763t2820r963b2866],
4	mostly	RB	O	mostly	advmod	6	SENT_127	[p8l1003t2791r1272b2894],
5	mild	JJ	O	mild	amod	6	SENT_127	[p8l1307t2791r1490b2866],
6	(	NN	O	(	_	0	SENT_127	[p8l1530t2791r1767b2881],
7	35	CD	PERCENT	35	number	8	SENT_127	[p8l1530t2791r1767b2881],
8	%	NN	PERCENT	%	amod	6	SENT_127	[p8l1530t2791r1767b2881],
9	)	CD	NUMBER	)	dep	15	SENT_127	[p8l1530t2791r1767b2881],
10	or	CC	O	or	_	0	SENT_127	[p8l1810t2820r1894b2866],
11	moderate	JJ	O	moderate	amod	12	SENT_127	[p8l1930t2791r2141b2866, p8l10t2918r213b2976],
12	(	NN	O	(	conj_or	9	SENT_127	[p8l261t2902r498b2990],
13	45	CD	PERCENT	45	num	14	SENT_127	[p8l261t2902r498b2990],
14	%	NN	PERCENT	%	dep	15	SENT_127	[p8l261t2902r498b2990],
15	)	CD	NUMBER	)	dep	6	SENT_127	[p8l261t2902r498b2990],
16	in	IN	O	in	_	0	SENT_127	[p8l544t2912r619b2975],
17	severity	NN	O	severity	prep_in	15	SENT_127	[p8l663t2912r988b3004],
18	.	.	O	.	_	0	SENT_127	[p8l663t2912r988b3004],

1	One	CD	NUMBER	one	num	3	SENT_128	[p8l1038t2908r1207b2976],
2	subject	JJ	O	subject	amod	3	SENT_128	[p8l1252t2902r1543b3004],
3	(	NN	O	(	nsubj	11	SENT_128	[p8l1588t2902r1851b2991],
4	0.9	CD	PERCENT	0.9	num	5	SENT_128	[p8l1588t2902r1851b2991],
5	%	NN	PERCENT	%	dep	3	SENT_128	[p8l1588t2902r1851b2991],
6	)	CD	NUMBER	)	dep	3	SENT_128	[p8l1588t2902r1851b2991],
7	in	IN	O	in	_	0	SENT_128	[p8l1896t2912r1972b2975],
8	the	DT	O	the	det	10	SENT_128	[p8l2013t2902r2142b2976],
9	ivacaftor	NN	O	ivacaftor	nn	10	SENT_128	[p8l8t3014r356b3089],
10	group	NN	O	group	prep_in	6	SENT_128	[p8l387t3041r620b3117],
11	had	VBD	O	have	_	0	SENT_128	[p8l654t3014r801b3089],
12	three	CD	NUMBER	three	num	14	SENT_128	[p8l833t3014r1042b3089],
13	adverse	JJ	O	adverse	amod	14	SENT_128	[p8l1078t3014r1380b3089],
14	events	NNS	O	event	dobj	11	SENT_128	[p8l1415t3030r1667b3089],
15	considered	VBN	O	consider	partmod	14	SENT_128	[p8l1703t3014r2144b3089],
16	life	NN	O	life	dobj	15	SENT_128	[p8l8t3126r133b3201],
17	threatening	VBG	O	threaten	partmod	16	SENT_128	[p8l161t3126r644b3229],
18	:	:	O	:	_	0	SENT_128	[p8l161t3126r644b3229],
19	fatigue	NN	O	fatigue	dobj	11	SENT_128	[p8l678t3126r973b3229],
20	,	,	O	,	_	0	SENT_128	[p8l678t3126r973b3229],
21	depression	NN	O	depression	appos	19	SENT_128	[p8l1004t3126r1457b3229],
22	,	,	O	,	_	0	SENT_128	[p8l1004t3126r1457b3229],
23	and	CC	O	and	_	0	SENT_128	[p8l1489t3126r1634b3201],
24	suicidal	JJ	O	suicidal	amod	25	SENT_128	[p8l1661t3126r1963b3201],
25	ideation	NN	O	ideation	conj_and	14	SENT_128	[p8l1988t3126r2141b3201, p8l10t3248r227b3313],
26	.	.	O	.	_	0	SENT_128	[p8l1988t3126r2141b3201, p8l10t3248r227b3313],

1	Ten	CD	NUMBER	ten	num	2	SENT_129	[p8l261t3245r413b3313],
2	subjects	NNS	O	subject	nsubj	11	SENT_129	[p8l446t3238r764b3341],
3	(	JJ	O	(	amod	2	SENT_129	[p8l801t3238r1059b3327],
4	8.9	CD	PERCENT	8.9	num	5	SENT_129	[p8l801t3238r1059b3327],
5	%	NN	PERCENT	%	dep	2	SENT_129	[p8l801t3238r1059b3327],
6	)	CD	NUMBER	)	dep	2	SENT_129	[p8l801t3238r1059b3327],
7	in	IN	O	in	_	0	SENT_129	[p8l1094t3248r1169b3312],
8	the	DT	O	the	det	10	SENT_129	[p8l1199t3238r1325b3313],
9	ivacaftor	NN	O	ivacaftor	nn	10	SENT_129	[p8l1357t3238r1704b3313],
10	group	NN	O	group	prep_in	6	SENT_129	[p8l1733t3265r1965b3341],
11	had	VBD	O	have	_	0	SENT_129	[p8l1997t3238r2144b3313],
12	14	CD	NUMBER	14	num	14	SENT_129	[p8l15t3355r105b3422],
13	adverse	JJ	O	adverse	amod	14	SENT_129	[p8l136t3349r449b3423],
14	events	NNS	O	event	dobj	11	SENT_129	[p8l481t3365r742b3423],
15	considered	VBN	O	consider	partmod	14	SENT_129	[p8l775t3349r1235b3423],
16	by	IN	O	by	_	0	SENT_129	[p8l1261t3349r1361b3451],
17	the	DT	O	the	det	18	SENT_129	[p8l1386t3349r1516b3423],
18	investigator	NN	O	investigator	agent	15	SENT_129	[p8l1547t3359r2038b3451],
19	to	TO	O	to	aux	21	SENT_129	[p8l2064t3365r2142b3423],
20	be	VB	O	be	cop	21	SENT_129	[p8l8t3461r104b3537],
21	severe	JJ	O	severe	xcomp	15	SENT_129	[p8l138t3490r412b3550],
22	;	:	O	;	_	0	SENT_129	[p8l138t3490r412b3550],
23	all	DT	O	all	nsubj	26	SENT_129	[p8l448t3461r538b3536],
24	were	VBD	O	be	cop	26	SENT_129	[p8l565t3490r761b3536],
25	single	JJ	O	single	amod	26	SENT_129	[p8l796t3461r1024b3564],
26	events	NNS	O	event	parataxis	11	SENT_129	[p8l1057t3477r1309b3536],
27	of	IN	O	of	_	0	SENT_129	[p8l1343t3461r1429b3536],
28	nasal	JJ	O	nasal	amod	29	SENT_129	[p8l1450t3461r1649b3536],
29	congestion	NN	O	congestion	prep_of	26	SENT_129	[p8l1679t3471r2139b3564],
30	,	,	O	,	_	0	SENT_129	[p8l1679t3471r2139b3564],
31	nasal	JJ	O	nasal	amod	32	SENT_129	[p8l9t3574r200b3649],
32	polyps	NNS	O	polyp	appos	29	SENT_129	[p8l233t3574r500b3677],
33	,	,	O	,	_	0	SENT_129	[p8l233t3574r500b3677],
34	epistaxis	NN	O	epistaxi	appos	32	SENT_129	[p8l541t3584r878b3677],
35	,	,	O	,	_	0	SENT_129	[p8l541t3584r878b3677],
36	increased	VBD	O	increase	amod	37	SENT_129	[p8l916t3574r1285b3649],
37	viscosity	NN	O	viscosity	appos	32	SENT_129	[p8l1316t3584r1639b3677],
38	of	IN	O	of	_	0	SENT_129	[p8l1671t3574r1755b3649],
39	bronchial	JJ	O	bronchial	amod	40	SENT_129	[p8l1779t3574r2144b3650],
40	secretions	NNS	O	secretion	prep_of	37	SENT_129	[p9l10t35r442b113],
41	,	,	O	,	_	0	SENT_129	[p9l10t35r442b113],
42	sinusitis	NN	O	sinusitis	appos	40	SENT_129	[p9l476t35r822b113],
43	,	,	O	,	_	0	SENT_129	[p9l476t35r822b113],
44	laryngitis	NN	O	laryngitis	appos	40	SENT_129	[p9l854t25r1249b127],
45	,	,	O	,	_	0	SENT_129	[p9l854t25r1249b127],
46	pulmonary	JJ	O	pulmonary	amod	47	SENT_129	[p9l1280t25r1727b127],
47	exacerbation	NN	O	exacerbation	appos	40	SENT_129	[p9l1752t25r2141b99, p9l8t147r184b225],
48	,	,	O	,	_	0	SENT_129	[p9l1752t25r2141b99, p9l8t147r184b225],
49	diarrhea	NN	O	diarrhea	appos	40	SENT_129	[p9l213t137r568b225],
50	,	,	O	,	_	0	SENT_129	[p9l213t137r568b225],
51	dental	JJ	O	dental	amod	52	SENT_129	[p9l597t137r846b212],
52	caries	NNS	O	caries	appos	40	SENT_129	[p9l869t147r1119b225],
53	,	,	O	,	_	0	SENT_129	[p9l869t147r1119b225],
54	asthenia	NN	O	asthenia	appos	40	SENT_129	[p9l1147t137r1496b225],
55	,	,	O	,	_	0	SENT_129	[p9l1147t137r1496b225],
56	rash	NN	O	rash	appos	40	SENT_129	[p9l1525t137r1710b225],
57	,	,	O	,	_	0	SENT_129	[p9l1525t137r1710b225],
58	headache	NN	O	headache	appos	40	SENT_129	[p9l1737t137r2139b225],
59	,	,	O	,	_	0	SENT_129	[p9l1737t137r2139b225],
60	arthritis	NN	O	arthritis	appos	40	SENT_129	[p9l10t248r345b336],
61	,	,	O	,	_	0	SENT_129	[p9l10t248r345b336],
62	and	CC	O	and	_	0	SENT_129	[p9l385t248r530b322],
63	nephrolithiasis	NN	O	nephrolithiasis	conj_and	54	SENT_129	[p9l564t248r1173b350],
64	.	.	O	.	_	0	SENT_129	[p9l564t248r1173b350],

1	No	DT	O	no	det	3	SENT_130	[p9l1216t255r1334b322],
2	severe	JJ	O	severe	amod	3	SENT_130	[p9l1371t277r1623b322],
3	events	NNS	O	event	nsubjpass	5	SENT_130	[p9l1660t264r1911b322],
4	were	VBD	O	be	auxpass	5	SENT_130	[p9l1945t277r2142b322],
5	reported	VBN	O	report	_	0	SENT_130	[p9l10t360r360b463],
6	in	IN	O	in	_	0	SENT_130	[p9l397t370r472b434],
7	the	DT	O	the	det	9	SENT_130	[p9l510t360r636b435],
8	placebo	NN	O	placebo	nn	9	SENT_130	[p9l675t360r987b463],
9	group	NN	O	group	prep_in	5	SENT_130	[p9l1027t387r1281b463],
10	.	.	O	.	_	0	SENT_130	[p9l1027t387r1281b463],

1	No	DT	O	no	det	2	SENT_131	[p9l1328t367r1446b435],
2	deaths	NNS	O	death	nsubj	3	SENT_131	[p9l1487t360r1743b435],
3	occurred	VBD	O	occur	_	0	SENT_131	[p9l1785t360r2144b435],
4	during	IN	O	during	_	0	SENT_131	[p9l10t471r284b575],
5	the	DT	O	the	det	6	SENT_131	[p9l313t472r443b547],
6	study	NN	O	study	prep_during	3	SENT_131	[p9l477t471r710b575],
7	.	.	O	.	_	0	SENT_131	[p9l477t471r710b575],

1	Twenty-one	CD	NUMBER	twenty-one	num	2	SENT_132	[p9l745t479r1236b575],
2	subjects	NNS	O	subject	npadvmod	3	SENT_132	[p9l1270t472r1602b575],
3	(	JJ	O	(	_	0	SENT_132	[p9l1640t472r1958b561],
4	15.0	CD	PERCENT	15.0	num	5	SENT_132	[p9l1640t472r1958b561],
5	%	NN	PERCENT	%	nsubj	7	SENT_132	[p9l1640t472r1958b561],
6	)	CD	NUMBER	)	dep	5	SENT_132	[p9l1640t472r1958b561],
7	had	VBD	O	have	dep	3	SENT_132	[p9l1993t472r2144b547],
8	at	IN	O	at	quantmod	10	SENT_132	[p9l10t599r82b657],
9	least	JJS	O	least	mwe	8	SENT_132	[p9l114t583r299b657],
10	one	CD	NUMBER	one	num	11	SENT_132	[p9l332t612r477b657],
11	event	NN	O	event	dobj	7	SENT_132	[p9l513t599r735b657],
12	that	WDT	O	that	nsubj	13	SENT_132	[p9l767t583r926b657],
13	met	VBD	O	meet	rcmod	11	SENT_132	[p9l959t599r1116b657],
14	the	DT	O	the	det	15	SENT_132	[p9l1147t583r1275b657],
15	criteria	NNS	O	criterion	dobj	13	SENT_132	[p9l1311t593r1605b657],
16	for	IN	O	for	_	0	SENT_132	[p9l1636t583r1753b657],
17	a	DT	O	a	det	20	SENT_132	[p9l1785t612r1826b657],
18	serious	JJ	O	serious	amod	20	SENT_132	[p9l1858t593r2141b657],
19	adverse	JJ	O	adverse	amod	20	SENT_132	[p9l10t694r311b770],
20	event	NN	O	event	prep_for	13	SENT_132	[p9l350t711r589b784],
21	,	,	O	,	_	0	SENT_132	[p9l350t711r589b784],
22	including	VBG	O	include	_	0	SENT_132	[p9l628t695r1006b798],
23	15	CD	PERCENT	15	number	24	SENT_132	[p9l1047t698r1134b770],
24	(	CD	PERCENT	(	prep_including	13	SENT_132	[p9l1176t695r1484b784],
25	13.4	CD	PERCENT	13.4	num	26	SENT_132	[p9l1176t695r1484b784],
26	%	NN	PERCENT	%	dep	24	SENT_132	[p9l1176t695r1484b784],
27	)	CD	NUMBER	)	dep	24	SENT_132	[p9l1176t695r1484b784],
28	in	IN	O	in	_	0	SENT_132	[p9l1524t705r1598b769],
29	the	DT	O	the	det	31	SENT_132	[p9l1635t695r1761b770],
30	ivacaftor	NN	O	ivacaftor	nn	31	SENT_132	[p9l1798t695r2145b770],
31	group	NN	O	group	prep_in	27	SENT_132	[p9l9t834r235b910],
32	and	CC	O	and	_	0	SENT_132	[p9l273t807r415b882],
33	six	CD	PERCENT	six	prep_including	13	SENT_132	[p9l451t817r546b882],
34	(	CD	PERCENT	(	number	35	SENT_132	[p9l584t807r879b896],
35	21.4	CD	PERCENT	21.4	num	36	SENT_132	[p9l584t807r879b896],
36	%	NN	PERCENT	%	dep	33	SENT_132	[p9l584t807r879b896],
37	)	CD	NUMBER	)	tmod	7	SENT_132	[p9l584t807r879b896],
38	in	IN	O	in	_	0	SENT_132	[p9l919t817r992b881],
39	the	DT	O	the	det	41	SENT_132	[p9l1027t807r1149b882],
40	placebo	NN	O	placebo	nn	41	SENT_132	[p9l1185t807r1486b910],
41	group	NN	O	group	prep_in	7	SENT_132	[p9l1523t834r1766b910],
42	.	.	O	.	_	0	SENT_132	[p9l1523t834r1766b910],

1	This	DT	O	this	det	2	SENT_133	[p9l1807t807r1972b882],
2	difference	NN	O	difference	nsubj	5	SENT_133	[p9l2012t806r2141b882, p9l9t920r310b994],
3	was	VBD	O	be	cop	5	SENT_133	[p9l334t949r479b994],
4	predominantly	RB	O	predominantly	advmod	5	SENT_133	[p9l506t920r1101b1022],
5	due	JJ	O	due	_	0	SENT_133	[p9l1125t920r1271b994],
6	to	TO	O	to	_	0	SENT_133	[p9l1299t936r1374b994],
7	pulmonary	JJ	O	pulmonary	amod	8	SENT_133	[p9l1400t920r1839b1022],
8	exacerbations	NNS	O	exacerbation	prep_to	5	SENT_133	[p9l1862t949r2141b994, p9l8t1073r290b1161],
9	,	,	O	,	_	0	SENT_133	[p9l1862t949r2141b994, p9l8t1073r290b1161],

1	which	WDT	O	which	nsubj	4	SENT_134	[p9l319t1073r545b1147],
2	were	VBD	O	be	cop	4	SENT_134	[p9l570t1102r755b1147],
3	more	JJR	O	more	advmod	4	SENT_134	[p9l787t1102r981b1147],
4	frequent	JJ	O	frequent	_	0	SENT_134	[p9l1012t1073r1333b1175],
5	in	IN	O	in	_	0	SENT_134	[p9l1360t1083r1431b1146],
6	the	DT	O	the	det	10	SENT_134	[p9l1459t1073r1577b1147],
7	placebo	NN	O	placebo	nn	10	SENT_134	[p9l1606t1073r1894b1175],
8	group	NN	O	group	nn	10	SENT_134	[p9l1925t1099r2142b1175],
9	(	CD	NUMBER	(	num	10	SENT_134	[p9l13t1185r93b1275],
10	n	NN	O	n	prep_in	4	SENT_134	[p9l13t1185r93b1275],
11	=	JJ	O	=	amod	10	SENT_134	[p9l123t1215r181b1237],
12	5	CD	NUMBER	5	tmod	11	SENT_134	[p9l211t1188r279b1274],
13	,	,	O	,	_	0	SENT_134	[p9l211t1188r279b1274],
14	17.9	CD	PERCENT	17.9	num	15	SENT_134	[p9l324t1185r607b1274],
15	%	NN	PERCENT	%	appos	10	SENT_134	[p9l324t1185r607b1274],
16	)	CD	NUMBER	)	npadvmod	17	SENT_134	[p9l324t1185r607b1274],
17	than	IN	O	than	advmod	15	SENT_134	[p9l647t1185r830b1260],
18	in	IN	O	in	_	0	SENT_134	[p9l865t1195r941b1259],
19	the	DT	O	the	det	23	SENT_134	[p9l977t1185r1107b1260],
20	ivacaftor	NN	O	ivacaftor	nn	23	SENT_134	[p9l1144t1185r1506b1260],
21	group	NN	O	group	nn	23	SENT_134	[p9l1540t1212r1781b1288],
22	(	CD	NUMBER	(	num	23	SENT_134	[p9l1822t1185r1902b1274],
23	n	NN	O	n	prep_in	15	SENT_134	[p9l1822t1185r1902b1274],
24	=	JJ	O	=	amod	15	SENT_134	[p9l1931t1215r1990b1237],
25	10	CD	NUMBER	10	tmod	24	SENT_134	[p9l2026t1191r2139b1274],
26	,	,	O	,	_	0	SENT_134	[p9l2026t1191r2139b1274],
27	8.9	CD	PERCENT	8.9	number	28	SENT_134	[p9l10t1296r252b1385],
28	%	NN	PERCENT	%	amod	15	SENT_134	[p9l10t1296r252b1385],
29	)	CD	NUMBER	)	tmod	4	SENT_134	[p9l10t1296r252b1385],
30	.	.	O	.	_	0	SENT_134	[p9l10t1296r252b1385],

1	Other	JJ	O	other	amod	4	SENT_135	[p9l287t1296r518b1370],
2	serious	JJ	O	serious	amod	4	SENT_135	[p9l545t1306r810b1370],
3	adverse	JJ	O	adverse	amod	4	SENT_135	[p9l841t1296r1130b1370],
4	events	NNS	O	event	nsubj	7	SENT_135	[p9l1161t1312r1403b1370],
5	were	VBD	O	be	cop	7	SENT_135	[p9l1429t1325r1620b1370],
6	single	JJ	O	single	amod	7	SENT_135	[p9l1651t1296r1869b1398],
7	events	NNS	O	event	_	0	SENT_135	[p9l1899t1312r2141b1370],
8	of	IN	O	of	_	0	SENT_135	[p9l10t1408r96b1483],
9	hemoptysis	NN	O	hemoptysis	prep_of	7	SENT_135	[p9l110t1408r583b1511],
10	,	,	O	,	_	0	SENT_135	[p9l110t1408r583b1511],
11	hypoxia	NN	O	hypoxium	appos	9	SENT_135	[p9l612t1408r938b1511],
12	,	,	O	,	_	0	SENT_135	[p9l612t1408r938b1511],
13	nasal	JJ	O	nasal	amod	14	SENT_135	[p9l968t1408r1167b1483],
14	polyps	NNS	O	polyp	appos	9	SENT_135	[p9l1191t1408r1469b1511],
15	,	,	O	,	_	0	SENT_135	[p9l1191t1408r1469b1511],
16	abdominal	JJ	O	abdominal	amod	17	SENT_135	[p9l1500t1408r1922b1483],
17	pain	NN	O	pain	appos	9	SENT_135	[p9l1946t1418r2139b1511],
18	,	,	O	,	_	0	SENT_135	[p9l1946t1418r2139b1511],

1	myopathy	NN	O	myopathy	_	0	SENT_136	[p9l10t1562r416b1665],
2	,	,	O	,	_	0	SENT_136	[p9l10t1562r416b1665],
3	fatigue	NN	O	fatigue	conj_and	1	SENT_136	[p9l459t1562r754b1665],
4	,	,	O	,	_	0	SENT_136	[p9l459t1562r754b1665],
5	depression	NN	O	depression	conj_and	1	SENT_136	[p9l798t1562r1251b1665],
6	,	,	O	,	_	0	SENT_136	[p9l798t1562r1251b1665],
7	and	CC	O	and	_	0	SENT_136	[p9l1295t1562r1441b1637],
8	suicidal	JJ	O	suicidal	amod	9	SENT_136	[p9l1480t1562r1781b1637],
9	ideation	NN	O	ideation	conj_and	1	SENT_136	[p9l1819t1562r2143b1637],
10	in	IN	O	in	_	0	SENT_136	[p9l8t1726r83b1790],
11	the	DT	O	the	det	13	SENT_136	[p9l120t1716r245b1791],
12	ivacaftor	NN	O	ivacaftor	nn	13	SENT_136	[p9l284t1716r625b1791],
13	group	NN	O	group	prep_in	9	SENT_136	[p9l661t1743r912b1819],
14	;	:	O	;	_	0	SENT_136	[p9l661t1743r912b1819],
15	and	CC	O	and	_	0	SENT_136	[p9l955t1716r1099b1791],
16	bronchopneumonia	NN	O	bronchopneumonium	prep_in	9	SENT_136	[p9l1134t1716r1935b1819],
17	,	,	O	,	_	0	SENT_136	[p9l1134t1716r1935b1819],
18	cognitive	JJ	O	cognitive	amod	19	SENT_136	[p9l1977t1743r2141b1819, p9l9t1838r226b1903],
19	disorder	NN	O	disorder	conj_and	1	SENT_136	[p9l258t1828r597b1917],
20	,	,	O	,	_	0	SENT_136	[p9l258t1828r597b1917],
21	and	CC	O	and	_	0	SENT_136	[p9l632t1827r776b1903],
22	venous	JJ	O	venous	amod	23	SENT_136	[p9l801t1857r1077b1903],
23	thrombosis	NN	O	thrombosis	conj_and	1	SENT_136	[p9l1108t1828r1545b1904],
24	in	IN	O	in	_	0	SENT_136	[p9l1577t1838r1651b1902],
25	the	DT	O	the	det	27	SENT_136	[p9l1680t1828r1805b1903],
26	placebo	NN	O	placebo	nn	27	SENT_136	[p9l1835t1828r2142b1931],
27	group	NN	O	group	prep_in	23	SENT_136	[p9l10t1965r263b2040],
28	.	.	O	.	_	0	SENT_136	[p9l10t1965r263b2040],

1	In	IN	O	in	_	0	SENT_137	[p9l105t2057r190b2123],
2	the	DT	O	the	det	4	SENT_137	[p9l222t2050r348b2124],
3	ivacaftor	NN	O	ivacaftor	nn	4	SENT_137	[p9l382t2050r729b2124],
4	group	NN	O	group	prep_in	13	SENT_137	[p9l760t2077r1014b2152],
5	,	,	O	,	_	0	SENT_137	[p9l760t2077r1014b2152],
6	three	CD	NUMBER	three	num	7	SENT_137	[p9l1050t2050r1260b2124],
7	subjects	NNS	O	subject	nsubjpass	13	SENT_137	[p9l1296t2050r1614b2152],
8	(	JJ	O	(	amod	7	SENT_137	[p9l1653t2050r1911b2139],
9	2.7	CD	PERCENT	2.7	dep	10	SENT_137	[p9l1653t2050r1911b2139],
10	%	NN	PERCENT	%	advmod	8	SENT_137	[p9l1653t2050r1911b2139],
11	)	CD	NUMBER	)	tmod	8	SENT_137	[p9l1653t2050r1911b2139],
12	were	VBD	O	be	auxpass	13	SENT_137	[p9l1945t2079r2142b2124],
13	discontinued	VBN	O	discontinue	_	0	SENT_137	[p9l10t2161r562b2237],
14	from	IN	O	from	_	0	SENT_137	[p9l599t2162r798b2237],
15	the	DT	O	the	det	16	SENT_137	[p9l836t2162r968b2237],
16	study	NN	O	study	prep_from	13	SENT_137	[p9l1009t2162r1236b2265],
17	because	IN	O	because	_	0	SENT_137	[p9l1268t2162r1606b2237],
18	of	IN	O	of	_	0	SENT_137	[p9l1645t2162r1735b2237],
19	a	DT	O	a	det	20	SENT_137	[p9l1763t2191r1803b2237],
20	total	NN	O	total	prep_because_of	13	SENT_137	[p9l1838t2162r2027b2237],
21	of	IN	O	of	_	0	SENT_137	[p9l2065t2162r2153b2237],
22	ﬁve	NN	O	ﬁve	nn	23	SENT_137	[p9l10t2274r143b2349],
23	events	NNS	O	event	prep_of	20	SENT_137	[p9l172t2290r435b2363],
24	,	,	O	,	_	0	SENT_137	[p9l172t2290r435b2363],
25	which	WDT	O	which	nsubj	26	SENT_137	[p9l460t2274r695b2349],
26	included	VBD	O	include	rcmod	23	SENT_137	[p9l720t2274r1058b2349],
27	asthenia	NN	O	asthenia	dobj	26	SENT_137	[p9l1084t2274r1417b2363],
28	,	,	O	,	_	0	SENT_137	[p9l1084t2274r1417b2363],
29	fatigue	NN	O	fatigue	dobj	26	SENT_137	[p9l1447t2274r1728b2377],
30	,	,	O	,	_	0	SENT_137	[p9l1447t2274r1728b2377],
31	and	CC	O	and	_	0	SENT_137	[p9l1759t2274r1901b2349],
32	headache	NN	O	headache	dobj	26	SENT_137	[p9l1924t2274r2141b2349, p9l10t2385r185b2459],
33	in	IN	O	in	_	0	SENT_137	[p9l216t2395r289b2458],
34	one	CD	NUMBER	one	num	35	SENT_137	[p9l320t2414r459b2459],
35	subject	NN	O	subject	prep_in	26	SENT_137	[p9l492t2385r784b2487],
36	,	,	O	,	_	0	SENT_137	[p9l492t2385r784b2487],
37	arthritis	NN	O	arthritis	conj_and	35	SENT_137	[p9l819t2385r1114b2459],
38	in	IN	O	in	_	0	SENT_137	[p9l1146t2395r1219b2458],
39	another	DT	O	another	prep_in	37	SENT_137	[p9l1250t2385r1558b2473],
40	,	,	O	,	_	0	SENT_137	[p9l1250t2385r1558b2473],
41	and	CC	O	and	_	0	SENT_137	[p9l1593t2385r1735b2459],
42	myopathy	NN	O	myopathy	conj_and	35	SENT_137	[p9l1765t2385r2147b2487],
43	in	IN	O	in	_	0	SENT_137	[p9l8t2506r83b2569],
44	the	DT	O	the	det	45	SENT_137	[p9l108t2496r232b2570],
45	third	JJ	ORDINAL	third	prep_in	26	SENT_137	[p9l258t2496r468b2570],
46	.	.	O	.	_	0	SENT_137	[p9l258t2496r468b2570],

1	In	IN	O	in	_	0	SENT_138	[p9l501t2503r585b2569],
2	the	DT	O	the	det	4	SENT_138	[p9l610t2496r734b2570],
3	placebo	NN	O	placebo	nn	4	SENT_138	[p9l761t2496r1066b2598],
4	group	NN	O	group	prep_in	13	SENT_138	[p9l1094t2523r1344b2598],
5	,	,	O	,	_	0	SENT_138	[p9l1094t2523r1344b2598],
6	two	CD	NUMBER	two	num	7	SENT_138	[p9l1372t2512r1514b2570],
7	subjects	NNS	O	subject	nsubjpass	13	SENT_138	[p9l1542t2496r1854b2598],
8	(	JJ	O	(	amod	7	SENT_138	[p9l1886t2496r2139b2585],
9	7.1	CD	PERCENT	7.1	dep	10	SENT_138	[p9l1886t2496r2139b2585],
10	%	NN	PERCENT	%	advmod	8	SENT_138	[p9l1886t2496r2139b2585],
11	)	CD	NUMBER	)	tmod	8	SENT_138	[p9l1886t2496r2139b2585],
12	were	VBD	O	be	auxpass	13	SENT_138	[p9l6t2637r196b2682],
13	discontinued	VBN	O	discontinue	_	0	SENT_138	[p9l228t2607r726b2682],
14	because	IN	O	because	mark	15	SENT_138	[p9l752t2607r1061b2683],
15	of	IN	O	of	advcl	13	SENT_138	[p9l1092t2607r1176b2682],
16	adverse	JJ	O	adverse	amod	17	SENT_138	[p9l1196t2607r1486b2682],
17	events	NNS	O	event	pobj	15	SENT_138	[p9l1517t2623r1759b2682],
18	of	IN	O	of	_	0	SENT_138	[p9l1792t2607r1875b2682],
19	abnormal	JJ	O	abnormal	amod	20	SENT_138	[p9l1896t2607r2141b2682, p9l10t2719r159b2793],
20	feelings	NNS	O	feeling	prep_of	17	SENT_138	[p9l193t2719r513b2821],
21	and	CC	O	and	_	0	SENT_138	[p9l551t2719r700b2793],
22	cognitive	JJ	O	cognitive	amod	23	SENT_138	[p9l733t2729r1109b2821],
23	disorder	NN	O	disorder	pobj	15	SENT_138	[p9l1146t2719r1494b2793],
24	in	IN	O	in	_	0	SENT_138	[p9l1525t2729r1602b2792],
25	one	CD	NUMBER	one	num	26	SENT_138	[p9l1636t2748r1783b2793],
26	subject	NN	O	subject	prep_in	23	SENT_138	[p9l1820t2719r2139b2821],
27	,	,	O	,	_	0	SENT_138	[p9l1820t2719r2139b2821],

1	Original	NNP	O	Original	nn	2	SENT_139	[p9l1628t2961r1847b3023],
2	Research	NNP	O	Research	_	0	SENT_139	[p9l1874t2962r2141b3010],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_140	[p9l302t3099r479b3123],
2	From	IN	O	from	dep	1	SENT_140	[p9l488t3099r576b3122],
3	:	:	O	:	_	0	SENT_140	[p9l488t3099r576b3122],
4	http://journal.puhlications.chestnet.org/	NN	O	http://journal.puhlications.chestnet.org/	dep	1	SENT_140	[p9l587t3098r1156b3129],
5	by	IN	O	by	dep	4	SENT_140	[p9l1163t3099r1198b3129],
6	a	DT	O	a	det	10	SENT_140	[p9l1207t3106r1223b3122],
7	University	NNP	ORGANIZATION	University	dep	10	SENT_140	[p9l1232t3098r1379b3129],
8	of	IN	ORGANIZATION	of	_	0	SENT_140	[p9l1389t3098r1418b3122],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_140	[p9l1425t3098r1570b3123],
10	User	NN	ORGANIZATION	user	pobj	5	SENT_140	[p9l1579t3099r1645b3123],
11	on	IN	O	on	_	0	SENT_140	[p9l1663t3106r1697b3122],
12	01/05/2014	CD	DATE	01/05/2014	prep_on	10	SENT_140	[p9l1706t3098r1857b3123],

1	and	CC	O	and	cc	4	SENT_141	[p10l11t91r161b166],
2	liver	NN	O	liver	nn	3	SENT_141	[p10l187t91r372b166],
3	enzymes	NNS	O	enzyme	nsubj	4	SENT_141	[p10l398t121r753b193],
4	(	VBP	O	(	dep	17	SENT_141	[p10l787t91r1116b180],
5	alanine	NN	O	alanine	nn	6	SENT_141	[p10l787t91r1116b180],
6	aminotransferase	NN	O	aminotransferase	dobj	4	SENT_141	[p10l1146t91r1863b166],
7	[	CD	NUMBER	[	num	9	SENT_141	[p10l1898t91r2138b180],
8	ALT	NN	O	alt	nn	9	SENT_141	[p10l1898t91r2138b180],
9	]	NN	O	]	dep	6	SENT_141	[p10l1898t91r2138b180],
10	and	CC	O	and	_	0	SENT_141	[p10l11t202r155b277],
11	aspartate	NN	O	aspartate	dobj	4	SENT_141	[p10l187t218r538b304],
12	aminotransferase	NN	O	aminotransferase	nn	14	SENT_141	[p10l573t202r1245b277],
13	[	CD	NUMBER	[	num	14	SENT_141	[p10l1285t202r1542b291],
14	AST	NNP	O	AST	dep	11	SENT_141	[p10l1285t202r1542b291],
15	]	CD	NUMBER	]	num	16	SENT_141	[p10l1285t202r1542b291],
16	)	CD	NUMBER	)	nsubj	31	SENT_141	[p10l1285t202r1542b291],
17	elevated	VBD	O	elevate	_	0	SENT_141	[p10l1579t202r1908b277],
18	more	JJR	O	more	mwe	19	SENT_141	[p10l1939t232r2143b277],
19	than	IN	O	than	quantmod	21	SENT_141	[p10l9t313r193b388],
20	eight	CD	NUMBER	eight	number	21	SENT_141	[p10l230t313r438b415],
21	times	NNS	O	time	num	24	SENT_141	[p10l473t324r696b388],
22	the	DT	O	the	det	24	SENT_141	[p10l734t313r865b388],
23	upper	JJ	O	upper	amod	24	SENT_141	[p10l903t343r1152b415],
24	limit	NN	O	limit	dobj	17	SENT_141	[p10l1185t313r1379b388],
25	of	IN	O	of	_	0	SENT_141	[p10l1415t313r1503b388],
26	normal	JJ	O	normal	amod	29	SENT_141	[p10l1529t313r1823b388],
27	(	NN	O	(	nn	29	SENT_141	[p10l1864t313r2140b402],
28	ULN	NN	O	uln	nn	29	SENT_141	[p10l1864t313r2140b402],
29	)	NN	O	)	prep_of	24	SENT_141	[p10l1864t313r2140b402],
30	and	CC	O	and	_	0	SENT_141	[p10l11t424r155b499],
31	increased	VBD	O	increase	conj_and	17	SENT_141	[p10l181t424r558b499],
32	lactate	NN	O	lactate	nn	34	SENT_141	[p10l585t424r840b499],
33	dehydrogenase	NN	O	dehydrogenase	nn	34	SENT_141	[p10l871t424r1463b526],
34	levels	NNS	O	level	dobj	31	SENT_141	[p10l1492t424r1708b499],
35	in	IN	O	in	_	0	SENT_141	[p10l1738t435r1812b497],
36	another	DT	O	another	det	37	SENT_141	[p10l1842t424r2146b499],
37	subject	NN	O	subject	prep_in	31	SENT_141	[p10l12t535r329b637],
38	.	.	O	.	_	0	SENT_141	[p10l12t535r329b637],

1	The	DT	O	the	det	4	SENT_142	[p10l370t535r532b610],
2	liver	NN	O	liver	nn	4	SENT_142	[p10l569t535r754b610],
3	enzyme	NN	O	enzyme	nn	4	SENT_142	[p10l789t565r1106b637],
4	abnormalities	NNS	O	abnormality	nsubj	8	SENT_142	[p10l1146t535r1712b610],
5	may	MD	O	may	aux	8	SENT_142	[p10l1752t565r1922b637],
6	have	VB	O	have	aux	8	SENT_142	[p10l1954t535r2143b610],
7	been	VBN	O	be	cop	8	SENT_142	[p10l9t646r206b721],
8	due	JJ	O	due	_	0	SENT_142	[p10l241t646r388b721],
9	to	TO	O	to	_	0	SENT_142	[p10l422t662r498b721],
10	concomitant	JJ	O	concomitant	amod	11	SENT_142	[p10l533t657r1032b721],
11	use	NN	O	use	prep_to	8	SENT_142	[p10l1065t676r1196b721],
12	of	IN	O	of	_	0	SENT_142	[p10l1231t646r1318b721],
13	an	DT	O	a	det	17	SENT_142	[p10l1342t676r1433b721],
14	anabolic	JJ	O	anabolic	amod	17	SENT_142	[p10l1468t646r2142b721],
15	—	NN	O	—	nn	17	SENT_142	[p10l1468t646r2142b721],
16	steroid	NN	O	steroid	nn	17	SENT_142	[p10l1468t646r2142b721],
17	—	NN	O	—	prep_of	11	SENT_142	[p10l1468t646r2142b721],

1	like	IN	O	like	_	0	SENT_143	[p10l9t757r150b832],
2	nutritional	JJ	O	nutritional	amod	3	SENT_143	[p10l184t757r607b832],
3	supplement	NN	O	supplement	pobj	1	SENT_143	[p10l640t757r1132b859],
4	.	.	O	.	_	0	SENT_143	[p10l640t757r1132b859],

1	The	DT	O	the	det	4	SENT_144	[p10l1169t757r1327b832],
2	liver	NN	O	liver	nn	4	SENT_144	[p10l1360t757r1537b832],
3	enzyme	NN	O	enzyme	nn	4	SENT_144	[p10l1567t787r1874b859],
4	elevations	NNS	O	elevation	nsubjpass	17	SENT_144	[p10l1909t757r2142b832, p10l9t879r191b943],
5	in	IN	O	in	_	0	SENT_144	[p10l229t879r302b941],
6	the	DT	O	the	det	8	SENT_144	[p10l338t868r460b943],
7	placebo	NN	O	placebo	nn	8	SENT_144	[p10l496t868r797b970],
8	subject	NN	O	subject	prep_in	4	SENT_144	[p10l835t868r1109b970],
9	were	VBD	O	be	auxpass	10	SENT_144	[p10l1141t898r1332b943],
10	considered	VBN	O	consider	_	0	SENT_144	[p10l1370t868r1794b943],
11	to	TO	O	to	aux	12	SENT_144	[p10l1828t884r1902b943],
12	be	VB	O	be	xcomp	10	SENT_144	[p10l1938t868r2032b943],
13	of	IN	O	of	_	0	SENT_144	[p10l2071t868r2154b943],
14	moderate	JJ	O	moderate	amod	15	SENT_144	[p10l11t979r379b1054],
15	severity	NN	O	severity	prep_of	12	SENT_144	[p10l408t990r704b1081],
16	and	CC	O	and	_	0	SENT_144	[p10l727t979r869b1054],
17	resolved	VBN	O	resolve	conj_and	10	SENT_144	[p10l894t979r1216b1054],
18	without	IN	O	without	_	0	SENT_144	[p10l1237t979r1535b1054],
19	treatment	NN	O	treatment	prep_without	17	SENT_144	[p10l1560t995r1958b1054],
20	.	.	O	.	_	0	SENT_144	[p10l1560t995r1958b1054],

1	The	DT	O	the	det	2	SENT_145	[p10l1989t979r2143b1054],
2	majority	NN	O	majority	nsubj	5	SENT_145	[p10l11t1101r345b1192],
3	of	IN	O	of	_	0	SENT_145	[p10l374t1090r460b1165],
4	subjects	NNS	O	subject	prep_of	2	SENT_145	[p10l483t1090r802b1192],
5	had	VBD	O	have	_	0	SENT_145	[p10l835t1090r983b1165],
6	ALT	NNP	O	ALT	dobj	5	SENT_145	[p10l1012t1097r1193b1164],
7	(	CD	PERCENT	(	number	8	SENT_145	[p10l1229t1090r1561b1179],
8	90.7	CD	PERCENT	90.7	num	9	SENT_145	[p10l1229t1090r1561b1179],
9	%	NN	PERCENT	%	dep	6	SENT_145	[p10l1229t1090r1561b1179],
10	)	CD	NUMBER	)	dep	6	SENT_145	[p10l1229t1090r1561b1179],
11	,	,	O	,	_	0	SENT_145	[p10l1229t1090r1561b1179],
12	AST	NNP	O	AST	dobj	5	SENT_145	[p10l1595t1097r1772b1165],
13	(	CD	PERCENT	(	number	14	SENT_145	[p10l1808t1090r2140b1179],
14	94.3	CD	PERCENT	94.3	num	15	SENT_145	[p10l1808t1090r2140b1179],
15	%	NN	PERCENT	%	dep	12	SENT_145	[p10l1808t1090r2140b1179],
16	)	CD	NUMBER	)	dep	12	SENT_145	[p10l1808t1090r2140b1179],
17	,	,	O	,	_	0	SENT_145	[p10l1808t1090r2140b1179],
18	or	CC	O	or	_	0	SENT_145	[p10l11t1232r95b1277],
19	total	JJ	O	total	amod	20	SENT_145	[p10l127t1202r309b1277],
20	bilirubin	NN	O	bilirubin	dobj	5	SENT_145	[p10l341t1202r696b1278],
21	(	CD	PERCENT	(	number	22	SENT_145	[p10l735t1202r1048b1291],
22	98.6	CD	PERCENT	98.6	num	23	SENT_145	[p10l735t1202r1048b1291],
23	%	NN	PERCENT	%	dep	20	SENT_145	[p10l735t1202r1048b1291],
24	)	CD	NUMBER	)	num	25	SENT_145	[p10l735t1202r1048b1291],
25	values	NNS	O	value	dep	5	SENT_145	[p10l1084t1202r1335b1277],
26	that	WDT	O	that	nsubj	27	SENT_145	[p10l1371t1202r1531b1277],
27	remained	VBD	O	remain	rcmod	25	SENT_145	[p10l1565t1202r1962b1277],
28	less	JJR	O	less	dep	29	SENT_145	[p10l1996t1202r2142b1277],
29	than	IN	O	than	advmod	27	SENT_145	[p10l9t1313r181b1388],
30	or	CC	O	or	_	0	SENT_145	[p10l211t1343r292b1388],
31	equal	JJ	O	equal	rcmod	25	SENT_145	[p10l320t1313r530b1415],
32	to	TO	O	to	_	0	SENT_145	[p10l558t1329r632b1388],
33	two	CD	NUMBER	two	num	34	SENT_145	[p10l662t1329r801b1388],
34	times	NNS	O	time	prep_to	31	SENT_145	[p10l831t1324r1037b1388],
35	ULN	NNP	O	ULN	dep	34	SENT_145	[p10l1071t1320r1293b1388],
36	.	.	O	.	_	0	SENT_145	[p10l1071t1320r1293b1388],

1	Four	CD	NUMBER	four	num	2	SENT_146	[p10l1329t1320r1523b1388],
2	subjects	NNS	O	subject	_	0	SENT_146	[p10l1551t1313r1856b1415],
3	(	JJ	O	(	dep	5	SENT_146	[p10l1892t1313r2140b1402],
4	3.6	CD	PERCENT	3.6	number	5	SENT_146	[p10l1892t1313r2140b1402],
5	%	NN	PERCENT	%	amod	2	SENT_146	[p10l1892t1313r2140b1402],
6	)	CD	NUMBER	)	advmod	2	SENT_146	[p10l1892t1313r2140b1402],
7	in	IN	O	in	_	0	SENT_146	[p10l9t1435r85b1497],
8	the	DT	O	the	det	10	SENT_146	[p10l116t1424r242b1499],
9	ivacaftor	NN	O	ivacaftor	nn	10	SENT_146	[p10l275t1424r622b1499],
10	group	NN	O	group	prep_in	6	SENT_146	[p10l651t1451r884b1526],
11	and	CC	O	and	_	0	SENT_146	[p10l918t1424r1064b1499],
12	two	CD	PERCENT	two	conj_and	10	SENT_146	[p10l1094t1440r1237b1499],
13	(	CD	PERCENT	(	number	14	SENT_146	[p10l1274t1424r1532b1513],
14	7.1	CD	PERCENT	7.1	num	15	SENT_146	[p10l1274t1424r1532b1513],
15	%	NN	PERCENT	%	dep	2	SENT_146	[p10l1274t1424r1532b1513],
16	)	CD	NUMBER	)	nsubj	21	SENT_146	[p10l1274t1424r1532b1513],
17	in	IN	O	in	_	0	SENT_146	[p10l1567t1435r1642b1497],
18	the	DT	O	the	det	20	SENT_146	[p10l1673t1424r1800b1499],
19	placebo	NN	O	placebo	nn	20	SENT_146	[p10l1831t1424r2143b1526],
20	group	NN	O	group	prep_in	16	SENT_146	[p10l10t1562r251b1637],
21	had	VBD	O	have	rcmod	2	SENT_146	[p10l289t1535r441b1610],
22	at	IN	O	at	quantmod	24	SENT_146	[p10l477t1551r550b1610],
23	least	JJS	O	least	mwe	22	SENT_146	[p10l585t1535r775b1610],
24	one	CD	NUMBER	one	dobj	21	SENT_146	[p10l811t1565r958b1610],
25	measured	VBN	O	measure	partmod	24	SENT_146	[p10l998t1535r1406b1610],
26	ALT	NNP	O	ALT	dobj	25	SENT_146	[p10l1439t1542r1624b1609],
27	and/or	IN	O	and/or	_	0	SENT_146	[p10l1662t1535r1931b1610],
28	AST	NNP	O	AST	nn	29	SENT_146	[p10l1964t1542r2145b1610],
29	value	NN	O	value	prep_and/or	25	SENT_146	[p10l7t1646r206b1721],
30	greater	JJR	O	greater	mwe	31	SENT_146	[p10l237t1662r507b1748],
31	than	IN	O	than	quantmod	33	SENT_146	[p10l533t1646r701b1721],
32	three	CD	NUMBER	three	number	33	SENT_146	[p10l729t1646r928b1721],
33	times	NNS	O	time	dep	24	SENT_146	[p10l957t1657r1160b1721],
34	ULN	NNP	O	ULN	dep	33	SENT_146	[p10l1193t1653r1413b1721],
35	.	.	O	.	_	0	SENT_146	[p10l1193t1653r1413b1721],

1	Study	NNP	O	Study	nn	3	SENT_147	[p10l1451t1646r1668b1748],
2	drug	NN	O	drug	nn	3	SENT_147	[p10l1694t1646r1872b1748],
3	dosing	NN	O	dosing	nsubjpass	5	SENT_147	[p10l1900t1646r2146b1748],
4	was	VBD	O	be	auxpass	5	SENT_147	[p10l7t1786r151b1831],
5	interrupted	VBN	O	interrupt	_	0	SENT_147	[p10l195t1756r660b1858],
6	for	IN	O	for	_	0	SENT_147	[p10l700t1756r815b1831],
7	two	CD	NUMBER	two	prep_for	5	SENT_147	[p10l854t1772r998b1831],
8	of	IN	O	of	_	0	SENT_147	[p10l1041t1756r1127b1831],
9	these	DT	O	these	det	11	SENT_147	[p10l1158t1756r1368b1831],
10	ivacaftor	JJ	O	ivacaftor	amod	11	SENT_147	[p10l1411t1756r1758b1831],
11	subjects	NNS	O	subject	prep_of	7	SENT_147	[p10l1799t1756r2140b1858],
12	,	,	O	,	_	0	SENT_147	[p10l1799t1756r2140b1858],
13	but	CC	O	but	_	0	SENT_147	[p10l9t1868r144b1943],
14	alternative	JJ	O	alternative	amod	15	SENT_147	[p10l173t1868r594b1943],
15	causes	NNS	O	cause	nsubjpass	21	SENT_147	[p10l625t1898r878b1943],
16	of	IN	O	of	_	0	SENT_147	[p10l910t1868r996b1943],
17	liver	NN	O	liver	nn	19	SENT_147	[p10l1014t1868r1191b1943],
18	enzyme	NN	O	enzyme	nn	19	SENT_147	[p10l1218t1898r1525b1970],
19	increases	NNS	O	increase	prep_of	15	SENT_147	[p10l1554t1879r1919b1943],
20	were	VBD	O	be	auxpass	21	SENT_147	[p10l1946t1898r2143b1943],
21	identiﬁed	VBN	O	identiﬁed	conj_but	5	SENT_147	[p10l9t1979r396b2054],
22	in	IN	O	in	_	0	SENT_147	[p10l421t1990r497b2052],
23	both	DT	O	both	det	24	SENT_147	[p10l523t1979r706b2054],
24	cases	NNS	O	case	nsubj	25	SENT_147	[p10l735t2009r935b2054],
25	(	VBP	O	(	prep_in	21	SENT_147	[p10l970t1979r1387b2081],
26	gallstones	NNS	O	gallstone	dobj	25	SENT_147	[p10l970t1979r1387b2081],
27	with	IN	O	with	_	0	SENT_147	[p10l1414t1979r1590b2054],
28	focal	JJ	O	focal	amod	30	SENT_147	[p10l1618t1979r1808b2054],
29	nodular	JJ	O	nodular	amod	30	SENT_147	[p10l1835t1979r2146b2054],
30	hyperplasia	NN	O	hyperplasium	prep_with	25	SENT_147	[p10l9t2090r470b2192],
31	and	CC	O	and	_	0	SENT_147	[p10l500t2090r645b2165],
32	use	NN	O	use	conj_and	25	SENT_147	[p10l675t2120r806b2165],
33	of	IN	O	of	_	0	SENT_147	[p10l840t2090r925b2165],
34	acetaminophen	NN	O	acetaminophen	prep_of	32	SENT_147	[p10l948t2090r1566b2192],
35	with	IN	O	with	_	0	SENT_147	[p10l1593t2090r1770b2165],
36	alcohol	NN	O	alcohol	nn	37	SENT_147	[p10l1802t2090r2140b2179],
37	)	NN	O	)	prep_with	34	SENT_147	[p10l1802t2090r2140b2179],
38	;	:	O	;	_	0	SENT_147	[p10l1802t2090r2140b2179],
39	in	IN	O	in	_	0	SENT_147	[p10l9t2212r85b2274],
40	both	DT	O	both	det	41	SENT_147	[p10l112t2201r295b2276],
41	cases	NNS	O	case	prep_in	45	SENT_147	[p10l324t2231r548b2290],
42	,	,	O	,	_	0	SENT_147	[p10l324t2231r548b2290],
43	dosing	NN	O	dosing	nsubjpass	45	SENT_147	[p10l582t2201r842b2303],
44	was	VBD	O	be	auxpass	45	SENT_147	[p10l866t2231r1010b2276],
45	resumed	VBN	O	resume	parataxis	5	SENT_147	[p10l1042t2201r1392b2276],
46	and	CC	O	and	_	0	SENT_147	[p10l1420t2201r1566b2276],
47	tolerated	VBN	O	tolerate	parataxis	5	SENT_147	[p10l1593t2201r1955b2276],
48	well	RB	O	well	advmod	45	SENT_147	[p10l1979t2201r2145b2276],
49	for	IN	O	for	_	0	SENT_147	[p10l10t2312r121b2387],
50	the	DT	O	the	det	51	SENT_147	[p10l146t2312r268b2387],
51	remainder	NN	O	remainder	prep_for	45	SENT_147	[p10l299t2312r704b2387],
52	of	IN	O	of	_	0	SENT_147	[p10l730t2312r814b2387],
53	the	DT	O	the	det	55	SENT_147	[p10l831t2312r954b2387],
54	treatment	NN	O	treatment	nn	55	SENT_147	[p10l983t2328r1365b2387],
55	period	NN	O	period	prep_of	51	SENT_147	[p10l1391t2312r1660b2414],
56	.	.	O	.	_	0	SENT_147	[p10l1391t2312r1660b2414],

1	There	EX	O	there	expl	2	SENT_148	[p10l1693t2312r1926b2387],
2	were	VBD	O	be	dep	10	SENT_148	[p10l1952t2342r2143b2387],
3	no	DT	O	no	det	6	SENT_148	[p10l10t2453r105b2498],
4	clinically	RB	O	clinically	advmod	5	SENT_148	[p10l145t2423r482b2525],
5	important	JJ	O	important	amod	6	SENT_148	[p10l515t2434r900b2525],
6	trends	NNS	O	trend	nsubj	2	SENT_148	[p10l936t2423r1177b2498],
7	attributable	JJ	O	attributable	amod	6	SENT_148	[p10l1219t2423r1664b2498],
8	to	TO	O	to	_	0	SENT_148	[p10l1703t2439r1777b2498],
9	ivacaftor	NN	O	ivacaftor	prep_to	7	SENT_148	[p10l1815t2423r2146b2498],
10	identiﬁed	VBD	O	identiﬁed	_	0	SENT_148	[p10l9t2534r372b2609],
11	in	IN	O	in	_	0	SENT_148	[p10l398t2545r470b2607],
12	clinical	JJ	O	clinical	amod	13	SENT_148	[p10l498t2534r760b2609],
13	laboratory	NN	O	laboratory	prep_in	10	SENT_148	[p10l787t2534r1172b2636],
14	(	NN	O	(	nn	16	SENT_148	[p10l1200t2534r1462b2623],
15	serum	NN	O	serum	nn	16	SENT_148	[p10l1200t2534r1462b2623],
16	chemistry	NN	O	chemistry	nsubj	10	SENT_148	[p10l1491t2534r1871b2636],
17	,	,	O	,	_	0	SENT_148	[p10l1491t2534r1871b2636],
18	hematology	NN	O	hematology	conj_and	16	SENT_148	[p10l1902t2534r2142b2609, p10l9t2645r266b2747],
19	,	,	O	,	_	0	SENT_148	[p10l1902t2534r2142b2609, p10l9t2645r266b2747],
20	coagulation	NN	O	coagulation	nn	21	SENT_148	[p10l301t2645r761b2747],
21	studies	NNS	O	study	nsubj	10	SENT_148	[p10l793t2645r1091b2733],
22	,	,	O	,	_	0	SENT_148	[p10l793t2645r1091b2733],
23	and	CC	O	and	_	0	SENT_148	[p10l1127t2645r1273b2720],
24	urinalysis	NN	O	urinalysis	nn	25	SENT_148	[p10l1302t2645r1730b2747],
25	)	NN	O	)	conj_and	16	SENT_148	[p10l1302t2645r1730b2747],
26	,	,	O	,	_	0	SENT_148	[p10l1302t2645r1730b2747],
27	vital	JJ	O	vital	amod	28	SENT_148	[p10l1762t2645r1931b2720],
28	sign	NN	O	sign	conj_and	16	SENT_148	[p10l1963t2656r2140b2747],
29	,	,	O	,	_	0	SENT_148	[p10l1963t2656r2140b2747],
30	digital	JJ	O	digital	amod	31	SENT_148	[p10l11t2756r258b2858],
31	ECG	NN	O	ecg	conj_and	16	SENT_148	[p10l293t2763r521b2845],
32	,	,	O	,	_	0	SENT_148	[p10l293t2763r521b2845],
33	ambulatory	JJ	O	ambulatory	amod	34	SENT_148	[p10l559t2756r1017b2858],
34	ECG	NN	O	ecg	conj_and	16	SENT_148	[p10l1049t2763r1276b2845],
35	,	,	O	,	_	0	SENT_148	[p10l1049t2763r1276b2845],
36	or	CC	O	or	_	0	SENT_148	[p10l1314t2786r1398b2831],
37	physical	JJ	O	physical	amod	39	SENT_148	[p10l1427t2756r1749b2858],
38	examination	NN	O	examination	nn	39	SENT_148	[p10l1783t2767r2142b2831, p10l9t2878r165b2942],
39	results	NNS	O	result	conj_and	16	SENT_148	[p10l194t2867r474b2942],
40	.	.	O	.	_	0	SENT_148	[p10l194t2867r474b2942],

1	Eﬁeacy	NNP	O	Eﬁeacy	nn	2	SENT_149	[p10l8t3091r329b3193],
2	Measures	NNS	O	measure	_	0	SENT_149	[p10l359t3098r736b3166],

1	Lung	NN	O	lung	nn	3	SENT_150	[p10l101t3221r308b3316],
2	Function	NN	O	function	nn	3	SENT_150	[p10l338t3221r683b3289],
3	Results	NNS	O	result	_	0	SENT_150	[p10l713t3214r1005b3289],
4	:	:	O	:	_	0	SENT_150	[p10l713t3214r1005b3289],
5	The	DT	O	the	det	7	SENT_150	[p10l1039t3214r1193b3289],
6	adjusted	JJ	O	adjusted	amod	7	SENT_150	[p10l1226t3214r1551b3316],
7	mean	NN	O	mean	dep	3	SENT_150	[p10l1580t3244r1793b3289],
8	absolute	JJ	O	absolute	amod	9	SENT_150	[p10l1824t3214r2143b3289],
9	change	NN	O	change	nsubj	27	SENT_150	[p10l10t3325r278b3427],
10	from	IN	O	from	_	0	SENT_150	[p10l310t3325r492b3400],
11	baseline	NN	O	baseline	prep_from	9	SENT_150	[p10l521t3325r828b3400],
12	through	IN	O	through	_	0	SENT_150	[p10l859t3325r1160b3427],
13	week	NN	DURATION	week	prep_through	11	SENT_150	[p10l1186t3325r1389b3400],
14	16	CD	NUMBER	16	num	13	SENT_150	[p10l1422t3332r1507b3399],
15	in	IN	O	in	_	0	SENT_150	[p10l1536t3336r1608b3398],
16	FEV1	NN	PERCENT	fev1	nn	17	SENT_150	[p10l1640t3332r1847b3423],
17	%	NN	PERCENT	%	prep_in	13	SENT_150	[p10l1884t3332r1954b3399],
18	predicted	VBN	O	predict	partmod	17	SENT_150	[p10l1986t3355r2142b3427, p10l11t3436r261b3511],
19	in	IN	O	in	_	0	SENT_150	[p10l291t3447r366b3509],
20	the	DT	O	the	det	22	SENT_150	[p10l398t3436r524b3511],
21	ivacaftor	NN	O	ivacaftor	nn	22	SENT_150	[p10l557t3436r904b3511],
22	group	NN	O	group	prep_in	18	SENT_150	[p10l935t3463r1168b3538],
23	was	VBD	O	be	cop	27	SENT_150	[p10l1198t3466r1343b3511],
24	an	DT	O	a	det	27	SENT_150	[p10l1379t3466r1470b3511],
25	estimated	JJ	O	estimated	amod	27	SENT_150	[p10l1503t3436r1895b3511],
26	treatment	NN	O	treatment	nn	27	SENT_150	[p10l1925t3452r2142b3511, p10l11t3565r225b3623],
27	difference	NN	O	difference	rcmod	7	SENT_150	[p10l277t3548r703b3623],
28	of	IN	O	of	_	0	SENT_150	[p10l757t3548r845b3623],
29	1.7	CD	PERCENT	1.7	number	30	SENT_150	[p10l893t3551r1090b3623],
30	%	NN	PERCENT	%	amod	34	SENT_150	[p10l893t3551r1090b3623],
31	(	CD	PERCENT	(	number	33	SENT_150	[p10l1150t3548r1357b3637],
32	95	CD	PERCENT	95	number	33	SENT_150	[p10l1150t3548r1357b3637],
33	%	NN	PERCENT	%	amod	34	SENT_150	[p10l1150t3548r1357b3637],
34	CI	NN	O	ci	prep_of	27	SENT_150	[p10l1414t3555r1541b3637],
35	,	,	O	,	_	0	SENT_150	[p10l1414t3555r1541b3637],
36	-0.6	CD	NUMBER	-0.6	advmod	27	SENT_150	[p10l1607t3555r1803b3623],
37	to	TO	O	to	_	0	SENT_150	[p10l1856t3565r1934b3623],
38	4.1	CD	NUMBER	4.1	number	39	SENT_150	[p10l1985t3548r2140b3637],
39	)	CD	NUMBER	)	prep_to	36	SENT_150	[p10l1985t3548r2140b3637],

1	Table	NNP	O	Table	_	0	SENT_151	[p11l133t91r343b156],
2	2	CD	NUMBER	2	dep	1	SENT_151	[p11l372t97r682b155],
3	.	.	O	.	_	0	SENT_151	[p11l372t97r682b155],

1	—	NN	O	—	_	0	SENT_152	[p11l372t97r682b155],
2	.	.	O	.	_	0	SENT_152	[p11l372t97r682b155],

1	Most	JJS	O	most	amod	4	SENT_153	[p11l372t97r682b155],
2	Common	JJ	O	common	amod	4	SENT_153	[p11l711t96r1045b155],
3	Adverse	JJ	O	adverse	amod	4	SENT_153	[p11l1068t91r1368b155],
4	Events	NNS	O	event	nsubj	5	SENT_153	[p11l1393t97r1646b155],
5	Reported	VBN	O	report	_	0	SENT_153	[p11l1673t91r2020b178],

1	During	IN	O	during	_	0	SENT_154	[p11l341t188r613b271],
2	the	DT	O	the	det	3	SENT_154	[p11l639t184r753b249],
3	Study	NN	O	study	pobj	1	SENT_154	[p11l785t184r1001b271],
4	by	IN	O	by	_	0	SENT_154	[p11l1028t184r1122b271],
5	Treatment	NNP	ORGANIZATION	Treatment	nn	6	SENT_154	[p11l1154t190r1537b249],
6	Group	NNP	ORGANIZATION	Group	prep_by	3	SENT_154	[p11l1567t190r1807b271],

1	Placebo	NN	O	placebo	nn	2	SENT_155	[p11l1317t364r1556b421],
2	Ivacaftor	NNP	O	Ivacaftor	_	0	SENT_155	[p11l1869t364r2142b421],
3	Adverse	JJ	O	adverse	amod	6	SENT_155	[p11l8t457r256b515],
4	Event	NN	O	event	nn	6	SENT_155	[p11l280t463r463b515],
5	(	NN	O	(	nn	6	SENT_155	[p11l1318t458r1377b526],
6	n	NN	O	n	dep	2	SENT_155	[p11l1318t458r1377b526],
7	=	JJ	O	=	quantmod	9	SENT_155	[p11l1396t481r1441b498],
8	28	CD	NUMBER	28	number	9	SENT_155	[p11l1461t458r1555b526],
9	)	CD	NUMBER	)	num	14	SENT_155	[p11l1461t458r1555b526],
10	(	NN	O	(	nn	14	SENT_155	[p11l1866t458r1925b526],
11	n	NN	O	n	nn	14	SENT_155	[p11l1866t458r1925b526],
12	=	JJ	O	=	amod	14	SENT_155	[p11l1945t481r1990b498],
13	112	CD	NUMBER	112	num	14	SENT_155	[p11l2014t458r2141b526],
14	)	NN	O	)	dep	6	SENT_155	[p11l2014t458r2141b526],

1	Subjects	NNS	O	subject	dep	167	SENT_156	[p11l13t603r266b681],
2	with	IN	O	with	dep	167	SENT_156	[p11l287t603r421b660],
3	any	DT	O	any	dep	167	SENT_156	[p11l444t625r550b681],
4	adverse	JJ	O	adverse	dep	167	SENT_156	[p11l570t603r799b660],
5	event	NN	O	event	dep	167	SENT_156	[p11l823t615r989b660],
6	25	CD	NUMBER	25	dep	167	SENT_156	[p11l1301t605r1372b660],
7	(	CD	NUMBER	(	dep	167	SENT_156	[p11l1399t603r1570b671],
8	89.3	CD	NUMBER	89.3	dep	167	SENT_156	[p11l1399t603r1570b671],
9	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1399t603r1570b671],
10	98	CD	NUMBER	98	dep	167	SENT_156	[p11l1872t607r1943b660],
11	(	NN	O	(	dep	167	SENT_156	[p11l1969t603r2141b671],
12	87.5	CD	NUMBER	87.5	dep	167	SENT_156	[p11l1969t603r2141b671],
13	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t603r2141b671],
14	Cough	NN	O	cough	dep	167	SENT_156	[p11l11t696r213b775],
15	4	CD	NUMBER	4	dep	167	SENT_156	[p11l1338t702r1373b753],
16	(	CD	NUMBER	(	dep	167	SENT_156	[p11l1399t697r1492b765],
17	14	CD	NUMBER	14	dep	167	SENT_156	[p11l1399t697r1492b765],
18	3	CD	NUMBER	3	dep	167	SENT_156	[p11l1515t697r1570b765],
19	)	NN	O	)	dep	167	SENT_156	[p11l1515t697r1570b765],
20	34	CD	NUMBER	34	dep	167	SENT_156	[p11l1872t702r1943b754],
21	(	CD	NUMBER	(	dep	167	SENT_156	[p11l1969t697r2141b765],
22	30.4	CD	NUMBER	30.4	dep	167	SENT_156	[p11l1969t697r2141b765],
23	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t697r2141b765],
24	Pulmonary	JJ	O	pulmonary	dep	167	SENT_156	[p11l11t789r347b867],
25	exacerbationa	NN	O	exacerbationa	dep	167	SENT_156	[p11l367t789r776b847],
26	11	CD	NUMBER	11	dep	167	SENT_156	[p11l1306t794r1371b846],
27	(	CD	NUMBER	(	dep	167	SENT_156	[p11l1399t789r1570b857],
28	39.3	CD	NUMBER	39.3	dep	167	SENT_156	[p11l1399t789r1570b857],
29	)	NN	O	)	dep	167	SENT_156	[p11l1399t789r1570b857],
30	25	CD	NUMBER	25	dep	167	SENT_156	[p11l1872t792r1943b846],
31	(	CD	NUMBER	(	dep	167	SENT_156	[p11l1969t789r2141b858],
32	22.3	CD	NUMBER	22.3	dep	167	SENT_156	[p11l1969t789r2141b858],
33	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t789r2141b858],
34	Nasal	JJ	O	nasal	dep	167	SENT_156	[p11l12t882r179b939],
35	congestion	NN	O	congestion	dep	167	SENT_156	[p11l201t890r529b960],
36	2	CD	NUMBER	2	dep	167	SENT_156	[p11l1339t887r1372b938],
37	(	NN	O	(	dep	167	SENT_156	[p11l1399t882r1533b950],
38	7.1	CD	NUMBER	7.1	dep	167	SENT_156	[p11l1399t882r1533b950],
39	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1399t882r1533b950],
40	13	CD	NUMBER	13	dep	167	SENT_156	[p11l1876t887r1943b939],
41	(	NN	O	(	dep	167	SENT_156	[p11l1969t882r2141b950],
42	11.6	CD	NUMBER	11.6	dep	167	SENT_156	[p11l1969t882r2141b950],
43	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t882r2141b950],
44	Headache	NN	O	headache	dep	167	SENT_156	[p11l12t975r319b1033],
45	2	CD	NUMBER	2	dep	167	SENT_156	[p11l1339t981r1373b1032],
46	(	CD	NUMBER	(	dep	167	SENT_156	[p11l1399t976r1533b1044],
47	7.1	CD	NUMBER	7.1	dep	167	SENT_156	[p11l1399t976r1533b1044],
48	)	NN	O	)	dep	167	SENT_156	[p11l1399t976r1533b1044],
49	11	CD	NUMBER	11	dep	167	SENT_156	[p11l1876t980r1940b1032],
50	(	NN	O	(	dep	167	SENT_156	[p11l1969t976r2103b1044],
51	9.8	CD	NUMBER	9.8	dep	167	SENT_156	[p11l1969t976r2103b1044],
52	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t976r2103b1044],
53	Upper	NNP	O	Upper	dep	167	SENT_156	[p11l12t1076r210b1149],
54	respiratory	JJ	O	respiratory	dep	167	SENT_156	[p11l231t1079r564b1148],
55	tract	NN	O	tract	dep	167	SENT_156	[p11l583t1082r723b1128],
56	infection	NN	O	infection	dep	167	SENT_156	[p11l743t1070r1014b1128],
57	2	CD	NUMBER	2	dep	167	SENT_156	[p11l1339t1075r1372b1126],
58	(	CD	NUMBER	(	dep	167	SENT_156	[p11l1399t1070r1533b1138],
59	7.1	CD	NUMBER	7.1	dep	167	SENT_156	[p11l1399t1070r1533b1138],
60	)	NN	O	)	dep	167	SENT_156	[p11l1399t1070r1533b1138],
61	11	CD	NUMBER	11	dep	167	SENT_156	[p11l1876t1075r1941b1127],
62	(	NN	O	(	dep	167	SENT_156	[p11l1969t1070r2103b1138],
63	9.8	CD	NUMBER	9.8	dep	167	SENT_156	[p11l1969t1070r2103b1138],
64	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t1070r2103b1138],
65	Nausea	NN	O	nausea	dep	167	SENT_156	[p11l12t1167r238b1219],
66	1	CD	NUMBER	1	dep	167	SENT_156	[p11l1344t1167r1371b1219],
67	(	NN	O	(	dep	167	SENT_156	[p11l1399t1162r1533b1230],
68	3.6	CD	NUMBER	3.6	dep	167	SENT_156	[p11l1399t1162r1533b1230],
69	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1399t1162r1533b1230],
70	10	CD	NUMBER	10	dep	167	SENT_156	[p11l1876t1166r1944b1219],
71	(	NN	O	(	dep	167	SENT_156	[p11l1969t1162r2103b1230],
72	8.9	CD	NUMBER	8.9	dep	167	SENT_156	[p11l1969t1162r2103b1230],
73	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t1162r2103b1230],
74	Oropharyngeal	NNP	ORGANIZATION	Oropharyngeal	dep	167	SENT_156	[p11l11t1256r470b1335],
75	pain	NN	O	pain	dep	167	SENT_156	[p11l490t1265r621b1335],
76	3	CD	NUMBER	3	dep	167	SENT_156	[p11l1339t1261r1372b1313],
77	(	NN	O	(	dep	167	SENT_156	[p11l1399t1257r1570b1324],
78	10.7	CD	NUMBER	10.7	dep	167	SENT_156	[p11l1399t1257r1570b1324],
79	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1399t1257r1570b1324],
80	10	CD	NUMBER	10	dep	167	SENT_156	[p11l1876t1261r1944b1313],
81	(	NN	O	(	dep	167	SENT_156	[p11l1969t1256r2103b1325],
82	8.9	CD	NUMBER	8.9	dep	167	SENT_156	[p11l1969t1256r2103b1325],
83	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t1256r2103b1325],
84	Fatigue	NN	O	fatigue	dep	167	SENT_156	[p11l11t1354r243b1427],
85	3	CD	NUMBER	3	dep	167	SENT_156	[p11l1339t1354r1372b1406],
86	(	NN	O	(	dep	167	SENT_156	[p11l1399t1349r1570b1417],
87	10.7	CD	NUMBER	10.7	dep	167	SENT_156	[p11l1399t1349r1570b1417],
88	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1399t1349r1570b1417],
89	9	CD	NUMBER	9	dep	167	SENT_156	[p11l1910t1354r1943b1406],
90	(	NN	O	(	dep	167	SENT_156	[p11l1969t1349r2103b1417],
91	8.0	CD	NUMBER	8.0	dep	167	SENT_156	[p11l1969t1349r2103b1417],
92	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t1349r2103b1417],
93	Productive	JJ	O	productive	dep	167	SENT_156	[p11l11t1442r342b1499],
94	cough	NN	O	cough	dep	167	SENT_156	[p11l365t1442r549b1520],
95	1	CD	NUMBER	1	dep	167	SENT_156	[p11l1344t1447r1370b1499],
96	(	NN	O	(	dep	167	SENT_156	[p11l1399t1442r1533b1510],
97	3.6	CD	NUMBER	3.6	dep	167	SENT_156	[p11l1399t1442r1533b1510],
98	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1399t1442r1533b1510],
99	9	CD	NUMBER	9	dep	167	SENT_156	[p11l1910t1446r1943b1499],
100	(	NN	O	(	dep	167	SENT_156	[p11l1969t1442r2103b1510],
101	8.0	CD	NUMBER	8.0	dep	167	SENT_156	[p11l1969t1442r2103b1510],
102	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t1442r2103b1510],
103	Pyrexia	NN	ORGANIZATION	pyrexia	dep	167	SENT_156	[p11l11t1541r233b1614],
104	2	CD	NUMBER	2	dep	167	SENT_156	[p11l1339t1540r1373b1592],
105	(	NN	O	(	dep	167	SENT_156	[p11l1399t1535r1533b1604],
106	7.1	CD	NUMBER	7.1	dep	167	SENT_156	[p11l1399t1535r1533b1604],
107	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1399t1535r1533b1604],
108	9	CD	NUMBER	9	dep	167	SENT_156	[p11l1910t1540r1943b1592],
109	(	NN	O	(	dep	167	SENT_156	[p11l1969t1535r2103b1604],
110	8.0	CD	NUMBER	8.0	dep	167	SENT_156	[p11l1969t1535r2103b1604],
111	)	NN	O	)	dep	167	SENT_156	[p11l1969t1535r2103b1604],
112	Bash	NN	O	bash	dep	167	SENT_156	[p11l12t1630r159b1688],
113	o	NN	O	o	dep	167	SENT_156	[p11l1420t1635r1454b1687],
114	9	CD	NUMBER	9	dep	167	SENT_156	[p11l1910t1635r1943b1687],
115	(	NN	O	(	dep	167	SENT_156	[p11l1969t1630r2103b1698],
116	8.0	CD	NUMBER	8.0	dep	167	SENT_156	[p11l1969t1630r2103b1698],
117	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t1630r2103b1698],
118	Sinusitis	NN	O	sinusitis	dep	167	SENT_156	[p11l13t1727r263b1780],
119	1	CD	NUMBER	1	dep	167	SENT_156	[p11l1344t1728r1370b1780],
120	(	NN	O	(	dep	167	SENT_156	[p11l1399t1723r1533b1791],
121	3.6	CD	NUMBER	3.6	dep	167	SENT_156	[p11l1399t1723r1533b1791],
122	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1399t1723r1533b1791],
123	8	CD	NUMBER	8	dep	167	SENT_156	[p11l1910t1727r1943b1780],
124	(	NN	O	(	dep	167	SENT_156	[p11l1969t1723r2103b1791],
125	7.1	CD	NUMBER	7.1	dep	167	SENT_156	[p11l1969t1723r2103b1791],
126	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t1723r2103b1791],
127	Upper	NNP	O	Upper	dep	167	SENT_156	[p11l11t1823r210b1896],
128	abdominal	JJ	O	abdominal	dep	167	SENT_156	[p11l231t1817r552b1875],
129	pain	NN	O	pain	dep	167	SENT_156	[p11l572t1826r704b1896],
130	1	CD	NUMBER	1	dep	167	SENT_156	[p11l1344t1822r1371b1874],
131	(	NN	O	(	dep	167	SENT_156	[p11l1399t1817r1533b1886],
132	3.6	CD	NUMBER	3.6	dep	167	SENT_156	[p11l1399t1817r1533b1886],
133	)	NN	O	)	dep	167	SENT_156	[p11l1399t1817r1533b1886],
134	7	CD	NUMBER	7	dep	167	SENT_156	[p11l1911t1820r1945b1874],
135	(	NN	O	(	dep	167	SENT_156	[p11l1969t1817r2103b1886],
136	6.3	CD	NUMBER	6.3	dep	167	SENT_156	[p11l1969t1817r2103b1886],
137	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t1817r2103b1886],
138	Increase	NN	O	increase	dep	167	SENT_156	[p11l11t1915r269b1967],
139	in	IN	O	in	dep	167	SENT_156	[p11l292t1918r349b1966],
140	C	NN	O	c	dep	167	SENT_156	[p11l372t1915r687b1967],
141	—	CD	NUMBER	—	dep	167	SENT_156	[p11l372t1915r687b1967],
142	reactive	JJ	O	reactive	dep	167	SENT_156	[p11l372t1915r687b1967],
143	protein	NN	O	protein	dep	167	SENT_156	[p11l709t1918r932b1988],
144	1	CD	NUMBER	1	dep	167	SENT_156	[p11l1344t1915r1371b1967],
145	(	NN	O	(	dep	167	SENT_156	[p11l1399t1910r1533b1978],
146	3.6	CD	NUMBER	3.6	dep	167	SENT_156	[p11l1399t1910r1533b1978],
147	)	NN	O	)	dep	167	SENT_156	[p11l1399t1910r1533b1978],
148	6	CD	NUMBER	6	dep	167	SENT_156	[p11l1910t1915r1944b1967],
149	(	NN	O	(	dep	167	SENT_156	[p11l1969t1910r2103b1978],
150	5.4	CD	NUMBER	5.4	dep	167	SENT_156	[p11l1969t1910r2103b1978],
151	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t1910r2103b1978],
152	Contact	NN	O	contact	dep	167	SENT_156	[p11l11t2009r252b2061],
153	dermatitis	NN	O	dermatitis	dep	167	SENT_156	[p11l274t2003r581b2061],
154	o	NN	O	o	dep	167	SENT_156	[p11l1420t2009r1454b2061],
155	6	CD	NUMBER	6	dep	167	SENT_156	[p11l1910t2009r1944b2061],
156	(	NN	O	(	dep	167	SENT_156	[p11l1969t2004r2103b2072],
157	5.4	CD	NUMBER	5.4	dep	167	SENT_156	[p11l1969t2004r2103b2072],
158	)	CD	NUMBER	)	dep	167	SENT_156	[p11l1969t2004r2103b2072],
159	Diarrhea	NN	O	diarrhea	dep	167	SENT_156	[p11l12t2097r288b2154],
160	2	CD	NUMBER	2	dep	167	SENT_156	[p11l1339t2101r1373b2153],
161	(	CD	NUMBER	(	dep	167	SENT_156	[p11l1399t2097r1533b2165],
162	7.1	CD	NUMBER	7.1	dep	167	SENT_156	[p11l1399t2097r1533b2165],
163	)	NN	O	)	dep	167	SENT_156	[p11l1399t2097r1533b2165],
164	6	CD	NUMBER	6	dep	167	SENT_156	[p11l1910t2101r1944b2154],
165	(	NN	O	(	dep	167	SENT_156	[p11l1969t2097r2103b2165],
166	5.4	CD	NUMBER	5.4	dep	167	SENT_156	[p11l1969t2097r2103b2165],
167	)	NN	O	)	_	0	SENT_156	[p11l1969t2097r2103b2165],

1	Data	NNS	O	datum	nsubjpass	3	SENT_157	[p11l12t2232r160b2284],
2	are	VBP	O	be	auxpass	3	SENT_157	[p11l178t2249r271b2284],
3	presented	VBN	O	present	_	0	SENT_157	[p11l290t2226r598b2305],
4	as	IN	O	as	_	0	SENT_157	[p11l617t2249r672b2284],
5	No.	NN	O	no.	prep_as	3	SENT_157	[p11l696t2232r801b2284],
6	(	CD	PERCENT	(	num	7	SENT_157	[p11l828t2227r949b2295],
7	%	NN	PERCENT	%	tmod	3	SENT_157	[p11l828t2227r949b2295],
8	)	CD	NUMBER	)	dep	7	SENT_157	[p11l828t2227r949b2295],
9	.	.	O	.	_	0	SENT_157	[p11l828t2227r949b2295],

1	Minimum	NNP	O	Minimum	nn	2	SENT_158	[p11l976t2232r1280b2284],
2	frequency	NN	O	frequency	_	0	SENT_158	[p11l1300t2226r1611b2305],
3	of	IN	O	of	_	0	SENT_158	[p11l1628t2226r1694b2284],
4	5	CD	PERCENT	5	num	5	SENT_158	[p11l1705t2229r1799b2284],
5	%	NN	PERCENT	%	prep_of	2	SENT_158	[p11l1705t2229r1799b2284],
6	of	IN	O	of	_	0	SENT_158	[p11l1822t2226r1887b2284],
7	subjects	NNS	O	subject	prep_of	2	SENT_158	[p11l1900t2226r2143b2305],
8	in	IN	O	in	_	0	SENT_158	[p11l9t2328r67b2376],
9	the	DT	O	the	det	11	SENT_158	[p11l88t2320r184b2377],
10	ivacaftor	NN	O	ivacaftor	nn	11	SENT_158	[p11l206t2320r471b2377],
11	group	NN	O	group	prep_in	7	SENT_158	[p11l491t2340r684b2398],
12	.	.	O	.	_	0	SENT_158	[p11l491t2340r684b2398],

1	aCoded	VBN	O	acode	_	0	SENT_159	[p11l9t2412r234b2470],
2	as	IN	O	as	_	0	SENT_159	[p11l256t2435r311b2470],
3	cystic	JJ	O	cystic	amod	5	SENT_159	[p11l335t2421r502b2490],
4	ﬁbrosis	NN	O	ﬁbrosis	nn	5	SENT_159	[p11l525t2412r740b2470],
5	lung	NN	O	lung	prep_as	1	SENT_159	[p11l763t2412r911b2490],
6	.	.	O	.	_	0	SENT_159	[p11l763t2412r911b2490],

1	journal.publications.chestnet.org	NN	O	journal.publications.chestnet.org	_	0	SENT_160	[p11l6t2639r960b2700],
2	compared	VBN	O	compare	_	0	SENT_160	[p11l10t2868r399b2970],
3	with	IN	O	with	prepc_compared_with	1	SENT_160	[p11l435t2868r605b2943],
4	placebo	NN	O	placebo	pobj	1	SENT_160	[p11l644t2868r964b2970],
5	;	:	O	;	_	0	SENT_160	[p11l644t2868r964b2970],
6	however	RB	O	however	advmod	15	SENT_160	[p11l1007t2868r1348b2957],
7	,	,	O	,	_	0	SENT_160	[p11l1007t2868r1348b2957],
8	this	DT	O	this	det	9	SENT_160	[p11l1392t2868r1526b2943],
9	difference	NN	O	difference	nsubj	15	SENT_160	[p11l1570t2868r1962b2943],
10	was	VBD	O	be	cop	15	SENT_160	[p11l2000t2898r2141b2943],
11	not	RB	O	not	neg	15	SENT_160	[p11l9t2995r135b3054],
12	statistically	RB	O	statistically	advmod	13	SENT_160	[p11l166t2979r584b3081],
13	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_160	[p11l611t2979r1001b3081],
14	(	NN	O	(	nn	15	SENT_160	[p11l1035t2979r1113b3068],
15	P	NN	O	p	dep	1	SENT_160	[p11l1035t2979r1113b3068],
16	=	JJ	O	=	amod	15	SENT_160	[p11l1134t3009r1193b3032],
17	.15	CD	NUMBER	.15	num	18	SENT_160	[p11l1220t2979r1378b3068],
18	)	NN	O	)	dep	16	SENT_160	[p11l1220t2979r1378b3068],
19	.	.	O	.	_	0	SENT_160	[p11l1220t2979r1378b3068],

1	This	DT	O	this	nsubj	2	SENT_161	[p11l1413t2979r1578b3054],
2	corresponded	VBD	O	correspond	_	0	SENT_161	[p11l1612t2979r2144b3081],
3	to	TO	O	to	_	0	SENT_161	[p11l9t3106r86b3165],
4	a	DT	O	a	det	6	SENT_161	[p11l125t3120r166b3165],
5	relative	JJ	O	relative	amod	6	SENT_161	[p11l202t3090r502b3165],
6	change	NN	O	change	prep_to	2	SENT_161	[p11l542t3090r829b3192],
7	of	IN	O	of	_	0	SENT_161	[p11l868t3090r955b3165],
8	2.4	CD	PERCENT	2.4	number	9	SENT_161	[p11l982t3097r1182b3164],
9	%	NN	PERCENT	%	amod	13	SENT_161	[p11l982t3097r1182b3164],
10	(	CD	PERCENT	(	number	11	SENT_161	[p11l1228t3090r1432b3179],
11	95	CD	PERCENT	95	dep	12	SENT_161	[p11l1228t3090r1432b3179],
12	%	NN	PERCENT	%	dep	13	SENT_161	[p11l1228t3090r1432b3179],
13	CI	NN	O	ci	prep_of	6	SENT_161	[p11l1474t3097r1600b3179],
14	,	,	O	,	_	0	SENT_161	[p11l1474t3097r1600b3179],
15	-0.9	CD	NUMBER	-0.9	number	17	SENT_161	[p11l1650t3097r1844b3164],
16	to	TO	O	to	dep	17	SENT_161	[p11l1881t3106r1958b3165],
17	5.8	CD	NUMBER	5.8	appos	6	SENT_161	[p11l1996t3093r2139b3179],
18	;	:	O	;	_	0	SENT_161	[p11l1996t3093r2139b3179],
19	P	NN	O	p	dep	17	SENT_161	[p11l7t3209r61b3275],
20	=	JJ	O	=	amod	22	SENT_161	[p11l86t3231r144b3254],
21	.16	CD	NUMBER	.16	tmod	20	SENT_161	[p11l176t3201r341b3290],
22	)	NN	O	)	dep	19	SENT_161	[p11l176t3201r341b3290],
23	.	.	O	.	_	0	SENT_161	[p11l176t3201r341b3290],

1	No	DT	O	no	det	4	SENT_162	[p11l387t3208r505b3276],
2	statistically	RB	O	statistically	advmod	3	SENT_162	[p11l544t3201r985b3303],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_162	[p11l1020t3201r1428b3303],
4	differences	NNS	O	difference	nsubjpass	6	SENT_162	[p11l1464t3201r1909b3276],
5	were	VBD	O	be	auxpass	6	SENT_162	[p11l1945t3231r2142b3276],
6	seen	VBN	O	see	_	0	SENT_162	[p11l11t3342r180b3387],
7	for	IN	O	for	mark	11	SENT_162	[p11l214t3312r322b3387],
8	other	JJ	O	other	amod	10	SENT_162	[p11l354t3312r557b3387],
9	spirometric	JJ	O	spirometric	amod	10	SENT_162	[p11l589t3323r1019b3414],
10	parameters	NNS	O	parameter	nsubj	11	SENT_162	[p11l1051t3328r1475b3414],
11	(	VBP	O	(	advcl	6	SENT_162	[p11l1515t3312r1624b3401],
12	ie	FW	O	ie	nsubj	16	SENT_162	[p11l1515t3312r1624b3401],
13	,	,	O	,	_	0	SENT_162	[p11l1515t3312r1624b3401],
14	FVC	NN	O	fvc	appos	12	SENT_162	[p11l1663t3319r1864b3400],
15	,	,	O	,	_	0	SENT_162	[p11l1663t3319r1864b3400],
16	forced	VBD	O	force	ccomp	11	SENT_162	[p11l1902t3312r2144b3387],
17	expiratory	JJ	O	expiratory	amod	18	SENT_162	[p11l10t3434r433b3525],
18	ﬁow	NN	O	ﬁow	dobj	16	SENT_162	[p11l459t3423r632b3498],
19	at	IN	O	at	_	0	SENT_162	[p11l660t3439r733b3498],
20	25	CD	PERCENT	25	num	21	SENT_162	[p11l761t3426r1159b3497],
21	%	NN	PERCENT	%	prep_at	16	SENT_162	[p11l761t3426r1159b3497],
22	.	.	O	.	_	0	SENT_162	[p11l761t3426r1159b3497],

1	—	NN	O	—	_	0	SENT_163	[p11l761t3426r1159b3497],
2	.	.	O	.	_	0	SENT_163	[p11l761t3426r1159b3497],

1	75	CD	PERCENT	75	num	2	SENT_164	[p11l761t3426r1159b3497],
2	%	NN	PERCENT	%	_	0	SENT_164	[p11l761t3426r1159b3497],
3	capacity	NN	O	capacity	nn	4	SENT_164	[p11l1194t3423r1587b3525],
4	)	NN	O	)	dep	2	SENT_164	[p11l1194t3423r1587b3525],
5	.	.	O	.	_	0	SENT_164	[p11l1194t3423r1587b3525],

1	The	DT	O	the	det	2	SENT_165	[p11l1622t3423r1783b3498],
2	number	NN	O	number	nsubj	21	SENT_165	[p11l1814t3423r2145b3498],
3	of	IN	O	of	_	0	SENT_165	[p11l10t3534r95b3609],
4	subjects	NNS	O	subject	prep_of	2	SENT_165	[p11l121t3534r432b3636],
5	who	WP	O	who	nsubj	6	SENT_165	[p11l466t3534r632b3609],
6	qualiﬁed	VBD	O	qualiﬁed	rcmod	4	SENT_165	[p11l669t3534r1011b3636],
7	for	IN	O	for	_	0	SENT_165	[p11l1045t3534r1158b3609],
8	the	DT	O	the	det	10	SENT_165	[p11l1190t3534r1314b3609],
9	extension	NN	O	extension	nn	10	SENT_165	[p11l1351t3545r1721b3609],
10	period	NN	O	period	prep_for	6	SENT_165	[p11l1754t3534r2013b3636],
11	on	IN	O	on	_	0	SENT_165	[p11l2047t3564r2143b3609],
12	the	DT	O	the	det	13	SENT_165	[p11l9t3645r135b3720],
13	basis	NN	O	basis	prep_on	6	SENT_165	[p11l168t3645r358b3720],
14	of	IN	O	of	_	0	SENT_165	[p11l394t3645r480b3720],
15	F	NN	O	f	nn	17	SENT_165	[p11l504t3652r561b3719],
16	EV1	NN	O	ev1	nn	17	SENT_165	[p11l568t3652r721b3743],
17	improvement	NN	O	improvement	prep_of	13	SENT_165	[p11l754t3656r1299b3747],
18	was	VBD	O	be	cop	21	SENT_165	[p11l1328t3675r1472b3720],
19	also	RB	O	also	advmod	21	SENT_165	[p11l1509t3645r1658b3720],
20	not	RB	O	not	neg	21	SENT_165	[p11l1692t3661r1822b3720],
21	statistically	RB	O	statistically	_	0	SENT_165	[p11l1855t3656r2141b3720, p12l9t11r182b113],

1	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_166	[p12l204t11r589b113],
2	(	NN	O	(	nn	3	SENT_166	[p12l617t11r695b100],
3	P	NN	O	p	_	0	SENT_166	[p12l617t11r695b100],
4	=	JJ	O	=	amod	6	SENT_166	[p12l715t41r773b64],
5	.46	CD	NUMBER	.46	tmod	4	SENT_166	[p12l799t11r934b100],
6	)	NN	O	)	dep	3	SENT_166	[p12l799t11r934b100],
7	between	IN	O	between	_	0	SENT_166	[p12l962t11r1291b86],
8	ivacaftor	NN	O	ivacaftor	prep_between	6	SENT_166	[p12l1315t11r1642b86],
9	(	CD	NUMBER	(	number	10	SENT_166	[p12l1669t11r1786b100],
10	36	CD	NUMBER	36	num	11	SENT_166	[p12l1669t11r1786b100],
11	[	NN	O	[	dep	3	SENT_166	[p12l1818t11r2139b100],
12	32.1	CD	PERCENT	32.1	num	13	SENT_166	[p12l1818t11r2139b100],
13	%	NN	PERCENT	%	dep	11	SENT_166	[p12l1818t11r2139b100],
14	]	CD	NUMBER	]	num	15	SENT_166	[p12l1818t11r2139b100],
15	)	NN	O	)	dep	3	SENT_166	[p12l1818t11r2139b100],
16	and	CC	O	and	_	0	SENT_166	[p12l10t121r156b196],
17	placebo	NN	O	placebo	dep	3	SENT_166	[p12l181t121r493b223],
18	(	CD	PERCENT	(	number	19	SENT_166	[p12l527t121r779b210],
19	seven	CD	PERCENT	seven	dep	17	SENT_166	[p12l527t121r779b210],
20	[	CD	PERCENT	[	number	21	SENT_166	[p12l814t121r1176b210],
21	25.0	CD	PERCENT	25.0	num	22	SENT_166	[p12l814t121r1176b210],
22	%	NN	PERCENT	%	dep	3	SENT_166	[p12l814t121r1176b210],
23	]	CD	NUMBER	]	num	24	SENT_166	[p12l814t121r1176b210],
24	)	NN	O	)	dep	22	SENT_166	[p12l814t121r1176b210],
25	.	.	O	.	_	0	SENT_166	[p12l814t121r1176b210],

1	Sweat	NN	O	sweat	nn	3	SENT_167	[p12l106t324r344b392],
2	Test	NN	O	test	nn	3	SENT_167	[p12l373t324r528b392],
3	Results	NNS	O	result	nsubj	11	SENT_167	[p12l553t317r859b392],
4	:	:	O	:	_	0	SENT_167	[p12l553t317r859b392],
5	The	DT	O	the	det	8	SENT_167	[p12l891t317r1049b392],
6	adjusted	VBN	O	adjust	amod	8	SENT_167	[p12l1079t317r1418b419],
7	mean	NN	O	mean	nn	8	SENT_167	[p12l1446t347r1665b392],
8	sweat	NN	O	sweat	parataxis	11	SENT_167	[p12l1695t333r1916b392],
9	chloride	NN	O	chloride	nn	10	SENT_167	[p12l1944t317r2141b392, p12l10t429r166b504],
10	concentration	NN	O	concentration	nsubj	11	SENT_167	[p12l210t440r765b504],
11	decreased	VBD	O	decrease	_	0	SENT_167	[p12l808t429r1213b504],
12	slightly	RB	O	slightly	advmod	11	SENT_167	[p12l1255t429r1542b531],
13	from	IN	O	from	_	0	SENT_167	[p12l1581t429r1772b504],
14	baseline	NN	O	baseline	prep_from	11	SENT_167	[p12l1814t429r2142b504],
15	through	IN	O	through	_	0	SENT_167	[p12l8t540r316b642],
16	week	NN	DURATION	week	prep_through	11	SENT_167	[p12l343t540r549b615],
17	16	CD	NUMBER	16	num	16	SENT_167	[p12l582t547r668b614],
18	in	IN	O	in	_	0	SENT_167	[p12l698t551r771b613],
19	the	DT	O	the	det	21	SENT_167	[p12l801t540r923b615],
20	ivacaftor	NN	O	ivacaftor	nn	21	SENT_167	[p12l954t540r1286b615],
21	group	NN	O	group	prep_in	16	SENT_167	[p12l1315t567r1560b642],
22	,	,	O	,	_	0	SENT_167	[p12l1315t567r1560b642],
23	whereas	IN	O	whereas	mark	25	SENT_167	[p12l1590t540r1907b615],
24	there	EX	O	there	expl	25	SENT_167	[p12l1939t540r2142b615],
25	was	VBD	O	be	advcl	11	SENT_167	[p12l6t681r154b726],
26	no	DT	O	no	det	27	SENT_167	[p12l189t681r288b726],
27	change	NN	O	change	nsubj	25	SENT_167	[p12l322t651r614b753],
28	in	IN	O	in	_	0	SENT_167	[p12l646t662r724b724],
29	placebo	NN	O	placebo	prep_in	27	SENT_167	[p12l754t651r1101b753],
30	,	,	O	,	_	0	SENT_167	[p12l754t651r1101b753],
31	with	IN	O	with	_	0	SENT_167	[p12l1134t651r1316b726],
32	an	DT	O	a	det	35	SENT_167	[p12l1350t681r1443b726],
33	estimated	JJ	O	estimated	amod	35	SENT_167	[p12l1476t651r1884b726],
34	treatment	NN	O	treatment	nn	35	SENT_167	[p12l1914t667r2141b726, p12l10t779r227b838],
35	difference	NN	O	difference	prep_with	25	SENT_167	[p12l268t763r704b838],
36	of	IN	O	of	_	0	SENT_167	[p12l747t763r836b838],
37	-2.9	CD	NUMBER	-2.9	num	38	SENT_167	[p12l877t770r1076b838],
38	mmol/L	NN	O	mmol/l	prep_of	35	SENT_167	[p12l1120t763r1457b838],
39	(	CD	PERCENT	(	num	42	SENT_167	[p12l1502t763r1712b852],
40	95	CD	PERCENT	95	number	41	SENT_167	[p12l1502t763r1712b852],
41	%	NN	PERCENT	%	amod	42	SENT_167	[p12l1502t763r1712b852],
42	CI	NN	O	ci	dep	38	SENT_167	[p12l1759t770r1888b852],
43	,	,	O	,	_	0	SENT_167	[p12l1759t770r1888b852],
44	-5.6	CD	NUMBER	-5.6	appos	38	SENT_167	[p12l1943t766r2143b838],
45	to	TO	O	to	_	0	SENT_167	[p12l8t890r86b949],
46	-0.2	CD	NUMBER	-0.2	num	47	SENT_167	[p12l132t874r382b963],
47	)	CD	NUMBER	)	prep_to	44	SENT_167	[p12l132t874r382b963],
48	;	:	O	;	_	0	SENT_167	[p12l132t874r382b963],
49	this	DT	O	this	det	50	SENT_167	[p12l421t874r564b949],
50	difference	NN	O	difference	nsubj	55	SENT_167	[p12l603t874r1021b949],
51	was	VBD	O	be	cop	55	SENT_167	[p12l1055t904r1201b949],
52	statistically	RB	O	statistically	advmod	53	SENT_167	[p12l1241t874r1694b976],
53	significant	JJ	O	significant	amod	55	SENT_167	[p12l1728t874r2144b976],
54	(	NN	O	(	nn	55	SENT_167	[p12l13t985r94b1074],
55	P	NN	O	p	parataxis	11	SENT_167	[p12l13t985r94b1074],
56	=	JJ	O	=	advmod	55	SENT_167	[p12l118t1015r177b1038],
57	.04	CD	NUMBER	.04	num	58	SENT_167	[p12l208t985r374b1074],
58	)	NN	O	)	dep	56	SENT_167	[p12l208t985r374b1074],
59	.	.	O	.	_	0	SENT_167	[p12l208t985r374b1074],

1	The	DT	O	the	det	2	SENT_168	[p12l414t985r571b1060],
2	change	NN	O	change	nsubj	6	SENT_168	[p12l608t985r890b1087],
3	in	IN	O	in	_	0	SENT_168	[p12l926t996r1001b1058],
4	sweat	NN	O	sweat	nn	5	SENT_168	[p12l1038t1001r1259b1060],
5	chloride	NN	O	chloride	prep_in	2	SENT_168	[p12l1293t985r1621b1060],
6	occurred	VBD	O	occur	_	0	SENT_168	[p12l1658t985r2017b1060],
7	by	IN	O	by	_	0	SENT_168	[p12l2049t985r2147b1087],
8	day	NN	DURATION	day	prep_by	6	SENT_168	[p12l10t1096r151b1198],
9	15	CD	NUMBER	15	num	8	SENT_168	[p12l190t1099r278b1170],
10	and	CC	O	and	_	0	SENT_168	[p12l318t1096r465b1171],
11	was	VBD	O	be	auxpass	12	SENT_168	[p12l497t1126r643b1171],
12	sustained	VBN	O	sustain	conj_and	6	SENT_168	[p12l684t1096r1067b1171],
13	throughout	IN	O	throughout	_	0	SENT_168	[p12l1102t1096r1564b1198],
14	the	DT	DURATION	the	det	16	SENT_168	[p12l1599t1096r1727b1171],
15	16	CD	DURATION	16	num	16	SENT_168	[p12l1771t1103r1860b1170],
16	weeks	NNS	NUMBER	week	prep_throughout	12	SENT_168	[p12l1894t1096r2141b1171],
17	(	CD	NUMBER	(	num	20	SENT_168	[p12l13t1207r176b1309],
18	Fig	NN	O	fig	nn	20	SENT_168	[p12l13t1207r176b1309],
19	2	CD	NUMBER	2	num	20	SENT_168	[p12l203t1207r300b1296],
20	)	NN	O	)	nsubjpass	12	SENT_168	[p12l203t1207r300b1296],
21	.	.	O	.	_	0	SENT_168	[p12l203t1207r300b1296],

1	As	IN	O	as	mark	2	SENT_169	[p12l101t1325r197b1393],
2	described	VBN	O	describe	_	0	SENT_169	[p12l234t1318r626b1393],
3	in	IN	O	in	_	0	SENT_169	[p12l658t1329r733b1391],
4	the	DT	O	the	det	6	SENT_169	[p12l767t1318r893b1393],
5	“	NNP	O	“	nn	6	SENT_169	[p12l929t1318r1342b1393],
6	Materials	NNPS	O	Materials	prep_in	2	SENT_169	[p12l929t1318r1342b1393],
7	and	CC	O	and	_	0	SENT_169	[p12l1379t1318r1525b1393],
8	Methods	NNS	O	method	prep_in	2	SENT_169	[p12l1562t1318r1952b1393],
9	”	CD	NUMBER	”	num	10	SENT_169	[p12l1562t1318r1952b1393],
10	section	NN	O	section	dep	8	SENT_169	[p12l1988t1348r2141b1393, p12l8t1440r192b1517],
11	,	,	O	,	_	0	SENT_169	[p12l1988t1348r2141b1393, p12l8t1440r192b1517],

1	(	NN	O	(	nsubjpass	11	SENT_170	[p12l233t1429r305b1518],
2	a	DT	O	a	dep	1	SENT_170	[p12l233t1429r305b1518],
3	priori	FW	O	priori	nn	4	SENT_170	[p12l334t1429r598b1531],
4	)	FW	O	)	advmod	6	SENT_170	[p12l334t1429r598b1531],
5	threshold	NN	O	threshold	nn	6	SENT_170	[p12l634t1429r1032b1504],
6	changes	NNS	O	change	rcmod	1	SENT_170	[p12l1065t1429r1394b1531],
7	in	IN	O	in	_	0	SENT_170	[p12l1428t1440r1505b1502],
8	sweat	NN	O	sweat	nn	9	SENT_170	[p12l1539t1445r1768b1504],
9	chloride	NN	O	chloride	prep_in	6	SENT_170	[p12l1801t1429r2142b1504],
10	were	VBD	O	be	auxpass	11	SENT_170	[p12l6t1570r202b1615],
11	established	VBN	O	establish	_	0	SENT_170	[p12l243t1540r692b1615],
12	that	WDT	O	that	nsubjpass	15	SENT_170	[p12l728t1540r885b1615],
13	would	MD	O	would	aux	15	SENT_170	[p12l919t1540r1168b1615],
14	be	VB	O	be	auxpass	15	SENT_170	[p12l1204t1540r1300b1615],
15	used	VBN	O	use	ccomp	11	SENT_170	[p12l1340t1540r1527b1615],
16	for	IN	O	for	_	0	SENT_170	[p12l1565t1540r1680b1615],
17	analysis	NN	O	analysis	prep_for	15	SENT_170	[p12l1717t1540r2039b1642],
18	.	.	O	.	_	0	SENT_170	[p12l1717t1540r2039b1642],

1	A	DT	O	a	det	2	SENT_171	[p12l2082t1547r2145b1614],
2	subset	NN	O	subset	nsubj	6	SENT_171	[p12l10t1651r254b1726],
3	of	IN	O	of	_	0	SENT_171	[p12l289t1651r373b1726],
4	ivacaftor	JJ	O	ivacaftor	amod	5	SENT_171	[p12l399t1651r730b1726],
5	subjects	NNS	O	subject	prep_of	2	SENT_171	[p12l765t1651r1070b1753],
6	met	VBD	O	meet	_	0	SENT_171	[p12l1110t1667r1261b1726],
7	one	CD	NUMBER	one	dobj	6	SENT_171	[p12l1296t1681r1435b1726],
8	or	CC	O	or	_	0	SENT_171	[p12l1474t1681r1556b1726],
9	more	JJR	O	more	dobj	6	SENT_171	[p12l1591t1681r1791b1726],
10	of	IN	O	of	_	0	SENT_171	[p12l1830t1651r1914b1726],
11	these	DT	O	these	det	13	SENT_171	[p12l1939t1651r2142b1726],
12	predetermined	JJ	O	predetermined	amod	13	SENT_171	[p12l7t1762r617b1864],
13	criteria	NNS	O	criterion	prep_of	7	SENT_171	[p12l645t1773r932b1837],
14	for	IN	O	for	_	0	SENT_171	[p12l959t1762r1073b1837],
15	change	NN	O	change	prep_for	13	SENT_171	[p12l1100t1762r1387b1864],
16	in	IN	O	in	_	0	SENT_171	[p12l1418t1773r1494b1835],
17	sweat	NN	O	sweat	nn	18	SENT_171	[p12l1526t1778r1751b1837],
18	chloride	NN	O	chloride	prep_in	6	SENT_171	[p12l1781t1762r2138b1851],
19	,	,	O	,	_	0	SENT_171	[p12l1781t1762r2138b1851],
20	whereas	IN	O	whereas	mark	24	SENT_171	[p12l6t1873r334b1948],
21	no	DT	O	no	det	23	SENT_171	[p12l372t1903r470b1948],
22	placebo	NN	O	placebo	nn	23	SENT_171	[p12l504t1873r816b1975],
23	subjects	NNS	O	subject	nsubj	24	SENT_171	[p12l854t1873r1172b1975],
24	met	VBD	O	meet	advcl	6	SENT_171	[p12l1211t1889r1366b1948],
25	any	DT	O	any	dobj	24	SENT_171	[p12l1401t1903r1541b1975],
26	of	IN	O	of	_	0	SENT_171	[p12l1572t1873r1659b1948],
27	these	DT	O	these	det	28	SENT_171	[p12l1683t1873r1893b1948],
28	criteria	NNS	O	criterion	prep_of	25	SENT_171	[p12l1931t1884r2141b1948, p12l10t1995r133b2059],
29	.	.	O	.	_	0	SENT_171	[p12l1931t1884r2141b1948, p12l10t1995r133b2059],

1	Six	CD	NUMBER	six	num	2	SENT_172	[p12l170t1991r284b2059],
2	subjects	NNS	O	subject	nsubj	79	SENT_172	[p12l312t1984r637b2086],
3	(	JJ	O	(	dep	5	SENT_172	[p12l671t1984r926b2073],
4	54	CD	PERCENT	54	number	5	SENT_172	[p12l671t1984r926b2073],
5	%	NN	PERCENT	%	amod	2	SENT_172	[p12l671t1984r926b2073],
6	,	,	O	,	_	0	SENT_172	[p12l671t1984r926b2073],
7	P	NN	O	p	dep	2	SENT_172	[p12l956t1992r1010b2058],
8	=	JJ	O	=	amod	10	SENT_172	[p12l1037t2014r1095b2037],
9	.6	CD	NUMBER	.6	num	10	SENT_172	[p12l1129t1984r1223b2073],
10	)	NN	O	)	nsubj	11	SENT_172	[p12l1129t1984r1223b2073],
11	had	VBD	O	have	rcmod	7	SENT_172	[p12l1255t1984r1404b2059],
12	a	DT	O	a	det	13	SENT_172	[p12l1432t2014r1472b2059],
13	change	NN	O	change	dobj	11	SENT_172	[p12l1498t1984r1785b2086],
14	in	IN	O	in	_	0	SENT_172	[p12l1813t1995r1890b2057],
15	sweat	NN	O	sweat	nn	16	SENT_172	[p12l1919t2000r2144b2059],
16	chloride	NN	O	chloride	prep_in	13	SENT_172	[p12l9t2095r337b2170],
17	2	CD	NUMBER	2	number	18	SENT_172	[p12l378t2110r445b2161],
18	15	CD	NUMBER	15	num	19	SENT_172	[p12l473t2098r560b2169],
19	mmol/L	NN	O	mmol/l	npadvmod	20	SENT_172	[p12l597t2095r919b2170],
20	at	IN	O	at	advmod	11	SENT_172	[p12l953t2111r1022b2170],
21	both	CC	O	both	dep	2	SENT_172	[p12l1050t2095r1227b2170],
22	the	DT	DATE	the	det	23	SENT_172	[p12l1257t2095r1379b2170],
23	day	NN	DATE	day	conj	2	SENT_172	[p12l1412t2095r1547b2197],
24	15	CD	NUMBER	15	nsubj	28	SENT_172	[p12l1579t2098r1664b2169],
25	and	CC	O	and	_	0	SENT_172	[p12l1697t2095r1839b2170],
26	week	NN	DURATION	week	conj_and	24	SENT_172	[p12l1865t2095r2070b2170],
27	8	CD	NUMBER	8	num	26	SENT_172	[p12l2099t2102r2142b2169],
28	Visits	VBZ	O	visit	rcmod	23	SENT_172	[p12l6t2217r211b2281],
29	(	CD	NUMBER	(	dobj	28	SENT_172	[p12l253t2206r413b2295],
30	the	DT	O	the	det	31	SENT_172	[p12l253t2206r413b2295],
31	criterion	NN	O	criterion	tmod	28	SENT_172	[p12l450t2217r810b2281],
32	for	IN	O	for	_	0	SENT_172	[p12l846t2206r964b2281],
33	eligibility	NN	O	eligibility	prep_for	31	SENT_172	[p12l998t2206r1392b2308],
34	for	IN	O	for	_	0	SENT_172	[p12l1424t2206r1542b2281],
35	part	NN	O	part	nn	37	SENT_172	[p12l1574t2222r1742b2308],
36	B	NN	O	b	nn	37	SENT_172	[p12l1779t2206r1896b2295],
37	)	NN	O	)	prep_for	28	SENT_172	[p12l1779t2206r1896b2295],
38	,	,	O	,	_	0	SENT_172	[p12l1779t2206r1896b2295],
39	eight	CD	PERCENT	eight	number	40	SENT_172	[p12l1936t2206r2144b2308],
40	(	CD	PERCENT	(	amod	2	SENT_172	[p12l13t2318r264b2407],
41	7.1	CD	PERCENT	7.1	num	42	SENT_172	[p12l13t2318r264b2407],
42	%	NN	PERCENT	%	dep	40	SENT_172	[p12l13t2318r264b2407],
43	,	,	O	,	_	0	SENT_172	[p12l13t2318r264b2407],
44	P	NN	O	p	conj	2	SENT_172	[p12l293t2326r347b2392],
45	=	JJ	O	=	amod	47	SENT_172	[p12l371t2348r430b2371],
46	.36	CD	NUMBER	.36	num	47	SENT_172	[p12l462t2318r604b2407],
47	)	NN	O	)	nsubj	48	SENT_172	[p12l462t2318r604b2407],
48	had	VBD	O	have	rcmod	44	SENT_172	[p12l635t2318r783b2393],
49	a	DT	O	a	det	51	SENT_172	[p12l809t2348r850b2393],
50	mean	JJ	O	mean	amod	51	SENT_172	[p12l877t2348r1095b2393],
51	decrease	NN	O	decrease	dobj	48	SENT_172	[p12l1123t2318r1472b2393],
52	of	IN	O	of	_	0	SENT_172	[p12l1502t2318r1588b2393],
53	2	CD	NUMBER	2	number	54	SENT_172	[p12l1611t2334r1677b2385],
54	15	CD	NUMBER	15	num	55	SENT_172	[p12l1705t2321r1792b2392],
55	mmol/L	NN	O	mmol/l	prep_of	51	SENT_172	[p12l1822t2318r2144b2393],
56	from	IN	O	from	_	0	SENT_172	[p12l9t2430r207b2505],
57	baseline	NN	O	baseline	prep_from	55	SENT_172	[p12l239t2430r605b2519],
58	,	,	O	,	_	0	SENT_172	[p12l239t2430r605b2519],
59	and	CC	O	and	_	0	SENT_172	[p12l642t2430r792b2505],
60	17	CD	PERCENT	17	number	61	SENT_172	[p12l828t2433r920b2504],
61	(	CD	PERCENT	(	conj_and	55	SENT_172	[p12l956t2430r1267b2519],
62	15.2	CD	PERCENT	15.2	number	63	SENT_172	[p12l956t2430r1267b2519],
63	%	NN	PERCENT	%	amod	51	SENT_172	[p12l956t2430r1267b2519],
64	,	,	O	,	_	0	SENT_172	[p12l956t2430r1267b2519],
65	P	NN	O	p	appos	2	SENT_172	[p12l1302t2438r1355b2504],
66	=	JJ	O	=	amod	68	SENT_172	[p12l1384t2460r1443b2483],
67	.02	CD	NUMBER	.02	num	68	SENT_172	[p12l1478t2430r1626b2519],
68	)	NN	O	)	nsubj	69	SENT_172	[p12l1478t2430r1626b2519],
69	had	VBD	O	have	rcmod	65	SENT_172	[p12l1662t2430r1814b2505],
70	a	DT	O	a	det	72	SENT_172	[p12l1846t2460r1887b2505],
71	mean	JJ	O	mean	amod	72	SENT_172	[p12l1918t2460r2143b2505],
72	decrease	NN	O	decrease	dobj	69	SENT_172	[p12l10t2541r373b2616],
73	of	IN	O	of	_	0	SENT_172	[p12l417t2541r505b2616],
74	Z	NN	O	z	nn	76	SENT_172	[p12l542t2556r608b2607],
75	10	CD	NUMBER	10	num	76	SENT_172	[p12l640t2548r730b2615],
76	mmol/L	NN	O	mmol/l	prep_of	72	SENT_172	[p12l774t2541r1106b2616],
77	from	IN	O	from	_	0	SENT_172	[p12l1147t2541r1344b2616],
78	baseline	NN	O	baseline	prep_from	69	SENT_172	[p12l1386t2541r1728b2616],
79	averaged	VBD	O	average	_	0	SENT_172	[p12l1772t2541r2144b2643],
80	across	IN	O	across	_	0	SENT_172	[p12l10t2682r249b2727],
81	all	DT	O	all	det	83	SENT_172	[p12l284t2652r380b2727],
82	time	NN	O	time	nn	83	SENT_172	[p12l413t2663r601b2727],
83	points	NNS	O	point	prep_across	79	SENT_172	[p12l636t2663r894b2754],
84	through	IN	O	through	_	0	SENT_172	[p12l930t2652r1267b2754],
85	week	NN	DURATION	week	prep_through	79	SENT_172	[p12l1298t2652r1515b2727],
86	16	CD	NUMBER	16	num	85	SENT_172	[p12l1551t2659r1659b2726],
87	.	.	O	.	_	0	SENT_172	[p12l1551t2659r1659b2726],

1	Other	JJ	O	other	amod	4	SENT_173	[p12l105t2848r344b2923],
2	Clinically	RB	O	clinically	advmod	3	SENT_173	[p12l387t2848r770b2950],
3	Relevant	JJ	O	relevant	amod	4	SENT_173	[p12l816t2848r1167b2923],
4	Measures	NNS	O	measure	_	0	SENT_173	[p12l1210t2855r1610b2923],
5	:	:	O	:	_	0	SENT_173	[p12l1210t2855r1610b2923],
6	There	EX	O	there	expl	7	SENT_173	[p12l1660t2848r1901b2923],
7	were	VBD	O	be	dep	4	SENT_173	[p12l1945t2878r2142b2923],
8	no	DT	O	no	det	10	SENT_173	[p12l9t2990r107b3035],
9	significant	JJ	O	significant	amod	10	SENT_173	[p12l150t2960r566b3062],
10	differences	NNS	O	difference	nsubj	7	SENT_173	[p12l606t2960r1060b3035],
11	in	IN	O	in	_	0	SENT_173	[p12l1102t2971r1178b3033],
12	either	CC	O	either	preconj	14	SENT_173	[p12l1219t2960r1462b3035],
13	the	DT	O	the	det	14	SENT_173	[p12l1499t2960r1627b3035],
14	ivacaftor	NN	O	ivacaftor	prep_in	10	SENT_173	[p12l1668t2960r2023b3035],
15	or	CC	O	or	_	0	SENT_173	[p12l2061t2990r2145b3035],
16	placebo	NN	O	placebo	nn	17	SENT_173	[p12l8t3071r320b3173],
17	group	NN	O	group	conj_or	14	SENT_173	[p12l357t3098r589b3173],
18	in	IN	O	in	_	0	SENT_173	[p12l626t3082r701b3144],
19	the	DT	O	the	det	21	SENT_173	[p12l736t3071r862b3146],
20	Cystic	JJ	MISC	cystic	amod	21	SENT_173	[p12l901t3078r1145b3173],
21	Fibrosis	NN	MISC	fibrosis	prep_in	10	SENT_173	[p12l1182t3071r1500b3146],
22	QuestionnaireRevised	VBN	MISC	questionnairerevise	partmod	21	SENT_173	[p12l1541t3078r2141b3166, p12l12t3183r327b3258],
23	respiratory	JJ	O	respiratory	amod	25	SENT_173	[p12l361t3194r800b3285],
24	domain	NN	O	domain	nn	25	SENT_173	[p12l832t3183r1131b3258],
25	scores	NNS	O	score	dobj	22	SENT_173	[p12l1167t3213r1432b3271],
26	,	,	O	,	_	0	SENT_173	[p12l1167t3213r1432b3271],
27	pulmonary	JJ	O	pulmonary	amod	28	SENT_173	[p12l1470t3183r1908b3285],
28	exacerbations	NNS	O	exacerbation	appos	25	SENT_173	[p12l1940t3213r2141b3258, p12l10t3294r410b3382],
29	,	,	O	,	_	0	SENT_173	[p12l1940t3213r2141b3258, p12l10t3294r410b3382],
30	or	CC	O	or	_	0	SENT_173	[p12l448t3324r533b3369],
31	antibiotic	JJ	O	antibiotic	amod	32	SENT_173	[p12l566t3294r950b3369],
32	treatment	NN	O	treatment	conj_or	25	SENT_173	[p12l984t3310r1390b3369],
33	of	IN	O	of	_	0	SENT_173	[p12l1424t3294r1510b3369],
34	sinopulmonary	JJ	O	sinopulmonary	amod	35	SENT_173	[p12l1535t3294r2147b3396],
35	signs	NNS	O	sign	prep_of	32	SENT_173	[p12l11t3416r193b3507],
36	or	CC	O	or	_	0	SENT_173	[p12l229t3435r310b3480],
37	symptoms	NNS	O	symptom	prep_of	32	SENT_173	[p12l342t3421r731b3507],
38	(	RB	O	(	advmod	32	SENT_173	[p12l770t3405r1007b3494],
39	Table	NNP	O	Table	nn	41	SENT_173	[p12l770t3405r1007b3494],
40	3	CD	NUMBER	3	num	41	SENT_173	[p12l1041t3405r1135b3494],
41	)	NN	O	)	dep	25	SENT_173	[p12l1041t3405r1135b3494],
42	.	.	O	.	_	0	SENT_173	[p12l1041t3405r1135b3494],

1	Change	NNP	O	Change	_	0	SENT_174	[p12l1174t3405r1470b3507],
2	from	IN	O	from	dep	1	SENT_174	[p12l1505t3405r1691b3480],
3	baseline	NN	O	baseline	pobj	2	SENT_174	[p12l1723t3405r2036b3480],
4	in	IN	O	in	_	0	SENT_174	[p12l2070t3416r2143b3478],
5	weight	NN	O	weight	prep_in	3	SENT_174	[p12l6t3516r268b3618],
6	and	CC	O	and	_	0	SENT_174	[p12l304t3516r445b3591],
7	BMI	NN	O	bmus	prep_in	3	SENT_174	[p12l483t3523r665b3590],
8	(	CD	NUMBER	(	num	7	SENT_174	[p12l707t3516r821b3605],
9	all	DT	O	all	det	10	SENT_174	[p12l707t3516r821b3605],
10	subjects	NNS	O	subject	dep	7	SENT_174	[p12l858t3516r1191b3618],
11	)	JJ	O	)	dep	13	SENT_174	[p12l858t3516r1191b3618],
12	and	CC	O	and	_	0	SENT_174	[p12l1232t3516r1374b3591],
13	weight-for-age	JJ	O	weight-for-age	amod	10	SENT_174	[p12l1405t3516r1964b3618],
14	and	CC	O	and	_	0	SENT_174	[p12l2003t3516r2144b3591],
15	BMI-for-age	JJ	O	bmi-for-age	amod	10	SENT_174	[p12l12t3626r524b3728],
16	z	SYM	O	z	dep	3	SENT_174	[p12l557t3654r595b3701],
17	score	VBP	NUMBER	score	rcmod	3	SENT_174	[p12l634t3656r844b3701],
18	(	JJ	O	(	amod	19	SENT_174	[p12l885t3626r1241b3728],
19	subjects	NNS	O	subject	nsubj	20	SENT_174	[p12l885t3626r1241b3728],
20	S	NN	O	s	xcomp	17	SENT_174	[p12l1284t3641r1350b3692],
21	20	CD	DURATION	20	num	22	SENT_174	[p12l1374t3633r1469b3700],
22	years	NNS	NUMBER	year	dep	20	SENT_174	[p12l1502t3656r1734b3728],
23	;	:	O	;	_	0	SENT_174	[p12l1502t3656r1734b3728],
24	ivacaftor	NN	O	ivacaftor	dep	20	SENT_174	[p12l1772t3626r2139b3715],
25	,	,	O	,	_	0	SENT_174	[p12l1772t3626r2139b3715],

1	n	NN	O	n	_	0	SENT_175	[p13l9t42r58b85],
2	=	JJ	O	=	amod	1	SENT_175	[p13l82t42r140b65],
3	56	CD	NUMBER	56	tmod	2	SENT_175	[p13l165t15r278b101],
4	;	:	O	;	_	0	SENT_175	[p13l165t15r278b101],
5	placebo	NN	O	placebo	dep	1	SENT_175	[p13l309t12r635b114],
6	,	,	O	,	_	0	SENT_175	[p13l309t12r635b114],
7	n	NN	O	n	appos	5	SENT_175	[p13l668t42r717b85],
8	=	JJ	O	=	amod	10	SENT_175	[p13l741t42r799b65],
9	7	CD	NUMBER	7	num	10	SENT_175	[p13l826t12r896b101],
10	)	NN	O	)	nsubj	14	SENT_175	[p13l826t12r896b101],
11	were	VBD	O	be	cop	14	SENT_175	[p13l925t42r1119b87],
12	not	RB	O	not	neg	14	SENT_175	[p13l1149t28r1277b87],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_175	[p13l1307t12r1775b114],
14	different	JJ	O	different	rcmod	7	SENT_175	[p13l1801t12r2144b87],
15	between	IN	O	between	_	0	SENT_175	[p13l8t123r351b198],
16	arms	NNS	O	arm	prep_between	14	SENT_175	[p13l382t153r592b198],
17	.	.	O	.	_	0	SENT_175	[p13l382t153r592b198],

1	Open-Label	NNP	MISC	Open-Label	nn	3	SENT_176	[p13l11t348r488b449],
2	Extension	NNP	MISC	Extension	nn	3	SENT_176	[p13l514t354r905b422],
3	Period	NN	MISC	period	nsubj	4	SENT_176	[p13l935t348r1199b422],
4	(	VBD	O	(	_	0	SENT_176	[p13l1226t348r1428b441],
5	Part	NN	O	part	nn	6	SENT_176	[p13l1226t348r1428b441],
6	B	NN	O	b	dobj	4	SENT_176	[p13l1456t355r1512b421],
7	)	CD	NUMBER	)	num	6	SENT_176	[p13l1517t348r1546b441],

1	Of	IN	O	of	_	0	SENT_177	[p13l105t472r213b547],
2	42	CD	NUMBER	42	num	4	SENT_177	[p13l233t478r325b546],
3	ivacaftor	NN	O	ivacaftor	nn	4	SENT_177	[p13l357t472r689b547],
4	subjects	NNS	O	subject	prep_of	16	SENT_177	[p13l719t472r1024b575],
5	in	IN	O	in	_	0	SENT_177	[p13l1057t483r1130b546],
6	part	NN	O	part	prep_in	4	SENT_177	[p13l1160t488r1317b575],
7	A	DT	O	a	det	8	SENT_177	[p13l1345t478r1408b546],
8	eligible	NN	O	eligible	nsubj	16	SENT_177	[p13l1439t472r1716b575],
9	for	IN	O	for	_	0	SENT_177	[p13l1750t472r1860b547],
10	enrollment	NN	O	enrollment	prep_for	8	SENT_177	[p13l1890t472r2141b547, p13l10t599r224b657],
11	in	IN	O	in	_	0	SENT_177	[p13l259t593r336b656],
12	part	NN	O	part	nn	13	SENT_177	[p13l372t599r541b685],
13	B	NN	O	b	prep_in	10	SENT_177	[p13l580t590r661b671],
14	,	,	O	,	_	0	SENT_177	[p13l580t590r661b671],
15	33	CD	NUMBER	33	appos	13	SENT_177	[p13l703t589r797b657],
16	entered	VBD	O	enter	_	0	SENT_177	[p13l837t583r1161b657],
17	the	DT	O	the	det	19	SENT_177	[p13l1196t583r1326b657],
18	open-label	JJ	O	open-label	amod	19	SENT_177	[p13l1366t583r1810b685],
19	period	NN	O	period	dobj	16	SENT_177	[p13l1845t583r2137b685],
20	.	.	O	.	_	0	SENT_177	[p13l1845t583r2137b685],

1	Twenty	CD	NUMBER	twenty	nsubj	7	SENT_178	[p13l8t695r561b798],
2	—	CD	NUMBER	—	number	3	SENT_178	[p13l8t695r561b798],
3	eight	CD	NUMBER	eight	npadvmod	1	SENT_178	[p13l8t695r561b798],
4	of	IN	O	of	_	0	SENT_178	[p13l590t695r678b770],
5	these	DT	O	these	det	6	SENT_178	[p13l698t695r915b770],
6	subjects	NNS	O	subject	prep_of	1	SENT_178	[p13l949t695r1281b798],
7	met	VBD	O	meet	_	0	SENT_178	[p13l1316t711r1474b770],
8	the	DT	O	the	det	11	SENT_178	[p13l1503t695r1633b770],
9	F	NN	O	f	nn	11	SENT_178	[p13l1667t702r1723b769],
10	EV1	NN	O	ev1	nn	11	SENT_178	[p13l1733t702r1889b794],
11	criterion	NN	O	criterion	nsubj	14	SENT_178	[p13l1921t705r2141b770, p13l10t816r175b880],
12	and	CC	O	and	_	0	SENT_178	[p13l216t806r366b880],
13	ﬁve	NN	O	ﬁve	conj_and	11	SENT_178	[p13l405t806r547b880],
14	met	VBD	O	meet	ccomp	7	SENT_178	[p13l590t822r749b880],
15	the	DT	O	the	det	18	SENT_178	[p13l787t806r918b880],
16	sweat	NN	O	sweat	nn	18	SENT_178	[p13l961t822r1191b880],
17	chloride	NN	O	chloride	nn	18	SENT_178	[p13l1230t806r1571b880],
18	criterion	NN	O	criterion	dobj	14	SENT_178	[p13l1613t816r1994b880],
19	.	.	O	.	_	0	SENT_178	[p13l1613t816r1994b880],

1	Of	IN	O	of	_	0	SENT_179	[p13l2041t806r2153b880],
2	six	CD	NUMBER	six	num	4	SENT_179	[p13l10t928r111b993],
3	placebo	NN	O	placebo	nn	4	SENT_179	[p13l139t918r457b1021],
4	subjects	NNS	O	subject	prep_of	12	SENT_179	[p13l491t918r816b1021],
5	eligible	JJ	O	eligible	amod	4	SENT_179	[p13l851t918r1148b1021],
6	for	IN	O	for	_	0	SENT_179	[p13l1182t918r1298b993],
7	part	NN	O	part	nn	8	SENT_179	[p13l1326t934r1492b1021],
8	B	NN	O	b	prep_for	5	SENT_179	[p13l1525t925r1605b1007],
9	,	,	O	,	_	0	SENT_179	[p13l1525t925r1605b1007],
10	ﬁve	JJ	O	ﬁve	amod	11	SENT_179	[p13l1641t918r1781b993],
11	subjects	NNS	O	subject	nsubj	12	SENT_179	[p13l1815t918r2141b1021],
12	enrolled	VBD	O	enrol	_	0	SENT_179	[p13l10t1030r363b1119],
13	,	,	O	,	_	0	SENT_179	[p13l10t1030r363b1119],
14	all	DT	O	all	dep	12	SENT_179	[p13l397t1030r487b1105],
15	on	IN	O	on	_	0	SENT_179	[p13l515t1059r613b1105],
16	the	DT	O	the	det	17	SENT_179	[p13l641t1030r767b1105],
17	basis	NN	O	basis	prep_on	12	SENT_179	[p13l796t1030r986b1105],
18	of	IN	O	of	_	0	SENT_179	[p13l1018t1030r1103b1105],
19	F	NN	O	f	nn	21	SENT_179	[p13l1123t1037r1180b1104],
20	EV1	NN	O	ev1	nn	21	SENT_179	[p13l1188t1037r1340b1129],
21	changes	NNS	O	change	prep_of	17	SENT_179	[p13l1371t1030r1710b1133],
22	.	.	O	.	_	0	SENT_179	[p13l1371t1030r1710b1133],

1	There	EX	O	there	expl	2	SENT_180	[p13l102t1142r333b1217],
2	were	VBD	O	be	_	0	SENT_180	[p13l364t1171r553b1217],
3	no	DT	O	no	det	5	SENT_180	[p13l586t1171r681b1217],
4	meaningful	JJ	O	meaningful	amod	5	SENT_180	[p13l715t1142r1148b1245],
5	ﬁndings	NNS	O	ﬁndings	nsubj	2	SENT_180	[p13l1180t1142r1479b1245],
6	regarding	VBG	O	regard	_	0	SENT_180	[p13l1514t1142r1881b1245],
7	safety	NN	O	safety	prep_regarding	5	SENT_180	[p13l1913t1142r2139b1245],
8	,	,	O	,	_	0	SENT_180	[p13l1913t1142r2139b1245],
9	lung	NN	O	lung	nn	10	SENT_180	[p13l8t1254r178b1357],
10	function	NN	O	function	conj_and	7	SENT_180	[p13l206t1254r542b1343],
11	,	,	O	,	_	0	SENT_180	[p13l206t1254r542b1343],
12	and	CC	O	and	_	0	SENT_180	[p13l576t1254r717b1329],
13	sweat	NN	O	sweat	nn	14	SENT_180	[p13l746t1270r959b1329],
14	chloride	NN	O	chloride	prep_regarding	5	SENT_180	[p13l987t1254r1297b1329],
15	with	IN	O	with	_	0	SENT_180	[p13l1325t1254r1494b1329],
16	continued	JJ	O	continued	amod	17	SENT_180	[p13l1524t1253r1909b1329],
17	treatment	NN	O	treatment	prep_with	14	SENT_180	[p13l1937t1270r2141b1329, p13l10t1381r221b1439],
18	with	IN	O	with	_	0	SENT_180	[p13l246t1365r425b1439],
19	ivacaftor	NN	O	ivacaftor	prep_with	17	SENT_180	[p13l455t1365r820b1439],
20	.	.	O	.	_	0	SENT_180	[p13l455t1365r820b1439],

1	Further	JJ	O	further	amod	2	SENT_181	[p13l858t1365r1181b1439],
2	details	NNS	O	detail	nsubjpass	10	SENT_181	[p13l1210t1365r1470b1439],
3	of	IN	O	of	_	0	SENT_181	[p13l1504t1365r1591b1439],
4	the	DT	O	the	det	5	SENT_181	[p13l1610t1365r1738b1439],
5	results	NNS	O	result	prep_of	2	SENT_181	[p13l1770t1365r2035b1439],
6	in	IN	O	in	_	0	SENT_181	[p13l2067t1375r2143b1438],
7	part	NN	O	part	nn	8	SENT_181	[p13l7t1492r170b1578],
8	B	NN	O	b	prep_in	5	SENT_181	[p13l200t1483r256b1549],
9	are	VBP	O	be	auxpass	10	SENT_181	[p13l289t1505r410b1550],
10	included	VBN	O	include	_	0	SENT_181	[p13l439t1476r791b1550],
11	in	IN	O	in	_	0	SENT_181	[p13l817t1486r893b1549],
12	e-Appendix	NN	O	e-appendix	prep_in	10	SENT_181	[p13l922t1476r1388b1578],
13	2	CD	NUMBER	2	num	12	SENT_181	[p13l1414t1482r1479b1550],
14	.	.	O	.	_	0	SENT_181	[p13l1414t1482r1479b1550],

1	CHEST	NN	O	chest	_	0	SENT_182	[p13l800t1718r1054b1768],
2	/	:	O	/	punct	7	SENT_182	[p13l800t1718r1054b1768],
3	142	CD	NUMBER	142	dep	7	SENT_182	[p13l1077t1720r1177b1767],
4	/	:	O	/	punct	5	SENT_182	[p13l1198t1718r1222b1768],
5	3	CD	NUMBER	3	dep	3	SENT_182	[p13l1241t1720r1273b1768],
6	/	:	O	/	punct	5	SENT_182	[p13l1293t1718r1317b1768],
7	SEPTEMBER	NNP	DATE	SEPTEMBER	dep	1	SENT_182	[p13l1336t1718r1722b1768],
8	2012	CD	DATE	2012	num	9	SENT_182	[p13l1744t1720r1885b1768],
9	721	CD	NUMBER	721	dep	1	SENT_182	[p13l2022t1713r2133b1767],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_183	[p13l302t1844r479b1868],
2	From	IN	O	from	dep	1	SENT_183	[p13l488t1844r576b1867],
3	:	:	O	:	_	0	SENT_183	[p13l488t1844r576b1867],
4	http://journal.puhlications.chestnet.org/	NN	O	http://journal.puhlications.chestnet.org/	dep	1	SENT_183	[p13l587t1843r1156b1874],
5	by	IN	O	by	dep	4	SENT_183	[p13l1163t1844r1198b1874],
6	a	DT	O	a	det	10	SENT_183	[p13l1207t1851r1223b1867],
7	University	NNP	ORGANIZATION	University	dep	10	SENT_183	[p13l1232t1843r1379b1874],
8	of	IN	ORGANIZATION	of	_	0	SENT_183	[p13l1389t1843r1418b1867],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_183	[p13l1425t1843r1570b1868],
10	User	NN	ORGANIZATION	user	pobj	5	SENT_183	[p13l1579t1844r1645b1868],
11	on	IN	O	on	_	0	SENT_183	[p13l1663t1851r1697b1867],
12	01/05/2014	CD	DATE	01/05/2014	prep_on	10	SENT_183	[p13l1706t1843r1857b1868],

1	-	:	O	-	_	0	SENT_184	[p13l331t2043r416b2089],
2	o	NN	O	o	_	0	SENT_184	[p13l331t2043r416b2089],
3	-	:	O	-	_	0	SENT_184	[p13l331t2043r416b2089],
4	Placebo	NN	O	placebo	dep	2	SENT_184	[p13l463t2044r659b2087],
5	-	:	O	-	_	0	SENT_184	[p13l331t2118r416b2164],
6	CI	NN	O	ci	dep	4	SENT_184	[p13l331t2118r416b2164],
7	-	:	O	-	_	0	SENT_184	[p13l331t2118r416b2164],
8	Ivacaftor	NN	O	ivacaftor	dep	6	SENT_184	[p13l464t2120r668b2162],

1	A	DT	O	a	_	0	SENT_185	[p13l186t2050r202b2092],

1	|	RB	O	|	dep	2	SENT_186	[p13l247t2062r272b2169],
2	_	CD	NUMBER	_	_	0	SENT_186	[p13l247t2062r272b2169],
3	I	PRP	O	I	nsubj	4	SENT_186	[p13l247t2062r272b2169],
4	_	VBP	O	_	rcmod	2	SENT_186	[p13l247t2062r272b2169],
5	|	CD	NUMBER	|	num	6	SENT_186	[p13l247t2062r272b2169],
6	_	CD	NUMBER	_	dobj	4	SENT_186	[p13l247t2062r272b2169],
7	l	NN	O	l	tmod	4	SENT_186	[p13l247t2062r272b2169],

1	Change	NNP	O	Change	_	0	SENT_187	[p13l7t3023r66b3231],
2	in	IN	O	in	_	0	SENT_187	[p13l7t2958r53b3001],
3	sweat	NN	O	sweat	nn	4	SENT_187	[p13l9t2780r54b2937],
4	chloride	NN	O	chloride	prep_in	1	SENT_187	[p13l7t2547r54b2758],
5	(	CD	NUMBER	(	num	7	SENT_187	[p13l7t2283r67b2524],
6	mmol/L	NN	O	mmol/l	nn	7	SENT_187	[p13l7t2283r67b2524],
7	)	NN	O	)	dep	1	SENT_187	[p13l7t2283r67b2524],

1	mean	JJ	O	mean	amod	2	SENT_188	[p13l87t2842r113b2954],
2	(	NN	O	(	_	0	SENT_188	[p13l78t2767r122b2820],
3	+	CC	O	+	rcmod	2	SENT_188	[p13l78t2767r122b2820],
4	/	:	O	/	punct	6	SENT_188	[p13l78t2767r122b2820],
5	95	CD	PERCENT	95	num	6	SENT_188	[p13l78t2641r114b2733],
6	%	NN	PERCENT	%	dep	2	SENT_188	[p13l78t2641r114b2733],
7	CI	NN	O	ci	nn	8	SENT_188	[p13l78t2558r122b2621],
8	)	NN	O	)	dep	2	SENT_188	[p13l78t2558r122b2621],

1	I	PRP	O	I	nsubj	2	SENT_189	[p13l162t3442r179b3448],
2	3c	VBP	O	3c	_	0	SENT_189	[p13l186t2208r240b3460],
3	'	''	O	'	_	0	SENT_189	[p13l186t2208r240b3460],
4	o6o	NN	O	o6o	dep	15	SENT_189	[p13l186t2208r240b3460],
5	'	''	O	'	_	0	SENT_189	[p13l186t2208r240b3460],
6	x1c	NN	O	x1c	dep	4	SENT_189	[p13l186t2208r240b3460],
7	'	''	O	'	_	0	SENT_189	[p13l186t2208r240b3460],
8	nc	NN	O	nc	dep	6	SENT_189	[p13l186t2208r240b3460],
9	'	''	O	'	_	0	SENT_189	[p13l186t2208r240b3460],
10	n4	NN	O	n4	dep	12	SENT_189	[p13l186t2208r240b3460],
11	'	''	O	'	_	0	SENT_189	[p13l186t2208r240b3460],
12	>	JJR	O	>	dep	8	SENT_189	[p13l186t2208r240b3460],
13	doI	NN	O	dous	dep	8	SENT_189	[p13l186t2208r240b3460],
14	'	''	O	'	_	0	SENT_189	[p13l186t2208r240b3460],
15	vLoAMw4	NN	O	vloamw4	prep	2	SENT_189	[p13l186t2208r240b3460],
16	>	JJR	O	>	dep	15	SENT_189	[p13l186t2208r240b3460],
17	mou	FW	O	mou	dep	15	SENT_189	[p13l186t2208r240b3460],
18	~	FW	O	~	nn	20	SENT_189	[p13l186t2208r240b3460],
19	1oo	FW	O	1oo	dep	20	SENT_189	[p13l186t2208r240b3460],
20	LOO	NN	O	loo	advmod	2	SENT_189	[p13l212t2050r240b2159],

1	Day	NN	DATE	day	_	0	SENT_190	[p13l491t3495r590b3549],
2	15	CD	DATE	15	num	3	SENT_190	[p13l613t3494r671b3538],
3	Week	NN	DATE	week	dep	1	SENT_190	[p13l1104t3495r1253b3538],
4	8	CD	DATE	8	num	5	SENT_190	[p13l1273t3494r1302b3538],
5	Week	NN	DATE	week	tmod	3	SENT_190	[p13l1916t3495r2064b3538],
6	16	CD	DATE	16	dep	1	SENT_190	[p13l2089t3494r2145b3538],

1	FIGURE	NN	O	figure	_	0	SENT_191	[p14l10t67r273b121],
2	2	CD	NUMBER	2	dep	1	SENT_191	[p14l302t66r356b121],
3	.	.	O	.	_	0	SENT_191	[p14l302t66r356b121],

1	Average	JJ	O	average	amod	2	SENT_192	[p14l387t66r658b144],
2	change	NN	O	change	_	0	SENT_192	[p14l687t61r923b144],
3	from	IN	O	from	_	0	SENT_192	[p14l952t61r1112b122],
4	baseline	NN	O	baseline	prep_from	2	SENT_192	[p14l1140t61r1416b122],
5	(	CD	NUMBER	(	num	4	SENT_192	[p14l1448t61r1528b133],
6	:	:	O	:	_	0	SENT_192	[p14l1448t61r1528b133],
7	95	CD	PERCENT	95	number	8	SENT_192	[p14l1553t64r1695b121],
8	%	NN	PERCENT	%	amod	10	SENT_192	[p14l1553t64r1695b121],
9	CI	NN	O	ci	nn	10	SENT_192	[p14l1727t61r1837b133],
10	)	NN	O	)	dep	2	SENT_192	[p14l1727t61r1837b133],
11	in	IN	O	in	_	0	SENT_192	[p14l1867t70r1929b121],
12	sweat	NN	O	sweat	nn	14	SENT_192	[p14l1958t74r2145b122],
13	chloride	NN	O	chloride	nn	14	SENT_192	[p14l9t145r274b206],
14	concentration	NN	O	concentration	prep_in	10	SENT_192	[p14l305t154r771b217],
15	,	,	O	,	_	0	SENT_192	[p14l305t154r771b217],
16	a	DT	O	a	det	17	SENT_192	[p14l805t169r838b206],
17	biomarker	NN	O	biomarker	appos	14	SENT_192	[p14l864t145r1203b206],
18	of	IN	O	of	_	0	SENT_192	[p14l1231t145r1301b206],
19	cystic	JJ	O	cystic	amod	28	SENT_192	[p14l1322t154r1500b228],
20	ﬁbrosis	NN	O	ﬁbrosis	nn	28	SENT_192	[p14l1530t145r1758b206],
21	transmem	NN	O	transmem	nn	28	SENT_192	[p14l1789t158r2142b206],
22	—	NN	O	—	nn	28	SENT_192	[p14l1789t158r2142b206],
23	brane	NN	O	brane	nn	28	SENT_192	[p14l7t229r190b290],
24	conductance	NN	O	conductance	nn	28	SENT_192	[p14l219t229r623b290],
25	regulator	NN	O	regulator	nn	28	SENT_192	[p14l652t229r943b312],
26	chloride	NN	O	chloride	nn	28	SENT_192	[p14l969t229r1229b290],
27	transport	NN	O	transport	nn	28	SENT_192	[p14l1257t242r1549b312],
28	activity	NN	O	activity	prep_of	17	SENT_192	[p14l1577t238r1809b312],
29	.	.	O	.	_	0	SENT_192	[p14l1577t238r1809b312],

1	A	DT	O	a	det	3	SENT_193	[p14l1839t234r1891b289],
2	greater	JJR	O	greater	amod	3	SENT_193	[p14l1918t242r2145b312],
3	proportion	NN	O	proportion	nsubj	6	SENT_193	[p14l7t322r380b397],
4	of	IN	O	of	_	0	SENT_193	[p14l422t313r494b374],
5	subjects	NNS	O	subject	prep_of	3	SENT_193	[p14l529t313r803b397],
6	had	VBD	O	have	_	0	SENT_193	[p14l846t313r971b374],
7	a	DT	O	a	det	9	SENT_193	[p14l1013t338r1046b374],
8	mean	JJ	O	mean	amod	9	SENT_193	[p14l1087t338r1271b374],
9	decrease	NN	O	decrease	dobj	6	SENT_193	[p14l1314t313r1613b374],
10	from	IN	O	from	_	0	SENT_193	[p14l1657t313r1819b374],
11	baseline	NN	O	baseline	prep_from	9	SENT_193	[p14l1860t313r2142b374],
12	through	IN	O	through	_	0	SENT_193	[p14l8t398r276b481],
13	week	NN	DURATION	week	prep_through	6	SENT_193	[p14l302t398r468b459],
14	16	CD	NUMBER	16	num	13	SENT_193	[p14l493t403r562b458],
15	of	IN	O	of	_	0	SENT_193	[p14l585t398r653b459],
16	Z	NN	O	z	nn	20	SENT_193	[p14l672t410r725b452],
17	10	CD	NUMBER	10	num	20	SENT_193	[p14l745t403r814b458],
18	mmol/L	NN	O	mmol/l	nn	20	SENT_193	[p14l838t398r1091b459],
19	(	NN	O	(	nn	20	SENT_193	[p14l1115t398r1405b470],
20	ivacaftor	NN	O	ivacaftor	prep_of	13	SENT_193	[p14l1115t398r1405b470],
21	[	CD	PERCENT	[	number	22	SENT_193	[p14l1429t398r1665b471],
22	15.2	CD	PERCENT	15.2	num	23	SENT_193	[p14l1429t398r1665b471],
23	%	NN	PERCENT	%	nn	34	SENT_193	[p14l1429t398r1665b471],
24	]	CD	NUMBER	]	dep	23	SENT_193	[p14l1429t398r1665b471],
25	vs	CC	O	vs	_	0	SENT_193	[p14l1690t422r1750b459],
26	placebo	NN	O	placebo	nn	29	SENT_193	[p14l1773t398r2016b481],
27	[	CD	NUMBER	[	num	29	SENT_193	[p14l2044t398r2141b471],
28	O	NN	O	o	nn	29	SENT_193	[p14l2044t398r2141b471],
29	]	NN	O	]	nn	34	SENT_193	[p14l2044t398r2141b471],
30	;	:	O	;	_	0	SENT_193	[p14l2044t398r2141b471],
31	P	NN	O	p	dep	29	SENT_193	[p14l7t488r51b543],
32	=	JJ	O	=	amod	34	SENT_193	[p14l71t507r119b525],
33	.0240	CD	NUMBER	.0240	tmod	32	SENT_193	[p14l144t482r357b554],
34	)	NN	O	)	dobj	6	SENT_193	[p14l144t482r357b554],
35	.	.	O	.	_	0	SENT_193	[p14l144t482r357b554],

1	DISCUSSION	NN	O	discussion	_	0	SENT_194	[p14l825t723r1330b791],

1	This	DT	O	this	nsubj	2	SENT_195	[p14l102t903r267b978],
2	randomized	VBN	O	randomize	_	0	SENT_195	[p14l311t903r791b991],
3	,	,	O	,	_	0	SENT_195	[p14l311t903r791b991],
4	double	JJ	O	double	dep	6	SENT_195	[p14l836t903r1352b991],
5	—	RB	O	—	advmod	6	SENT_195	[p14l836t903r1352b991],
6	blind	JJ	O	blind	ccomp	2	SENT_195	[p14l836t903r1352b991],
7	,	,	O	,	_	0	SENT_195	[p14l836t903r1352b991],
8	placebo	NN	O	placebo	nn	9	SENT_195	[p14l1394t903r2139b1005],
9	—	NN	O	—	nsubj	10	SENT_195	[p14l1394t903r2139b1005],
10	controlled	VBN	O	control	dep	2	SENT_195	[p14l1394t903r2139b1005],
11	,	,	O	,	_	0	SENT_195	[p14l1394t903r2139b1005],
12	multicenter	JJ	O	multicenter	amod	13	SENT_195	[p14l10t1014r501b1089],
13	study	NN	O	study	nsubj	14	SENT_195	[p14l532t1014r755b1116],
14	evaluated	VBD	O	evaluate	ccomp	2	SENT_195	[p14l784t1014r1184b1089],
15	the	DT	O	the	det	16	SENT_195	[p14l1214t1014r1344b1089],
16	safety	NN	O	safety	dobj	14	SENT_195	[p14l1379t1014r1620b1116],
17	and	CC	O	and	_	0	SENT_195	[p14l1649t1014r1799b1089],
18	efﬁcacy	NN	O	efﬁcacy	conj_and	16	SENT_195	[p14l1830t1014r2147b1116],
19	of	IN	O	of	_	0	SENT_195	[p14l10t1125r96b1200],
20	the	DT	O	the	det	23	SENT_195	[p14l124t1125r250b1200],
21	CF	NN	O	cf	nn	23	SENT_195	[p14l293t1132r419b1200],
22	TR	NN	O	tr	nn	23	SENT_195	[p14l424t1132r551b1199],
23	potentiator	NN	O	potentiator	prep_of	16	SENT_195	[p14l589t1136r1050b1227],
24	,	,	O	,	_	0	SENT_195	[p14l589t1136r1050b1227],
25	ivacaftor	NN	O	ivacaftor	appos	23	SENT_195	[p14l1093t1125r1451b1213],
26	,	,	O	,	_	0	SENT_195	[p14l1093t1125r1451b1213],
27	in	IN	O	in	_	0	SENT_195	[p14l1493t1136r1569b1198],
28	subjects	NNS	O	subject	prep_in	14	SENT_195	[p14l1610t1125r1928b1227],
29	with	IN	O	with	_	0	SENT_195	[p14l1967t1125r2143b1200],
30	CF	NN	O	cf	prep_with	28	SENT_195	[p14l10t1243r139b1311],
31	homozygous	JJ	O	homozygous	amod	30	SENT_195	[p14l181t1236r696b1338],
32	for	IN	O	for	_	0	SENT_195	[p14l741t1236r859b1311],
33	the	DT	O	the	det	34	SENT_195	[p14l898t1236r1028b1311],
34	F508del	NN	O	f508del	prep_for	31	SENT_195	[p14l1070t1236r1574b1311],
35	.	.	O	.	_	0	SENT_195	[p14l1070t1236r1574b1311],

1	—	NN	O	—	_	0	SENT_196	[p14l1070t1236r1574b1311],
2	.	.	O	.	_	0	SENT_196	[p14l1070t1236r1574b1311],

1	CF	NN	O	cf	nn	4	SENT_197	[p14l1070t1236r1574b1311],
2	T	NN	O	t	nn	4	SENT_197	[p14l1580t1243r1637b1310],
3	R	NN	O	r	nn	4	SENT_197	[p14l1636t1243r1699b1310],
4	mutation	NN	O	mutation	_	0	SENT_197	[p14l1741t1247r2137b1311],
5	.	.	O	.	_	0	SENT_197	[p14l1741t1247r2137b1311],

1	The	DT	O	the	det	3	SENT_198	[p14l8t1347r166b1422],
2	safety	NN	O	safety	nn	3	SENT_198	[p14l195t1347r426b1449],
3	proﬁle	NN	O	proﬁle	nsubj	12	SENT_198	[p14l446t1347r706b1449],
4	of	IN	O	of	_	0	SENT_198	[p14l734t1347r820b1422],
5	ivacaftor	NN	O	ivacaftor	prep_of	3	SENT_198	[p14l835t1347r1182b1422],
6	compared	VBN	O	compare	_	0	SENT_198	[p14l1206t1347r1609b1449],
7	with	IN	O	with	prepc_compared_with	5	SENT_198	[p14l1630t1347r1806b1422],
8	placebo	NN	O	placebo	pobj	5	SENT_198	[p14l1830t1347r2142b1449],
9	in	IN	O	in	_	0	SENT_198	[p14l8t1469r86b1531],
10	this	DT	O	this	det	11	SENT_198	[p14l118t1458r264b1533],
11	study	NN	O	study	prep_in	8	SENT_198	[p14l302t1458r525b1560],
12	supports	VBZ	O	support	_	0	SENT_198	[p14l556t1474r910b1560],
13	further	JJ	O	further	amod	15	SENT_198	[p14l946t1458r1244b1533],
14	clinical	JJ	O	clinical	amod	15	SENT_198	[p14l1275t1458r1571b1533],
15	evaluation	NN	O	evaluation	nsubjpass	25	SENT_198	[p14l1605t1458r2033b1533],
16	in	IN	O	in	_	0	SENT_198	[p14l2066t1469r2143b1531],
17	patients	NNS	O	patient	prep_in	15	SENT_198	[p14l8t1580r323b1671],
18	with	IN	O	with	_	0	SENT_198	[p14l361t1569r537b1644],
19	CF.	NNP	O	CF.	nn	20	SENT_198	[p14l578t1576r725b1644],
20	Treatment	NN	O	treatment	prep_with	17	SENT_198	[p14l769t1577r1199b1644],
21	with	IN	O	with	_	0	SENT_198	[p14l1233t1569r1409b1644],
22	ivacaftor	NN	O	ivacaftor	prep_with	20	SENT_198	[p14l1447t1569r1794b1644],
23	was	VBD	O	be	auxpass	25	SENT_198	[p14l1828t1599r1973b1644],
24	not	RB	O	not	neg	25	SENT_198	[p14l2014t1585r2144b1644],
25	associated	VBN	O	associate	ccomp	12	SENT_198	[p14l10t1680r417b1755],
26	with	IN	O	with	_	0	SENT_198	[p14l444t1680r620b1755],
27	signiﬁcant	JJ	O	signiﬁcant	amod	28	SENT_198	[p14l653t1680r1061b1782],
28	improvements	NNS	O	improvement	prep_with	25	SENT_198	[p14l1091t1691r1669b1782],
29	in	IN	O	in	_	0	SENT_198	[p14l1703t1691r1777b1753],
30	F	NN	O	f	nn	31	SENT_198	[p14l1811t1687r1868b1754],
31	EV1	NN	O	ev1	prep_in	28	SENT_198	[p14l1876t1687r2028b1778],
32	or	CC	O	or	_	0	SENT_198	[p14l2062t1710r2145b1755],
33	other	JJ	O	other	amod	36	SENT_198	[p14l10t1791r224b1866],
34	clinical	JJ	O	clinical	amod	36	SENT_198	[p14l248t1791r530b1866],
35	end	NN	O	end	nn	36	SENT_198	[p14l555t1791r705b1866],
36	points	NNS	O	point	conj_or	31	SENT_198	[p14l727t1802r992b1893],
37	.	.	O	.	_	0	SENT_198	[p14l727t1802r992b1893],

1	There	EX	O	there	expl	2	SENT_199	[p14l1021t1791r1263b1866],
2	was	VBD	O	be	_	0	SENT_199	[p14l1286t1821r1431b1866],
3	a	DT	O	a	det	5	SENT_199	[p14l1459t1821r1500b1866],
4	small	JJ	O	small	amod	5	SENT_199	[p14l1524t1791r1731b1866],
5	reduction	NN	O	reduction	nsubj	2	SENT_199	[p14l1756t1791r2143b1866],
6	in	IN	O	in	_	0	SENT_199	[p14l8t1913r84b1975],
7	sweat	NN	O	sweat	nn	9	SENT_199	[p14l118t1918r340b1977],
8	chloride	NN	O	chloride	nn	9	SENT_199	[p14l372t1902r700b1977],
9	concentration	NN	O	concentration	prep_in	5	SENT_199	[p14l735t1913r1290b1977],
10	observed	VBN	O	observe	partmod	9	SENT_199	[p14l1324t1902r1687b1977],
11	during	IN	O	during	_	0	SENT_199	[p14l1720t1902r1984b2004],
12	the	DT	O	the	prep_during	10	SENT_199	[p14l2015t1902r2142b1977],
13	randomized	VBN	O	randomize	partmod	12	SENT_199	[p14l10t2013r490b2088],
14	controlled	JJ	O	controlled	amod	15	SENT_199	[p14l522t2013r933b2088],
15	portion	NN	O	portion	dobj	13	SENT_199	[p14l964t2024r1259b2115],
16	of	IN	O	of	_	0	SENT_199	[p14l1293t2013r1379b2088],
17	the	DT	O	the	det	18	SENT_199	[p14l1402t2013r1529b2088],
18	study	NN	O	study	prep_of	15	SENT_199	[p14l1566t2013r1781b2115],
19	that	WDT	O	that	nsubjpass	22	SENT_199	[p14l1811t2013r1967b2088],
20	was	VBD	O	be	auxpass	22	SENT_199	[p14l1996t2043r2141b2088],
21	not	RB	O	not	neg	22	SENT_199	[p14l9t2140r141b2199],
22	reflected	VBN	O	reflect	rcmod	18	SENT_199	[p14l168t2124r531b2199],
23	in	IN	O	in	_	0	SENT_199	[p14l555t2135r632b2197],
24	the	DT	O	the	det	25	SENT_199	[p14l658t2124r786b2199],
25	population	NN	O	population	prep_in	22	SENT_199	[p14l813t2124r1255b2226],
26	enrolled	VBN	O	enrol	partmod	25	SENT_199	[p14l1283t2124r1624b2199],
27	in	IN	O	in	_	0	SENT_199	[p14l1649t2135r1725b2197],
28	the	DT	O	the	det	30	SENT_199	[p14l1751t2124r1880b2199],
29	openlabel	JJ	O	openlabel	amod	30	SENT_199	[p14l1909t2154r2141b2226, p14l9t2235r201b2310],
30	extension	NN	O	extension	prep_in	26	SENT_199	[p14l230t2246r626b2310],
31	.	.	O	.	_	0	SENT_199	[p14l230t2246r626b2310],

1	Gaining	NNP	O	Gaining	nn	4	SENT_200	[p14l106t2353r417b2448],
2	additional	JJ	O	additional	amod	4	SENT_200	[p14l453t2346r842b2421],
3	safety	NN	O	safety	nn	4	SENT_200	[p14l879t2346r1106b2448],
4	experience	NN	O	experience	nsubj	11	SENT_200	[p14l1138t2357r1564b2448],
5	with	IN	O	with	_	0	SENT_200	[p14l1598t2346r1771b2421],
6	ivacaftor	NN	O	ivacaftor	prep_with	4	SENT_200	[p14l1806t2346r2145b2421],
7	was	VBD	O	be	cop	11	SENT_200	[p14l6t2487r154b2532],
8	a	DT	O	a	det	11	SENT_200	[p14l208t2487r249b2532],
9	primary	JJ	O	primary	amod	11	SENT_200	[p14l295t2468r627b2559],
10	study	NN	O	study	nn	11	SENT_200	[p14l675t2457r898b2559],
11	objective	NN	O	objective	_	0	SENT_200	[p14l945t2457r1343b2559],
12	.	.	O	.	_	0	SENT_200	[p14l945t2457r1343b2559],

1	The	DT	O	the	det	2	SENT_201	[p14l1398t2457r1559b2532],
2	incidence	NN	O	incidence	nsubj	8	SENT_201	[p14l1611t2457r2013b2532],
3	of	IN	O	of	_	0	SENT_201	[p14l2065t2457r2153b2532],
4	adverse	JJ	O	adverse	amod	5	SENT_201	[p14l10t2568r300b2643],
5	events	NNS	O	event	prep_of	2	SENT_201	[p14l334t2584r576b2643],
6	was	VBD	O	be	cop	8	SENT_201	[p14l606t2598r747b2643],
7	generally	RB	O	generally	advmod	8	SENT_201	[p14l782t2568r1135b2670],
8	similar	JJ	O	similar	_	0	SENT_201	[p14l1165t2568r1423b2643],
9	between	IN	O	between	_	0	SENT_201	[p14l1451t2568r1783b2643],
10	ivacaftor	NN	O	ivacaftor	prep_between	8	SENT_201	[p14l1814t2568r2145b2643],
11	and	CC	O	and	_	0	SENT_201	[p14l10t2679r156b2754],
12	placebo	NN	O	placebo	conj_and	10	SENT_201	[p14l186t2679r519b2781],
13	,	,	O	,	_	0	SENT_201	[p14l186t2679r519b2781],
14	with	IN	O	with	_	0	SENT_201	[p14l552t2679r729b2754],
15	many	JJ	O	many	nsubj	33	SENT_201	[p14l762t2709r982b2781],
16	of	IN	O	of	_	0	SENT_201	[p14l1011t2679r1097b2754],
17	the	DT	O	the	det	20	SENT_201	[p14l1119t2679r1245b2754],
18	most	RBS	O	most	advmod	19	SENT_201	[p14l1280t2695r1473b2754],
19	common	JJ	O	common	amod	20	SENT_201	[p14l1505t2709r1856b2754],
20	events	NNS	O	event	prep_of	15	SENT_201	[p14l1889t2695r2141b2754],
21	being	VBG	O	be	cop	33	SENT_201	[p14l8t2791r229b2893],
22	respiratory	JJ	O	respiratory	amod	33	SENT_201	[p14l258t2802r687b2893],
23	related	JJ	O	related	amod	33	SENT_201	[p14l714t2791r1008b2880],
24	,	,	O	,	_	0	SENT_201	[p14l714t2791r1008b2880],
25	as	IN	O	as	mark	26	SENT_201	[p14l1043t2821r1114b2866],
26	expected	VBN	O	expect	dep	33	SENT_201	[p14l1148t2791r1500b2893],
27	in	IN	O	in	_	0	SENT_201	[p14l1528t2802r1603b2864],
28	patients	NNS	O	patient	prep_in	26	SENT_201	[p14l1631t2802r1940b2893],
29	with	IN	O	with	_	0	SENT_201	[p14l1970t2791r2143b2866],
30	CF.	NNP	PERSON	CF.	nn	31	SENT_201	[p14l10t2909r141b2977],
31	Cough	NNP	PERSON	Cough	prep_with	28	SENT_201	[p14l176t2902r451b3004],
32	,	,	O	,	_	0	SENT_201	[p14l176t2902r451b3004],
33	rash	NN	O	rash	prepc_with	8	SENT_201	[p14l483t2902r658b2990],
34	,	,	O	,	_	0	SENT_201	[p14l483t2902r658b2990],
35	and	CC	O	and	_	0	SENT_201	[p14l691t2902r831b2977],
36	contact	NN	O	contact	nn	37	SENT_201	[p14l858t2918r1135b2977],
37	dermatitis	NN	O	dermatitis	nsubj	38	SENT_201	[p14l1162t2902r1542b2977],
38	occurred	VBD	O	occur	conj_and	8	SENT_201	[p14l1573t2902r1916b2977],
39	more	RBR	O	more	advmod	40	SENT_201	[p14l1942t2932r2142b2977],
40	frequently	RB	O	frequently	advmod	38	SENT_201	[p14l9t3014r421b3116],
41	in	IN	O	in	_	0	SENT_201	[p14l448t3025r522b3087],
42	the	DT	O	the	det	44	SENT_201	[p14l553t3014r678b3089],
43	ivacaftor	NN	O	ivacaftor	nn	44	SENT_201	[p14l710t3014r1049b3089],
44	group	NN	O	group	prep_in	38	SENT_201	[p14l1079t3041r1329b3116],
45	,	,	O	,	_	0	SENT_201	[p14l1079t3041r1329b3116],
46	whereas	IN	O	whereas	mark	56	SENT_201	[p14l1361t3014r1684b3089],
47	pulmonary	JJ	O	pulmonary	amod	48	SENT_201	[p14l1716t3014r2147b3116],
48	exacerbation	NN	O	exacerbation	nsubjpass	56	SENT_201	[p14l14t3126r512b3202],
49	as	IN	O	as	amod	48	SENT_201	[p14l547t3156r619b3202],
50	deﬁned	VBN	O	deﬁned	partmod	48	SENT_201	[p14l655t3126r953b3202],
51	by	IN	O	by	_	0	SENT_201	[p14l984t3126r1081b3229],
52	the	DT	O	the	det	54	SENT_201	[p14l1110t3126r1234b3201],
53	treating	VBG	O	treat	amod	54	SENT_201	[p14l1269t3137r1576b3229],
54	physician	NN	O	physician	agent	50	SENT_201	[p14l1606t3126r1974b3229],
55	was	VBD	O	be	auxpass	56	SENT_201	[p14l2003t3156r2146b3201],
56	reported	VBN	O	report	advcl	38	SENT_201	[p14l14t3239r364b3342],
57	more	RBR	O	more	advmod	58	SENT_201	[p14l396t3269r603b3315],
58	frequently	RB	O	frequently	advmod	56	SENT_201	[p14l638t3239r1058b3342],
59	in	IN	O	in	_	0	SENT_201	[p14l1086t3250r1161b3313],
60	the	DT	O	the	det	62	SENT_201	[p14l1193t3239r1320b3315],
61	placebo	NN	O	placebo	nn	62	SENT_201	[p14l1352t3239r1665b3342],
62	group	NN	O	group	prep_in	56	SENT_201	[p14l1699t3266r1952b3342],
63	.	.	O	.	_	0	SENT_201	[p14l1699t3266r1952b3342],

1	The	DT	O	the	det	3	SENT_202	[p14l1990t3239r2147b3314],
2	numeric	JJ	O	numeric	amod	3	SENT_202	[p14l13t3362r360b3427],
3	differences	NNS	O	difference	nsubj	8	SENT_202	[p14l399t3351r864b3427],
4	between	IN	O	between	_	0	SENT_202	[p14l904t3351r1259b3427],
5	arms	NNS	O	arm	prep_between	3	SENT_202	[p14l1299t3381r1494b3427],
6	may	MD	O	may	aux	8	SENT_202	[p14l1537t3381r1707b3454],
7	be	VB	O	be	cop	8	SENT_202	[p14l1741t3351r1839b3427],
8	due	JJ	O	due	_	0	SENT_202	[p14l1880t3351r2030b3427],
9	to	TO	O	to	_	0	SENT_202	[p14l2070t3368r2148b3426],
10	the	DT	O	the	det	13	SENT_202	[p14l12t3464r142b3539],
11	small	JJ	O	small	amod	13	SENT_202	[p14l182t3464r389b3539],
12	sample	NN	O	sample	nn	13	SENT_202	[p14l423t3464r702b3567],
13	size	NN	O	size	prep_to	8	SENT_202	[p14l738t3475r882b3539],
14	in	IN	O	in	_	0	SENT_202	[p14l916t3475r991b3538],
15	the	DT	O	the	det	17	SENT_202	[p14l1024t3464r1150b3539],
16	placebo	NN	O	placebo	nn	17	SENT_202	[p14l1183t3464r1495b3567],
17	group	NN	O	group	prep_in	13	SENT_202	[p14l1530t3491r1762b3567],
18	resulting	VBG	O	result	partmod	17	SENT_202	[p14l1798t3464r2151b3567],
19	from	IN	O	from	_	0	SENT_202	[p14l13t3575r204b3650],
20	the	DT	O	the	det	22	SENT_202	[p14l246t3575r372b3650],
21	skewed	JJ	O	skewed	amod	22	SENT_202	[p14l416t3575r711b3650],
22	randomization	NN	O	randomization	prep_from	18	SENT_202	[p14l751t3575r1351b3650],
23	.	.	O	.	_	0	SENT_202	[p14l751t3575r1351b3650],

1	All	DT	O	all	det	3	SENT_203	[p14l1396t3575r1509b3649],
2	adverse	JJ	O	adverse	amod	3	SENT_203	[p14l1550t3575r1851b3650],
3	events	NNS	O	event	nsubjpass	10	SENT_203	[p14l1895t3591r2146b3650],
4	considered	VBN	O	consider	partmod	3	SENT_203	[p15l13t25r455b101],
5	severe	JJ	O	severe	acomp	4	SENT_203	[p15l490t55r742b101],
6	by	IN	O	by	_	0	SENT_203	[p15l777t25r875b128],
7	the	DT	O	the	det	8	SENT_203	[p15l905t25r1031b101],
8	investigator	NN	O	investigator	agent	4	SENT_203	[p15l1067t36r1537b128],
9	were	VBD	O	be	auxpass	10	SENT_203	[p15l1566t55r1762b101],
10	reported	VBN	O	report	_	0	SENT_203	[p15l1800t25r2150b128],
11	in	IN	O	in	_	0	SENT_203	[p15l12t149r87b212],
12	the	DT	O	the	det	14	SENT_203	[p15l124t138r250b213],
13	ivacaftor	NN	O	ivacaftor	nn	14	SENT_203	[p15l289t138r636b214],
14	group	NN	O	group	prep_in	10	SENT_203	[p15l672t165r925b241],
15	.	.	O	.	_	0	SENT_203	[p15l672t165r925b241],

1	One	CD	NUMBER	one	num	3	SENT_204	[p15l970t145r1138b214],
2	possible	JJ	O	possible	amod	3	SENT_204	[p15l1175t138r1498b241],
3	explanation	NN	O	explanation	nsubj	8	SENT_204	[p15l1538t138r1999b241],
4	for	IN	O	for	_	0	SENT_204	[p15l2037t138r2151b213],
5	this	DT	O	this	det	6	SENT_204	[p15l12t250r152b325],
6	ﬁnding	NN	O	ﬁnding	prep_for	3	SENT_204	[p15l187t250r469b353],
7	is	VBZ	O	be	cop	8	SENT_204	[p15l498t261r555b325],
8	chance	NN	O	chance	_	0	SENT_204	[p15l589t250r890b339],
9	,	,	O	,	_	0	SENT_204	[p15l589t250r890b339],
10	given	VBN	O	give	partmod	8	SENT_204	[p15l927t261r1139b353],
11	that	IN	O	that	complm	15	SENT_204	[p15l1171t250r1327b325],
12	more	JJR	O	more	amod	13	SENT_204	[p15l1359t280r1566b325],
13	subjects	NNS	O	subject	nsubjpass	15	SENT_204	[p15l1601t250r1920b353],
14	were	VBD	O	be	auxpass	15	SENT_204	[p15l1950t280r2147b326],
15	randomized	VBN	O	randomize	ccomp	10	SENT_204	[p15l14t362r494b438],
16	to	TO	O	to	_	0	SENT_204	[p15l532t379r608b438],
17	ivacaftor	NN	O	ivacaftor	prep_to	15	SENT_204	[p15l648t362r995b438],
18	than	IN	O	than	dep	24	SENT_204	[p15l1032t362r1209b437],
19	to	TO	O	to	_	0	SENT_204	[p15l1249t379r1325b437],
20	placebo	NN	O	placebo	prep_to	18	SENT_204	[p15l1364t362r1677b465],
21	(	CD	NUMBER	(	number	22	SENT_204	[p15l1721t362r1865b452],
22	4:1	CD	NUMBER	4:1	num	24	SENT_204	[p15l1721t362r1865b452],
23	ratio	NN	O	ratio	nn	24	SENT_204	[p15l1910t362r2145b452],
24	)	NN	O	)	dep	17	SENT_204	[p15l1910t362r2145b452],
25	;	:	O	;	_	0	SENT_204	[p15l1910t362r2145b452],
26	there	EX	O	there	expl	28	SENT_204	[p15l12t472r222b547],
27	would	MD	O	would	aux	28	SENT_204	[p15l249t472r498b548],
28	need	VB	O	need	parataxis	8	SENT_204	[p15l525t472r724b548],
29	to	TO	O	to	aux	34	SENT_204	[p15l750t489r826b547],
30	be	VB	O	be	cop	34	SENT_204	[p15l854t472r950b548],
31	only	RB	O	only	advmod	33	SENT_204	[p15l981t472r1152b575],
32	two	CD	NUMBER	two	num	33	SENT_204	[p15l1176t489r1320b548],
33	subjects	NNS	O	subject	npadvmod	34	SENT_204	[p15l1351t472r1670b575],
34	(	JJ	O	(	xcomp	28	SENT_204	[p15l1706t472r1961b562],
35	about	IN	O	about	_	0	SENT_204	[p15l1706t472r1961b562],
36	7	CD	PERCENT	7	num	37	SENT_204	[p15l1991t472r2144b562],
37	%	NN	PERCENT	%	prep_about	34	SENT_204	[p15l1991t472r2144b562],
38	)	CD	NUMBER	)	nsubj	48	SENT_204	[p15l1991t472r2144b562],
39	in	IN	O	in	_	0	SENT_204	[p15l12t597r87b660],
40	the	DT	O	the	det	42	SENT_204	[p15l126t586r252b661],
41	placebo	NN	O	placebo	nn	42	SENT_204	[p15l292t586r604b689],
42	group	NN	O	group	prep_in	38	SENT_204	[p15l645t613r878b689],
43	for	IN	O	for	prep	42	SENT_204	[p15l920t586r1035b661],
44	there	RB	O	there	pobj	43	SENT_204	[p15l1071t586r1281b661],
45	to	TO	O	to	aux	48	SENT_204	[p15l1322t603r1398b661],
46	be	VB	O	be	cop	48	SENT_204	[p15l1437t586r1533b662],
47	no	DT	O	no	det	48	SENT_204	[p15l1574t616r1672b661],
48	difference	NN	O	difference	infmod	37	SENT_204	[p15l1713t586r2143b662],
49	.	.	O	.	_	0	SENT_204	[p15l1713t586r2143b662],

1	Conversely	RB	O	conversely	advmod	4	SENT_205	[p15l14t698r474b801],
2	,	,	O	,	_	0	SENT_205	[p15l14t698r474b801],
3	there	EX	O	there	expl	4	SENT_205	[p15l514t698r725b774],
4	was	VBD	O	be	_	0	SENT_205	[p15l759t728r904b774],
5	a	DT	O	a	det	7	SENT_205	[p15l944t728r985b774],
6	higher	JJR	O	higher	amod	7	SENT_205	[p15l1018t698r1280b801],
7	frequency	NN	O	frequency	nsubj	4	SENT_205	[p15l1315t698r1723b801],
8	of	IN	O	of	_	0	SENT_205	[p15l1756t698r1842b773],
9	serious	JJ	O	serious	amod	11	SENT_205	[p15l1870t709r2146b774],
10	adverse	JJ	O	adverse	amod	11	SENT_205	[p15l14t811r327b887],
11	events	NNS	O	event	prep_of	7	SENT_205	[p15l360t828r621b887],
12	(	VBP	O	(	rcmod	7	SENT_205	[p15l659t811r805b914],
13	eg	FW	O	eg	nsubj	23	SENT_205	[p15l659t811r805b914],
14	,	,	O	,	_	0	SENT_205	[p15l659t811r805b914],
15	hospitalization	NN	O	hospitalization	nn	16	SENT_205	[p15l838t811r1481b914],
16	)	NN	O	)	appos	13	SENT_205	[p15l838t811r1481b914],
17	reported	VBN	O	report	partmod	16	SENT_205	[p15l1517t811r1881b914],
18	in	IN	O	in	_	0	SENT_205	[p15l1910t822r1987b885],
19	the	DT	O	the	det	21	SENT_205	[p15l2017t811r2147b886],
20	placebo	NN	O	placebo	nn	21	SENT_205	[p15l11t963r324b1066],
21	group	NN	O	group	prep_in	17	SENT_205	[p15l358t990r613b1066],
22	,	,	O	,	_	0	SENT_205	[p15l358t990r613b1066],
23	supporting	VBG	O	support	dep	12	SENT_205	[p15l653t974r1086b1066],
24	the	DT	O	the	det	25	SENT_205	[p15l1118t963r1244b1039],
25	conclusion	NN	O	conclusion	dobj	23	SENT_205	[p15l1280t963r1708b1039],
26	that	IN	O	that	complm	32	SENT_205	[p15l1741t963r1898b1039],
27	treatment	NN	O	treatment	nsubj	32	SENT_205	[p15l1930t980r2147b1039, p15l14t1093r221b1152],
28	with	IN	O	with	_	0	SENT_205	[p15l247t1076r423b1151],
29	ivacaftor	NN	O	ivacaftor	prep_with	27	SENT_205	[p15l452t1076r800b1151],
30	does	VBZ	O	do	aux	32	SENT_205	[p15l828t1076r1007b1152],
31	not	RB	O	not	neg	32	SENT_205	[p15l1039t1093r1170b1151],
32	lead	VB	O	lead	ccomp	23	SENT_205	[p15l1198t1076r1365b1152],
33	to	TO	O	to	_	0	SENT_205	[p15l1393t1093r1469b1151],
34	clinically	RB	O	clinically	advmod	35	SENT_205	[p15l1500t1076r1855b1179],
35	important	JJ	O	important	amod	37	SENT_205	[p15l1880t1087r2147b1179, p15l12t1205r160b1263],
36	safety	NN	O	safety	nn	37	SENT_205	[p15l190t1188r407b1291],
37	concerns	NNS	O	concern	prep_to	32	SENT_205	[p15l433t1218r787b1264],
38	.	.	O	.	_	0	SENT_205	[p15l433t1218r787b1264],

1	No	DT	O	no	det	4	SENT_206	[p15l825t1195r940b1263],
2	new	JJ	O	new	amod	4	SENT_206	[p15l970t1218r1132b1264],
3	safety	NN	O	safety	nn	4	SENT_206	[p15l1159t1188r1377b1291],
4	events	NNS	O	event	nsubj	5	SENT_206	[p15l1403t1205r1640b1263],
5	arose	VBD	O	arise	_	0	SENT_206	[p15l1674t1218r1868b1263],
6	during	IN	O	during	_	0	SENT_206	[p15l1901t1188r2151b1291],
7	the	DT	O	the	det	12	SENT_206	[p15l12t1300r138b1375],
8	40-week	JJ	DURATION	40-week	amod	12	SENT_206	[p15l167t1300r508b1376],
9	open	JJ	O	open	amod	12	SENT_206	[p15l535t1300r961b1403],
10	—	NN	O	—	nn	12	SENT_206	[p15l535t1300r961b1403],
11	label	NN	O	label	nn	12	SENT_206	[p15l535t1300r961b1403],
12	extension	NN	O	extension	prep_during	5	SENT_206	[p15l990t1311r1388b1375],
13	.	.	O	.	_	0	SENT_206	[p15l990t1311r1388b1375],

1	Another	DT	O	another	det	2	SENT_207	[p15l105t1412r457b1487],
2	objective	NN	O	objective	nsubj	6	SENT_207	[p15l502t1412r886b1515],
3	of	IN	O	of	_	0	SENT_207	[p15l935t1412r1024b1487],
4	the	DT	O	the	det	5	SENT_207	[p15l1060t1412r1192b1488],
5	study	NN	O	study	prep_of	2	SENT_207	[p15l1243t1412r1470b1515],
6	was	VBD	O	be	_	0	SENT_207	[p15l1510t1442r1660b1488],
7	to	TO	O	to	aux	8	SENT_207	[p15l1709t1429r1788b1487],
8	explore	VB	O	explore	xcomp	6	SENT_207	[p15l1837t1412r2147b1515],
9	potential	JJ	O	potential	amod	11	SENT_207	[p15l11t1524r369b1627],
10	clinical	JJ	O	clinical	amod	11	SENT_207	[p15l412t1524r694b1599],
11	improvement	NN	O	improvement	dobj	8	SENT_207	[p15l737t1535r1283b1627],
12	with	IN	O	with	_	0	SENT_207	[p15l1322t1524r1498b1600],
13	ivacaftor	NN	O	ivacaftor	nn	14	SENT_207	[p15l1541t1524r1889b1599],
14	treatment	NN	O	treatment	prep_with	8	SENT_207	[p15l1930t1541r2147b1600, p15l14t1653r233b1725],
15	,	,	O	,	_	0	SENT_207	[p15l1930t1541r2147b1600, p15l14t1653r233b1725],
16	although	IN	O	although	mark	20	SENT_207	[p15l265t1636r602b1739],
17	the	DT	O	the	det	18	SENT_207	[p15l628t1636r750b1711],
18	study	NN	O	study	nsubjpass	20	SENT_207	[p15l780t1636r988b1739],
19	was	VBD	O	be	auxpass	20	SENT_207	[p15l1007t1666r1148b1712],
20	powered	VBN	O	power	advcl	8	SENT_207	[p15l1176t1636r1517b1739],
21	based	VBN	O	base	_	0	SENT_207	[p15l1541t1636r1766b1712],
22	on	IN	O	on	prepc_based_on	20	SENT_207	[p15l1791t1666r1887b1711],
23	safety	NN	O	safety	pobj	20	SENT_207	[p15l1915t1636r2145b1739],
24	,	,	O	,	_	0	SENT_207	[p15l1915t1636r2145b1739],
25	not	RB	O	not	neg	23	SENT_207	[p15l13t1765r143b1823],
26	efficacy	NN	O	efficacy	dep	23	SENT_207	[p15l178t1748r505b1851],
27	.	.	O	.	_	0	SENT_207	[p15l178t1748r505b1851],

1	There	EX	O	there	expl	2	SENT_208	[p15l550t1748r799b1823],
2	were	VBD	O	be	_	0	SENT_208	[p15l837t1778r1039b1823],
3	no	DT	O	no	det	6	SENT_208	[p15l1080t1778r1180b1823],
4	statistically	RB	O	statistically	advmod	5	SENT_208	[p15l1222t1748r1687b1851],
5	significant	JJ	O	significant	amod	6	SENT_208	[p15l1724t1748r2150b1851],
6	improvements	NNS	O	improvement	nsubj	2	SENT_208	[p15l12t1872r594b1964],
7	in	IN	O	in	_	0	SENT_208	[p15l634t1872r709b1935],
8	pulmonary	JJ	O	pulmonary	amod	9	SENT_208	[p15l746t1861r1185b1964],
9	function	NN	O	function	prep_in	6	SENT_208	[p15l1220t1861r1555b1937],
10	with	IN	O	with	_	0	SENT_208	[p15l1590t1861r1766b1937],
11	ivacaftor	NN	O	ivacaftor	nn	12	SENT_208	[p15l1804t1861r2151b1937],
12	treatment	NN	O	treatment	prep_with	2	SENT_208	[p15l12t1990r427b2049],
13	in	IN	O	in	_	0	SENT_208	[p15l460t1984r537b2047],
14	F508del-C	NN	O	f508del-c	nn	18	SENT_208	[p15l570t1973r1010b2049],
15	F	NN	O	f	nn	18	SENT_208	[p15l1017t1980r1074b2048],
16	TR	NN	O	tr	nn	18	SENT_208	[p15l1081t1980r1199b2048],
17	homozygous	JJ	O	homozygous	amod	18	SENT_208	[p15l1233t1973r1749b2076],
18	subjects	NNS	O	subject	prep_in	12	SENT_208	[p15l1787t1973r2143b2076],
19	.	.	O	.	_	0	SENT_208	[p15l1787t1973r2143b2076],

1	Similarly	RB	O	similarly	advmod	7	SENT_209	[p15l17t2085r363b2188],
2	,	,	O	,	_	0	SENT_209	[p15l17t2085r363b2188],
3	no	DT	O	no	det	5	SENT_209	[p15l401t2115r497b2160],
4	notable	JJ	O	notable	amod	5	SENT_209	[p15l531t2085r817b2161],
5	changes	NNS	O	change	nsubjpass	7	SENT_209	[p15l853t2085r1159b2188],
6	were	VBD	O	be	auxpass	7	SENT_209	[p15l1192t2115r1383b2160],
7	observed	VBN	O	observe	_	0	SENT_209	[p15l1418t2085r1768b2161],
8	for	IN	O	for	_	0	SENT_209	[p15l1801t2085r1912b2160],
9	other	JJ	O	other	amod	12	SENT_209	[p15l1944t2085r2151b2160],
10	clinical	JJ	O	clinical	amod	12	SENT_209	[p15l13t2198r282b2273],
11	end	NN	O	end	nn	12	SENT_209	[p15l317t2198r463b2274],
12	points	NNS	O	point	prep_for	7	SENT_209	[p15l495t2209r750b2301],
13	,	,	O	,	_	0	SENT_209	[p15l495t2209r750b2301],
14	including	VBG	O	include	_	0	SENT_209	[p15l789t2198r1151b2301],
15	weight	NN	O	weight	nn	16	SENT_209	[p15l1181t2198r1443b2301],
16	gain	NN	O	gain	prep_including	7	SENT_209	[p15l1478t2209r1637b2301],
17	and	CC	O	and	_	0	SENT_209	[p15l1674t2198r1815b2274],
18	patientreported	JJ	O	patientreported	prep_including	7	SENT_209	[p15l1848t2209r2147b2301, p15l14t2353r364b2456],

1	respiratory	JJ	O	respiratory	amod	2	SENT_210	[p15l386t2364r825b2456],
2	symptoms	NNS	O	symptom	_	0	SENT_210	[p15l845t2370r1269b2456],
3	.	.	O	.	_	0	SENT_210	[p15l845t2370r1269b2456],

1	A	DT	O	a	det	3	SENT_211	[p15l1295t2360r1358b2428],
2	numeric	JJ	O	numeric	amod	3	SENT_211	[p15l1379t2364r1714b2429],
3	difference	NN	O	difference	nsubj	18	SENT_211	[p15l1738t2353r2147b2429],
4	between	IN	O	between	_	0	SENT_211	[p15l11t2508r355b2584],
5	treatment	NN	O	treatment	nn	6	SENT_211	[p15l393t2525r792b2583],
6	groups	NNS	O	group	prep_between	3	SENT_211	[p15l830t2535r1099b2611],
7	in	IN	O	in	_	0	SENT_211	[p15l1139t2519r1215b2582],
8	the	DT	O	the	det	9	SENT_211	[p15l1253t2508r1379b2583],
9	risk	NN	O	risk	prep_in	6	SENT_211	[p15l1420t2508r1564b2583],
10	of	IN	O	of	_	0	SENT_211	[p15l1600t2508r1687b2583],
11	pulmonary	JJ	O	pulmonary	amod	12	SENT_211	[p15l1713t2508r2153b2611],
12	exacerbations	NNS	O	exacerbation	prep_of	9	SENT_211	[p15l14t2619r557b2694],
13	over	IN	O	over	_	0	SENT_211	[p15l601t2649r776b2694],
14	16	CD	DURATION	16	num	15	SENT_211	[p15l821t2626r909b2693],
15	weeks	NNS	NUMBER	week	prep_over	12	SENT_211	[p15l947t2619r1191b2694],
16	did	VBD	O	do	aux	18	SENT_211	[p15l1236t2619r1363b2694],
17	not	RB	O	not	neg	18	SENT_211	[p15l1403t2635r1534b2694],
18	achieve	VB	O	achieve	_	0	SENT_211	[p15l1575t2619r1873b2694],
19	statistical	JJ	O	statistical	acomp	18	SENT_211	[p15l1917t2630r2147b2694, p15l12t2731r179b2807],

1	signiﬁcance	NN	O	signiﬁcance	_	0	SENT_212	[p15l215t2731r701b2834],
2	.	.	O	.	_	0	SENT_212	[p15l215t2731r701b2834],

1	It	PRP	O	it	nsubjpass	4	SENT_213	[p15l744t2739r809b2807],
2	should	MD	O	should	aux	4	SENT_213	[p15l845t2731r1111b2807],
3	be	VB	O	be	auxpass	4	SENT_213	[p15l1144t2731r1240b2807],
4	noted	VBN	O	note	_	0	SENT_213	[p15l1277t2731r1508b2807],
5	that	IN	O	that	complm	12	SENT_213	[p15l1541t2731r1698b2806],
6	some	DT	O	some	det	7	SENT_213	[p15l1734t2761r1940b2806],
7	subjects	NNS	O	subject	nsubj	12	SENT_213	[p15l1979t2731r2147b2807, p15l6t2854r182b2946],
8	in	IN	O	in	_	0	SENT_213	[p15l215t2854r288b2917],
9	the	DT	O	the	det	11	SENT_213	[p15l318t2843r441b2919],
10	placebo	NN	O	placebo	nn	11	SENT_213	[p15l471t2843r772b2946],
11	group	NN	O	group	prep_in	7	SENT_213	[p15l804t2870r1029b2946],
12	met	VBD	O	meet	ccomp	4	SENT_213	[p15l1063t2860r1214b2919],
13	the	DT	O	the	det	14	SENT_213	[p15l1243t2843r1365b2918],
14	criterion	NN	O	criterion	dobj	12	SENT_213	[p15l1398t2854r1726b2919],
15	for	IN	O	for	_	0	SENT_213	[p15l1757t2843r1868b2918],
16	Part	NN	O	part	nn	17	SENT_213	[p15l1898t2850r2057b2919],
17	B	NN	O	b	prep_for	14	SENT_213	[p15l2090t2850r2145b2918],
18	by	IN	O	by	_	0	SENT_213	[p15l11t2956r107b3059],
19	experiencing	VBG	O	experience	prepc_by	12	SENT_213	[p15l140t2967r635b3059],
20	an	DT	O	a	det	21	SENT_213	[p15l671t2986r760b3032],
21	improvement	NN	O	improvement	dobj	19	SENT_213	[p15l796t2967r1322b3059],
22	in	IN	O	in	_	0	SENT_213	[p15l1355t2967r1429b3030],
23	their	PRP$	O	they	poss	24	SENT_213	[p15l1464t2956r1649b3032],
24	FEV1	NN	O	fev1	prep_in	19	SENT_213	[p15l1684t2963r1914b3055],
25	.	.	O	.	_	0	SENT_213	[p15l1684t2963r1914b3055],

1	Such	PDT	O	such	predet	3	SENT_214	[p15l1960t2956r2149b3031],
2	an	DT	O	a	det	3	SENT_214	[p15l14t3098r103b3143],
3	increase	NN	O	increase	nsubj	9	SENT_214	[p15l129t3079r441b3144],
4	in	IN	O	in	_	0	SENT_214	[p15l469t3079r541b3142],
5	some	DT	O	some	det	6	SENT_214	[p15l570t3098r769b3143],
6	subjects	NNS	O	subject	prep_in	3	SENT_214	[p15l800t3068r1101b3171],
7	is	VBZ	O	be	cop	9	SENT_214	[p15l1130t3079r1184b3143],
8	not	RB	O	not	neg	9	SENT_214	[p15l1213t3085r1339b3143],
9	unusual	JJ	O	unusual	_	0	SENT_214	[p15l1365t3068r1664b3144],
10	in	IN	O	in	_	0	SENT_214	[p15l1690t3079r1763b3142],
11	CF	NN	O	cf	nn	12	SENT_214	[p15l1791t3075r1915b3143],
12	trials	NNS	O	trial	prep_in	9	SENT_214	[p15l1943t3068r2143b3143],
13	.	.	O	.	_	0	SENT_214	[p15l1943t3068r2143b3143],

1	Possible	JJ	O	possible	amod	2	SENT_215	[p15l14t3180r339b3256],
2	explanations	NNS	O	explanation	nsubj	3	SENT_215	[p15l372t3180r867b3283],
3	include	VBP	O	include	ccomp	18	SENT_215	[p15l899t3180r1195b3256],
4	artiﬁcially	RB	O	artiﬁcially	advmod	5	SENT_215	[p15l1229t3180r1625b3283],
5	low	JJ	O	low	amod	6	SENT_215	[p15l1651t3180r1794b3256],
6	baseline	NN	O	baseline	dobj	3	SENT_215	[p15l1819t3180r2147b3256],
7	and	CC	O	and	_	0	SENT_215	[p15l14t3292r159b3368],
8	regression	NN	O	regression	dobj	3	SENT_215	[p15l193t3303r604b3395],
9	to	TO	O	to	aux	10	SENT_215	[p15l638t3309r715b3368],
10	mean	VB	O	mean	xcomp	3	SENT_215	[p15l751t3322r991b3381],
11	,	,	O	,	_	0	SENT_215	[p15l751t3322r991b3381],
12	a	DT	O	a	det	13	SENT_215	[p15l1031t3322r1072b3367],
13	change	NN	O	change	nsubj	18	SENT_215	[p15l1104t3292r1386b3395],
14	related	JJ	O	related	amod	13	SENT_215	[p15l1423t3292r1704b3368],
15	to	TO	O	to	_	0	SENT_215	[p15l1737t3309r1813b3367],
16	chronic	JJ	O	chronic	amod	17	SENT_215	[p15l1849t3292r2149b3367],
17	therapies	NNS	O	therapy	prep_to	14	SENT_215	[p15l12t3404r372b3507],
18	(	VBP	O	(	_	0	SENT_215	[p15l410t3404r548b3507],
19	eg	FW	O	eg	dobj	18	SENT_215	[p15l410t3404r548b3507],
20	,	,	O	,	_	0	SENT_215	[p15l410t3404r548b3507],
21	inhaled	VBD	O	inhale	dep	19	SENT_215	[p15l583t3404r876b3480],
22	cycled	VBN	O	cycle	dep	21	SENT_215	[p15l907t3404r1156b3507],
23	antibiotics	NNS	O	antibiotic	dobj	22	SENT_215	[p15l1189t3404r1643b3494],
24	)	RB	O	)	advmod	22	SENT_215	[p15l1189t3404r1643b3494],
25	,	,	O	,	_	0	SENT_215	[p15l1189t3404r1643b3494],
26	or	CC	O	or	_	0	SENT_215	[p15l1679t3434r1762b3479],
27	improvement	NN	O	improvement	dobj	18	SENT_215	[p15l1790t3415r2147b3507, p15l14t3533r221b3592],
28	due	JJ	O	due	_	0	SENT_215	[p15l250t3516r397b3591],
29	to	TO	O	to	_	0	SENT_215	[p15l426t3533r502b3591],
30	antibiotic	JJ	O	antibiotic	amod	31	SENT_215	[p15l533t3516r909b3592],
31	use	NN	O	use	prep_due_to	27	SENT_215	[p15l937t3546r1069b3592],
32	during	IN	O	during	_	0	SENT_215	[p15l1100t3516r1365b3619],
33	exacerbation	NN	O	exacerbation	prep_during	31	SENT_215	[p15l1393t3516r1921b3592],
34	.	.	O	.	_	0	SENT_215	[p15l1393t3516r1921b3592],

1	Sweat	NN	O	sweat	_	0	SENT_216	[p15l111t3635r338b3703],
2	chloride	NN	O	chloride	nn	3	SENT_216	[p15l378t3628r692b3703],
3	concentration	NN	O	concentration	dep	1	SENT_216	[p15l735t3639r1286b3717],
4	,	,	O	,	_	0	SENT_216	[p15l735t3639r1286b3717],
5	a	DT	O	a	det	6	SENT_216	[p15l1332t3658r1373b3703],
6	measure	NN	O	measure	appos	3	SENT_216	[p15l1412t3658r1739b3703],
7	of	IN	O	of	_	0	SENT_216	[p15l1781t3628r1865b3703],
8	CFTR	NNP	O	CFTR	prep_of	6	SENT_216	[p15l1897t3635r2149b3703],

1	function	NN	O	function	nsubj	3	SENT_217	[p16l13t18r361b107],
2	,	,	O	,	_	0	SENT_217	[p16l13t18r361b107],
3	showed	VBD	O	show	_	0	SENT_217	[p16l395t18r692b93],
4	a	DT	O	a	det	10	SENT_217	[p16l721t48r762b93],
5	small	JJ	O	small	amod	10	SENT_217	[p16l789t18r992b93],
6	decrease	NN	O	decrease	nn	10	SENT_217	[p16l1022t18r1363b93],
7	(	NN	O	(	nn	10	SENT_217	[p16l1398t18r1541b107],
8	2.9	CD	NUMBER	2.9	num	10	SENT_217	[p16l1398t18r1541b107],
9	mmol/L	NN	O	mmol/l	nn	10	SENT_217	[p16l1573t18r1917b107],
10	)	NN	O	)	dobj	3	SENT_217	[p16l1573t18r1917b107],
11	compared	VBN	O	compare	_	0	SENT_217	[p16l1950t48r2147b93, p16l11t131r251b234],
12	with	IN	O	with	prepc_compared_with	10	SENT_217	[p16l290t131r472b207],
13	placebo	NN	O	placebo	pobj	10	SENT_217	[p16l514t131r839b234],
14	through	IN	O	through	_	0	SENT_217	[p16l882t131r1214b234],
15	16	CD	DURATION	16	num	16	SENT_217	[p16l1263t138r1353b206],
16	weeks	NNS	NUMBER	week	prep_through	3	SENT_217	[p16l1394t131r1645b207],
17	of	IN	O	of	_	0	SENT_217	[p16l1692t131r1780b206],
18	therapy	NN	O	therapy	prep_of	16	SENT_217	[p16l1813t131r2145b234],
19	,	,	O	,	_	0	SENT_217	[p16l1813t131r2145b234],
20	although	IN	O	although	mark	25	SENT_217	[p16l14t243r357b346],
21	this	DT	O	this	det	22	SENT_217	[p16l388t243r525b318],
22	change	NN	O	change	nsubjpass	25	SENT_217	[p16l559t243r836b346],
23	was	VBD	O	be	auxpass	25	SENT_217	[p16l864t273r1007b318],
24	not	RB	O	not	neg	25	SENT_217	[p16l1040t260r1169b319],
25	sustained	VBN	O	sustain	advcl	3	SENT_217	[p16l1200t243r1568b319],
26	for	IN	O	for	_	0	SENT_217	[p16l1597t243r1710b318],
27	the	DT	O	the	det	28	SENT_217	[p16l1738t243r1863b318],
28	majority	NN	O	majority	prep_for	25	SENT_217	[p16l1896t254r2147b346, p16l12t366r117b458],
29	of	IN	O	of	_	0	SENT_217	[p16l153t355r241b430],
30	subjects	NNS	O	subject	prep_of	28	SENT_217	[p16l272t355r604b458],
31	in	IN	O	in	_	0	SENT_217	[p16l646t366r723b429],
32	the	DT	O	the	det	37	SENT_217	[p16l762t355r892b431],
33	open	JJ	O	open	amod	37	SENT_217	[p16l934t355r1378b458],
34	—	NN	O	—	nn	37	SENT_217	[p16l934t355r1378b458],
35	label	NN	O	label	nn	37	SENT_217	[p16l934t355r1378b458],
36	extension	NN	O	extension	nn	37	SENT_217	[p16l1418t366r1812b431],
37	period	NN	O	period	prep_in	30	SENT_217	[p16l1850t355r2143b458],
38	.	.	O	.	_	0	SENT_217	[p16l1850t355r2143b458],

1	By	IN	O	by	_	0	SENT_218	[p16l15t474r122b570],
2	contrast	NN	O	contrast	prep_by	5	SENT_218	[p16l145t484r486b556],
3	,	,	O	,	_	0	SENT_218	[p16l145t484r486b556],
4	ivacaftor	NN	O	ivacaftor	nsubj	5	SENT_218	[p16l516t467r864b543],
5	demonstrated	VBD	O	demonstrate	_	0	SENT_218	[p16l889t467r1447b543],
6	a	DT	O	a	det	8	SENT_218	[p16l1474t497r1515b543],
7	median	JJ	O	median	amod	8	SENT_218	[p16l1540t467r1838b543],
8	change	NN	O	change	dobj	5	SENT_218	[p16l1865t467r2147b570],

1	Table	NNP	O	Table	_	0	SENT_219	[p16l770t645r864b674],
2	3	CD	NUMBER	3	dep	1	SENT_219	[p16l876t645r1032b674],
3	.	.	O	.	_	0	SENT_219	[p16l876t645r1032b674],

1	—	NN	O	—	_	0	SENT_220	[p16l876t645r1032b674],
2	.	.	O	.	_	0	SENT_220	[p16l876t645r1032b674],

1	Other	JJ	O	other	_	0	SENT_221	[p16l876t645r1032b674],
2	Clinically	RB	O	clinically	advmod	1	SENT_221	[p16l1045t645r1209b684],
3	Relevant	JJ	O	relevant	amod	4	SENT_221	[p16l1220t645r1368b674],
4	Measures	NNS	O	measure	dep	1	SENT_221	[p16l1378t648r1536b674],

1	Measure	NN	O	measure	nn	2	SENT_222	[p16l156t726r273b750],
2	Placebo	NN	O	placebo	_	0	SENT_222	[p16l1375t724r1482b750],
3	(	CD	NUMBER	(	num	4	SENT_222	[p16l1493t724r1520b754],
4	n	NN	O	n	npadvmod	5	SENT_222	[p16l1493t724r1520b754],
5	=	JJ	O	=	amod	2	SENT_222	[p16l1528t734r1548b742],
6	28	CD	NUMBER	28	number	7	SENT_222	[p16l1557t724r1599b754],
7	)	CD	NUMBER	)	num	10	SENT_222	[p16l1557t724r1599b754],
8	Ivacaftor	NNP	O	Ivacaftor	nn	10	SENT_222	[p16l1898t724r2019b750],
9	(	CD	NUMBER	(	num	10	SENT_222	[p16l2030t724r2056b754],
10	n	NN	O	n	dep	2	SENT_222	[p16l2030t724r2056b754],
11	=	JJ	O	=	amod	10	SENT_222	[p16l2065t734r2085b742],
12	112	CD	NUMBER	112	num	13	SENT_222	[p16l2095t724r2152b754],
13	)	NN	O	)	dep	11	SENT_222	[p16l2095t724r2152b754],

1	Absolute	JJ	O	absolute	amod	2	SENT_223	[p16l154t798r274b824],
2	change	NN	O	change	nsubj	7	SENT_223	[p16l285t798r380b833],
3	in	IN	O	in	_	0	SENT_223	[p16l390t802r416b823],
4	FEV	NN	O	fev	prep_in	2	SENT_223	[p16l426t800r497b832],
5	]	CD	PERCENT	]	num	6	SENT_223	[p16l426t800r497b832],
6	%	NN	PERCENT	%	dep	4	SENT_223	[p16l511t800r534b823],
7	predicted	VBD	O	predict	_	0	SENT_223	[p16l545t798r677b833],
8	-0.2	CD	NUMBER	-0.2	number	9	SENT_223	[p16l1429t800r1494b824],
9	1.5	CD	NUMBER	1.5	num	11	SENT_223	[p16l2010t799r2048b824],
10	Absolute	JJ	O	absolute	amod	11	SENT_223	[p16l154t839r274b865],
11	change	NN	O	change	dobj	7	SENT_223	[p16l285t839r380b874],
12	in	IN	O	in	_	0	SENT_223	[p16l390t843r416b864],
13	CFQ	NNP	O	CFQ	prep_in	7	SENT_223	[p16l426t841r528b872],
14	.	.	O	.	_	0	SENT_223	[p16l426t841r528b872],

1	—	NN	O	—	_	0	SENT_224	[p16l426t841r528b872],
2	.	.	O	.	_	0	SENT_224	[p16l426t841r528b872],

1	R	NN	O	r	_	0	SENT_225	[p16l426t841r528b872],
2	respiratory	JJ	O	respiratory	amod	4	SENT_225	[p16l538t843r687b874],
3	domain	NN	O	domain	nn	4	SENT_225	[p16l695t839r797b865],
4	score	NN	NUMBER	score	nsubj	33	SENT_225	[p16l807t849r877b865],
5	-	:	O	-	_	0	SENT_225	[p16l1429t852r1449b854],
6	1.4	CD	NUMBER	1.4	number	7	SENT_225	[p16l1456t842r1494b865],
7	-0.1	CD	NUMBER	-0.1	dep	4	SENT_225	[p16l1984t842r2047b865],
8	Absolute	JJ	O	absolute	amod	9	SENT_225	[p16l154t880r274b906],
9	change	NN	O	change	dep	25	SENT_225	[p16l285t880r380b915],
10	in	IN	O	in	_	0	SENT_225	[p16l390t884r416b905],
11	weight	NN	O	weight	prep_in	9	SENT_225	[p16l424t880r523b915],
12	,	,	O	,	_	0	SENT_225	[p16l424t880r523b915],
13	kg	NN	O	kg	appos	11	SENT_225	[p16l534t880r565b915],
14	0.96	CD	NUMBER	0.96	num	13	SENT_225	[p16l1454t882r1510b906],
15	0.84	CD	NUMBER	0.84	num	17	SENT_225	[p16l2009t882r2065b906],
16	Absolute	JJ	O	absolute	amod	17	SENT_225	[p16l154t921r274b947],
17	change	NN	O	change	dep	13	SENT_225	[p16l285t921r380b956],
18	in	IN	O	in	_	0	SENT_225	[p16l390t925r416b946],
19	BMI	NNP	O	BMI	prep_in	17	SENT_225	[p16l426t923r497b951],
20	,	,	O	,	_	0	SENT_225	[p16l426t923r497b951],
21	kg/m2	NN	O	kg/m2	dep	25	SENT_225	[p16l508t921r585b956],
22	0.25	CD	NUMBER	0.25	num	21	SENT_225	[p16l1454t922r1510b946],
23	0.21	CD	NUMBER	0.21	num	25	SENT_225	[p16l2009t923r2064b946],
24	Absolute	JJ	O	absolute	amod	25	SENT_225	[p16l154t962r274b988],
25	change	NN	O	change	dep	4	SENT_225	[p16l285t962r380b997],
26	in	IN	O	in	_	0	SENT_225	[p16l390t966r416b987],
27	weight	NN	O	weight	nn	28	SENT_225	[p16l424t962r622b997],
28	—	NN	O	—	prep_in	25	SENT_225	[p16l424t962r622b997],
29	for	IN	O	for	_	0	SENT_225	[p16l424t962r622b997],
30	—	JJ	O	—	amod	31	SENT_225	[p16l424t962r622b997],
31	age	NN	O	age	prep_for	4	SENT_225	[p16l424t962r622b997],
32	z	SYM	O	z	dep	4	SENT_225	[p16l631t971r644b988],
33	score	VBP	NUMBER	score	rcmod	1	SENT_225	[p16l655t972r725b988],
34	0.0007	CD	NUMBER	0.0007	number	35	SENT_225	[p16l1454t963r1544b988],
35	0.43	CD	NUMBER	0.43	num	37	SENT_225	[p16l2009t964r2065b988],
36	Absolute	JJ	O	absolute	amod	37	SENT_225	[p16l154t1003r274b1029],
37	change	NN	O	change	dobj	33	SENT_225	[p16l285t1003r380b1038],
38	in	IN	O	in	_	0	SENT_225	[p16l390t1007r416b1028],
39	BMI	NNP	O	BMI	prep_in	37	SENT_225	[p16l426t1003r596b1038],
40	—	CD	NUMBER	—	num	39	SENT_225	[p16l426t1003r596b1038],
41	for	IN	O	for	_	0	SENT_225	[p16l426t1003r596b1038],
42	—	CD	NUMBER	—	num	43	SENT_225	[p16l426t1003r596b1038],
43	age	NN	O	age	prep_for	33	SENT_225	[p16l426t1003r596b1038],
44	z	SYM	O	z	dep	45	SENT_225	[p16l605t1013r618b1029],
45	score	VBP	NUMBER	score	dep	81	SENT_225	[p16l629t1013r699b1029],
46	-0002	CD	NUMBER	-0002	num	47	SENT_225	[p16l1429t1005r1527b1029],
47	0.73	CD	NUMBER	0.73	dobj	45	SENT_225	[p16l2009t1004r2065b1029],
48	Pulmonary	JJ	O	pulmonary	amod	49	SENT_225	[p16l155t1044r305b1079],
49	exacerbation	NN	O	exacerbation	dep	45	SENT_225	[p16l313t1044r503b1074],
50	,	,	O	,	_	0	SENT_225	[p16l313t1044r503b1074],
51	“	CD	NUMBER	“	num	52	SENT_225	[p16l313t1044r503b1074],
52	No.	NN	O	no.	dep	65	SENT_225	[p16l513t1047r560b1070],
53	(	CD	PERCENT	(	num	54	SENT_225	[p16l573t1044r619b1074],
54	%	NN	PERCENT	%	dep	52	SENT_225	[p16l573t1044r619b1074],
55	)	CD	NUMBER	)	number	56	SENT_225	[p16l573t1044r619b1074],
56	10	CD	NUMBER	10	num	57	SENT_225	[p16l1441t1046r1471b1070],
57	(	NN	O	(	dep	54	SENT_225	[p16l1482t1044r1534b1074],
58	32	CD	NUMBER	32	number	59	SENT_225	[p16l1482t1044r1534b1074],
59	)	CD	NUMBER	)	num	57	SENT_225	[p16l1482t1044r1534b1074],
60	25	CD	NUMBER	25	num	61	SENT_225	[p16l1978t1045r2009b1070],
61	(	NN	O	(	dep	65	SENT_225	[p16l2021t1044r2072b1074],
62	21	CD	NUMBER	21	number	63	SENT_225	[p16l2021t1044r2072b1074],
63	)	CD	NUMBER	)	num	65	SENT_225	[p16l2021t1044r2072b1074],
64	Antibiotic	JJ	O	antibiotic	amod	65	SENT_225	[p16l154t1086r289b1112],
65	treatment	NN	O	treatment	dep	72	SENT_225	[p16l298t1092r433b1112],
66	of	IN	O	of	_	0	SENT_225	[p16l443t1086r472b1112],
67	sinopulmonary	JJ	O	sinopulmonary	amod	68	SENT_225	[p16l479t1086r682b1121],
68	signs	NNS	O	sign	prep_of	65	SENT_225	[p16l691t1090r755b1121],
69	or	CC	O	or	_	0	SENT_225	[p16l766t1096r794b1112],
70	symptoms	NNS	O	symptom	conj_or	68	SENT_225	[p16l804t1088r960b1121],
71	}	CD	NUMBER	}	num	72	SENT_225	[p16l804t1088r960b1121],
72	No.	NN	O	no.	dep	77	SENT_225	[p16l970t1089r1017b1112],
73	(	CD	PERCENT	(	num	74	SENT_225	[p16l1030t1086r1076b1117],
74	%	NN	PERCENT	%	dep	72	SENT_225	[p16l1030t1086r1076b1117],
75	)	CD	NUMBER	)	number	76	SENT_225	[p16l1030t1086r1076b1117],
76	16	CD	NUMBER	16	dep	74	SENT_225	[p16l1441t1088r1471b1112],
77	(	NN	O	(	dep	81	SENT_225	[p16l1482t1086r1534b1116],
78	56	CD	NUMBER	56	num	77	SENT_225	[p16l1482t1086r1534b1116],
79	)	CD	NUMBER	)	num	81	SENT_225	[p16l1482t1086r1534b1116],
80	48	CD	NUMBER	48	num	81	SENT_225	[p16l1977t1088r2009b1112],
81	(	NN	O	(	dep	1	SENT_225	[p16l2021t1086r2072b1116],
82	43	CD	NUMBER	43	number	83	SENT_225	[p16l2021t1086r2072b1116],
83	)	CD	NUMBER	)	num	85	SENT_225	[p16l2021t1086r2072b1116],
84	P	NN	O	p	nn	85	SENT_225	[p16l154t1152r172b1176],
85	values	NNS	O	value	nsubj	91	SENT_225	[p16l180t1150r264b1176],
86	for	IN	O	for	_	0	SENT_225	[p16l274t1150r313b1176],
87	all	DT	O	all	det	88	SENT_225	[p16l323t1150r353b1176],
88	measures	NNS	O	measure	prep_for	85	SENT_225	[p16l363t1160r489b1176],
89	were	VBD	O	be	cop	91	SENT_225	[p16l499t1160r565b1176],
90	not	RB	O	not	neg	91	SENT_225	[p16l575t1155r619b1176],
91	signiﬁcant	JJ	O	signiﬁcant	rcmod	81	SENT_225	[p16l629t1150r773b1185],
92	.	.	O	.	_	0	SENT_225	[p16l629t1150r773b1185],

1	CFQ	NNP	O	CFQ	_	0	SENT_226	[p16l785t1152r888b1183],
2	.	.	O	.	_	0	SENT_226	[p16l785t1152r888b1183],

1	—	NN	O	—	_	0	SENT_227	[p16l785t1152r888b1183],
2	.	.	O	.	_	0	SENT_227	[p16l785t1152r888b1183],

1	R	NN	O	r	nsubj	2	SENT_228	[p16l785t1152r888b1183],
2	=	JJ	O	=	_	0	SENT_228	[p16l896t1160r916b1168],
3	Cystic	JJ	MISC	cystic	amod	5	SENT_228	[p16l926t1152r1008b1185],
4	Fibrosis	NNP	MISC	Fibrosis	nn	5	SENT_228	[p16l1019t1150r1126b1176],
5	Questionnaire	NNP	MISC	Questionnaire	dobj	2	SENT_228	[p16l1137t1150r1457b1183],
6	.	.	O	.	_	0	SENT_228	[p16l1137t1150r1457b1183],

1	—	NN	O	—	_	0	SENT_229	[p16l1137t1150r1457b1183],
2	.	.	O	.	_	0	SENT_229	[p16l1137t1150r1457b1183],

1	Revised	VBN	O	revise	_	0	SENT_230	[p16l1137t1150r1457b1183],
2	.	.	O	.	_	0	SENT_230	[p16l1137t1150r1457b1183],

1	aTreatment	NN	O	atreatment	_	0	SENT_231	[p16l155t1195r306b1218],
2	with	IN	O	with	_	0	SENT_231	[p16l314t1192r374b1218],
3	new	JJ	O	new	amod	7	SENT_231	[p16l383t1202r440b1218],
4	or	CC	O	or	_	0	SENT_231	[p16l449t1202r477b1218],
5	changed	JJ	O	changed	amod	7	SENT_231	[p16l486t1192r601b1227],
6	antibiotic	JJ	O	antibiotic	amod	7	SENT_231	[p16l610t1192r737b1218],
7	therapy	NN	O	therapy	prep_with	1	SENT_231	[p16l747t1192r851b1227],
8	for	IN	O	for	_	0	SENT_231	[p16l860t1192r899b1218],
9	2	CD	NUMBER	2	number	10	SENT_231	[p16l909t1197r932b1215],
10	4	CD	NUMBER	4	num	12	SENT_231	[p16l939t1195r955b1217],
11	sinopulmonary	JJ	O	sinopulmonary	amod	12	SENT_231	[p16l965t1192r1168b1227],
12	signs/symptoms	NNS	O	signs/symptoms	prep_for	1	SENT_231	[p16l1177t1194r1397b1227],
13	.	.	O	.	_	0	SENT_231	[p16l1177t1194r1397b1227],

1	bEvents	NNS	O	bevent	_	0	SENT_232	[p16l154t1235r258b1259],
2	requiring	VBG	O	require	partmod	1	SENT_232	[p16l269t1237r395b1268],
3	new	JJ	O	new	amod	7	SENT_232	[p16l404t1243r461b1259],
4	or	CC	O	or	_	0	SENT_232	[p16l470t1243r498b1259],
5	changed	JJ	O	changed	amod	7	SENT_232	[p16l507t1233r621b1268],
6	antibiotic	JJ	O	antibiotic	amod	7	SENT_232	[p16l631t1233r758b1259],
7	therapy	NN	O	therapy	dobj	2	SENT_232	[p16l768t1233r872b1268],
8	for	IN	O	for	_	0	SENT_232	[p16l881t1233r920b1259],
9	2	CD	NUMBER	2	number	10	SENT_232	[p16l930t1238r953b1256],
10	1	CD	NUMBER	1	num	12	SENT_232	[p16l962t1235r974b1258],
11	sinopulmonary	JJ	O	sinopulmonary	amod	12	SENT_232	[p16l986t1233r1189b1268],
12	sign/symptom	NN	O	sign/symptom	prep_for	7	SENT_232	[p16l1198t1235r1393b1268],
13	.	.	O	.	_	0	SENT_232	[p16l1198t1235r1393b1268],

1	722	CD	NUMBER	722	_	0	SENT_233	[p16l157t1331r211b1355],
2	Original	NNP	O	Original	nn	3	SENT_233	[p16l1926t1333r2024b1361],
3	Research	NNP	O	Research	dep	1	SENT_233	[p16l2035t1334r2154b1355],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_234	[p16l6t1437r183b1461],
2	From	IN	O	from	dep	1	SENT_234	[p16l192t1437r280b1461],
3	:	:	O	:	_	0	SENT_234	[p16l192t1437r280b1461],
4	http://journal.publications.chestnet.org/	NN	O	http://journal.publications.chestnet.org/	dep	1	SENT_234	[p16l291t1436r859b1467],
5	by	IN	O	by	dep	4	SENT_234	[p16l867t1437r902b1467],
6	a	DT	O	a	det	10	SENT_234	[p16l911t1444r927b1460],
7	University	NNP	ORGANIZATION	University	dep	10	SENT_234	[p16l936t1436r1083b1467],
8	of	IN	ORGANIZATION	of	_	0	SENT_234	[p16l1092t1436r1122b1460],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_234	[p16l1128t1436r1274b1461],
10	User	NN	ORGANIZATION	user	pobj	5	SENT_234	[p16l1283t1437r1349b1461],
11	on	IN	O	on	_	0	SENT_234	[p16l1366t1444r1401b1460],
12	01/05/2014	CD	DATE	01/05/2014	prep_on	10	SENT_234	[p16l1410t1436r1561b1461],

1	of	IN	O	of	_	0	SENT_235	[p16l13t1636r101b1711],
2	-59.5	CD	NUMBER	-59.5	num	3	SENT_235	[p16l144t1639r390b1711],
3	mmol/L	NN	O	mmol/l	pobj	1	SENT_235	[p16l437t1636r769b1711],
4	after	IN	O	after	_	0	SENT_235	[p16l813t1636r1007b1711],
5	28	CD	DURATION	28	num	6	SENT_235	[p16l1048t1643r1144b1710],
6	days	NNS	NUMBER	day	prep_after	3	SENT_235	[p16l1190t1636r1365b1738],
7	at	IN	O	at	_	0	SENT_235	[p16l1412t1653r1485b1711],
8	the	DT	O	the	det	10	SENT_235	[p16l1527t1636r1657b1711],
9	same	JJ	O	same	amod	10	SENT_235	[p16l1704t1666r1910b1711],
10	dose	NN	O	dose	prep_at	6	SENT_235	[p16l1956t1636r2142b1711],
11	in	IN	O	in	_	0	SENT_235	[p16l12t1758r89b1821],
12	the	DT	O	the	det	14	SENT_235	[p16l135t1747r265b1822],
13	G551D-CFTR	NN	O	g551d-cftr	nn	14	SENT_235	[p16l316t1751r906b1822],
14	population	NN	O	population	prep_in	10	SENT_235	[p16l952t1747r1489b1849],
15	.	.	O	.	_	0	SENT_235	[p16l952t1747r1489b1849],

1	”	NN	O	”	ccomp	8	SENT_236	[p16l952t1747r1489b1849],
2	Moreover	RB	O	moreover	advmod	1	SENT_236	[p16l1540t1755r1961b1836],
3	,	,	O	,	_	0	SENT_236	[p16l1540t1755r1961b1836],
4	the	DT	O	the	det	6	SENT_236	[p16l2011t1747r2142b1822],
5	G551D-CFTR	NN	O	g551d-cftr	nn	6	SENT_236	[p16l15t1862r570b1933],
6	trial	NN	O	trial	nsubj	8	SENT_236	[p16l604t1858r755b1933],
7	also	RB	O	also	advmod	8	SENT_236	[p16l790t1858r933b1933],
8	showed	VBD	O	show	_	0	SENT_236	[p16l970t1858r1262b1933],
9	a	DT	O	a	det	11	SENT_236	[p16l1296t1888r1337b1933],
10	significant	JJ	O	significant	amod	11	SENT_236	[p16l1371t1858r1760b1960],
11	improvement	NN	O	improvement	dobj	8	SENT_236	[p16l1792t1869r2141b1960, p16l14t1986r221b2044],
12	in	IN	O	in	_	0	SENT_236	[p16l255t1980r330b2043],
13	F	NN	O	f	nn	14	SENT_236	[p16l368t1977r425b2043],
14	EV1	NN	O	ev1	prep_in	8	SENT_236	[p16l433t1977r605b2067],
15	.	.	O	.	_	0	SENT_236	[p16l433t1977r605b2067],

1	Interestingly	RB	O	interestingly	advmod	16	SENT_237	[p16l649t1969r1171b2071],
2	,	,	O	,	_	0	SENT_237	[p16l649t1969r1171b2071],
3	in	IN	O	in	_	0	SENT_237	[p16l1211t1980r1286b2043],
4	the	DT	O	the	det	6	SENT_237	[p16l1321t1969r1448b2044],
5	current	JJ	DATE	current	amod	6	SENT_237	[p16l1486t1986r1783b2044],
6	study	NN	O	study	prep_in	16	SENT_237	[p16l1819t1969r2035b2071],
7	of	IN	O	of	_	0	SENT_237	[p16l2068t1969r2153b2044],
8	F508del-CFTR	NN	O	f508del-cftr	nn	9	SENT_237	[p16l11t2080r606b2155],
9	homozygotes	NNS	O	homozygote	prep_of	6	SENT_237	[p16l640t2080r1175b2182],
10	,	,	O	,	_	0	SENT_237	[p16l640t2080r1175b2182],
11	15.2	CD	PERCENT	15.2	num	12	SENT_237	[p16l1219t2084r1455b2155],
12	%	NN	PERCENT	%	nsubj	16	SENT_237	[p16l1219t2084r1455b2155],
13	of	IN	O	of	_	0	SENT_237	[p16l1495t2080r1580b2155],
14	ivacaftor	JJ	O	ivacaftor	amod	15	SENT_237	[p16l1604t2080r1943b2155],
15	subjects	NNS	O	subject	prep_of	12	SENT_237	[p16l1977t2080r2141b2155, p16l6t2202r190b2293],
16	demonstrated	VBD	O	demonstrate	_	0	SENT_237	[p16l224t2191r781b2266],
17	an	DT	O	a	det	21	SENT_237	[p16l811t2221r903b2266],
18	average	JJ	O	average	amod	21	SENT_237	[p16l935t2218r1237b2293],
19	sweat	NN	O	sweat	nn	21	SENT_237	[p16l1271t2208r1492b2266],
20	chloride	NN	O	chloride	nn	21	SENT_237	[p16l1523t2191r1849b2266],
21	reduction	NN	O	reduction	dobj	16	SENT_237	[p16l1882t2191r2141b2266, p16l12t2313r170b2377],
22	of	IN	O	of	_	0	SENT_237	[p16l206t2302r293b2377],
23	2	CD	NUMBER	2	number	24	SENT_237	[p16l324t2318r389b2368],
24	10	CD	NUMBER	10	num	25	SENT_237	[p16l420t2309r508b2376],
25	mmol/L	NN	O	mmol/l	prep_of	21	SENT_237	[p16l546t2302r872b2377],
26	across	IN	O	across	_	0	SENT_237	[p16l908t2332r1151b2377],
27	all	DT	O	all	det	29	SENT_237	[p16l1190t2302r1282b2377],
28	time	NN	O	time	nn	29	SENT_237	[p16l1316t2313r1498b2377],
29	points	NNS	O	point	prep_across	16	SENT_237	[p16l1534t2313r1781b2404],
30	through	IN	O	through	_	0	SENT_237	[p16l1819t2302r2143b2404],
31	week	NN	DURATION	week	prep_through	16	SENT_237	[p16l9t2413r220b2488],
32	16	CD	NUMBER	16	num	31	SENT_237	[p16l261t2420r370b2502],
33	,	,	O	,	_	0	SENT_237	[p16l261t2420r370b2502],
34	compared	VBN	O	compare	_	0	SENT_237	[p16l412t2413r815b2515],
35	with	IN	O	with	prepc_compared_with	16	SENT_237	[p16l847t2413r1024b2488],
36	no	DT	O	no	det	37	SENT_237	[p16l1061t2443r1159b2488],
37	subjects	NNS	O	subject	pobj	16	SENT_237	[p16l1198t2413r1516b2515],
38	in	IN	O	in	_	0	SENT_237	[p16l1555t2424r1630b2487],
39	the	DT	O	the	det	41	SENT_237	[p16l1667t2413r1793b2488],
40	placebo	NN	O	placebo	nn	41	SENT_237	[p16l1831t2413r2142b2515],
41	group	NN	O	group	prep_in	37	SENT_237	[p16l13t2552r261b2627],
42	.	.	O	.	_	0	SENT_237	[p16l13t2552r261b2627],

1	This	DT	DATE	this	nsubj	3	SENT_238	[p16l300t2525r469b2600],
2	may	MD	DATE	may	aux	3	SENT_238	[p16l507t2555r671b2627],
3	indicate	VB	O	indicate	_	0	SENT_238	[p16l701t2525r1012b2600],
4	a	DT	O	a	det	5	SENT_238	[p16l1049t2555r1090b2600],
5	subpopulation	NN	O	subpopulation	dobj	3	SENT_238	[p16l1124t2525r1684b2627],
6	of	IN	O	of	_	0	SENT_238	[p16l1719t2525r1804b2600],
7	subjects	NNS	O	subject	prep_of	5	SENT_238	[p16l1830t2525r2141b2627],
8	homozygous	JJ	O	homozygous	amod	7	SENT_238	[p16l12t2636r526b2738],
9	for	IN	O	for	_	0	SENT_238	[p16l568t2636r686b2711],
10	the	DT	O	the	det	12	SENT_238	[p16l722t2636r852b2711],
11	F508del-CFTR	NN	O	f508del-cftr	nn	12	SENT_238	[p16l890t2636r1517b2711],
12	mutation	NN	O	mutation	prep_for	8	SENT_238	[p16l1557t2647r1932b2711],
13	with	IN	O	with	_	0	SENT_238	[p16l1967t2636r2143b2711],
14	some	DT	O	some	det	16	SENT_238	[p16l14t2777r220b2822],
15	F508del-CFTR	NN	O	f508del-cftr	nn	16	SENT_238	[p16l267t2747r893b2822],
16	protein	NN	O	protein	prep_with	3	SENT_238	[p16l934t2758r1227b2849],
17	that	WDT	O	that	nsubj	18	SENT_238	[p16l1270t2747r1426b2822],
18	reaches	VBZ	O	reach	rcmod	16	SENT_238	[p16l1469t2747r1769b2822],
19	the	DT	O	the	det	22	SENT_238	[p16l1815t2747r1941b2822],
20	epithelial	JJ	O	epithelial	amod	22	SENT_238	[p16l1987t2758r2141b2849, p16l12t2858r254b2933],
21	cell	NN	O	cell	nn	22	SENT_238	[p16l288t2858r423b2933],
22	surface	NN	O	surface	dobj	18	SENT_238	[p16l457t2858r756b2947],
23	,	,	O	,	_	0	SENT_238	[p16l457t2858r756b2947],
24	supporting	VBG	O	support	partmod	18	SENT_238	[p16l795t2869r1219b2960],
25	in	FW	O	in	nn	26	SENT_238	[p16l1250t2869r1324b2932],
26	vitro	FW	O	vitro	advmod	24	SENT_238	[p16l1354t2869r1534b2933],
27	evidence	NN	O	evidence	dobj	24	SENT_238	[p16l1569t2858r1935b2933],
28	.	.	O	.	_	0	SENT_238	[p16l1569t2858r1935b2933],

1	One	CD	NUMBER	one	nsubj	5	SENT_239	[p16l1976t2865r2142b2933],
2	in	FW	O	in	nn	3	SENT_239	[p16l12t2980r85b3043],
3	vitro	FW	O	vitro	advmod	4	SENT_239	[p16l114t2980r290b3044],
4	study	NN	O	study	rcmod	1	SENT_239	[p16l325t2969r532b3071],
5	tested	VBD	O	test	_	0	SENT_239	[p16l561t2969r794b3044],
6	ivacaftor	NN	O	ivacaftor	dobj	5	SENT_239	[p16l825t2969r1156b3044],
7	in	IN	O	in	_	0	SENT_239	[p16l1185t2980r1258b3043],
8	human	JJ	O	human	amod	14	SENT_239	[p16l1290t2969r1561b3044],
9	bronchial	JJ	O	bronchial	amod	14	SENT_239	[p16l1592t2969r1957b3044],
10	epithelial	JJ	O	epithelial	amod	14	SENT_239	[p16l1990t2980r2141b3071, p16l12t3080r260b3155],
11	(	NN	O	(	nn	14	SENT_239	[p16l296t3081r564b3169],
12	HBE	NN	O	hbe	nn	14	SENT_239	[p16l296t3081r564b3169],
13	)	NN	O	)	nn	14	SENT_239	[p16l296t3081r564b3169],
14	cells	NNS	O	cell	prep_in	5	SENT_239	[p16l601t3080r772b3155],
15	from	IN	O	from	_	0	SENT_239	[p16l807t3080r998b3155],
16	subjects	NNS	O	subject	prep_from	14	SENT_239	[p16l1033t3080r1351b3182],
17	with	IN	O	with	_	0	SENT_239	[p16l1382t3080r1558b3155],
18	CF	NN	O	cf	prep_with	5	SENT_239	[p16l1591t3087r1717b3155],
19	who	WP	O	who	nsubj	21	SENT_239	[p16l1748t3080r1916b3155],
20	were	VBD	O	be	cop	21	SENT_239	[p16l1945t3110r2142b3155],
21	homozygous	JJ	O	homozygous	rcmod	18	SENT_239	[p16l12t3191r491b3293],
22	for	IN	O	for	_	0	SENT_239	[p16l519t3191r630b3266],
23	the	DT	O	the	det	28	SENT_239	[p16l653t3191r775b3266],
24	F	NN	O	f	nn	28	SENT_239	[p16l801t3198r858b3265],
25	508del-C	NN	O	508del-c	nn	28	SENT_239	[p16l858t3191r1207b3266],
26	F	NN	O	f	nn	28	SENT_239	[p16l1211t3198r1268b3265],
27	TR	NN	O	tr	nn	28	SENT_239	[p16l1271t3198r1385b3266],
28	mutation	NN	O	mutation	prep_for	21	SENT_239	[p16l1411t3201r1836b3266],
29	.	.	O	.	_	0	SENT_239	[p16l1411t3201r1836b3266],

1	”	RB	O	”	_	0	SENT_240	[p16l1411t3201r1836b3266],
2	Among	IN	O	among	_	0	SENT_240	[p16l1860t3198r2145b3293],
3	HBE	NNP	O	HBE	prep_among	24	SENT_240	[p16l15t3310r215b3376],
4	that	WDT	O	that	nsubj	5	SENT_240	[p16l253t3302r404b3377],
5	showed	VBD	O	show	rcmod	3	SENT_240	[p16l439t3302r731b3377],
6	potentiation	NN	O	potentiation	dobj	5	SENT_240	[p16l762t3313r1230b3404],
7	by	IN	O	by	_	0	SENT_240	[p16l1263t3302r1359b3404],
8	ivacaftor	NN	O	ivacaftor	prep_by	5	SENT_240	[p16l1389t3302r1729b3391],
9	,	,	O	,	_	0	SENT_240	[p16l1389t3302r1729b3391],
10	the	DT	O	the	det	12	SENT_240	[p16l1767t3302r1889b3377],
11	effect	NN	O	effect	nn	12	SENT_240	[p16l1927t3302r2144b3377],
12	size	NN	O	size	nsubj	24	SENT_240	[p16l14t3424r158b3488],
13	(	CD	NUMBER	(	dep	14	SENT_240	[p16l198t3414r326b3515],
14	up	RP	O	up	advmod	12	SENT_240	[p16l198t3414r326b3515],
15	to	TO	O	to	_	0	SENT_240	[p16l361t3430r437b3488],
16	16	CD	PERCENT	16	num	17	SENT_240	[p16l478t3420r644b3487],
17	%	NN	PERCENT	%	prep_to	12	SENT_240	[p16l478t3420r644b3487],
18	of	IN	O	of	_	0	SENT_240	[p16l683t3413r769b3488],
19	normal	JJ	O	normal	amod	21	SENT_240	[p16l792t3413r1077b3488],
20	activity	NN	O	activity	nn	21	SENT_240	[p16l1111t3414r1422b3515],
21	)	NN	O	)	prep_of	17	SENT_240	[p16l1111t3414r1422b3515],
22	was	VBD	O	be	cop	24	SENT_240	[p16l1457t3443r1601b3488],
23	considerably	RB	O	considerably	advmod	24	SENT_240	[p16l1638t3413r2147b3515],
24	lower	JJR	O	lower	ccomp	1	SENT_240	[p16l12t3524r244b3599],
25	than	IN	O	than	prep	24	SENT_240	[p16l279t3524r461b3599],
26	in	IN	O	in	pcomp	25	SENT_240	[p16l498t3535r575b3598],
27	HBE	NNP	O	HBE	pobj	26	SENT_240	[p16l614t3532r822b3598],
28	from	IN	O	from	_	0	SENT_240	[p16l864t3524r1061b3599],
29	a	DT	O	a	det	31	SENT_240	[p16l1100t3554r1141b3599],
30	G551D/F508del	NN	O	g551d/f508del	nn	31	SENT_240	[p16l1179t3524r1862b3599],
31	donor	NN	O	donor	prep_from	24	SENT_240	[p16l1900t3524r2145b3599],

1	(	NN	O	(	_	0	SENT_241	[p16l17t3635r294b3737],
2	nearly	RB	O	nearly	quantmod	3	SENT_241	[p16l17t3635r294b3737],
3	50	CD	PERCENT	50	num	4	SENT_241	[p16l319t3639r491b3709],
4	%	NN	PERCENT	%	dep	1	SENT_241	[p16l319t3639r491b3709],
5	normal	JJ	O	normal	amod	6	SENT_241	[p16l524t3635r859b3725],
6	)	NN	O	)	dep	4	SENT_241	[p16l524t3635r859b3725],
7	.	.	O	.	_	0	SENT_241	[p16l524t3635r859b3725],

1	CONCLUSIONS	NNS	O	conclusion	_	0	SENT_242	[p17l782t127r1372b194],

1	This	DT	O	this	det	2	SENT_243	[p17l105t306r282b381],
2	study	NN	O	study	nsubj	10	SENT_243	[p17l329t306r552b408],
3	augments	VBZ	O	augment	_	0	SENT_243	[p17l592t323r990b408],
4	the	DT	O	the	det	6	SENT_243	[p17l1035t306r1165b381],
5	safety	NN	O	safety	nn	6	SENT_243	[p17l1211t306r1452b408],
6	information	NN	O	information	dobj	3	SENT_243	[p17l1490t306r1984b381],
7	for	IN	O	for	_	0	SENT_243	[p17l2027t306r2145b381],
8	ivacaftor	NN	O	ivacaftor	prep_for	3	SENT_243	[p17l12t417r374b492],
9	and	CC	O	and	_	0	SENT_243	[p17l407t417r557b492],
10	supports	VBZ	O	support	conj_and	3	SENT_243	[p17l591t434r945b519],
11	the	DT	O	the	det	13	SENT_243	[p17l982t417r1112b492],
12	continued	JJ	O	continued	amod	13	SENT_243	[p17l1148t417r1569b492],
13	evaluation	NN	O	evaluation	dobj	10	SENT_243	[p17l1603t417r2031b492],
14	of	IN	O	of	_	0	SENT_243	[p17l2065t417r2153b492],
15	ivacaftor	NN	O	ivacaftor	prep_of	13	SENT_243	[p17l12t528r342b603],
16	in	IN	O	in	_	0	SENT_243	[p17l373t539r446b602],
17	subjects	NNS	O	subject	prep_in	10	SENT_243	[p17l481t528r785b630],
18	with	IN	O	with	_	0	SENT_243	[p17l817t528r987b603],
19	CF.	NNP	O	CF.	prep_with	17	SENT_243	[p17l1022t535r1154b603],
20	The	DT	O	the	det	21	SENT_243	[p17l1192t528r1345b603],
21	lack	NN	O	lack	dobj	3	SENT_243	[p17l1380t528r1533b603],
22	of	IN	O	of	_	0	SENT_243	[p17l1564t528r1648b603],
23	an	DT	O	a	det	26	SENT_243	[p17l1673t558r1762b603],
24	observed	VBN	O	observe	amod	26	SENT_243	[p17l1796t528r2144b603],
25	clinical	JJ	O	clinical	amod	26	SENT_243	[p17l13t639r295b714],
26	effect	NN	O	effect	prep_of	21	SENT_243	[p17l332t639r559b714],
27	suggests	VBZ	O	suggest	rcmod	26	SENT_243	[p17l596t656r923b741],
28	that	IN	O	that	complm	36	SENT_243	[p17l961t639r1117b714],
29	CFTR	NNP	ORGANIZATION	CFTR	nn	30	SENT_243	[p17l1153t646r1410b714],
30	potentiation	NN	O	potentiation	nsubj	36	SENT_243	[p17l1445t650r1934b741],
31	with	IN	O	with	_	0	SENT_243	[p17l1967t639r2143b714],
32	ivacaftor	NN	O	ivacaftor	prep_with	30	SENT_243	[p17l12t750r358b825],
33	alone	RB	O	alone	advmod	36	SENT_243	[p17l387t750r599b825],
34	will	MD	O	will	aux	36	SENT_243	[p17l627t750r771b825],
35	not	RB	O	not	neg	36	SENT_243	[p17l800t767r931b825],
36	beneﬁt	VB	O	beneﬁt	ccomp	27	SENT_243	[p17l958t750r1241b825],
37	patients	NNS	O	patient	dobj	36	SENT_243	[p17l1268t761r1583b852],
38	with	IN	O	with	_	0	SENT_243	[p17l1612t750r1788b825],
39	CF	NN	O	cf	prep_with	36	SENT_243	[p17l1820t757r1946b825],
40	who	WP	O	who	nsubj	42	SENT_243	[p17l1974t750r2142b825],
41	are	VBP	O	be	cop	42	SENT_243	[p17l14t891r138b936],
42	homozygous	JJ	O	homozygous	rcmod	39	SENT_243	[p17l181t861r696b963],
43	for	IN	O	for	_	0	SENT_243	[p17l741t861r859b936],
44	the	DT	O	the	det	46	SENT_243	[p17l899t861r1029b936],
45	F508del-CFTR	NN	O	f508del-cftr	nn	46	SENT_243	[p17l1071t861r1698b936],
46	mutation	NN	O	mutation	prep_for	42	SENT_243	[p17l1742t872r2137b936],
47	.	.	O	.	_	0	SENT_243	[p17l1742t872r2137b936],

1	Although	IN	O	although	mark	9	SENT_244	[p17l10t973r362b1075],
2	a	DT	O	a	det	3	SENT_244	[p17l394t1003r435b1048],
3	proportion	NN	O	proportion	nsubj	9	SENT_244	[p17l461t984r867b1075],
4	of	IN	O	of	_	0	SENT_244	[p17l898t973r981b1048],
5	subjects	NNS	O	subject	prep_of	3	SENT_244	[p17l1002t973r1299b1075],
6	treated	VBN	O	treat	partmod	5	SENT_244	[p17l1331t973r1600b1048],
7	with	IN	O	with	_	0	SENT_244	[p17l1626t973r1793b1048],
8	ivacaftor	NN	O	ivacaftor	prep_with	6	SENT_244	[p17l1823t973r2145b1048],
9	showed	VBD	O	show	advcl	22	SENT_244	[p17l14t1084r331b1159],
10	a	DT	O	a	det	12	SENT_244	[p17l368t1114r408b1159],
11	small	JJ	O	small	amod	12	SENT_244	[p17l445t1084r663b1159],
12	change	NN	O	change	dobj	9	SENT_244	[p17l700t1084r996b1186],
13	in	IN	O	in	_	0	SENT_244	[p17l1035t1095r1113b1158],
14	the	DT	O	the	det	17	SENT_244	[p17l1150t1084r1281b1159],
15	sweat	NN	O	sweat	nn	17	SENT_244	[p17l1322t1101r1555b1159],
16	chloride	NN	O	chloride	nn	17	SENT_244	[p17l1591t1084r1939b1159],
17	biomarker	NN	O	biomarker	prep_in	9	SENT_244	[p17l1977t1084r2141b1159, p17l14t1196r313b1285],
18	,	,	O	,	_	0	SENT_244	[p17l1977t1084r2141b1159, p17l14t1196r313b1285],
19	this	DT	O	this	nsubjpass	22	SENT_244	[p17l352t1196r492b1272],
20	was	VBD	O	be	auxpass	22	SENT_244	[p17l526t1226r670b1272],
21	not	RB	O	not	neg	22	SENT_244	[p17l708t1213r839b1272],
22	associated	VBN	O	associate	_	0	SENT_244	[p17l874t1196r1279b1272],
23	with	IN	O	with	_	0	SENT_244	[p17l1310t1196r1486b1272],
24	clinical	JJ	O	clinical	amod	25	SENT_244	[p17l1522t1196r1804b1272],
25	beneﬁt	NN	O	beneﬁt	prep_with	22	SENT_244	[p17l1837t1196r2137b1272],
26	.	.	O	.	_	0	SENT_244	[p17l1837t1196r2137b1272],

1	Additional	JJ	O	additional	amod	2	SENT_245	[p17l10t1307r418b1382],
2	studies	NNS	O	study	nsubjpass	4	SENT_245	[p17l451t1307r716b1382],
3	are	VBP	O	be	auxpass	4	SENT_245	[p17l752t1337r870b1382],
4	needed	VBN	O	need	_	0	SENT_245	[p17l904t1307r1194b1382],
5	to	TO	O	to	aux	6	SENT_245	[p17l1225t1324r1299b1382],
6	explore	VB	O	explore	xcomp	4	SENT_245	[p17l1333t1307r1616b1409],
7	any	DT	O	any	det	8	SENT_245	[p17l1651t1337r1787b1409],
8	relationship	NN	O	relationship	dobj	6	SENT_245	[p17l1816t1307r2141b1382, p17l14t1418r178b1520],
9	between	IN	O	between	_	0	SENT_245	[p17l209t1418r558b1493],
10	sweat	NN	O	sweat	nn	11	SENT_245	[p17l590t1435r816b1493],
11	chloride	NN	O	chloride	prep_between	8	SENT_245	[p17l846t1418r1180b1493],
12	and	CC	O	and	_	0	SENT_245	[p17l1214t1418r1361b1493],
13	a	DT	O	a	det	15	SENT_245	[p17l1392t1448r1433b1493],
14	clinical	JJ	O	clinical	amod	15	SENT_245	[p17l1463t1418r1751b1493],
15	response	NN	O	response	conj_and	8	SENT_245	[p17l1782t1448r2142b1520],
16	in	IN	O	in	_	0	SENT_245	[p17l12t1540r85b1603],
17	this	DT	O	this	det	18	SENT_245	[p17l116t1529r250b1604],
18	group	NN	O	group	prep_in	15	SENT_245	[p17l284t1556r527b1631],
19	.	.	O	.	_	0	SENT_245	[p17l284t1556r527b1631],

1	Alternative	JJ	O	alternative	amod	3	SENT_246	[p17l562t1529r986b1604],
2	therapeutic	JJ	O	therapeutic	amod	3	SENT_246	[p17l1019t1529r1460b1631],
3	approaches	NNS	O	approach	nsubjpass	27	SENT_246	[p17l1492t1529r1946b1631],
4	,	,	O	,	_	0	SENT_246	[p17l1492t1529r1946b1631],
5	possibly	RB	O	possibly	advmod	6	SENT_246	[p17l1980t1559r2141b1631, p17l14t1641r206b1743],
6	using	VBG	O	use	partmod	3	SENT_246	[p17l243t1652r466b1743],
7	a	DT	O	a	det	9	SENT_246	[p17l506t1671r547b1716],
8	corrector	NN	O	corrector	nn	9	SENT_246	[p17l587t1658r977b1716],
9	compound	NN	O	compound	dobj	6	SENT_246	[p17l1017t1641r1464b1743],
10	to	TO	O	to	aux	11	SENT_246	[p17l1503t1658r1582b1716],
11	increase	VB	O	increase	xcomp	6	SENT_246	[p17l1623t1652r1968b1716],
12	the	DT	O	the	det	13	SENT_246	[p17l2011t1641r2142b1716],
13	amount	NN	O	amount	dobj	11	SENT_246	[p17l14t1769r328b1827],
14	of	IN	O	of	_	0	SENT_246	[p17l359t1752r446b1827],
15	F	NN	O	f	nn	17	SENT_246	[p17l468t1760r525b1826],
16	508del-CFTR	NN	O	508del-cftr	nn	17	SENT_246	[p17l532t1752r1114b1827],
17	protein	NN	O	protein	prep_of	13	SENT_246	[p17l1143t1763r1446b1854],
18	that	WDT	O	that	nsubj	19	SENT_246	[p17l1476t1752r1638b1827],
19	reaches	VBZ	O	reach	rcmod	17	SENT_246	[p17l1668t1752r1979b1827],
20	the	DT	O	the	det	23	SENT_246	[p17l2012t1752r2142b1827],
21	epithelial	JJ	O	epithelial	amod	23	SENT_246	[p17l13t1863r377b1965],
22	cell	NN	O	cell	nn	23	SENT_246	[p17l407t1863r542b1938],
23	surface	NN	O	surface	dobj	19	SENT_246	[p17l573t1863r872b1952],
24	,	,	O	,	_	0	SENT_246	[p17l573t1863r872b1952],
25	should	MD	O	should	aux	27	SENT_246	[p17l908t1863r1168b1938],
26	be	VB	O	be	auxpass	27	SENT_246	[p17l1195t1863r1290b1938],
27	evaluated	VBN	O	evaluate	_	0	SENT_246	[p17l1323t1863r1699b1938],
28	for	IN	O	for	_	0	SENT_246	[p17l1728t1863r1841b1938],
29	clinical	JJ	O	clinical	amod	30	SENT_246	[p17l1869t1863r2144b1938],
30	beneﬁt	NN	O	beneﬁt	prep_for	27	SENT_246	[p17l11t1975r294b2050],
31	in	IN	O	in	_	0	SENT_246	[p17l320t1986r395b2049],
32	this	DT	O	this	det	33	SENT_246	[p17l423t1975r563b2050],
33	population	NN	O	population	prep_in	30	SENT_246	[p17l592t1975r1044b2077],
34	.	.	O	.	_	0	SENT_246	[p17l592t1975r1044b2077],

1	ACKNOWLEDGMENTS	NNS	O	acknowledgment	_	0	SENT_247	[p17l635t2246r1516b2313],

1	Author	NN	O	author	nn	2	SENT_248	[p17l9t2383r274b2444],
2	contributions	NNS	O	contribution	_	0	SENT_248	[p17l306t2383r828b2444],
3	:	:	O	:	_	0	SENT_248	[p17l306t2383r828b2444],
4	Dr	NNP	O	Dr	nn	5	SENT_248	[p17l868t2389r960b2443],
5	Flume	NNP	O	Flume	nsubj	6	SENT_248	[p17l990t2383r1209b2444],
6	served	VBD	O	serve	dep	2	SENT_248	[p17l1243t2383r1461b2444],
7	as	IN	O	as	_	0	SENT_248	[p17l1491t2407r1552b2444],
8	guarantor	NN	O	guarantor	prep_as	6	SENT_248	[p17l1585t2396r1914b2466],
9	of	IN	O	of	_	0	SENT_248	[p17l1944t2383r2015b2444],
10	the	DT	O	the	det	11	SENT_248	[p17l2037t2383r2142b2444],
11	manuscript	NN	O	manuscript	prep_of	8	SENT_248	[p17l13t2466r393b2540],
12	.	.	O	.	_	0	SENT_248	[p17l13t2466r393b2540],

1	Dr	NNP	O	Dr	nn	2	SENT_249	[p17l11t2547r106b2602],
2	Flume	NNP	O	Flume	nsubj	4	SENT_249	[p17l133t2541r360b2602],
3	:	:	O	:	_	0	SENT_249	[p17l133t2541r360b2602],
4	contributed	VBD	O	contribute	_	0	SENT_249	[p17l395t2541r793b2602],
5	to	TO	O	to	_	0	SENT_249	[p17l822t2555r885b2602],
6	the	DT	O	the	det	7	SENT_249	[p17l916t2541r1021b2602],
7	acquisition	NN	O	acquisition	prep_to	4	SENT_249	[p17l1053t2550r1420b2625],
8	of	IN	O	of	_	0	SENT_249	[p17l1451t2541r1522b2602],
9	data	NNS	O	datum	prep_of	7	SENT_249	[p17l1545t2541r1702b2614],
10	,	,	O	,	_	0	SENT_249	[p17l1545t2541r1702b2614],
11	analysis	NN	O	analysis	prep_of	7	SENT_249	[p17l1737t2541r1990b2625],
12	and	CC	O	and	_	0	SENT_249	[p17l2024t2541r2145b2602],
13	interpretation	NN	O	interpretation	conj_and	9	SENT_249	[p17l11t2635r464b2709],
14	of	IN	O	of	_	0	SENT_249	[p17l488t2626r557b2687],
15	data	NNS	O	datum	prep_of	7	SENT_249	[p17l573t2626r724b2698],
16	,	,	O	,	_	0	SENT_249	[p17l573t2626r724b2698],
17	drafting	VBG	O	draft	partmod	7	SENT_249	[p17l751t2626r1007b2709],
18	of	IN	O	of	_	0	SENT_249	[p17l1030t2626r1099b2687],
19	the	DT	O	the	det	20	SENT_249	[p17l1114t2626r1216b2687],
20	manuscript	NN	O	manuscript	prep_of	17	SENT_249	[p17l1241t2635r1622b2709],
21	,	,	O	,	_	0	SENT_249	[p17l1241t2635r1622b2709],
22	critical	JJ	O	critical	amod	23	SENT_249	[p17l1648t2626r1868b2687],
23	revision	NN	O	revision	prep_of	17	SENT_249	[p17l1891t2635r2143b2687],
24	of	IN	O	of	_	0	SENT_249	[p17l13t2710r82b2771],
25	the	DT	O	the	det	26	SENT_249	[p17l94t2710r196b2771],
26	manuscript	NN	O	manuscript	prep_of	23	SENT_249	[p17l219t2719r584b2793],
27	for	IN	O	for	_	0	SENT_249	[p17l604t2710r697b2771],
28	important	JJ	O	important	amod	30	SENT_249	[p17l715t2719r1039b2793],
29	intellectual	JJ	O	intellectual	amod	30	SENT_249	[p17l1058t2710r1421b2771],
30	content	NN	O	content	prep_for	26	SENT_249	[p17l1442t2723r1704b2782],
31	,	,	O	,	_	0	SENT_249	[p17l1442t2723r1704b2782],
32	and	CC	O	and	_	0	SENT_249	[p17l1728t2710r1846b2771],
33	approval	NN	O	approval	conj_and	20	SENT_249	[p17l1866t2710r2144b2793],
34	of	IN	O	of	_	0	SENT_249	[p17l13t2794r82b2855],
35	the	DT	O	the	det	37	SENT_249	[p17l97t2794r198b2855],
36	ﬁnal	JJ	O	ﬁnal	amod	37	SENT_249	[p17l223t2794r361b2855],
37	version	NN	O	version	prep_of	7	SENT_249	[p17l381t2803r632b2855],
38	.	.	O	.	_	0	SENT_249	[p17l381t2803r632b2855],

1	Dr	NNP	O	Dr	nn	2	SENT_250	[p17l11t2885r105b2939],
2	Liou	NNP	PERSON	Liou	nsubj	23	SENT_250	[p17l129t2885r297b2940],
3	:	:	O	:	_	0	SENT_250	[p17l129t2885r297b2940],
4	contributed	VBD	O	contribute	_	0	SENT_250	[p17l331t2879r713b2940],
5	to	TO	O	to	_	0	SENT_250	[p17l741t2892r802b2940],
6	the	DT	O	the	det	7	SENT_250	[p17l832t2879r934b2940],
7	acquisition	NN	O	acquisition	prep_to	4	SENT_250	[p17l965t2888r1316b2962],
8	of	IN	O	of	_	0	SENT_250	[p17l1346t2879r1415b2940],
9	data	NNS	O	datum	prep_of	7	SENT_250	[p17l1437t2879r1574b2940],
10	and	CC	O	and	_	0	SENT_250	[p17l1602t2879r1720b2940],
11	critical	JJ	O	critical	amod	12	SENT_250	[p17l1748t2879r1968b2940],
12	revision	NN	O	revision	prep_to	4	SENT_250	[p17l1997t2888r2142b2940, p17l13t2972r139b3024],
13	of	IN	O	of	_	0	SENT_250	[p17l168t2963r236b3024],
14	the	DT	O	the	det	15	SENT_250	[p17l256t2963r356b3024],
15	manuscript	NN	O	manuscript	prep_of	12	SENT_250	[p17l387t2972r745b3047],
16	for	IN	O	for	_	0	SENT_250	[p17l772t2963r863b3024],
17	important	JJ	O	important	amod	19	SENT_250	[p17l889t2972r1207b3046],
18	intellectual	JJ	O	intellectual	amod	19	SENT_250	[p17l1234t2963r1588b3024],
19	content	NN	O	content	prep_for	4	SENT_250	[p17l1616t2977r1857b3024],
20	and	CC	O	and	_	0	SENT_250	[p17l1886t2963r2002b3024],
21	saw	NN	O	saw	prep_for	4	SENT_250	[p17l2030t2988r2146b3024],
22	and	CC	O	and	_	0	SENT_250	[p17l13t3047r131b3108],
23	approved	VBD	O	approve	conj_and	4	SENT_250	[p17l154t3047r457b3131],
24	the	DT	O	the	det	26	SENT_250	[p17l479t3047r580b3108],
25	ﬁnal	JJ	O	ﬁnal	amod	26	SENT_250	[p17l606t3047r744b3108],
26	version	NN	O	version	dobj	23	SENT_250	[p17l763t3056r1014b3108],
27	.	.	O	.	_	0	SENT_250	[p17l763t3056r1014b3108],

1	Dr	NNP	O	Dr	nn	2	SENT_251	[p17l11t3138r106b3192],
2	Borowitz	NNP	PERSON	Borowitz	nsubj	23	SENT_251	[p17l127t3138r452b3193],
3	:	:	O	:	_	0	SENT_251	[p17l127t3138r452b3193],
4	contributed	VBD	O	contribute	_	0	SENT_251	[p17l482t3132r880b3193],
5	to	TO	O	to	_	0	SENT_251	[p17l903t3145r966b3193],
6	the	DT	O	the	det	7	SENT_251	[p17l991t3132r1096b3193],
7	acquisition	NN	O	acquisition	prep_to	4	SENT_251	[p17l1123t3141r1490b3215],
8	of	IN	O	of	_	0	SENT_251	[p17l1515t3132r1586b3193],
9	data	NNS	O	datum	prep_of	7	SENT_251	[p17l1604t3132r1745b3193],
10	and	CC	O	and	_	0	SENT_251	[p17l1769t3132r1889b3193],
11	critical	JJ	O	critical	amod	12	SENT_251	[p17l1914t3132r2144b3193],
12	revision	NN	O	revision	prep_to	4	SENT_251	[p17l13t3225r260b3277],
13	of	IN	O	of	_	0	SENT_251	[p17l291t3216r360b3277],
14	the	DT	O	the	det	15	SENT_251	[p17l382t3216r482b3277],
15	manuscript	NN	O	manuscript	prep_of	12	SENT_251	[p17l516t3225r874b3299],
16	for	IN	O	for	_	0	SENT_251	[p17l904t3216r995b3277],
17	important	JJ	O	important	amod	19	SENT_251	[p17l1024t3225r1341b3299],
18	intellectual	JJ	O	intellectual	amod	19	SENT_251	[p17l1371t3216r1725b3277],
19	content	NN	O	content	prep_for	4	SENT_251	[p17l1756t3229r1998b3277],
20	and	CC	O	and	_	0	SENT_251	[p17l2028t3216r2145b3277],
21	saw	NN	O	saw	prep_for	4	SENT_251	[p17l13t3325r131b3361],
22	and	CC	O	and	_	0	SENT_251	[p17l152t3300r270b3361],
23	approved	VBD	O	approve	conj_and	4	SENT_251	[p17l293t3300r596b3384],
24	the	DT	O	the	det	26	SENT_251	[p17l618t3300r720b3361],
25	ﬁnal	JJ	O	ﬁnal	amod	26	SENT_251	[p17l745t3300r883b3361],
26	version	NN	O	version	dobj	23	SENT_251	[p17l903t3309r1153b3361],
27	.	.	O	.	_	0	SENT_251	[p17l903t3309r1153b3361],

1	Dr	NNP	O	Dr	nn	2	SENT_252	[p17l11t3390r105b3445],
2	Li	NNP	PERSON	Li	nsubj	29	SENT_252	[p17l127t3391r214b3445],
3	:	:	O	:	_	0	SENT_252	[p17l127t3391r214b3445],
4	contributed	VBD	O	contribute	_	0	SENT_252	[p17l245t3385r627b3446],
5	to	TO	O	to	_	0	SENT_252	[p17l653t3398r715b3446],
6	the	DT	O	the	det	7	SENT_252	[p17l742t3385r844b3445],
7	analysis	NN	O	analysis	prep_to	4	SENT_252	[p17l873t3385r1116b3468],
8	and	CC	O	and	_	0	SENT_252	[p17l1146t3385r1264b3445],
9	interpretation	NN	O	interpretation	conj_and	7	SENT_252	[p17l1290t3394r1742b3468],
10	of	IN	O	of	_	0	SENT_252	[p17l1770t3385r1840b3445],
11	the	DT	O	the	det	12	SENT_252	[p17l1858t3385r1960b3445],
12	data	NNS	O	datum	prep_of	7	SENT_252	[p17l1989t3385r2141b3457],
13	,	,	O	,	_	0	SENT_252	[p17l1989t3385r2141b3457],
14	statistical	JJ	O	statistical	amod	15	SENT_252	[p17l14t3469r296b3530],
15	analysis	NN	O	analysis	conj_and	12	SENT_252	[p17l323t3469r554b3553],
16	and	CC	O	and	_	0	SENT_252	[p17l584t3469r699b3530],
17	critical	JJ	O	critical	amod	18	SENT_252	[p17l725t3469r933b3530],
18	revision	NN	O	revision	conj_and	12	SENT_252	[p17l960t3478r1202b3530],
19	of	IN	O	of	_	0	SENT_252	[p17l1229t3469r1297b3530],
20	the	DT	O	the	det	21	SENT_252	[p17l1315t3469r1414b3530],
21	manuscript	NN	O	manuscript	prep_of	18	SENT_252	[p17l1443t3478r1795b3553],
22	for	IN	O	for	_	0	SENT_252	[p17l1820t3469r1910b3530],
23	important	JJ	O	important	amod	25	SENT_252	[p17l1935t3478r2142b3553, p17l12t3568r138b3615],
24	intellectual	JJ	O	intellectual	amod	25	SENT_252	[p17l160t3554r523b3615],
25	content	NN	O	content	prep_for	4	SENT_252	[p17l546t3568r792b3615],
26	and	CC	O	and	_	0	SENT_252	[p17l815t3554r933b3615],
27	saw	NN	O	saw	prep_for	4	SENT_252	[p17l956t3579r1074b3615],
28	and	CC	O	and	_	0	SENT_252	[p17l1095t3554r1213b3615],
29	approved	VBD	O	approve	conj_and	4	SENT_252	[p17l1236t3554r1539b3638],
30	the	DT	O	the	det	32	SENT_252	[p17l1561t3554r1662b3615],
31	ﬁnal	JJ	O	ﬁnal	amod	32	SENT_252	[p17l1688t3554r1826b3615],
32	version	NN	O	version	dobj	29	SENT_252	[p17l1846t3563r2096b3615],
33	.	.	O	.	_	0	SENT_252	[p17l1846t3563r2096b3615],

1	Dr	NNP	O	Dr	nn	2	SENT_253	[p17l11t3644r105b3699],
2	Yen	NNP	O	Yen	_	0	SENT_253	[p17l126t3645r258b3699],
3	:	:	O	:	_	0	SENT_253	[p17l126t3645r258b3699],
4	contributed	VBD	O	contribute	dep	2	SENT_253	[p17l287t3639r669b3700],
5	to	TO	O	to	_	0	SENT_253	[p17l692t3652r754b3699],
6	the	DT	O	the	det	7	SENT_253	[p17l779t3639r880b3699],
7	concept	NN	O	concept	prep_to	4	SENT_253	[p17l907t3652r1163b3722],
8	and	CC	O	and	_	0	SENT_253	[p17l1188t3639r1305b3699],
9	design	NN	O	design	prep_to	4	SENT_253	[p17l1329t3639r1538b3722],
10	of	IN	O	of	_	0	SENT_253	[p17l1563t3639r1632b3699],
11	the	DT	O	the	det	12	SENT_253	[p17l1648t3639r1750b3699],
12	study	NN	O	study	prep_of	7	SENT_253	[p17l1777t3638r1959b3722],
13	,	,	O	,	_	0	SENT_253	[p17l1777t3638r1959b3722],
14	analysis	NN	O	analysis	conj_and	12	SENT_253	[p17l1987t3639r2142b3699, p17l10t3732r122b3806],
15	and	CC	O	and	_	0	SENT_253	[p17l152t3723r269b3784],
16	interpretation	NN	O	interpretation	conj_and	12	SENT_253	[p17l295t3732r747b3806],
17	of	IN	O	of	_	0	SENT_253	[p17l775t3723r844b3784],
18	data	NNS	O	datum	prep_of	12	SENT_253	[p17l864t3723r1015b3795],
19	,	,	O	,	_	0	SENT_253	[p17l864t3723r1015b3795],
20	and	CC	O	and	_	0	SENT_253	[p17l1046t3723r1164b3784],
21	critical	JJ	O	critical	amod	22	SENT_253	[p17l1190t3723r1409b3784],
22	revision	NN	O	revision	conj_and	12	SENT_253	[p17l1436t3732r1689b3784],
23	of	IN	O	of	_	0	SENT_253	[p17l1717t3723r1786b3784],
24	the	DT	O	the	det	25	SENT_253	[p17l1804t3723r1906b3784],
25	manuscript	NN	O	manuscript	prep_of	22	SENT_253	[p17l1935t3747r2142b3784, p18l14t16r196b90],

1	for	IN	O	for	dep	4	SENT_254	[p18l226t7r320b68],
2	important	JJ	O	important	amod	4	SENT_254	[p18l348t16r678b90],
3	intellectual	JJ	O	intellectual	amod	4	SENT_254	[p18l707t7r1079b68],
4	content	NN	O	content	_	0	SENT_254	[p18l1108t20r1360b68],
5	and	CC	O	and	_	0	SENT_254	[p18l1390t7r1509b68],
6	saw	NN	O	saw	conj_and	4	SENT_254	[p18l1539t31r1659b68],
7	and	CC	O	and	_	0	SENT_254	[p18l1687t7r1806b68],
8	approved	VBD	O	approve	conj_and	4	SENT_254	[p18l1836t7r2145b90],
9	the	DT	O	the	det	11	SENT_254	[p18l12t91r114b152],
10	ﬁnal	JJ	O	ﬁnal	amod	11	SENT_254	[p18l139t91r277b152],
11	version	NN	O	version	dobj	8	SENT_254	[p18l297t100r547b152],
12	.	.	O	.	_	0	SENT_254	[p18l297t100r547b152],

1	journal.publications.chestnet.org	NN	O	journal.publications.chestnet.org	_	0	SENT_255	[p18l8t321r961b382],

1	Dr	NNP	O	Dr	nn	2	SENT_256	[p18l8t556r103b610],
2	Ordoﬁez	NNP	O	Ordoﬁez	nsubj	33	SENT_256	[p18l127t550r423b611],
3	:	:	O	:	_	0	SENT_256	[p18l127t550r423b611],
4	contributed	VBD	O	contribute	_	0	SENT_256	[p18l453t550r836b611],
5	to	TO	O	to	_	0	SENT_256	[p18l861t563r922b611],
6	the	DT	O	the	det	7	SENT_256	[p18l948t550r1051b611],
7	concept	NN	O	concept	prep_to	4	SENT_256	[p18l1079t563r1335b633],
8	and	CC	O	and	_	0	SENT_256	[p18l1362t550r1480b611],
9	design	NN	O	design	conj_and	7	SENT_256	[p18l1506t550r1714b633],
10	of	IN	O	of	_	0	SENT_256	[p18l1741t550r1810b611],
11	the	DT	O	the	det	12	SENT_256	[p18l1828t550r1930b611],
12	study	NN	O	study	prep_of	7	SENT_256	[p18l1958t550r2141b633],
13	,	,	O	,	_	0	SENT_256	[p18l1958t550r2141b633],
14	analysis	NN	O	analysis	conj_and	12	SENT_256	[p18l11t634r242b717],
15	and	CC	O	and	_	0	SENT_256	[p18l271t634r386b695],
16	interpretation	NN	O	interpretation	conj_and	12	SENT_256	[p18l410t643r843b717],
17	of	IN	O	of	_	0	SENT_256	[p18l868t634r936b695],
18	data	NNS	O	datum	prep_of	12	SENT_256	[p18l955t634r1099b706],
19	,	,	O	,	_	0	SENT_256	[p18l955t634r1099b706],
20	and	CC	O	and	_	0	SENT_256	[p18l1129t634r1244b695],
21	critical	JJ	O	critical	amod	22	SENT_256	[p18l1269t634r1478b695],
22	revision	NN	O	revision	conj_and	12	SENT_256	[p18l1503t643r1745b695],
23	of	IN	O	of	_	0	SENT_256	[p18l1771t634r1839b695],
24	the	DT	O	the	det	25	SENT_256	[p18l1856t634r1955b695],
25	manuscript	NN	O	manuscript	prep_of	22	SENT_256	[p18l1983t658r2142b695, p18l9t728r238b802],
26	for	IN	O	for	_	0	SENT_256	[p18l262t719r356b780],
27	important	JJ	O	important	amod	29	SENT_256	[p18l378t728r709b802],
28	intellectual	JJ	O	intellectual	amod	29	SENT_256	[p18l732t719r1105b780],
29	content	NN	O	content	prep_for	4	SENT_256	[p18l1129t732r1380b780],
30	and	CC	O	and	_	0	SENT_256	[p18l1405t719r1525b780],
31	saw	NN	O	saw	prep_for	4	SENT_256	[p18l1549t743r1669b780],
32	and	CC	O	and	_	0	SENT_256	[p18l1692t719r1811b780],
33	approved	VBD	O	approve	conj_and	4	SENT_256	[p18l1836t719r2145b802],
34	the	DT	O	the	det	36	SENT_256	[p18l9t803r111b864],
35	final	JJ	O	final	amod	36	SENT_256	[p18l136t803r275b864],
36	version	NN	O	version	dobj	33	SENT_256	[p18l295t812r546b864],
37	.	.	O	.	_	0	SENT_256	[p18l295t812r546b864],

1	Dr	NNP	O	Dr	nn	2	SENT_257	[p18l8t896r103b951],
2	Geller	NNP	PERSON	Geller	nsubj	23	SENT_257	[p18l125t891r338b951],
3	:	:	O	:	_	0	SENT_257	[p18l125t891r338b951],
4	contributed	VBD	O	contribute	_	0	SENT_257	[p18l368t891r750b952],
5	to	TO	O	to	_	0	SENT_257	[p18l773t904r835b951],
6	the	DT	O	the	det	7	SENT_257	[p18l859t891r961b951],
7	acquisition	NN	O	acquisition	prep_to	4	SENT_257	[p18l988t900r1340b974],
8	of	IN	O	of	_	0	SENT_257	[p18l1365t891r1434b951],
9	data	NNS	O	datum	prep_of	7	SENT_257	[p18l1451t891r1588b951],
10	and	CC	O	and	_	0	SENT_257	[p18l1611t891r1729b951],
11	critical	JJ	O	critical	amod	12	SENT_257	[p18l1753t891r1972b951],
12	revision	NN	O	revision	prep_to	4	SENT_257	[p18l1997t900r2142b951, p18l11t983r139b1034],
13	of	IN	O	of	_	0	SENT_257	[p18l164t974r233b1034],
14	the	DT	O	the	det	15	SENT_257	[p18l249t974r351b1034],
15	manuscript	NN	O	manuscript	prep_of	12	SENT_257	[p18l377t983r743b1056],
16	for	IN	O	for	_	0	SENT_257	[p18l766t974r859b1034],
17	important	JJ	O	important	amod	19	SENT_257	[p18l881t983r1206b1057],
18	intellectual	JJ	O	intellectual	amod	19	SENT_257	[p18l1228t974r1592b1034],
19	content	NN	O	content	prep_for	4	SENT_257	[p18l1615t987r1862b1034],
20	and	CC	O	and	_	0	SENT_257	[p18l1886t974r2005b1034],
21	saw	NN	O	saw	prep_for	4	SENT_257	[p18l2029t998r2147b1034],
22	and	CC	O	and	_	0	SENT_257	[p18l11t1058r129b1118],
23	approved	VBD	O	approve	conj_and	4	SENT_257	[p18l152t1058r455b1141],
24	the	DT	O	the	det	26	SENT_257	[p18l477t1058r579b1118],
25	ﬁnal	JJ	O	ﬁnal	amod	26	SENT_257	[p18l604t1058r742b1118],
26	version	NN	O	version	dobj	23	SENT_257	[p18l762t1067r1013b1118],
27	.	.	O	.	_	0	SENT_257	[p18l762t1067r1013b1118],

1	Financial/non	NN	O	financial/non	nn	3	SENT_258	[p18l10t1141r818b1202],
2	ﬁnancial	JJ	O	ﬁnancial	amod	3	SENT_258	[p18l10t1141r818b1202],
3	disclosures	NNS	O	disclosure	_	0	SENT_258	[p18l840t1141r1255b1201],
4	:	:	O	:	_	0	SENT_258	[p18l840t1141r1255b1201],
5	The	DT	O	the	det	6	SENT_258	[p18l1280t1141r1407b1201],
6	authors	NNS	O	author	nsubj	8	SENT_258	[p18l1431t1141r1669b1201],
7	have	VBP	O	have	aux	8	SENT_258	[p18l1691t1141r1839b1201],
8	reported	VBN	O	report	dep	3	SENT_258	[p18l1862t1141r2145b1223],
9	to	TO	O	to	aux	10	SENT_258	[p18l9t1237r69b1284],
10	CHEST	VB	O	chest	xcomp	8	SENT_258	[p18l92t1229r342b1284],
11	the	DT	O	the	det	13	SENT_258	[p18l359t1224r458b1284],
12	following	VBG	O	follow	amod	13	SENT_258	[p18l480t1224r768b1307],
13	conflicts	NNS	O	conflict	dobj	10	SENT_258	[p18l787t1224r1042b1284],
14	of	IN	O	of	_	0	SENT_258	[p18l1064t1224r1132b1284],
15	interest	NN	O	interest	prep_of	13	SENT_258	[p18l1144t1233r1393b1284],
16	:	:	O	:	_	0	SENT_258	[p18l1144t1233r1393b1284],
17	Dr	NNP	O	Dr	nn	18	SENT_258	[p18l1421t1229r1510b1284],
18	Flume	NNP	O	Flume	nsubj	28	SENT_258	[p18l1530t1224r1736b1284],
19	has	VBZ	O	have	aux	20	SENT_258	[p18l1757t1224r1857b1284],
20	received	VBN	O	receive	parataxis	8	SENT_258	[p18l1880t1224r2145b1284],
21	grants	NNS	O	grant	dobj	20	SENT_258	[p18l10t1321r205b1391],
22	from	IN	O	from	_	0	SENT_258	[p18l232t1308r386b1369],
23	the	DT	O	the	det	26	SENT_258	[p18l411t1308r513b1369],
24	Cystic	JJ	ORGANIZATION	cystic	amod	26	SENT_258	[p18l539t1313r737b1391],
25	Fibrosis	NNP	ORGANIZATION	Fibrosis	nn	26	SENT_258	[p18l763t1308r1020b1369],
26	Foundation	NNP	ORGANIZATION	Foundation	prep_from	20	SENT_258	[p18l1047t1308r1426b1369],
27	and	CC	O	and	_	0	SENT_258	[p18l1451t1308r1569b1369],
28	received	VBD	O	receive	conj_and	20	SENT_258	[p18l1593t1308r1869b1369],
29	funding	NN	O	funding	dobj	28	SENT_258	[p18l1892t1308r2145b1391],
30	to	TO	O	to	aux	31	SENT_258	[p18l9t1405r72b1453],
31	participate	VB	O	participate	xcomp	28	SENT_258	[p18l96t1401r455b1475],
32	in	IN	O	in	_	0	SENT_258	[p18l480t1401r543b1452],
33	this	DT	O	this	det	35	SENT_258	[p18l566t1392r683b1453],
34	clinical	JJ	O	clinical	amod	35	SENT_258	[p18l710t1392r947b1453],
35	trial	NN	O	trial	prep_in	31	SENT_258	[p18l970t1392r1120b1453],
36	.	.	O	.	_	0	SENT_258	[p18l970t1392r1120b1453],

1	Dr	NNP	O	Dr	nn	2	SENT_259	[p18l1151t1398r1243b1452],
2	Liou	NNP	PERSON	Liou	nsubj	4	SENT_259	[p18l1268t1398r1421b1453],
3	has	VBZ	O	have	aux	4	SENT_259	[p18l1444t1392r1550b1453],
4	received	VBN	O	receive	_	0	SENT_259	[p18l1577t1392r1861b1453],
5	funding	NN	O	funding	dobj	4	SENT_259	[p18l1885t1392r2145b1475],
6	from	IN	O	from	_	0	SENT_259	[p18l10t1476r165b1537],
7	the	DT	O	the	det	17	SENT_259	[p18l190t1477r293b1537],
8	National	NNP	ORGANIZATION	National	dep	17	SENT_259	[p18l321t1476r598b1537],
9	Institutes	NNPS	ORGANIZATION	Institutes	dep	8	SENT_259	[p18l624t1482r927b1537],
10	of	IN	ORGANIZATION	of	_	0	SENT_259	[p18l954t1476r1024b1537],
11	Health/National	NNP	ORGANIZATION	Health/National	nn	12	SENT_259	[p18l1043t1476r1569b1537],
12	Heart	NNP	ORGANIZATION	Heart	prep_of	8	SENT_259	[p18l1595t1482r1800b1548],
13	,	,	O	,	_	0	SENT_259	[p18l1595t1482r1800b1548],
14	Lung	NN	O	lung	conj_and	12	SENT_259	[p18l1830t1482r2002b1560],
15	and	CC	O	and	_	0	SENT_259	[p18l2027t1477r2145b1537],
16	Blood	NN	ORGANIZATION	blood	conj_and	12	SENT_259	[p18l12t1561r204b1621],
17	Institute	NNP	ORGANIZATION	Institute	prep_from	4	SENT_259	[p18l233t1567r526b1632],
18	,	,	O	,	_	0	SENT_259	[p18l233t1567r526b1632],
19	the	DT	O	the	det	22	SENT_259	[p18l557t1561r659b1621],
20	Cystic	JJ	ORGANIZATION	cystic	amod	22	SENT_259	[p18l690t1566r888b1643],
21	Fibrosis	NNP	ORGANIZATION	Fibrosis	nn	22	SENT_259	[p18l918t1561r1176b1622],
22	Foundation	NNP	ORGANIZATION	Foundation	prep_from	4	SENT_259	[p18l1208t1561r1603b1632],
23	,	,	O	,	_	0	SENT_259	[p18l1208t1561r1603b1632],
24	and	CC	O	and	_	0	SENT_259	[p18l1637t1561r1754b1621],
25	the	DT	O	the	det	27	SENT_259	[p18l1782t1561r1884b1621],
26	Ben	NNP	PERSON	Ben	nn	27	SENT_259	[p18l1916t1566r2045b1621],
27	B.	NNP	PERSON	B.	prep_from	4	SENT_259	[p18l2076t1566r2139b1621],
28	and	CC	O	and	_	0	SENT_259	[p18l11t1644r127b1704],
29	Ira	NNP	ORGANIZATION	Ira	nn	33	SENT_259	[p18l155t1650r247b1704],
30	M.	NNP	ORGANIZATION	M.	nn	33	SENT_259	[p18l276t1649r357b1704],
31	Margolis	NNP	ORGANIZATION	Margolis	nn	33	SENT_259	[p18l393t1644r666b1726],
32	Family	NNP	ORGANIZATION	Family	nn	33	SENT_259	[p18l697t1644r920b1726],
33	Foundation	NNP	ORGANIZATION	Foundation	prep_from	4	SENT_259	[p18l946t1644r1318b1704],
34	of	IN	O	of	_	0	SENT_259	[p18l1346t1644r1415b1704],
35	Utah	NNP	LOCATION	Utah	prep_of	33	SENT_259	[p18l1436t1644r1592b1704],
36	for	IN	O	for	_	0	SENT_259	[p18l1620t1644r1712b1704],
37	work	NN	O	work	prep_for	35	SENT_259	[p18l1734t1644r1896b1704],
38	related	JJ	O	related	amod	33	SENT_259	[p18l1922t1644r2145b1704],
39	to	TO	O	to	_	0	SENT_259	[p18l9t1740r70b1787],
40	CF.	NNP	O	CF.	prep_to	38	SENT_259	[p18l97t1732r206b1787],
41	He	PRP	O	he	nsubj	44	SENT_259	[p18l238t1733r334b1787],
42	is	VBZ	O	be	cop	44	SENT_259	[p18l360t1736r405b1787],
43	a	DT	O	a	det	44	SENT_259	[p18l434t1751r467b1787],
44	member	NN	O	member	rcmod	40	SENT_259	[p18l492t1727r764b1788],
45	of	IN	O	of	_	0	SENT_259	[p18l789t1727r858b1787],
46	the	DT	O	the	det	49	SENT_259	[p18l875t1727r976b1787],
47	CHEST	NN	ORGANIZATION	chest	nn	49	SENT_259	[p18l1004t1732r1258b1787],
48	Editorial	NNP	ORGANIZATION	Editorial	nn	49	SENT_259	[p18l1282t1727r1562b1787],
49	Board	NNP	ORGANIZATION	Board	prep_of	44	SENT_259	[p18l1589t1727r1782b1787],
50	and	CC	ORGANIZATION	and	_	0	SENT_259	[p18l1808t1727r1924b1787],
51	Cystic	JJ	ORGANIZATION	cystic	amod	58	SENT_259	[p18l1950t1732r2143b1809],
52	Fibrosis	NNP	ORGANIZATION	Fibrosis	nn	58	SENT_259	[p18l11t1810r268b1871],
53	Foundation	NNP	ORGANIZATION	Foundation	nn	58	SENT_259	[p18l294t1810r673b1870],
54	Patient	NNP	ORGANIZATION	Patient	nn	58	SENT_259	[p18l695t1815r927b1870],
55	Registry	NNP	ORGANIZATION	Registry	nn	58	SENT_259	[p18l949t1816r1219b1893],
56	Data	NNP	ORGANIZATION	Data	nn	58	SENT_259	[p18l1240t1815r1396b1870],
57	Use	NNP	ORGANIZATION	Use	nn	58	SENT_259	[p18l1418t1815r1540b1870],
58	Committee	NNP	ORGANIZATION	Committee	conj_and	49	SENT_259	[p18l1564t1815r1949b1870],
59	.	.	O	.	_	0	SENT_259	[p18l1564t1815r1949b1870],

1	He	PRP	O	he	nsubj	6	SENT_260	[p18l1977t1816r2074b1870],
2	is	VBZ	O	be	cop	6	SENT_260	[p18l2096t1819r2142b1870],
3	a	DT	O	a	det	6	SENT_260	[p18l11t1918r44b1955],
4	steering	VBG	O	steer	amod	6	SENT_260	[p18l68t1903r322b1977],
5	committee	NN	O	committee	nn	6	SENT_260	[p18l345t1903r687b1955],
6	consultant	NN	O	consultant	dep	24	SENT_260	[p18l713t1894r1042b1955],
7	on	IN	O	on	_	0	SENT_260	[p18l1066t1918r1144b1955],
8	the	DT	O	the	det	9	SENT_260	[p18l1169t1894r1269b1955],
9	Registry	NN	MISC	registry	prep_on	6	SENT_260	[p18l1298t1900r1561b1977],
10	to	TO	MISC	to	aux	11	SENT_260	[p18l1582t1907r1643b1955],
11	Evaluate	VB	MISC	evaluate	infmod	9	SENT_260	[p18l1670t1894r1947b1955],
12	Early	JJ	MISC	early	amod	16	SENT_260	[p18l1975t1894r2147b1976],
13	and	CC	O	and	_	0	SENT_260	[p18l11t1978r129b2039],
14	Long	JJ	O	long	conj_and	12	SENT_260	[p18l160t1984r511b2061],
15	—	NN	O	—	nn	16	SENT_260	[p18l160t1984r511b2061],
16	term	NN	O	term	dobj	11	SENT_260	[p18l160t1984r511b2061],
17	Pulmonary	JJ	O	pulmonary	amod	23	SENT_260	[p18l544t1978r901b2061],
18	Arterial	JJ	O	arterial	amod	23	SENT_260	[p18l927t1978r1177b2039],
19	Hypertension	NN	O	hypertension	nn	23	SENT_260	[p18l1209t1984r1654b2061],
20	Disease	NNP	O	Disease	nn	23	SENT_260	[p18l1686t1984r1936b2039],
21	Management	NNP	O	Management	nn	23	SENT_260	[p18l1972t1984r2142b2039, p18l11t2076r291b2145],
22	(	NNP	O	(	nn	23	SENT_260	[p18l322t2062r684b2134],
23	REVEAL	NNP	O	REVEAL	nsubj	24	SENT_260	[p18l322t2062r684b2134],
24	)	VBD	O	)	_	0	SENT_260	[p18l322t2062r684b2134],
25	project	NN	O	project	dobj	24	SENT_260	[p18l715t2071r945b2145],
26	on	IN	O	on	_	0	SENT_260	[p18l973t2086r1052b2123],
27	pulmonary	JJ	O	pulmonary	amod	29	SENT_260	[p18l1079t2062r1434b2145],
28	arterial	JJ	O	arterial	amod	29	SENT_260	[p18l1461t2062r1691b2123],
29	hypertension	NN	O	hypertension	prep_on	24	SENT_260	[p18l1718t2062r2143b2145],
30	sponsored	VBN	O	sponsor	partmod	29	SENT_260	[p18l11t2147r355b2230],
31	by	IN	O	by	_	0	SENT_260	[p18l377t2147r457b2229],
32	Actelion	NNP	ORGANIZATION	Actelion	nn	34	SENT_260	[p18l477t2147r761b2207],
33	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	34	SENT_260	[p18l785t2147r1340b2207],
34	Ltd	NNP	ORGANIZATION	Ltd	agent	30	SENT_260	[p18l1368t2147r1486b2207],
35	and	CC	O	and	_	0	SENT_260	[p18l1510t2147r1631b2207],
36	was	VBD	O	be	cop	38	SENT_260	[p18l1650t2170r1771b2207],
37	formerly	RB	O	formerly	advmod	38	SENT_260	[p18l1797t2147r2091b2229],
38	a	DT	O	a	conj_and	24	SENT_260	[p18l2113t2170r2146b2207],
39	steering	VBG	O	steer	partmod	38	SENT_260	[p18l11t2240r259b2314],
40	committee	NN	O	committee	nn	41	SENT_260	[p18l285t2240r620b2292],
41	member	NN	O	member	dobj	39	SENT_260	[p18l649t2231r918b2292],
42	on	IN	O	on	_	0	SENT_260	[p18l943t2255r1020b2292],
43	the	DT	O	the	det	45	SENT_260	[p18l1047t2231r1146b2292],
44	Epidemiologic	NNP	O	Epidemiologic	nn	45	SENT_260	[p18l1176t2231r1632b2314],
45	Study	NNP	O	Study	prep_on	41	SENT_260	[p18l1663t2231r1842b2314],
46	of	IN	O	of	_	0	SENT_260	[p18l1866t2231r1934b2292],
47	Cystic	JJ	O	cystic	amod	49	SENT_260	[p18l1954t2236r2143b2314],
48	Fibrosis	NN	O	fibrosis	nn	49	SENT_260	[p18l11t2315r257b2376],
49	project	NN	O	project	prep_of	45	SENT_260	[p18l279t2324r501b2398],
50	on	IN	O	on	_	0	SENT_260	[p18l522t2339r599b2376],
51	CF	NN	O	cf	prep_on	39	SENT_260	[p18l622t2321r723b2376],
52	sponsored	VBN	O	sponsor	partmod	51	SENT_260	[p18l747t2315r1066b2398],
53	by	IN	O	by	_	0	SENT_260	[p18l1085t2315r1163b2398],
54	Genentech	NNP	ORGANIZATION	Genentech	nn	56	SENT_260	[p18l1184t2315r1545b2387],
55	,	,	ORGANIZATION	,	_	0	SENT_260	[p18l1184t2315r1545b2387],
56	Inc.	NNP	ORGANIZATION	Inc.	agent	52	SENT_260	[p18l1571t2321r1686b2376],
57	.	.	O	.	_	0	SENT_260	[p18l1571t2321r1686b2376],

1	As	IN	O	as	_	0	SENT_261	[p18l1711t2320r1787b2376],
2	the	DT	O	the	det	4	SENT_261	[p18l1810t2315r1909b2376],
3	principal	JJ	O	principal	amod	4	SENT_261	[p18l1930t2324r2142b2398, p18l8t2400r103b2483],
4	investigator	NN	O	investigator	prep_as	20	SENT_261	[p18l128t2409r490b2483],
5	for	IN	O	for	_	0	SENT_261	[p18l515t2400r605b2461],
6	the	DT	O	the	det	10	SENT_261	[p18l629t2400r728b2461],
7	Therapeutic	JJ	ORGANIZATION	therapeutic	amod	10	SENT_261	[p18l755t2400r1138b2483],
8	Development	NN	ORGANIZATION	development	nn	10	SENT_261	[p18l1167t2400r1598b2483],
9	Network	NNP	ORGANIZATION	Network	nn	10	SENT_261	[p18l1626t2400r1900b2461],
10	Center	NNP	ORGANIZATION	Center	prep_for	4	SENT_261	[p18l1926t2405r2146b2461],
11	at	IN	O	at	_	0	SENT_261	[p18l11t2497r68b2545],
12	the	DT	O	the	det	13	SENT_261	[p18l97t2484r199b2545],
13	University	NNP	ORGANIZATION	University	prep_at	10	SENT_261	[p18l233t2490r568b2567],
14	of	IN	ORGANIZATION	of	_	0	SENT_261	[p18l596t2484r666b2545],
15	Utah	NNP	ORGANIZATION	Utah	prep_of	13	SENT_261	[p18l690t2484r865b2556],
16	,	,	O	,	_	0	SENT_261	[p18l690t2484r865b2556],
17	Dr	NNP	O	Dr	nn	18	SENT_261	[p18l901t2490r991b2544],
18	Liou	NNP	PERSON	Liou	nsubj	20	SENT_261	[p18l1022t2490r1172b2545],
19	has	VBZ	O	have	aux	20	SENT_261	[p18l1201t2484r1304b2545],
20	received	VBN	O	receive	_	0	SENT_261	[p18l1337t2484r1613b2545],
21	funding	VBG	O	fund	xcomp	20	SENT_261	[p18l1643t2484r1896b2567],
22	to	TO	O	to	aux	23	SENT_261	[p18l1925t2497r1986b2545],
23	participate	VB	O	participate	xcomp	21	SENT_261	[p18l2016t2508r2142b2567, p18l9t2577r249b2652],
24	in	IN	O	in	_	0	SENT_261	[p18l278t2577r339b2628],
25	trials	NNS	O	trial	prep_in	23	SENT_261	[p18l368t2568r524b2629],
26	of	IN	O	of	_	0	SENT_261	[p18l556t2568r626b2629],
27	novel	JJ	O	novel	amod	28	SENT_261	[p18l647t2568r821b2629],
28	treatments	NNS	O	treatment	prep_of	25	SENT_261	[p18l849t2582r1198b2629],
29	for	IN	O	for	_	0	SENT_261	[p18l1230t2568r1323b2629],
30	CF	NN	O	cf	prep_for	23	SENT_261	[p18l1351t2574r1454b2629],
31	from	IN	O	from	_	0	SENT_261	[p18l1484t2568r1639b2629],
32	Altus	NNP	ORGANIZATION	Altus	nn	34	SENT_261	[p18l1668t2568r1834b2629],
33	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	34	SENT_261	[p18l1866t2568r2142b2629, p18l10t2653r300b2713],
34	Inc	NNP	ORGANIZATION	Inc	prep_from	30	SENT_261	[p18l347t2659r473b2724],
35	;	:	O	;	_	0	SENT_261	[p18l347t2659r473b2724],
36	AXCAN	NNP	ORGANIZATION	AXCAN	nn	38	SENT_261	[p18l517t2658r791b2713],
37	Scandipharm	NNP	ORGANIZATION	Scandipharm	nn	38	SENT_261	[p18l839t2653r1283b2735],
38	Inc	NNP	ORGANIZATION	Inc	conj_and	30	SENT_261	[p18l1328t2659r1455b2724],
39	;	:	O	;	_	0	SENT_261	[p18l1328t2659r1455b2724],
40	Bayer	NNP	ORGANIZATION	Bayer	conj_and	30	SENT_261	[p18l1502t2658r1713b2735],
41	;	:	O	;	_	0	SENT_261	[p18l1502t2658r1713b2735],
42	Boehringer	NNP	ORGANIZATION	Boehringer	nn	44	SENT_261	[p18l1762t2653r2146b2736],
43	Ingelheim	NNP	ORGANIZATION	Ingelheim	nn	44	SENT_261	[p18l11t2737r356b2819],
44	GmbH	NN	ORGANIZATION	gmbh	conj_and	30	SENT_261	[p18l392t2737r643b2808],
45	;	:	O	;	_	0	SENT_261	[p18l392t2737r643b2808],
46	Genentech	NNP	ORGANIZATION	Genentech	nn	48	SENT_261	[p18l681t2737r1070b2808],
47	,	,	O	,	_	0	SENT_261	[p18l681t2737r1070b2808],
48	Inc	NNP	ORGANIZATION	Inc	conj_and	30	SENT_261	[p18l1107t2743r1233b2808],
49	;	:	O	;	_	0	SENT_261	[p18l1107t2743r1233b2808],
50	Gilead	NNP	ORGANIZATION	Gilead	conj_and	30	SENT_261	[p18l1271t2737r1510b2808],
51	;	:	O	;	_	0	SENT_261	[p18l1271t2737r1510b2808],
52	Inspire	NNP	O	Inspire	conj_and	30	SENT_261	[p18l1547t2743r1805b2820],
53	;	:	O	;	_	0	SENT_261	[p18l1547t2743r1805b2820],
54	KaloBios	NNP	ORGANIZATION	KaloBios	nn	55	SENT_261	[p18l1843t2737r2142b2797],
55	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_for	23	SENT_261	[p18l11t2820r585b2891],
56	,	,	O	,	_	0	SENT_261	[p18l11t2820r585b2891],
57	Inc	NNP	ORGANIZATION	Inc	appos	55	SENT_261	[p18l615t2826r741b2891],
58	;	:	O	;	_	0	SENT_261	[p18l615t2826r741b2891],
59	MPEX	NNP	ORGANIZATION	MPEX	nn	60	SENT_261	[p18l773t2825r1001b2880],
60	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_for	23	SENT_261	[p18l1025t2820r1599b2891],
61	,	,	O	,	_	0	SENT_261	[p18l1025t2820r1599b2891],
62	Inc	NNP	ORGANIZATION	Inc	appos	60	SENT_261	[p18l1629t2826r1755b2892],
63	;	:	O	;	_	0	SENT_261	[p18l1629t2826r1755b2892],
64	and	CC	O	and	_	0	SENT_261	[p18l1784t2820r1905b2881],
65	Vertex	NNP	ORGANIZATION	Vertex	nn	67	SENT_261	[p18l1927t2826r2145b2881],
66	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	67	SENT_261	[p18l11t2904r543b2964],
67	Incorporated	NNP	ORGANIZATION	Incorporated	prep_for	23	SENT_261	[p18l588t2904r1031b2987],
68	.	.	O	.	_	0	SENT_261	[p18l588t2904r1031b2987],

1	Dr	NNP	O	Dr	nn	2	SENT_262	[p18l1080t2909r1171b2964],
2	Liou	NNP	PERSON	Liou	nsubj	14	SENT_262	[p18l1213t2910r1363b2964],
3	has	VBZ	O	have	aux	4	SENT_262	[p18l1404t2904r1508b2964],
4	consulted	VBN	O	consult	_	0	SENT_262	[p18l1552t2904r1866b2964],
5	for	IN	O	for	_	0	SENT_262	[p18l1908t2904r2000b2964],
6	the	DT	O	the	det	9	SENT_262	[p18l2040t2904r2142b2964],
7	Gehrson	NNP	ORGANIZATION	Gehrson	nn	9	SENT_262	[p18l12t2987r290b3047],
8	Lehman	NNP	ORGANIZATION	Lehman	nn	9	SENT_262	[p18l316t2987r586b3047],
9	Group	NNP	ORGANIZATION	Group	prep_for	4	SENT_262	[p18l613t2992r839b3070],
10	,	,	ORGANIZATION	,	_	0	SENT_262	[p18l613t2992r839b3070],
11	Inc	NNP	ORGANIZATION	Inc	appos	9	SENT_262	[p18l868t2993r972b3047],
12	and	CC	O	and	_	0	SENT_262	[p18l998t2987r1116b3047],
13	has	VBZ	O	have	aux	14	SENT_262	[p18l1138t2987r1241b3047],
14	provided	VBN	O	provide	conj_and	4	SENT_262	[p18l1266t2987r1557b3070],
15	expert	JJ	O	expert	amod	17	SENT_262	[p18l1581t3000r1784b3069],
16	legal	JJ	O	legal	amod	17	SENT_262	[p18l1807t2987r1958b3070],
17	testimony	NN	O	testimony	dobj	14	SENT_262	[p18l1981t2996r2142b3047, p18l11t3095r199b3153],
18	.	.	O	.	_	0	SENT_262	[p18l1981t2996r2142b3047, p18l11t3095r199b3153],

1	Dr	NNP	O	Dr	nn	2	SENT_263	[p18l232t3077r323b3131],
2	Borowitz	NNP	PERSON	Borowitz	nsubj	14	SENT_263	[p18l349t3077r641b3131],
3	was	VBD	O	be	cop	5	SENT_263	[p18l664t3095r781b3131],
4	a	DT	O	a	det	5	SENT_263	[p18l810t3095r843b3131],
5	member	NN	O	member	_	0	SENT_263	[p18l869t3071r1145b3132],
6	of	IN	O	of	_	0	SENT_263	[p18l1170t3071r1240b3131],
7	the	DT	O	the	det	11	SENT_263	[p18l1257t3071r1359b3131],
8	Vertex	NNP	ORGANIZATION	Vertex	nn	11	SENT_263	[p18l1385t3077r1595b3131],
9	Global	NNP	ORGANIZATION	Global	nn	11	SENT_263	[p18l1622t3071r1836b3132],
10	Advisory	NNP	ORGANIZATION	Advisory	nn	11	SENT_263	[p18l1861t3071r2147b3153],
11	Committee	NNP	ORGANIZATION	Committee	prep_of	5	SENT_263	[p18l11t3160r391b3216],
12	and	CC	O	and	_	0	SENT_263	[p18l428t3155r548b3216],
13	has	VBZ	O	have	aux	14	SENT_263	[p18l580t3155r687b3216],
14	received	VBN	O	receive	conj_and	5	SENT_263	[p18l723t3155r1010b3216],
15	funding	VBG	O	fund	xcomp	14	SENT_263	[p18l1044t3155r1306b3238],
16	to	TO	O	to	aux	17	SENT_263	[p18l1339t3168r1402b3216],
17	participate	VB	O	participate	xcomp	15	SENT_263	[p18l1435t3164r1799b3238],
18	in	IN	O	in	_	0	SENT_263	[p18l1833t3164r1895b3215],
19	Vertex	NNP	ORGANIZATION	Vertex	nn	23	SENT_263	[p18l1927t3161r2145b3216],
20	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	23	SENT_263	[p18l11t3239r565b3300],
21	Incorporated	NNP	O	Incorporated	nn	23	SENT_263	[p18l600t3239r1046b3323],
22	clinical	JJ	O	clinical	amod	23	SENT_263	[p18l1078t3239r1317b3300],
23	trials	NNS	O	trial	prep_in	17	SENT_263	[p18l1348t3239r1531b3300],
24	.	.	O	.	_	0	SENT_263	[p18l1348t3239r1531b3300],

1	Drs	NNS	PERSON	dr	nsubj	9	SENT_264	[p18l1569t3245r1689b3300],
2	Li	NNP	PERSON	Li	nsubj	9	SENT_264	[p18l1725t3245r1812b3311],
3	,	,	O	,	_	0	SENT_264	[p18l1725t3245r1812b3311],
4	Yen	NNP	O	Yen	nsubj	9	SENT_264	[p18l1845t3245r1988b3311],
5	,	,	O	,	_	0	SENT_264	[p18l1845t3245r1988b3311],
6	and	CC	O	and	_	0	SENT_264	[p18l2024t3239r2145b3300],
7	Ordoﬁez	NNP	PERSON	Ordoﬁez	conj_and	2	SENT_264	[p18l11t3324r304b3384],
8	are	VBP	O	be	cop	9	SENT_264	[p18l343t3348r444b3384],
9	employees	NNS	O	employee	_	0	SENT_264	[p18l484t3324r839b3407],
10	and	CC	O	and	_	0	SENT_264	[p18l880t3324r1001b3384],
11	stockholders	NNS	O	stockholder	conj_and	9	SENT_264	[p18l1039t3324r1462b3384],
12	of	IN	O	of	_	0	SENT_264	[p18l1502t3324r1573b3384],
13	Vertex	NNP	ORGANIZATION	Vertex	nn	15	SENT_264	[p18l1601t3330r1819b3384],
14	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	15	SENT_264	[p18l1857t3324r2142b3384, p18l10t3407r288b3467],
15	Incorporated	NNP	ORGANIZATION	Incorporated	prep_of	9	SENT_264	[p18l312t3407r755b3490],
16	.	.	O	.	_	0	SENT_264	[p18l312t3407r755b3490],

1	Dr	NNP	O	Dr	nn	2	SENT_265	[p18l783t3413r874b3467],
2	Geller	NNP	PERSON	Geller	nsubj	4	SENT_265	[p18l896t3407r1100b3467],
3	has	VBZ	O	have	aux	4	SENT_265	[p18l1119t3407r1222b3467],
4	consulted	VBN	O	consult	_	0	SENT_265	[p18l1245t3407r1560b3467],
5	for	IN	O	for	_	0	SENT_265	[p18l1581t3407r1673b3467],
6	CSL	NNP	ORGANIZATION	CSL	nn	7	SENT_265	[p18l1694t3412r1841b3467],
7	Behring	NNP	ORGANIZATION	Behring	prep_for	4	SENT_265	[p18l1864t3407r2141b3490],
8	,	,	O	,	_	0	SENT_265	[p18l1864t3407r2141b3490],
9	Aradigm	NNP	ORGANIZATION	Aradigm	nn	10	SENT_265	[p18l8t3490r289b3573],
10	Corporation	NNP	ORGANIZATION	Corporation	prep_for	4	SENT_265	[p18l315t3495r729b3573],
11	,	,	O	,	_	0	SENT_265	[p18l315t3495r729b3573],
12	Novartis	NNP	ORGANIZATION	Novartis	nn	13	SENT_265	[p18l759t3495r1029b3550],
13	AG	NNP	ORGANIZATION	AG	prep_for	4	SENT_265	[p18l1055t3495r1182b3561],
14	,	,	O	,	_	0	SENT_265	[p18l1055t3495r1182b3561],
15	Gilead	NNP	ORGANIZATION	Gilead	prep_for	4	SENT_265	[p18l1212t3490r1441b3561],
16	,	,	O	,	_	0	SENT_265	[p18l1212t3490r1441b3561],
17	and	CC	O	and	_	0	SENT_265	[p18l1470t3490r1589b3550],
18	Genentech	NNP	ORGANIZATION	Genentech	nn	20	SENT_265	[p18l1614t3490r1990b3562],
19	,	,	ORGANIZATION	,	_	0	SENT_265	[p18l1614t3490r1990b3562],
20	Inc.	NNP	ORGANIZATION	Inc.	conj_and	7	SENT_265	[p18l2019t3496r2139b3550],
21	.	.	O	.	_	0	SENT_265	[p18l2019t3496r2139b3550],

1	He	PRP	O	he	nsubj	3	SENT_266	[p18l12t3579r110b3633],
2	has	VBZ	O	have	aux	3	SENT_266	[p18l140t3573r247b3633],
3	received	VBN	O	receive	_	0	SENT_266	[p18l278t3573r565b3633],
4	funding	VBG	O	fund	xcomp	3	SENT_266	[p18l594t3573r856b3656],
5	to	TO	O	to	aux	6	SENT_266	[p18l884t3586r947b3633],
6	participate	VB	O	participate	xcomp	4	SENT_266	[p18l976t3582r1340b3656],
7	in	IN	O	in	_	0	SENT_266	[p18l1370t3582r1432b3632],
8	trials	NNS	O	trial	prep_in	6	SENT_266	[p18l1461t3573r1626b3633],
9	of	IN	O	of	_	0	SENT_266	[p18l1657t3573r1728b3633],
10	novel	JJ	O	novel	amod	11	SENT_266	[p18l1749t3573r1930b3633],
11	treatments	NNS	O	treatment	prep_of	8	SENT_266	[p18l1958t3586r2142b3633, p18l11t3670r202b3718],
12	for	IN	O	for	_	0	SENT_266	[p18l230t3657r321b3718],
13	CF	NN	O	cf	prep_for	11	SENT_266	[p18l345t3662r447b3718],
14	from	IN	O	from	_	0	SENT_266	[p18l473t3657r626b3718],
15	Novartis	NNP	ORGANIZATION	Novartis	nn	16	SENT_266	[p18l655t3662r919b3718],
16	AG	NNP	ORGANIZATION	AG	prep_from	13	SENT_266	[p18l944t3662r1070b3729],
17	,	,	O	,	_	0	SENT_266	[p18l944t3662r1070b3729],
18	Gilead	NNP	ORGANIZATION	Gilead	appos	16	SENT_266	[p18l1101t3657r1325b3729],
19	,	,	O	,	_	0	SENT_266	[p18l1101t3657r1325b3729],
20	MPEX	NNP	ORGANIZATION	MPEX	nn	21	SENT_266	[p18l1357t3663r1578b3717],
21	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	appos	16	SENT_266	[p18l1602t3657r2141b3728],
22	,	,	ORGANIZATION	,	_	0	SENT_266	[p18l1602t3657r2141b3728],
23	Inc	NNP	ORGANIZATION	Inc	appos	16	SENT_266	[p18l11t3747r133b3812],
24	,	,	O	,	_	0	SENT_266	[p18l11t3747r133b3812],
25	Bayer	NNP	ORGANIZATION	Bayer	appos	16	SENT_266	[p18l165t3747r362b3824],
26	,	,	O	,	_	0	SENT_266	[p18l165t3747r362b3824],
27	IN	IN	O	in	_	0	SENT_266	[p18l394t3746r480b3801],
28	SMED	NNP	O	SMED	nn	29	SENT_266	[p18l488t3746r717b3801],
29	Incorporated	NNP	O	Incorporated	prep_in	16	SENT_266	[p18l748t3740r1193b3824],
30	,	,	O	,	_	0	SENT_266	[p18l748t3740r1193b3824],
31	Pharmaxis	NNP	ORGANIZATION	Pharmaxis	nn	32	SENT_266	[p18l1224t3741r1555b3801],
32	Ltd	NNP	ORGANIZATION	Ltd	appos	16	SENT_266	[p18l1586t3741r1717b3812],
33	,	,	O	,	_	0	SENT_266	[p18l1586t3741r1717b3812],
34	Inspire	NNP	O	Inspire	appos	16	SENT_266	[p18l1749t3747r1996b3824],
35	,	,	O	,	_	0	SENT_266	[p18l1749t3747r1996b3824],
36	and	CC	O	and	cc	11	SENT_266	[p18l2027t3741r2145b3801],

1	Boehringer	NNP	ORGANIZATION	Boehringer	nn	2	SENT_267	[p19l12t7r382b90],
2	Ingelheim	NNP	ORGANIZATION	Ingelheim	_	0	SENT_267	[p19l404t7r736b90],
3	GmbH	NN	ORGANIZATION	gmbh	dep	2	SENT_267	[p19l763t7r1006b68],
4	.	.	O	.	_	0	SENT_267	[p19l763t7r1006b68],

1	Role	NN	O	role	nsubj	8	SENT_268	[p19l9t92r178b152],
2	of	IN	O	of	_	0	SENT_268	[p19l213t91r292b152],
3	sponsors	NNS	O	sponsor	prep_of	1	SENT_268	[p19l317t116r661b174],
4	:	:	O	:	_	0	SENT_268	[p19l317t116r661b174],
5	Vertex	NNP	ORGANIZATION	Vertex	nn	7	SENT_268	[p19l692t98r910b152],
6	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	7	SENT_268	[p19l940t91r1494b152],
7	Incorporated	NNP	ORGANIZATION	Incorporated	dep	3	SENT_268	[p19l1528t92r1974b174],
8	provided	VBD	O	provide	_	0	SENT_268	[p19l2002t116r2142b174, p19l7t176r187b236],
9	the	DT	O	the	det	11	SENT_268	[p19l211t176r313b236],
10	ﬁnancial	JJ	O	ﬁnancial	amod	11	SENT_268	[p19l340t176r612b236],
11	support	NN	O	support	dobj	8	SENT_268	[p19l638t189r887b259],
12	and	CC	O	and	_	0	SENT_268	[p19l912t176r1030b236],
13	study	NN	O	study	nn	14	SENT_268	[p19l1055t176r1229b259],
14	medication	NN	O	medication	conj_and	11	SENT_268	[p19l1252t176r1613b236],
15	for	IN	O	for	_	0	SENT_268	[p19l1639t176r1732b236],
16	the	DT	O	the	det	17	SENT_268	[p19l1755t176r1856b236],
17	conduct	NN	O	conduct	prep_for	8	SENT_268	[p19l1883t176r2144b236],
18	of	IN	O	of	_	0	SENT_268	[p19l10t260r80b321],
19	the	DT	O	the	det	20	SENT_268	[p19l101t260r203b321],
20	study	NN	O	study	prep_of	17	SENT_268	[p19l235t260r416b343],
21	.	.	O	.	_	0	SENT_268	[p19l235t260r416b343],

1	The	DT	O	the	det	4	SENT_269	[p19l450t260r577b321],
2	Cystic	JJ	MISC	cystic	amod	4	SENT_269	[p19l610t265r807b343],
3	Fibrosis	NNP	MISC	Fibrosis	nn	4	SENT_269	[p19l839t260r1096b321],
4	Foundation	NNP	MISC	Foundation	nsubj	5	SENT_269	[p19l1129t260r1509b321],
5	had	VBD	O	have	_	0	SENT_269	[p19l1538t260r1657b321],
6	no	DT	O	no	det	7	SENT_269	[p19l1686t284r1765b321],
7	role	NN	O	role	dobj	5	SENT_269	[p19l1796t260r1919b321],
8	in	IN	O	in	_	0	SENT_269	[p19l1950t269r2010b320],
9	the	DT	O	the	det	10	SENT_269	[p19l2040t260r2142b321],
10	design	NN	O	design	prep_in	7	SENT_269	[p19l11t344r219b427],
11	of	IN	O	of	_	0	SENT_269	[p19l248t345r318b405],
12	the	DT	O	the	det	13	SENT_269	[p19l338t345r440b405],
13	study	NN	O	study	prep_of	10	SENT_269	[p19l471t344r653b427],
14	,	,	O	,	_	0	SENT_269	[p19l471t344r653b427],
15	the	DT	O	the	det	16	SENT_269	[p19l684t345r787b405],
16	collection	NN	O	collection	appos	13	SENT_269	[p19l817t345r1132b405],
17	and	CC	O	and	_	0	SENT_269	[p19l1162t345r1280b405],
18	analysis	NN	O	analysis	appos	13	SENT_269	[p19l1308t345r1552b427],
19	of	IN	O	of	_	0	SENT_269	[p19l1583t344r1652b405],
20	the	DT	O	the	det	21	SENT_269	[p19l1672t345r1774b405],
21	data	NNS	O	datum	prep_of	16	SENT_269	[p19l1805t344r1957b416],
22	,	,	O	,	_	0	SENT_269	[p19l1805t344r1957b416],
23	or	CC	O	or	_	0	SENT_269	[p19l1989t368r2057b405],
24	in	IN	O	in	_	0	SENT_269	[p19l2083t353r2143b404],
25	the	DT	O	the	det	26	SENT_269	[p19l9t428r111b489],
26	preparation	NN	O	preparation	conj_or	10	SENT_269	[p19l134t437r514b512],
27	of	IN	O	of	_	0	SENT_269	[p19l538t428r608b489],
28	the	DT	O	the	det	29	SENT_269	[p19l622t429r724b489],
29	manuscript	NN	O	manuscript	prep_of	26	SENT_269	[p19l749t437r1130b512],
30	.	.	O	.	_	0	SENT_269	[p19l749t437r1130b512],

1	Other	JJ	O	other	amod	2	SENT_270	[p19l10t513r225b574],
2	contributions	NNS	O	contribution	_	0	SENT_270	[p19l266t513r769b574],
3	:	:	O	:	_	0	SENT_270	[p19l266t513r769b574],
4	The	DT	O	the	det	5	SENT_270	[p19l810t513r937b574],
5	authors	NNS	O	author	nsubj	6	SENT_270	[p19l978t513r1217b574],
6	thank	VBP	O	thank	dep	2	SENT_270	[p19l1257t513r1441b574],
7	all	PDT	O	all	dep	9	SENT_270	[p19l1478t513r1551b574],
8	the	DT	O	the	det	9	SENT_270	[p19l1589t513r1691b574],
9	patients	NNS	O	patient	dobj	6	SENT_270	[p19l1730t522r1985b596],
10	and	CC	O	and	_	0	SENT_270	[p19l2027t513r2145b574],
11	families	NNS	O	family	dobj	6	SENT_270	[p19l10t598r259b658],
12	who	WP	O	who	nsubj	13	SENT_270	[p19l278t598r414b658],
13	participated	VBD	O	participate	rcmod	9	SENT_270	[p19l433t597r826b680],
14	in	IN	O	in	_	0	SENT_270	[p19l844t606r905b657],
15	this	DT	O	this	det	16	SENT_270	[p19l924t598r1037b658],
16	research	NN	O	research	prep_in	13	SENT_270	[p19l1059t597r1334b658],
17	and	CC	O	and	_	0	SENT_270	[p19l1354t598r1472b658],
18	the	DT	O	the	det	19	SENT_270	[p19l1490t598r1592b658],
19	nurses	NNS	O	nurse	prep_in	13	SENT_270	[p19l1613t621r1820b658],
20	and	CC	O	and	_	0	SENT_270	[p19l1843t598r1961b658],
21	technicians	NNS	O	technician	conj_and	19	SENT_270	[p19l1978t597r2142b658, p19l10t690r232b742],
22	who	WP	O	who	nsubj	23	SENT_270	[p19l259t682r395b742],
23	made	VBD	O	make	rcmod	19	SENT_270	[p19l425t681r601b742],
24	this	DT	O	this	det	25	SENT_270	[p19l630t681r743b742],
25	research	NN	O	research	nsubj	26	SENT_270	[p19l774t682r1049b742],
26	possible	JJ	O	possible	xcomp	23	SENT_270	[p19l1075t682r1353b764],
27	.	.	O	.	_	0	SENT_270	[p19l1075t682r1353b764],

1	The	DT	O	the	det	2	SENT_271	[p19l1385t681r1513b742],
2	authors	NNS	O	author	nsubj	4	SENT_271	[p19l1543t681r1782b742],
3	also	RB	O	also	advmod	4	SENT_271	[p19l1813t682r1934b742],
4	thank	VBP	O	thank	_	0	SENT_271	[p19l1962t681r2146b742],
5	the	DT	O	the	det	7	SENT_271	[p19l9t896r114b956],
6	following	VBG	O	follow	amod	7	SENT_271	[p19l154t895r467b979],
7	employees	NNS	O	employee	dobj	4	SENT_271	[p19l504t896r859b979],
8	of	IN	O	of	_	0	SENT_271	[p19l900t896r971b956],
9	Vertex	NNP	ORGANIZATION	Vertex	nn	11	SENT_271	[p19l998t902r1216b957],
10	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	11	SENT_271	[p19l1254t895r1808b956],
11	Incorporated	NNP	ORGANIZATION	Incorporated	prep_of	7	SENT_271	[p19l1849t902r2142b979, p19l10t980r201b1041],
12	:	:	O	:	_	0	SENT_271	[p19l1849t902r2142b979, p19l10t980r201b1041],
13	Nikki	NNP	PERSON	Nikki	nn	18	SENT_271	[p19l232t980r413b1040],
14	Shannon	NNP	PERSON	Shannon	nn	18	SENT_271	[p19l441t980r752b1052],
15	,	,	O	,	_	0	SENT_271	[p19l441t980r752b1052],
16	RN	NNP	O	RN	appos	18	SENT_271	[p19l782t986r913b1052],
17	,	,	O	,	_	0	SENT_271	[p19l782t986r913b1052],
18	BHSCA	NNP	LOCATION	BHSCA	conj_and	7	SENT_271	[p19l943t985r1210b1052],
19	,	,	O	,	_	0	SENT_271	[p19l943t985r1210b1052],
20	for	IN	O	for	mark	23	SENT_271	[p19l1238t980r1334b1041],
21	clinical	JJ	O	clinical	amod	22	SENT_271	[p19l1357t980r1597b1041],
22	operations	NNS	O	operation	nsubj	23	SENT_271	[p19l1621t989r1974b1063],
23	support	VBP	O	support	dep	18	SENT_271	[p19l2002t1004r2142b1063, p19l8t1078r167b1147],
24	;	:	O	;	_	0	SENT_271	[p19l2002t1004r2142b1063, p19l8t1078r167b1147],
25	Tatyana	NNP	PERSON	Tatyana	nn	26	SENT_271	[p19l192t1071r455b1147],
26	Wanderer	NNP	PERSON	Wanderer	dep	18	SENT_271	[p19l472t1064r823b1136],
27	,	,	O	,	_	0	SENT_271	[p19l472t1064r823b1136],
28	PhD	NNP	O	PhD	appos	26	SENT_271	[p19l849t1065r1022b1136],
29	,	,	O	,	_	0	SENT_271	[p19l849t1065r1022b1136],
30	for	IN	O	for	_	0	SENT_271	[p19l1047t1065r1143b1125],
31	study	NN	O	study	nn	33	SENT_271	[p19l1165t1065r1346b1147],
32	document	NN	O	document	nn	33	SENT_271	[p19l1366t1065r1706b1125],
33	preparation	NN	O	preparation	prep_for	26	SENT_271	[p19l1726t1073r2141b1147],
34	;	:	O	;	_	0	SENT_271	[p19l1726t1073r2141b1147],
35	and	CC	O	and	_	0	SENT_271	[p19l11t1149r132b1209],
36	Adrienne	NNP	PERSON	Adrienne	nn	39	SENT_271	[p19l162t1149r477b1209],
37	Aiello	NNP	PERSON	Aiello	nn	39	SENT_271	[p19l510t1149r726b1220],
38	,	,	O	,	_	0	SENT_271	[p19l510t1149r726b1220],
39	PharmD	NNP	O	PharmD	dobj	4	SENT_271	[p19l763t1149r1070b1220],
40	,	,	O	,	_	0	SENT_271	[p19l763t1149r1070b1220],
41	and	CC	O	and	_	0	SENT_271	[p19l1107t1149r1228b1209],
42	Barry	NNP	PERSON	Barry	nn	43	SENT_271	[p19l1262t1155r1449b1232],
43	Lubarsky	NNP	PERSON	Lubarsky	conj_and	39	SENT_271	[p19l1480t1149r1804b1232],
44	,	,	O	,	_	0	SENT_271	[p19l1480t1149r1804b1232],
45	PhD	NNP	O	PhD	appos	39	SENT_271	[p19l1841t1149r2014b1220],
46	,	,	O	,	_	0	SENT_271	[p19l1841t1149r2014b1220],
47	for	IN	O	for	_	0	SENT_271	[p19l2050t1149r2146b1209],
48	coordinating	VBG	O	coordinate	prepc_for	39	SENT_271	[p19l10t1233r421b1316],
49	the	DT	O	the	det	50	SENT_271	[p19l442t1233r544b1293],
50	editing	NN	O	editing	dobj	48	SENT_271	[p19l569t1233r796b1316],
51	of	IN	O	of	_	0	SENT_271	[p19l818t1233r887b1293],
52	the	DT	O	the	det	54	SENT_271	[p19l901t1233r1004b1293],
53	submitted	VBN	O	submit	amod	54	SENT_271	[p19l1029t1233r1358b1294],
54	manuscript	NN	O	manuscript	prep_of	50	SENT_271	[p19l1381t1242r1761b1316],
55	.	.	O	.	_	0	SENT_271	[p19l1381t1242r1761b1316],

1	Additional	JJ	O	additional	amod	2	SENT_272	[p19l7t1317r386b1378],
2	information	NN	O	information	_	0	SENT_272	[p19l411t1317r860b1378],
3	:	:	O	:	_	0	SENT_272	[p19l411t1317r860b1378],
4	The	DT	O	the	dep	2	SENT_272	[p19l888t1317r1016b1378],
5	e	LS	O	e	dep	4	SENT_272	[p19l1041t1317r1482b1400],
6	.	.	O	.	_	0	SENT_272	[p19l1041t1317r1482b1400],

1	—	NN	O	—	_	0	SENT_273	[p19l1041t1317r1482b1400],
2	.	.	O	.	_	0	SENT_273	[p19l1041t1317r1482b1400],

1	AppendiXes	NNS	O	appendix	nsubjpass	4	SENT_274	[p19l1041t1317r1482b1400],
2	can	MD	O	can	aux	4	SENT_274	[p19l1508t1341r1618b1378],
3	be	VB	O	be	auxpass	4	SENT_274	[p19l1640t1317r1718b1378],
4	found	VBN	O	find	_	0	SENT_274	[p19l1744t1317r1934b1378],
5	in	IN	O	in	_	0	SENT_274	[p19l1956t1326r2017b1377],
6	the	DT	O	the	det	11	SENT_274	[p19l2040t1317r2142b1378],
7	“	CD	NUMBER	“	num	11	SENT_274	[p19l10t1400r495b1483],
8	Supplemental	NNP	O	Supplemental	nn	11	SENT_274	[p19l10t1400r495b1483],
9	Materials	NNPS	O	Materials	nn	11	SENT_274	[p19l521t1401r853b1461],
10	”	NNP	O	”	nn	11	SENT_274	[p19l521t1401r853b1461],
11	area	NN	O	area	prep_in	4	SENT_274	[p19l878t1425r1014b1461],
12	of	IN	O	of	_	0	SENT_274	[p19l1036t1400r1105b1461],
13	the	DT	O	the	det	15	SENT_274	[p19l1120t1401r1222b1461],
14	online	NN	O	online	nn	15	SENT_274	[p19l1247t1400r1447b1461],
15	article	NN	O	article	prep_of	4	SENT_274	[p19l1472t1401r1689b1461],
16	.	.	O	.	_	0	SENT_274	[p19l1472t1401r1689b1461],

1	REFERENCES	NNS	O	reference	_	0	SENT_275	[p19l804t1652r1349b1719],

1	1	LS	NUMBER	1	_	0	SENT_276	[p19l59t1794r106b1849],
2	.	.	O	.	_	0	SENT_276	[p19l59t1794r106b1849],

1	Rowe	NNP	PERSON	Rowe	nn	2	SENT_277	[p19l152t1795r329b1849],
2	SM	NNP	O	SM	_	0	SENT_277	[p19l355t1794r479b1860],
3	,	,	O	,	_	0	SENT_277	[p19l355t1794r479b1860],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_277	[p19l508t1789r699b1849],
5	S	NNP	O	S	appos	2	SENT_277	[p19l722t1794r774b1860],
6	,	,	O	,	_	0	SENT_277	[p19l722t1794r774b1860],
7	Sorscher	NNP	PERSON	Sorscher	nn	9	SENT_277	[p19l803t1788r1075b1849],
8	P	NN	O	p	nn	9	SENT_277	[p19l1097t1794r1190b1871],
9	ݘc	NN	O	ݘc	appos	2	SENT_277	[p19l1097t1794r1190b1871],
10	+	CC	O	+	_	0	SENT_277	[p19l1097t1794r1190b1871],
11	Cystic	JJ	O	cystic	amod	12	SENT_277	[p19l1218t1794r1407b1871],
12	ﬁbrosis	NN	O	ﬁbrosis	appos	2	SENT_277	[p19l1431t1788r1666b1850],
13	.	.	O	.	_	0	SENT_277	[p19l1431t1788r1666b1850],

1	N	NN	O	n	_	0	SENT_278	[p19l1691t1794r1749b1849],
2	Engl	NNP	O	Engl	nn	4	SENT_278	[p19l1767t1788r1915b1871],
3	]	NNP	O	]	nn	4	SENT_278	[p19l1927t1795r1965b1871],
4	Med	NNP	O	Med	dep	1	SENT_278	[p19l1984t1788r2139b1849],
5	.	.	O	.	_	0	SENT_278	[p19l1984t1788r2139b1849],

1	2005	CD	DATE	2005	_	0	SENT_279	[p19l150t1880r959b1952],
2	;	:	O	;	_	0	SENT_279	[p19l150t1880r959b1952],
3	352	CD	NUMBER	352	dep	1	SENT_279	[p19l150t1880r959b1952],
4	.	.	O	.	_	0	SENT_279	[p19l150t1880r959b1952],

1	(	NN	O	(	nn	2	SENT_280	[p19l150t1880r959b1952],
2	l9	NN	O	l9	_	0	SENT_280	[p19l150t1880r959b1952],
3	)	CD	NUMBER	)	dep	2	SENT_280	[p19l150t1880r959b1952],
4	:	:	O	:	_	0	SENT_280	[p19l150t1880r959b1952],
5	I992-2001	NN	O	i992-2001	dep	2	SENT_280	[p19l150t1880r959b1952],
6	.	.	O	.	_	0	SENT_280	[p19l150t1880r959b1952],

1	2	LS	NUMBER	2	_	0	SENT_281	[p19l54t1977r106b2033],
2	.	.	O	.	_	0	SENT_281	[p19l54t1977r106b2033],

1	McKone	NNP	PERSON	McKone	nn	2	SENT_282	[p19l153t1978r440b2033],
2	EF	NNP	O	EF	_	0	SENT_282	[p19l464t1978r578b2044],
3	,	,	O	,	_	0	SENT_282	[p19l464t1978r578b2044],
4	Emerson	NNP	ORGANIZATION	Emerson	nn	5	SENT_282	[p19l604t1978r909b2033],
5	SS	NNP	ORGANIZATION	SS	appos	2	SENT_282	[p19l934t1977r1033b2044],
6	,	,	O	,	_	0	SENT_282	[p19l934t1977r1033b2044],
7	Edwards	NNP	ORGANIZATION	Edwards	nn	8	SENT_282	[p19l1060t1972r1352b2033],
8	KL	NNP	ORGANIZATION	KL	appos	2	SENT_282	[p19l1378t1978r1500b2044],
9	,	,	O	,	_	0	SENT_282	[p19l1378t1978r1500b2044],
10	Aitken	NNP	PERSON	Aitken	nn	11	SENT_282	[p19l1523t1972r1746b2033],
11	ML	NNP	O	ML	appos	2	SENT_282	[p19l1771t1978r1908b2033],
12	.	.	O	.	_	0	SENT_282	[p19l1771t1978r1908b2033],

1	Effect	NN	O	effect	_	0	SENT_283	[p19l1936t1972r2144b2033],
2	of	IN	O	of	_	0	SENT_283	[p19l151t2065r221b2126],
3	genotype	NN	O	genotype	prep_of	1	SENT_283	[p19l243t2079r539b2148],
4	on	IN	O	on	_	0	SENT_283	[p19l572t2090r651b2126],
5	phenotype	NN	O	phenotype	prep_on	3	SENT_283	[p19l680t2065r1025b2148],
6	and	CC	O	and	_	0	SENT_283	[p19l1058t2065r1176b2126],
7	mortality	NN	O	mortality	conj_and	5	SENT_283	[p19l1206t2066r1502b2148],
8	in	IN	O	in	_	0	SENT_283	[p19l1529t2074r1590b2125],
9	cystic	JJ	O	cystic	amod	10	SENT_283	[p19l1621t2074r1799b2148],
10	ﬁbrosis	NN	O	ﬁbrosis	prep_in	1	SENT_283	[p19l1830t2065r2076b2126],
11	:	:	O	:	_	0	SENT_283	[p19l1830t2065r2076b2126],
12	a	DT	O	a	det	15	SENT_283	[p19l2112t2090r2145b2126],
13	retrospective	JJ	O	retrospective	amod	15	SENT_283	[p19l151t2167r554b2241],
14	cohort	NN	O	cohort	nn	15	SENT_283	[p19l576t2158r778b2219],
15	study	NN	O	study	dep	1	SENT_283	[p19l798t2158r970b2241],
16	Lancet	NNP	O	Lancet	dep	15	SENT_283	[p19l993t2164r1222b2219],
17	.	.	O	.	_	0	SENT_283	[p19l993t2164r1222b2219],

1	2003	CD	DATE	2003	_	0	SENT_284	[p19l1246t2158r2097b2230],
2	;	:	O	;	_	0	SENT_284	[p19l1246t2158r2097b2230],
3	361	CD	NUMBER	361	number	4	SENT_284	[p19l1246t2158r2097b2230],
4	(	CD	NUMBER	(	num	6	SENT_284	[p19l1246t2158r2097b2230],
5	9370	CD	NUMBER	9370	number	6	SENT_284	[p19l1246t2158r2097b2230],
6	)	CD	NUMBER	)	dep	1	SENT_284	[p19l1246t2158r2097b2230],
7	:1671	CD	DURATION	:1671	num	8	SENT_284	[p19l1246t2158r2097b2230],
8	-1676	CD	DURATION	-1676	dep	6	SENT_284	[p19l1246t2158r2097b2230],
9	.	.	O	.	_	0	SENT_284	[p19l1246t2158r2097b2230],

1	3	LS	NUMBER	3	_	0	SENT_285	[p19l54t2255r106b2311],
2	.	.	O	.	_	0	SENT_285	[p19l54t2255r106b2311],

1	Kerem	NNP	PERSON	Kerem	nn	2	SENT_286	[p19l152t2256r378b2311],
2	B	NNP	PERSON	B	_	0	SENT_286	[p19l407t2256r473b2322],
3	,	,	O	,	_	0	SENT_286	[p19l407t2256r473b2322],
4	Rommens	NNP	O	Rommens	nn	6	SENT_286	[p19l504t2256r839b2311],
5	]	CD	NUMBER	]	num	6	SENT_286	[p19l865t2256r986b2333],
6	M	NN	O	m	appos	2	SENT_286	[p19l865t2256r986b2333],
7	,	,	O	,	_	0	SENT_286	[p19l865t2256r986b2333],
8	Buchanan	NNP	PERSON	Buchanan	nn	10	SENT_286	[p19l1017t2250r1350b2311],
9	]	CD	NUMBER	]	num	10	SENT_286	[p19l1375t2255r1474b2333],
10	A	NN	O	a	appos	2	SENT_286	[p19l1375t2255r1474b2333],
11	,	,	O	,	_	0	SENT_286	[p19l1375t2255r1474b2333],
12	et	FW	O	et	nn	13	SENT_286	[p19l1503t2263r1565b2311],
13	al.	FW	O	al.	appos	2	SENT_286	[p19l1591t2250r1660b2311],
14	.	.	O	.	_	0	SENT_286	[p19l1591t2250r1660b2311],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_287	[p19l1692t2250r2143b2311],
2	of	IN	O	of	_	0	SENT_287	[p19l151t2341r222b2402],
3	the	DT	O	the	det	6	SENT_287	[p19l243t2342r348b2402],
4	cystic	JJ	O	cystic	amod	6	SENT_287	[p19l380t2350r565b2424],
5	ﬁbrosis	NN	O	ﬁbrosis	nn	6	SENT_287	[p19l596t2341r834b2403],
6	gene	NN	O	gene	prep_of	1	SENT_287	[p19l866t2363r1042b2424],
7	:	:	O	:	_	0	SENT_287	[p19l866t2363r1042b2424],
8	genetic	JJ	O	genetic	amod	9	SENT_287	[p19l1077t2350r1322b2424],
9	analysis	NN	O	analysis	dep	1	SENT_287	[p19l1353t2342r1626b2424],
10	.	.	O	.	_	0	SENT_287	[p19l1353t2342r1626b2424],

1	Science	NN	O	science	_	0	SENT_288	[p19l1663t2347r1927b2402],
2	.	.	O	.	_	0	SENT_288	[p19l1663t2347r1927b2402],

1	1989	CD	DATE	1989	_	0	SENT_289	[p19l1966t2347r2141b2413],
2	;	:	O	;	_	0	SENT_289	[p19l1966t2347r2141b2413],
3	245	CD	NUMBER	245	number	4	SENT_289	[p19l150t2433r860b2505],
4	(	CD	NUMBER	(	dep	1	SENT_289	[p19l150t2433r860b2505],
5	492.2	CD	NUMBER	492.2	num	6	SENT_289	[p19l150t2433r860b2505],
6	)	NN	O	)	dep	4	SENT_289	[p19l150t2433r860b2505],
7	:	:	O	:	_	0	SENT_289	[p19l150t2433r860b2505],
8	IO73	NN	O	io73	dep	4	SENT_289	[p19l150t2433r860b2505],
9	.	.	O	.	_	0	SENT_289	[p19l150t2433r860b2505],

1	—	NN	O	—	_	0	SENT_290	[p19l150t2433r860b2505],
2	.	.	O	.	_	0	SENT_290	[p19l150t2433r860b2505],

1	I080	NN	O	i080	_	0	SENT_291	[p19l150t2433r860b2505],
2	.	.	O	.	_	0	SENT_291	[p19l150t2433r860b2505],

1	4	LS	NUMBER	4	_	0	SENT_292	[p19l53t2531r106b2587],
2	.	.	O	.	_	0	SENT_292	[p19l53t2531r106b2587],

1	Riordan	NNP	PERSON	Riordan	nn	3	SENT_293	[p19l152t2526r412b2587],
2	]	CD	NUMBER	]	num	3	SENT_293	[p19l439t2532r538b2609],
3	R	NN	O	r	_	0	SENT_293	[p19l439t2532r538b2609],
4	,	,	O	,	_	0	SENT_293	[p19l439t2532r538b2609],
5	Rommens	NNP	O	Rommens	nn	7	SENT_293	[p19l571t2532r899b2587],
6	]	CD	NUMBER	]	num	7	SENT_293	[p19l927t2532r1045b2609],
7	M	NN	O	m	appos	3	SENT_293	[p19l927t2532r1045b2609],
8	,	,	O	,	_	0	SENT_293	[p19l927t2532r1045b2609],
9	Kerem	NNP	PERSON	Kerem	nn	10	SENT_293	[p19l1079t2532r1299b2587],
10	B	NNP	PERSON	B	appos	3	SENT_293	[p19l1331t2532r1395b2598],
11	,	,	O	,	_	0	SENT_293	[p19l1331t2532r1395b2598],
12	et	FW	O	et	nn	13	SENT_293	[p19l1426t2539r1487b2587],
13	al.	FW	O	al.	appos	3	SENT_293	[p19l1515t2526r1582b2587],
14	.	.	O	.	_	0	SENT_293	[p19l1515t2526r1582b2587],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_294	[p19l1616t2526r2054b2587],
2	of	IN	O	of	_	0	SENT_294	[p19l2082t2526r2152b2587],
3	the	DT	O	the	det	6	SENT_294	[p19l150t2618r252b2679],
4	cystic	JJ	O	cystic	amod	6	SENT_294	[p19l279t2627r457b2701],
5	ﬁbrosis	NN	O	ﬁbrosis	nn	6	SENT_294	[p19l483t2618r712b2680],
6	gene	NN	O	gene	prep_of	1	SENT_294	[p19l740t2640r909b2701],
7	:	:	O	:	_	0	SENT_294	[p19l740t2640r909b2701],
8	cloning	NN	O	cloning	dep	1	SENT_294	[p19l940t2619r1178b2701],
9	and	CC	O	and	_	0	SENT_294	[p19l1204t2618r1321b2679],
10	characterization	NN	O	characterization	conj_and	8	SENT_294	[p19l1346t2619r1867b2679],
11	of	IN	O	of	_	0	SENT_294	[p19l1893t2618r1963b2679],
12	complementary	JJ	O	complementary	amod	13	SENT_294	[p19l1981t2643r2142b2679, p19l149t2712r523b2795],
13	DNA	NN	O	dna	prep_of	8	SENT_294	[p19l546t2717r734b2772],
14	.	.	O	.	_	0	SENT_294	[p19l546t2717r734b2772],

1	Science	NN	O	science	_	0	SENT_295	[p19l764t2717r1017b2773],
2	.	.	O	.	_	0	SENT_295	[p19l764t2717r1017b2773],

1	1989	CD	DATE	1989	_	0	SENT_296	[p19l1050t2712r1934b2784],
2	;	:	O	;	_	0	SENT_296	[p19l1050t2712r1934b2784],
3	245	CD	NUMBER	245	number	4	SENT_296	[p19l1050t2712r1934b2784],
4	(	CD	NUMBER	(	num	6	SENT_296	[p19l1050t2712r1934b2784],
5	4922	CD	NUMBER	4922	number	6	SENT_296	[p19l1050t2712r1934b2784],
6	)	CD	NUMBER	)	dep	1	SENT_296	[p19l1050t2712r1934b2784],
7	:1066	CD	DURATION	:1066	num	8	SENT_296	[p19l1050t2712r1934b2784],
8	-1073	CD	DURATION	-1073	dep	6	SENT_296	[p19l1050t2712r1934b2784],
9	.	.	O	.	_	0	SENT_296	[p19l1050t2712r1934b2784],

1	5	CD	NUMBER	5	_	0	SENT_297	[p19l54t2807r106b2865],
2	.	.	O	.	_	0	SENT_297	[p19l54t2807r106b2865],

1	Rommens	NNS	MISC	rommen	_	0	SENT_298	[p19l152t2810r480b2865],
2	]	CD	NUMBER	]	num	3	SENT_298	[p19l511t2810r630b2887],
3	M	NN	O	m	dep	1	SENT_298	[p19l511t2810r630b2887],
4	,	,	O	,	_	0	SENT_298	[p19l511t2810r630b2887],
5	Iannuzzi	NNP	PERSON	Iannuzzi	nn	6	SENT_298	[p19l666t2810r944b2865],
6	MC	NNP	O	MC	appos	3	SENT_298	[p19l979t2809r1119b2876],
7	,	,	O	,	_	0	SENT_298	[p19l979t2809r1119b2876],
8	Kerem	NNP	PERSON	Kerem	nn	9	SENT_298	[p19l1155t2810r1376b2865],
9	B	NNP	PERSON	B	appos	3	SENT_298	[p19l1411t2810r1475b2876],
10	,	,	O	,	_	0	SENT_298	[p19l1411t2810r1475b2876],
11	et	FW	O	et	nn	12	SENT_298	[p19l1510t2817r1571b2865],
12	al.	FW	O	al.	appos	3	SENT_298	[p19l1602t2804r1669b2865],
13	.	.	O	.	_	0	SENT_298	[p19l1602t2804r1669b2865],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_299	[p19l1706t2804r2143b2865],
2	of	IN	O	of	_	0	SENT_299	[p19l151t2898r220b2958],
3	the	DT	O	the	det	6	SENT_299	[p19l236t2898r337b2958],
4	cystic	JJ	O	cystic	amod	6	SENT_299	[p19l363t2906r537b2980],
5	ﬁbrosis	NN	O	ﬁbrosis	nn	6	SENT_299	[p19l563t2897r787b2959],
6	gene	NN	O	gene	prep_of	1	SENT_299	[p19l815t2919r981b2980],
7	:	:	O	:	_	0	SENT_299	[p19l815t2919r981b2980],
8	chromosome	NN	O	chromosome	nn	9	SENT_299	[p19l1011t2898r1424b2958],
9	walking	NN	O	walking	dep	1	SENT_299	[p19l1448t2897r1694b2980],
10	and	CC	O	and	_	0	SENT_299	[p19l1719t2898r1836b2958],
11	jumping	VBG	O	jump	conj_and	9	SENT_299	[p19l1854t2906r2139b2980],
12	.	.	O	.	_	0	SENT_299	[p19l1854t2906r2139b2980],

1	Science	NN	O	science	_	0	SENT_300	[p19l153t2996r406b3052],
2	.	.	O	.	_	0	SENT_300	[p19l153t2996r406b3052],

1	I989	NN	O	i989	_	0	SENT_301	[p19l439t2991r1322b3063],
2	;	:	O	;	_	0	SENT_301	[p19l439t2991r1322b3063],
3	245	CD	NUMBER	245	number	4	SENT_301	[p19l439t2991r1322b3063],
4	(	CD	NUMBER	(	num	6	SENT_301	[p19l439t2991r1322b3063],
5	4922	CD	NUMBER	4922	number	6	SENT_301	[p19l439t2991r1322b3063],
6	)	CD	NUMBER	)	dep	1	SENT_301	[p19l439t2991r1322b3063],
7	:1059	CD	DURATION	:1059	num	8	SENT_301	[p19l439t2991r1322b3063],
8	-1065	CD	DURATION	-1065	dep	6	SENT_301	[p19l439t2991r1322b3063],
9	.	.	O	.	_	0	SENT_301	[p19l439t2991r1322b3063],

1	CHEST	NN	O	chest	_	0	SENT_302	[p19l801t3219r1055b3269],
2	/	:	O	/	punct	7	SENT_302	[p19l801t3219r1055b3269],
3	142	CD	NUMBER	142	dep	7	SENT_302	[p19l1078t3221r1178b3268],
4	/	:	O	/	punct	5	SENT_302	[p19l1198t3219r1223b3269],
5	3	CD	NUMBER	3	dep	3	SENT_302	[p19l1242t3221r1274b3269],
6	/	:	O	/	punct	5	SENT_302	[p19l1294t3219r1318b3269],
7	SEPTEMBER	NNP	DATE	SEPTEMBER	dep	1	SENT_302	[p19l1337t3220r1723b3269],
8	2012	CD	DATE	2012	num	9	SENT_302	[p19l1745t3221r1885b3269],
9	723	CD	NUMBER	723	dep	1	SENT_302	[p19l2023t3214r2144b3269],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_303	[p19l302t3345r479b3369],
2	From	IN	O	from	dep	1	SENT_303	[p19l488t3345r576b3369],
3	:	:	O	:	_	0	SENT_303	[p19l488t3345r576b3369],
4	http://journal.puhlications.chestnet.org/	NN	O	http://journal.puhlications.chestnet.org/	dep	1	SENT_303	[p19l587t3344r1156b3375],
5	by	IN	O	by	dep	4	SENT_303	[p19l1163t3345r1198b3375],
6	a	DT	O	a	det	10	SENT_303	[p19l1207t3352r1223b3368],
7	University	NNP	ORGANIZATION	University	dep	10	SENT_303	[p19l1232t3344r1379b3375],
8	of	IN	ORGANIZATION	of	_	0	SENT_303	[p19l1389t3344r1418b3368],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_303	[p19l1425t3344r1570b3369],
10	User	NN	ORGANIZATION	user	pobj	5	SENT_303	[p19l1579t3345r1645b3369],
11	on	IN	O	on	_	0	SENT_303	[p19l1663t3352r1697b3368],
12	01/05/2014	CD	DATE	01/05/2014	prep_on	10	SENT_303	[p19l1706t3344r1857b3369],

1	6	CD	NUMBER	6	_	0	SENT_304	[p20l52t96r103b151],
2	.	.	O	.	_	0	SENT_304	[p20l52t96r103b151],

1	Cystic	JJ	O	cystic	amod	5	SENT_305	[p20l148t96r338b174],
2	Fibrosis	NNP	O	Fibrosis	nn	5	SENT_305	[p20l363t91r610b152],
3	Foundation	NNP	O	Foundation	nn	5	SENT_305	[p20l636t91r1002b151],
4	Patient	NNP	O	Patient	nn	5	SENT_305	[p20l1025t96r1247b151],
5	Registry	NNP	O	Registry	_	0	SENT_305	[p20l1272t97r1535b174],
6	.	.	O	.	_	0	SENT_305	[p20l1272t97r1535b174],

1	2009	CD	DATE	2009	_	0	SENT_306	[p20l1559t96r1714b151],
2	Annual	JJ	SET	annual	amod	3	SENT_306	[p20l1733t91r1966b151],
3	Data	NNS	O	datum	dep	1	SENT_306	[p20l1988t96r2142b151],

1	Report	NNP	O	Report	_	0	SENT_307	[p20l145t189r369b265],
2	to	TO	O	to	_	0	SENT_307	[p20l389t196r449b244],
3	the	DT	O	the	det	5	SENT_307	[p20l472t183r572b244],
4	Center	NNP	O	Center	nn	5	SENT_307	[p20l598t188r822b244],
5	Directors	NNS	O	director	prep_to	1	SENT_307	[p20l840t189r1163b244],
6	.	.	O	.	_	0	SENT_307	[p20l840t189r1163b244],

1	Bethesda	NNP	LOCATION	Bethesda	nn	3	SENT_308	[p20l1192t183r1510b255],
2	,	,	O	,	_	0	SENT_308	[p20l1192t183r1510b255],
3	MD	NNP	O	MD	_	0	SENT_308	[p20l1539t189r1687b243],
4	:	:	O	:	_	0	SENT_308	[p20l1539t189r1687b243],
5	2010	CD	DATE	2010	dep	3	SENT_308	[p20l1715t188r1886b244],
6	.	.	O	.	_	0	SENT_308	[p20l1715t188r1886b244],

1	7	CD	NUMBER	7	_	0	SENT_309	[p20l53t278r103b336],
2	.	.	O	.	_	0	SENT_309	[p20l53t278r103b336],

1	Denning	VBG	ORGANIZATION	den	_	0	SENT_310	[p20l149t281r427b358],
2	GM	NNP	ORGANIZATION	GM	dobj	1	SENT_310	[p20l453t281r595b347],
3	,	,	O	,	_	0	SENT_310	[p20l453t281r595b347],
4	Anderson	NNP	PERSON	Anderson	nn	5	SENT_310	[p20l621t275r926b336],
5	MP	NNP	O	MP	appos	2	SENT_310	[p20l954t281r1072b347],
6	,	,	O	,	_	0	SENT_310	[p20l954t281r1072b347],
7	Amara	NNP	PERSON	Amara	nn	9	SENT_310	[p20l1099t281r1309b336],
8	]	CD	NUMBER	]	num	9	SENT_310	[p20l1331t281r1415b358],
9	F	NN	O	f	appos	2	SENT_310	[p20l1331t281r1415b358],
10	,	,	O	,	_	0	SENT_310	[p20l1331t281r1415b358],
11	Marshall	NNP	PERSON	Marshall	nn	12	SENT_310	[p20l1446t275r1717b336],
12	]	NNP	O	]	appos	2	SENT_310	[p20l1740t282r1783b358],
13	,	,	O	,	_	0	SENT_310	[p20l1740t282r1783b358],
14	Smith	NNP	PERSON	Smith	nn	15	SENT_310	[p20l1814t275r1998b336],
15	AE	NNP	O	AE	appos	2	SENT_310	[p20l2021t281r2141b347],
16	,	,	O	,	_	0	SENT_310	[p20l2021t281r2141b347],
17	Welsh	NNP	O	Welsh	nn	19	SENT_310	[p20l144t367r350b428],
18	M	NNP	O	M	nn	19	SENT_310	[p20l387t372r501b449],
19	]	NN	O	]	appos	2	SENT_310	[p20l387t372r501b449],
20	.	.	O	.	_	0	SENT_310	[p20l387t372r501b449],

1	Processing	NN	O	processing	nsubj	12	SENT_311	[p20l540t372r896b450],
2	of	IN	O	of	_	0	SENT_311	[p20l929t367r1000b427],
3	mutant	JJ	O	mutant	amod	8	SENT_311	[p20l1026t380r1263b427],
4	cystic	JJ	O	cystic	amod	8	SENT_311	[p20l1297t376r1478b449],
5	ﬁbrosis	NN	O	ﬁbrosis	nn	8	SENT_311	[p20l1513t367r1747b428],
6	transmembrane	NN	O	transmembrane	nn	8	SENT_311	[p20l1782t380r2142b427, p20l146t460r325b521],
7	conductance	NN	O	conductance	nn	8	SENT_311	[p20l357t460r753b521],
8	regulator	NN	O	regulator	prep_of	1	SENT_311	[p20l785t460r1071b543],
9	is	VBZ	O	be	cop	12	SENT_311	[p20l1098t469r1142b521],
10	temperature	NN	O	temperature	nn	12	SENT_311	[p20l1174t469r1871b543],
11	—	CD	NUMBER	—	num	12	SENT_311	[p20l1174t469r1871b543],
12	sensitiVe	NN	O	sensitive	_	0	SENT_311	[p20l1174t469r1871b543],
13	.	.	O	.	_	0	SENT_311	[p20l1174t469r1871b543],

1	Nature	NNP	O	Nature	_	0	SENT_312	[p20l1904t465r2139b521],
2	.	.	O	.	_	0	SENT_312	[p20l1904t465r2139b521],

1	1992	CD	DATE	1992	_	0	SENT_313	[p20l152t554r957b626],
2	;	:	O	;	_	0	SENT_313	[p20l152t554r957b626],
3	358	CD	NUMBER	358	number	4	SENT_313	[p20l152t554r957b626],
4	(	CD	NUMBER	(	num	6	SENT_313	[p20l152t554r957b626],
5	6389	CD	NUMBER	6389	number	6	SENT_313	[p20l152t554r957b626],
6	)	CD	NUMBER	)	dep	1	SENT_313	[p20l152t554r957b626],
7	:761	CD	NUMBER	:761	num	8	SENT_313	[p20l152t554r957b626],
8	—	NN	O	—	dep	6	SENT_313	[p20l152t554r957b626],
9	764	CD	NUMBER	764	dep	6	SENT_313	[p20l152t554r957b626],
10	.	.	O	.	_	0	SENT_313	[p20l152t554r957b626],

1	8	CD	NUMBER	8	_	0	SENT_314	[p20l52t650r103b705],
2	.	.	O	.	_	0	SENT_314	[p20l52t650r103b705],

1	Kartner	NNP	PERSON	Kartner	nn	2	SENT_315	[p20l149t651r393b705],
2	N	NNP	PERSON	N	_	0	SENT_315	[p20l416t650r487b716],
3	,	,	O	,	_	0	SENT_315	[p20l416t650r487b716],
4	Augustinas	NNP	PERSON	Augustinas	nn	5	SENT_315	[p20l512t650r852b728],
5	O	NNP	PERSON	O	appos	2	SENT_315	[p20l878t650r949b716],
6	,	,	O	,	_	0	SENT_315	[p20l878t650r949b716],
7	]	CD	NUMBER	]	num	10	SENT_315	[p20l973t651r1184b727],
8	ensen	JJ	O	ensen	amod	10	SENT_315	[p20l973t651r1184b727],
9	T	NN	O	t	nn	10	SENT_315	[p20l1206t651r1297b727],
10	]	NN	O	]	appos	2	SENT_315	[p20l1206t651r1297b727],
11	,	,	O	,	_	0	SENT_315	[p20l1206t651r1297b727],
12	Naismith	NNP	ORGANIZATION	Naismith	nn	13	SENT_315	[p20l1325t645r1609b705],
13	AL	NNP	ORGANIZATION	AL	appos	2	SENT_315	[p20l1630t650r1745b716],
14	,	,	O	,	_	0	SENT_315	[p20l1630t650r1745b716],
15	Riordan	NNP	PERSON	Riordan	nn	18	SENT_315	[p20l1773t645r2024b705],
16	]	NNP	O	]	nn	18	SENT_315	[p20l2044t650r2139b727],
17	R.	NNP	PERSON	R.	nn	18	SENT_315	[p20l2044t650r2139b727],
18	Mislocalization	NNP	PERSON	Mislocalization	appos	2	SENT_315	[p20l150t737r639b798],
19	of	IN	O	of	_	0	SENT_315	[p20l671t737r741b798],
20	delta	NN	O	delta	nn	21	SENT_315	[p20l765t737r926b798],
21	F508	NN	O	f508	prep_of	18	SENT_315	[p20l957t740r1123b797],
22	CF	NN	O	cf	nn	23	SENT_315	[p20l1157t742r1260b798],
23	TR	NN	O	tr	dep	2	SENT_315	[p20l1263t743r1366b797],
24	in	IN	O	in	_	0	SENT_315	[p20l1397t746r1458b797],
25	cystic	JJ	O	cystic	amod	28	SENT_315	[p20l1490t746r1668b820],
26	ﬁbrosis	NN	O	ﬁbrosis	nn	28	SENT_315	[p20l1701t737r1930b798],
27	sweat	NN	O	sweat	nn	28	SENT_315	[p20l1965t750r2145b798],
28	gland	NN	O	gland	prep_in	23	SENT_315	[p20l148t829r339b912],
29	.	.	O	.	_	0	SENT_315	[p20l148t829r339b912],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_316	[p20l365t835r486b890],
2	Genet	NNP	PERSON	Genet	_	0	SENT_316	[p20l509t835r717b890],
3	.	.	O	.	_	0	SENT_316	[p20l509t835r717b890],

1	1992	CD	DATE	1992	_	0	SENT_317	[p20l749t830r1356b901],
2	;	:	O	;	_	0	SENT_317	[p20l749t830r1356b901],
3	1	CD	NUMBER	1	number	4	SENT_317	[p20l749t830r1356b901],
4	(	CD	NUMBER	(	dep	1	SENT_317	[p20l749t830r1356b901],
5	5	CD	NUMBER	5	num	6	SENT_317	[p20l749t830r1356b901],
6	)	NN	O	)	dep	4	SENT_317	[p20l749t830r1356b901],
7	:321	CD	NUMBER	:321	num	8	SENT_317	[p20l749t830r1356b901],
8	-327	CD	NUMBER	-327	dep	4	SENT_317	[p20l749t830r1356b901],
9	.	.	O	.	_	0	SENT_317	[p20l749t830r1356b901],

1	9	CD	NUMBER	9	_	0	SENT_318	[p20l51t926r103b981],
2	.	.	O	.	_	0	SENT_318	[p20l51t926r103b981],

1	Van	NNP	O	Van	nn	3	SENT_319	[p20l144t926r265b981],
2	Goor	NNP	O	Goor	nn	3	SENT_319	[p20l299t926r460b981],
3	F	NN	O	f	_	0	SENT_319	[p20l491t926r544b992],
4	,	,	O	,	_	0	SENT_319	[p20l491t926r544b992],
5	Straley	NNP	PERSON	Straley	nn	6	SENT_319	[p20l582t921r797b1003],
6	KS	NN	O	k	appos	3	SENT_319	[p20l827t926r934b993],
7	,	,	O	,	_	0	SENT_319	[p20l827t926r934b993],
8	Cao	NNP	O	Cao	nn	9	SENT_319	[p20l970t926r1093b981],
9	D	NNP	O	D	appos	3	SENT_319	[p20l1127t926r1202b992],
10	,	,	O	,	_	0	SENT_319	[p20l1127t926r1202b992],
11	et	FW	O	et	nn	12	SENT_319	[p20l1237t934r1296b981],
12	al.	FW	O	al.	appos	3	SENT_319	[p20l1328t921r1392b981],
13	.	.	O	.	_	0	SENT_319	[p20l1328t921r1392b981],

1	Rescue	NN	O	rescue	_	0	SENT_320	[p20l1430t926r1654b981],
2	of	IN	O	of	_	0	SENT_320	[p20l1688t921r1756b981],
3	DeltaF508CFTR	NN	O	deltaf508cftr	nn	4	SENT_320	[p20l1781t921r2142b981, p20l148t1018r357b1074],
4	trafﬁcking	NN	O	trafﬁcking	prep_of	1	SENT_320	[p20l386t1013r718b1096],
5	and	CC	O	and	_	0	SENT_320	[p20l748t1013r866b1074],
6	gating	VBG	O	gate	prep_of	1	SENT_320	[p20l894t1022r1093b1096],
7	in	IN	O	in	_	0	SENT_320	[p20l1121t1022r1181b1073],
8	human	JJ	O	human	amod	13	SENT_320	[p20l1210t1013r1437b1074],
9	cystic	JJ	O	cystic	amod	13	SENT_320	[p20l1467t1022r1645b1096],
10	ﬁbrosis	NN	O	ﬁbrosis	nn	13	SENT_320	[p20l1675t1013r1904b1074],
11	airway	NN	O	airway	nn	13	SENT_320	[p20l1937t1022r2147b1096],
12	primary	JJ	O	primary	amod	13	SENT_320	[p20l145t1114r406b1188],
13	cultures	NNS	O	culture	prep_in	6	SENT_320	[p20l427t1105r686b1166],
14	by	IN	O	by	_	0	SENT_320	[p20l711t1105r790b1188],
15	small	JJ	O	small	amod	16	SENT_320	[p20l813t1105r980b1166],
16	molecules	NNS	O	molecule	prep_by	6	SENT_320	[p20l1005t1105r1347b1166],
17	.	.	O	.	_	0	SENT_320	[p20l1005t1105r1347b1166],

1	Am	VBP	O	be	dep	5	SENT_321	[p20l1371t1111r1538b1188],
2	]	CD	NUMBER	]	num	5	SENT_321	[p20l1371t1111r1538b1188],
3	Physiol	NNP	O	Physiol	nn	5	SENT_321	[p20l1559t1105r1796b1188],
4	Lung	NN	O	lung	nn	5	SENT_321	[p20l1818t1111r1990b1188],
5	Cell	NN	O	cell	_	0	SENT_321	[p20l2017t1105r2144b1166],
6	Mol	NNP	O	Mol	nn	7	SENT_321	[p20l146t1199r273b1259],
7	Physiol	NNP	O	Physiol	dep	5	SENT_321	[p20l294t1199r546b1282],
8	.	.	O	.	_	0	SENT_321	[p20l294t1199r546b1282],

1	2006	CD	DATE	2006	_	0	SENT_322	[p20l573t1199r1447b1271],
2	;	:	O	;	_	0	SENT_322	[p20l573t1199r1447b1271],
3	290	CD	NUMBER	290	number	4	SENT_322	[p20l573t1199r1447b1271],
4	(	CD	NUMBER	(	dep	1	SENT_322	[p20l573t1199r1447b1271],
5	6	CD	NUMBER	6	num	6	SENT_322	[p20l573t1199r1447b1271],
6	)	NN	O	)	dep	4	SENT_322	[p20l573t1199r1447b1271],
7	:	:	O	:	_	0	SENT_322	[p20l573t1199r1447b1271],
8	L1117-L1130	NN	O	l1117-l1130	dep	4	SENT_322	[p20l573t1199r1447b1271],
9	.	.	O	.	_	0	SENT_322	[p20l573t1199r1447b1271],

1	10	CD	NUMBER	10	_	0	SENT_323	[p20l16t1295r103b1351],
2	.	.	O	.	_	0	SENT_323	[p20l16t1295r103b1351],

1	Van	NNP	O	Van	nn	3	SENT_324	[p20l144t1296r271b1351],
2	Goor	NNP	O	Goor	nn	3	SENT_324	[p20l307t1295r478b1351],
3	F	NN	O	f	_	0	SENT_324	[p20l510t1296r567b1362],
4	,	,	O	,	_	0	SENT_324	[p20l510t1296r567b1362],
5	Hadida	NNP	PERSON	Hadida	nn	6	SENT_324	[p20l605t1290r852b1351],
6	S	NNP	O	S	appos	3	SENT_324	[p20l886t1295r941b1362],
7	,	,	O	,	_	0	SENT_324	[p20l886t1295r941b1362],
8	Crootenhuis	NNP	O	Crootenhuis	nn	9	SENT_324	[p20l979t1290r1400b1351],
9	PD	NN	O	pd	appos	3	SENT_324	[p20l1435t1296r1564b1362],
10	,	,	O	,	_	0	SENT_324	[p20l1435t1296r1564b1362],
11	et	FW	O	et	nn	12	SENT_324	[p20l1600t1303r1662b1351],
12	al.	FW	O	al.	appos	3	SENT_324	[p20l1696t1290r1766b1351],
13	.	.	O	.	_	0	SENT_324	[p20l1696t1290r1766b1351],

1	Rescue	NN	O	rescue	_	0	SENT_325	[p20l1805t1296r2046b1351],
2	of	IN	O	of	prep	1	SENT_325	[p20l2081t1290r2152b1351],

1	CF	NN	O	cf	nn	2	SENT_326	[p20l148t1389r251b1444],
2	airway	NN	O	airway	_	0	SENT_326	[p20l279t1392r489b1466],
3	epithelial	JJ	O	epithelial	amod	5	SENT_326	[p20l513t1383r815b1466],
4	cell	NN	O	cell	nn	5	SENT_326	[p20l841t1383r953b1444],
5	function	NN	O	function	dep	2	SENT_326	[p20l979t1383r1250b1444],
6	in	IN	O	in	_	0	SENT_326	[p20l1275t1392r1336b1443],
7	Vitro	NNP	O	Vitro	prep_in	5	SENT_326	[p20l1360t1392r1509b1444],
8	by	IN	O	by	_	0	SENT_326	[p20l1535t1383r1615b1466],
9	a	DT	O	a	det	11	SENT_326	[p20l1638t1408r1671b1444],
10	CFTR	NNP	O	CFTR	nn	11	SENT_326	[p20l1697t1389r1905b1444],
11	potentiator	NN	O	potentiator	prep_by	7	SENT_326	[p20l1930t1396r2142b1466, p20l147t1483r345b1546],
12	,	,	O	,	_	0	SENT_326	[p20l1930t1396r2142b1466, p20l147t1483r345b1546],
13	VX-770	NN	O	vx-770	appos	11	SENT_326	[p20l380t1476r656b1535],
14	.	.	O	.	_	0	SENT_326	[p20l380t1476r656b1535],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_327	[p20l693t1480r846b1535],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_327	[p20l879t1474r1027b1535],
3	Aead	NNP	ORGANIZATION	Aead	nn	7	SENT_327	[p20l1056t1474r1233b1535],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_327	[p20l1269t1479r1364b1535],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_327	[p20l1406t1479r1456b1535],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_327	[p20l1490t1479r1525b1535],
7	A.	NNP	O	A.	_	0	SENT_327	[p20l1556t1479r1627b1534],
8	2009	CD	DATE	2009	num	7	SENT_327	[p20l1666t1474r2139b1546],
9	;	:	O	;	_	0	SENT_327	[p20l1666t1474r2139b1546],
10	106	CD	NUMBER	106	num	11	SENT_327	[p20l1666t1474r2139b1546],
11	(	CD	NUMBER	(	dep	7	SENT_327	[p20l1666t1474r2139b1546],
12	44	CD	NUMBER	44	num	13	SENT_327	[p20l1666t1474r2139b1546],
13	)	NN	O	)	dep	7	SENT_327	[p20l1666t1474r2139b1546],
14	:	:	O	:	_	0	SENT_327	[p20l1666t1474r2139b1546],

1	11	CD	NUMBER	11	_	0	SENT_328	[p20l16t1665r103b1720],
2	.	.	O	.	_	0	SENT_328	[p20l16t1665r103b1720],

1	Bobadilla	NNP	PERSON	Bobadilla	nn	3	SENT_329	[p20l149t1659r458b1720],
2	]	CD	NUMBER	]	num	3	SENT_329	[p20l480t1666r576b1742],
3	L	NN	O	l	_	0	SENT_329	[p20l480t1666r576b1742],
4	,	,	O	,	_	0	SENT_329	[p20l480t1666r576b1742],
5	Macek	NNP	PERSON	Macek	nn	8	SENT_329	[p20l609t1659r826b1720],
6	M	NNP	O	M	nn	8	SENT_329	[p20l853t1665r916b1719],
7	]	NN	O	]	nn	8	SENT_329	[p20l944t1666r1013b1742],
8	r	NN	O	r	appos	3	SENT_329	[p20l944t1666r1013b1742],
9	,	,	O	,	_	0	SENT_329	[p20l944t1666r1013b1742],
10	Fine	JJ	O	fine	amod	12	SENT_329	[p20l1043t1665r1191b1720],
11	]	NN	O	]	nn	12	SENT_329	[p20l1217t1665r1298b1742],
12	P	NN	O	p	appos	3	SENT_329	[p20l1217t1665r1298b1742],
13	,	,	O	,	_	0	SENT_329	[p20l1217t1665r1298b1742],
14	Farrell	NNP	ORGANIZATION	Farrell	nn	15	SENT_329	[p20l1329t1659r1551b1720],
15	PM	NNP	ORGANIZATION	PM	appos	3	SENT_329	[p20l1577t1665r1710b1720],
16	.	.	O	.	_	0	SENT_329	[p20l1577t1665r1710b1720],

1	Cystic	JJ	O	cystic	amod	2	SENT_330	[p20l1741t1665r1939b1742],
2	ﬁbrosis	NN	O	ﬁbrosis	_	0	SENT_330	[p20l1966t1659r2142b1720, p20l148t1760r244b1811],
3	:	:	O	:	_	0	SENT_330	[p20l1966t1659r2142b1720, p20l148t1760r244b1811],
4	a	DT	O	a	det	6	SENT_330	[p20l280t1775r313b1811],
5	worldwide	JJ	O	worldwide	amod	6	SENT_330	[p20l338t1751r693b1811],
6	analysis	NN	O	analysis	dep	2	SENT_330	[p20l726t1751r981b1833],
7	of	IN	O	of	_	0	SENT_330	[p20l1013t1751r1084b1811],
8	CFTR	NNP	O	CFTR	nn	9	SENT_330	[p20l1107t1756r1321b1811],
9	mutations	NNS	O	mutation	prep_of	6	SENT_330	[p20l1352t1751r2144b1811],
10	—	CD	NUMBER	—	num	11	SENT_330	[p20l1352t1751r2144b1811],
11	correlation	NN	O	correlation	dep	9	SENT_330	[p20l1352t1751r2144b1811],
12	with	IN	O	with	_	0	SENT_330	[p20l144t1843r283b1904],
13	incidence	NN	O	incidence	nn	14	SENT_330	[p20l309t1843r613b1904],
14	data	NNS	O	datum	prep_with	11	SENT_330	[p20l641t1843r774b1904],
15	and	CC	O	and	_	0	SENT_330	[p20l799t1843r915b1904],
16	application	NN	O	application	prep_of	6	SENT_330	[p20l941t1843r1286b1926],
17	to	TO	O	to	_	0	SENT_330	[p20l1311t1856r1372b1904],
18	screening	NN	O	screening	prep_to	16	SENT_330	[p20l1399t1852r1716b1926],
19	.	.	O	.	_	0	SENT_330	[p20l1399t1852r1716b1926],

1	Hum	NNP	O	Hum	nn	2	SENT_331	[p20l1745t1848r1906b1904],
2	Mutat	NNP	O	Mutat	_	0	SENT_331	[p20l1931t1849r2139b1904],
3	.	.	O	.	_	0	SENT_331	[p20l1931t1849r2139b1904],

1	2002	CD	DATE	2002	_	0	SENT_332	[p20l147t1936r798b2008],
2	;	:	O	;	_	0	SENT_332	[p20l147t1936r798b2008],
3	19	CD	NUMBER	19	number	4	SENT_332	[p20l147t1936r798b2008],
4	(	CD	NUMBER	(	dep	1	SENT_332	[p20l147t1936r798b2008],
5	6	CD	NUMBER	6	num	6	SENT_332	[p20l147t1936r798b2008],
6	)	NN	O	)	dep	4	SENT_332	[p20l147t1936r798b2008],
7	:575	CD	NUMBER	:575	num	8	SENT_332	[p20l147t1936r798b2008],
8	—	NN	O	—	dep	4	SENT_332	[p20l147t1936r798b2008],
9	606	CD	NUMBER	606	dep	8	SENT_332	[p20l147t1936r798b2008],
10	.	.	O	.	_	0	SENT_332	[p20l147t1936r798b2008],

1	12	CD	NUMBER	12	_	0	SENT_333	[p20l16t2034r103b2089],
2	.	.	O	.	_	0	SENT_333	[p20l16t2034r103b2089],

1	Accurso	NNP	PERSON	Accurso	nn	3	SENT_334	[p20l145t2034r408b2089],
2	F	NN	O	f	nn	3	SENT_334	[p20l437t2034r531b2111],
3	]	NN	O	]	_	0	SENT_334	[p20l437t2034r531b2111],
4	,	,	O	,	_	0	SENT_334	[p20l437t2034r531b2111],
5	Rowe	NNP	PERSON	Rowe	nn	6	SENT_334	[p20l563t2035r744b2090],
6	SM	NNP	O	SM	appos	3	SENT_334	[p20l776t2034r904b2100],
7	,	,	O	,	_	0	SENT_334	[p20l776t2034r904b2100],
8	Clancy	NNP	PERSON	Clancy	nn	10	SENT_334	[p20l935t2029r1160b2111],
9	]	CD	NUMBER	]	num	10	SENT_334	[p20l1182t2034r1275b2111],
10	P	NN	O	p	appos	3	SENT_334	[p20l1182t2034r1275b2111],
11	,	,	O	,	_	0	SENT_334	[p20l1182t2034r1275b2111],
12	et	FW	O	et	nn	13	SENT_334	[p20l1306t2042r1367b2089],
13	al.	FW	O	al.	appos	3	SENT_334	[p20l1394t2029r1461b2089],
14	.	.	O	.	_	0	SENT_334	[p20l1394t2029r1461b2089],

1	Effect	NN	O	effect	_	0	SENT_335	[p20l1495t2029r1697b2089],
2	of	IN	O	of	_	0	SENT_335	[p20l1724t2029r1793b2089],
3	VX	NN	O	vx	nn	5	SENT_335	[p20l1810t2031r2055b2089],
4	—	CD	NUMBER	—	num	5	SENT_335	[p20l1810t2031r2055b2089],
5	77O	NN	O	77o	prep_of	1	SENT_335	[p20l1810t2031r2055b2089],
6	in	IN	O	in	_	0	SENT_335	[p20l2083t2038r2143b2088],
7	persons	NNS	O	person	prep_in	1	SENT_335	[p20l146t2145r395b2204],
8	with	IN	O	with	_	0	SENT_335	[p20l419t2121r562b2182],
9	cystic	JJ	O	cystic	amod	10	SENT_335	[p20l588t2130r766b2204],
10	ﬁbrosis	NN	O	ﬁbrosis	prep_with	7	SENT_335	[p20l793t2121r1022b2182],
11	and	CC	O	and	_	0	SENT_335	[p20l1051t2121r1169b2182],
12	the	DT	O	the	det	13	SENT_335	[p20l1193t2121r1296b2182],
13	G551D	NN	O	g551d	prep_with	7	SENT_335	[p20l1325t2124r1804b2182],
14	.	.	O	.	_	0	SENT_335	[p20l1325t2124r1804b2182],

1	—	NN	O	—	_	0	SENT_336	[p20l1325t2124r1804b2182],
2	.	.	O	.	_	0	SENT_336	[p20l1325t2124r1804b2182],

1	CFTR	NN	ORGANIZATION	cftr	_	0	SENT_337	[p20l1325t2124r1804b2182],
2	mutation	NN	O	mutation	dep	1	SENT_337	[p20l1831t2130r2139b2182],
3	.	.	O	.	_	0	SENT_337	[p20l1831t2130r2139b2182],

1	N	NN	O	n	_	0	SENT_338	[p20l145t2218r203b2274],
2	Engl	NNP	O	Engl	nn	4	SENT_338	[p20l223t2213r426b2296],
3	]	NNP	O	]	nn	4	SENT_338	[p20l223t2213r426b2296],
4	Med	NNP	O	Med	dep	1	SENT_338	[p20l447t2213r606b2274],
5	.	.	O	.	_	0	SENT_338	[p20l447t2213r606b2274],

1	2010	CD	DATE	2010	_	0	SENT_339	[p20l634t2214r1444b2285],
2	;	:	O	;	_	0	SENT_339	[p20l634t2214r1444b2285],
3	363	CD	NUMBER	363	num	4	SENT_339	[p20l634t2214r1444b2285],
4	(	CD	NUMBER	(	dep	1	SENT_339	[p20l634t2214r1444b2285],
5	21	CD	NUMBER	21	num	6	SENT_339	[p20l634t2214r1444b2285],
6	)	NN	O	)	dep	4	SENT_339	[p20l634t2214r1444b2285],
7	:1991	CD	NUMBER	:1991	number	8	SENT_339	[p20l634t2214r1444b2285],
8	—	CD	NUMBER	—	num	9	SENT_339	[p20l634t2214r1444b2285],
9	2003	CD	DATE	2003	dep	6	SENT_339	[p20l634t2214r1444b2285],
10	.	.	O	.	_	0	SENT_339	[p20l634t2214r1444b2285],

1	13	CD	NUMBER	13	_	0	SENT_340	[p20l7t2557r95b2613],
2	.	.	O	.	_	0	SENT_340	[p20l7t2557r95b2613],

1	Bronsveld	NN	MISC	bronsveld	_	0	SENT_341	[p20l141t2552r472b2613],
2	I	CD	NUMBER	i	num	1	SENT_341	[p20l496t2558r540b2624],
3	,	,	O	,	_	0	SENT_341	[p20l496t2558r540b2624],
4	Mekus	NNP	O	Mekus	nn	5	SENT_341	[p20l571t2552r787b2613],
5	F	NN	O	f	appos	1	SENT_341	[p20l814t2557r879b2624],
6	,	,	O	,	_	0	SENT_341	[p20l814t2557r879b2624],
7	Bijman	NN	PERSON	bijman	nn	9	SENT_341	[p20l908t2558r1142b2635],
8	p	NN	O	p	nn	9	SENT_341	[p20l1165t2558r1210b2635],
9	%	NN	O	%	appos	1	SENT_341	[p20l1165t2558r1210b2635],
10	˖	CD	NUMBER	˖	dep	9	SENT_341	[p20l1165t2558r1210b2635],
11	+	CC	O	+	_	0	SENT_341	[p20l1165t2558r1210b2635],
12	et	FW	O	et	nn	13	SENT_341	[p20l1238t2565r1299b2613],
13	al.	FW	O	al.	dep	9	SENT_341	[p20l1323t2552r1391b2613],
14	.	.	O	.	_	0	SENT_341	[p20l1323t2552r1391b2613],

1	Chloride	NN	O	chloride	nn	2	SENT_342	[p20l1421t2552r1708b2613],
2	conductance	NN	O	conductance	nsubj	6	SENT_342	[p20l1734t2552r2149b2613],
3	and	CC	O	and	_	0	SENT_342	[p20l140t2645r259b2706],
4	genetic	JJ	O	genetic	amod	5	SENT_342	[p20l288t2654r526b2729],
5	background	NN	O	background	conj_and	2	SENT_342	[p20l554t2645r945b2729],
6	modulate	VBP	O	modulate	_	0	SENT_342	[p20l974t2645r1281b2706],
7	the	DT	O	the	det	10	SENT_342	[p20l1312t2645r1415b2706],
8	cystic	JJ	O	cystic	amod	10	SENT_342	[p20l1446t2654r1626b2729],
9	ﬁbrosis	NN	O	ﬁbrosis	nn	10	SENT_342	[p20l1656t2645r1887b2707],
10	phenotype	NN	O	phenotype	dobj	6	SENT_342	[p20l1917t2645r2149b2729, p20l139t2752r280b2822],
11	of	IN	O	of	_	0	SENT_342	[p20l315t2738r386b2800],
12	Delta	NNP	ORGANIZATION	Delta	nn	13	SENT_342	[p20l413t2738r599b2800],
13	F508	NN	O	f508	prep_of	10	SENT_342	[p20l631t2741r801b2799],
14	homozygous	JJ	O	homozygous	amod	15	SENT_342	[p20l834t2738r1248b2822],
15	twins	NNS	O	twin	dep	10	SENT_342	[p20l1283t2747r1456b2800],
16	and	CC	O	and	_	0	SENT_342	[p20l1492t2738r1613b2800],
17	siblings	NNS	O	sibling	dep	10	SENT_342	[p20l1646t2738r1910b2822],
18	.	.	O	.	_	0	SENT_342	[p20l1646t2738r1910b2822],
19	]	SYM	O	]	dep	10	SENT_342	[p20l1938t2745r1976b2822],

1	Clin	NNP	O	Clin	nn	2	SENT_343	[p20l2010t2738r2148b2800],
2	Invest	NNP	O	Invest	_	0	SENT_343	[p20l138t2838r354b2893],
3	.	.	O	.	_	0	SENT_343	[p20l138t2838r354b2893],

1	2001	CD	DATE	2001	_	0	SENT_344	[p20l381t2832r1198b2905],
2	;	:	O	;	_	0	SENT_344	[p20l381t2832r1198b2905],
3	108	CD	NUMBER	108	number	4	SENT_344	[p20l381t2832r1198b2905],
4	(	CD	NUMBER	(	dep	1	SENT_344	[p20l381t2832r1198b2905],
5	11	CD	NUMBER	11	num	6	SENT_344	[p20l381t2832r1198b2905],
6	)	NN	O	)	dep	4	SENT_344	[p20l381t2832r1198b2905],
7	:1705	CD	DURATION	:1705	num	8	SENT_344	[p20l381t2832r1198b2905],
8	-1715	CD	DURATION	-1715	dep	4	SENT_344	[p20l381t2832r1198b2905],
9	.	.	O	.	_	0	SENT_344	[p20l381t2832r1198b2905],

1	14	CD	NUMBER	14	_	0	SENT_345	[p20l7t2931r95b2986],
2	.	.	O	.	_	0	SENT_345	[p20l7t2931r95b2986],

1	Veeze	NN	O	veeze	nn	2	SENT_346	[p20l136t2931r335b2986],
2	H	NN	O	h	_	0	SENT_346	[p20l363t2931r470b3009],
3	]	CD	NUMBER	]	dep	2	SENT_346	[p20l363t2931r470b3009],
4	,	,	O	,	_	0	SENT_346	[p20l363t2931r470b3009],
5	Halley	NNP	PERSON	Halley	nn	7	SENT_346	[p20l499t2925r714b3009],
6	D	NNP	O	D	nn	7	SENT_346	[p20l737t2931r844b3009],
7	]	NNP	O	]	appos	3	SENT_346	[p20l737t2931r844b3009],
8	,	,	O	,	_	0	SENT_346	[p20l737t2931r844b3009],
9	Bijman	NNP	O	Bijman	appos	3	SENT_346	[p20l874t2931r1108b3009],
10	]	CD	NUMBER	]	num	9	SENT_346	[p20l1130t2931r1175b3009],
11	,	,	O	,	_	0	SENT_346	[p20l1130t2931r1175b3009],
12	de	FW	O	de	nn	15	SENT_346	[p20l1203t2925r1280b2986],
13	]	FW	O	]	nn	15	SENT_346	[p20l1303t2931r1546b3009],
14	ongste	FW	O	ongste	nn	15	SENT_346	[p20l1303t2931r1546b3009],
15	]	FW	O	]	appos	3	SENT_346	[p20l1570t2931r1672b3009],
16	C	NN	O	c	nn	15	SENT_346	[p20l1570t2931r1672b3009],
17	,	,	O	,	_	0	SENT_346	[p20l1570t2931r1672b3009],
18	de	FW	O	de	dep	15	SENT_346	[p20l1700t2925r1776b2986],
19	]	FW	O	]	nn	21	SENT_346	[p20l1800t2931r1988b3009],
20	onge	FW	O	onge	nn	21	SENT_346	[p20l1800t2931r1988b3009],
21	HR	NN	DURATION	hr	dep	15	SENT_346	[p20l2015t2931r2147b2998],
22	,	,	O	,	_	0	SENT_346	[p20l2015t2931r2147b2998],
23	Sinaasappel	NNP	O	Sinaasappel	nn	25	SENT_346	[p20l143t3018r526b3102],
24	M.	NNP	O	M.	nn	25	SENT_346	[p20l564t3024r647b3079],
25	Determinants	NNP	O	Determinants	appos	3	SENT_346	[p20l689t3024r1142b3080],
26	of	IN	O	of	_	0	SENT_346	[p20l1180t3018r1250b3080],
27	mild	JJ	O	mild	amod	29	SENT_346	[p20l1277t3018r1425b3080],
28	clinical	JJ	O	clinical	amod	29	SENT_346	[p20l1458t3018r1689b3080],
29	symptoms	NNS	O	symptom	prep_of	25	SENT_346	[p20l1724t3032r2053b3102],
30	in	IN	O	in	_	0	SENT_346	[p20l2089t3027r2150b3079],
31	cystic	JJ	O	cystic	amod	33	SENT_346	[p20l140t3120r319b3195],
32	ﬁbrosis	NN	O	ﬁbrosis	nn	33	SENT_346	[p20l344t3111r575b3172],
33	patients	NNS	O	patient	prep_in	29	SENT_346	[p20l599t3120r875b3195],
34	.	.	O	.	_	0	SENT_346	[p20l599t3120r875b3195],

1	Residual	JJ	O	residual	amod	3	SENT_347	[p20l906t3111r1189b3172],
2	chloride	NN	O	chloride	nn	3	SENT_347	[p20l1213t3111r1480b3172],
3	secretion	NN	O	secretion	_	0	SENT_347	[p20l1507t3120r1805b3172],
4	measured	VBN	O	measure	partmod	3	SENT_347	[p20l1831t3111r2152b3172],
5	in	IN	O	in	_	0	SENT_347	[p20l139t3213r201b3264],
6	rectal	JJ	O	rectal	amod	7	SENT_347	[p20l230t3204r417b3265],
7	biopsies	NNS	O	biopsy	prep_in	4	SENT_347	[p20l444t3204r712b3288],
8	in	IN	O	in	_	0	SENT_347	[p20l742t3213r804b3264],
9	relation	NN	O	relation	prep_in	7	SENT_347	[p20l833t3204r1090b3265],
10	to	TO	O	to	_	0	SENT_347	[p20l1118t3217r1181b3265],
11	the	DT	O	the	det	12	SENT_347	[p20l1210t3204r1315b3265],
12	genotype	NN	O	genotype	prep_to	4	SENT_347	[p20l1345t3217r1667b3288],
13	.	.	O	.	_	0	SENT_347	[p20l1345t3217r1667b3288],
14	]	SYM	O	]	dep	3	SENT_347	[p20l1690t3211r1729b3288],

1	Clin	NNP	O	Clin	nn	2	SENT_348	[p20l1757t3204r1895b3265],
2	Invest	NNP	O	Invest	_	0	SENT_348	[p20l1925t3210r2146b3265],
3	.	.	O	.	_	0	SENT_348	[p20l1925t3210r2146b3265],

1	199-4	CD	NUMBER	199-4	_	0	SENT_349	[p20l144t3299r795b3372],
2	;	:	O	;	_	0	SENT_349	[p20l144t3299r795b3372],
3	93	CD	NUMBER	93	num	4	SENT_349	[p20l144t3299r795b3372],
4	(	NN	O	(	dep	1	SENT_349	[p20l144t3299r795b3372],
5	2	CD	NUMBER	2	number	6	SENT_349	[p20l144t3299r795b3372],
6	)	CD	NUMBER	)	dep	4	SENT_349	[p20l144t3299r795b3372],
7	:461	CD	NUMBER	:461	num	8	SENT_349	[p20l144t3299r795b3372],
8	—	NN	O	—	dep	6	SENT_349	[p20l144t3299r795b3372],
9	466	CD	NUMBER	466	dep	6	SENT_349	[p20l144t3299r795b3372],
10	.	.	O	.	_	0	SENT_349	[p20l144t3299r795b3372],

1	15	CD	NUMBER	15	_	0	SENT_350	[p20l7t3393r95b3451],
2	.	.	O	.	_	0	SENT_350	[p20l7t3393r95b3451],

1	Quittner	NNP	PERSON	Quittner	nn	2	SENT_351	[p20l141t3396r436b3468],
2	AL	NNP	PERSON	AL	_	0	SENT_351	[p20l467t3396r589b3463],
3	,	,	O	,	_	0	SENT_351	[p20l467t3396r589b3463],
4	Buu	NNP	MISC	Buu	nn	5	SENT_351	[p20l629t3397r766b3452],
5	A	NNP	MISC	A	conj_and	2	SENT_351	[p20l799t3396r868b3463],
6	,	,	O	,	_	0	SENT_351	[p20l799t3396r868b3463],
7	Messer	NNP	PERSON	Messer	nn	8	SENT_351	[p20l908t3397r1152b3452],
8	MA	NNP	PERSON	MA	conj_and	2	SENT_351	[p20l1188t3396r1328b3463],
9	,	,	O	,	_	0	SENT_351	[p20l1188t3396r1328b3463],
10	Modi	NNP	PERSON	Modi	nn	11	SENT_351	[p20l1368t3391r1546b3452],
11	AC	NN	O	ac	conj_and	2	SENT_351	[p20l1578t3396r1705b3463],
12	,	,	O	,	_	0	SENT_351	[p20l1578t3396r1705b3463],
13	Watrous	NNP	PERSON	Watrous	nn	15	SENT_351	[p20l1739t3397r2022b3452],
14	M.	NNP	O	M.	nn	15	SENT_351	[p20l2061t3396r2146b3451],
15	Development	NNP	O	Development	conj_and	2	SENT_351	[p20l141t3484r585b3568],
16	and	CC	O	and	_	0	SENT_351	[p20l609t3484r727b3545],
17	Validation	NNP	O	Validation	conj_and	2	SENT_351	[p20l748t3484r1062b3545],
18	of	IN	O	of	_	0	SENT_351	[p20l1087t3484r1157b3545],
19	The	DT	O	the	det	22	SENT_351	[p20l1173t3484r1300b3545],
20	Cystic	JJ	O	cystic	amod	22	SENT_351	[p20l1328t3490r1523b3568],
21	Fibrosis	NNP	O	Fibrosis	nn	22	SENT_351	[p20l1550t3484r1804b3545],
22	Questionnaire	NNP	O	Questionnaire	prep_of	17	SENT_351	[p20l1833t3490r2149b3562, p20l139t3586r296b3639],
23	in	IN	O	in	_	0	SENT_351	[p20l323t3586r383b3638],
24	the	DT	O	the	det	26	SENT_351	[p20l409t3577r509b3639],
25	United	NNP	LOCATION	United	nn	26	SENT_351	[p20l538t3577r758b3639],
26	States	NNPS	LOCATION	States	prep_in	22	SENT_351	[p20l787t3583r984b3639],
27	:	:	O	:	_	0	SENT_351	[p20l787t3583r984b3639],
28	a	DT	O	a	det	33	SENT_351	[p20l1016t3602r1049b3639],
29	health	NN	O	health	nn	33	SENT_351	[p20l1073t3577r1517b3639],
30	—	NN	O	—	nn	33	SENT_351	[p20l1073t3577r1517b3639],
31	related	JJ	O	related	amod	33	SENT_351	[p20l1073t3577r1517b3639],
32	quality	NN	O	quality	nn	33	SENT_351	[p20l1543t3577r1964b3661],
33	—	NN	O	—	dep	2	SENT_351	[p20l1543t3577r1964b3661],
34	of	IN	O	of	_	0	SENT_351	[p20l1543t3577r1964b3661],
35	—	CD	NUMBER	—	num	37	SENT_351	[p20l1543t3577r1964b3661],
36	life	NN	O	life	nn	37	SENT_351	[p20l1543t3577r1964b3661],
37	measure	NN	O	measure	prep_of	33	SENT_351	[p20l1993t3602r2149b3639, p20l141t3694r276b3731],
38	for	IN	O	for	_	0	SENT_351	[p20l301t3670r394b3731],
39	cystic	JJ	O	cystic	amod	40	SENT_351	[p20l416t3679r596b3754],
40	ﬁbrosis	NN	O	ﬁbrosis	prep_for	37	SENT_351	[p20l620t3670r868b3731],
41	.	.	O	.	_	0	SENT_351	[p20l620t3670r868b3731],

1	Chest	NN	O	chest	_	0	SENT_352	[p20l897t3670r1097b3731],
2	.	.	O	.	_	0	SENT_352	[p20l897t3670r1097b3731],

1	2005	CD	DATE	2005	_	0	SENT_353	[p20l1125t3670r1901b3743],
2	;	:	O	;	_	0	SENT_353	[p20l1125t3670r1901b3743],
3	128	CD	NUMBER	128	number	4	SENT_353	[p20l1125t3670r1901b3743],
4	(	CD	NUMBER	(	dep	1	SENT_353	[p20l1125t3670r1901b3743],
5	4	CD	NUMBER	4	num	6	SENT_353	[p20l1125t3670r1901b3743],
6	)	NN	O	)	dep	4	SENT_353	[p20l1125t3670r1901b3743],
7	:2347	CD	NUMBER	:2347	number	8	SENT_353	[p20l1125t3670r1901b3743],
8	—	CD	NUMBER	—	dep	4	SENT_353	[p20l1125t3670r1901b3743],
9	2354	CD	DATE	2354	dep	8	SENT_353	[p20l1125t3670r1901b3743],
10	.	.	O	.	_	0	SENT_353	[p20l1125t3670r1901b3743],

1	16	CD	NUMBER	16	_	0	SENT_354	[p21l7t17r95b72],
2	.	.	O	.	_	0	SENT_354	[p21l7t17r95b72],

1	American	JJ	O	american	_	0	SENT_355	[p21l137t17r469b72],
2	Thoracic	NNP	ORGANIZATION	Thoracic	nn	3	SENT_355	[p21l494t11r795b72],
3	Society	NNP	ORGANIZATION	Society	dep	1	SENT_355	[p21l824t17r1078b95],
4	.	.	O	.	_	0	SENT_355	[p21l824t17r1078b95],

1	Standardization	NN	O	standardization	nsubj	6	SENT_356	[p21l1112t11r1648b72],
2	of	IN	O	of	_	0	SENT_356	[p21l1675t11r1747b72],
3	spirometry	NN	O	spirometry	prep_of	1	SENT_356	[p21l1766t20r2147b95],
4	,	,	O	,	_	0	SENT_356	[p21l1766t20r2147b95],
5	1994	CD	DATE	1994	appos	3	SENT_356	[p21l144t111r301b166],
6	update	VBP	O	update	_	0	SENT_356	[p21l343t105r594b189],
7	.	.	O	.	_	0	SENT_356	[p21l343t105r594b189],

1	Am	VBP	O	be	dep	2	SENT_357	[p21l636t111r754b167],
2	]	CD	NUMBER	]	_	0	SENT_357	[p21l785t112r823b189],
3	Respir	NNP	O	Respir	nn	6	SENT_357	[p21l861t111r1086b189],
4	Crit	NNP	O	Crit	nn	6	SENT_357	[p21l1126t111r1263b167],
5	Care	NNP	O	Care	nn	6	SENT_357	[p21l1306t111r1466b167],
6	Med	NNP	O	Med	dep	2	SENT_357	[p21l1509t105r1674b167],
7	.	.	O	.	_	0	SENT_357	[p21l1509t105r1674b167],

1	1995	CD	DATE	1995	_	0	SENT_358	[p21l1725t106r2146b178],
2	;	:	O	;	_	0	SENT_358	[p21l1725t106r2146b178],
3	152	CD	NUMBER	152	number	4	SENT_358	[p21l1725t106r2146b178],
4	(	CD	NUMBER	(	dep	1	SENT_358	[p21l1725t106r2146b178],
5	3	CD	NUMBER	3	num	6	SENT_358	[p21l1725t106r2146b178],
6	)	NN	O	)	dep	4	SENT_358	[p21l1725t106r2146b178],
7	:	:	O	:	_	0	SENT_358	[p21l1725t106r2146b178],
8	1107-1136	CD	DATE	1107-1136	dep	4	SENT_358	[p21l144t203r514b261],
9	.	.	O	.	_	0	SENT_358	[p21l144t203r514b261],

1	17	CD	NUMBER	17	_	0	SENT_359	[p21l7t297r95b355],
2	.	.	O	.	_	0	SENT_359	[p21l7t297r95b355],

1	Rose	NNP	O	Rose	nn	3	SENT_360	[p21l141t300r293b355],
2	]	NN	O	]	nn	3	SENT_360	[p21l319t300r415b378],
3	B	NN	O	b	_	0	SENT_360	[p21l319t300r415b378],
4	,	,	O	,	_	0	SENT_360	[p21l319t300r415b378],
5	Ellis	NNP	PERSON	Ellis	nn	6	SENT_360	[p21l446t294r581b355],
6	L	NNP	O	L	appos	3	SENT_360	[p21l612t300r673b367],
7	,	,	O	,	_	0	SENT_360	[p21l612t300r673b367],
8	John	NNP	PERSON	John	nn	9	SENT_360	[p21l701t294r851b378],
9	B	NNP	PERSON	B	appos	3	SENT_360	[p21l880t300r943b367],
10	,	,	O	,	_	0	SENT_360	[p21l880t300r943b367],
11	et	FW	O	et	nn	12	SENT_360	[p21l973t307r1033b355],
12	al.	FW	O	al.	appos	3	SENT_360	[p21l1059t294r1124b355],
13	.	.	O	.	_	0	SENT_360	[p21l1059t294r1124b355],

1	Does	VBZ	O	do	_	0	SENT_361	[p21l1156t300r1318b355],
2	the	DT	O	the	det	5	SENT_361	[p21l1346t294r1446b355],
3	Macroduct	NN	O	macroduct	nn	5	SENT_361	[p21l1477t294r1822b355],
4	collection	NN	O	collection	nn	5	SENT_361	[p21l1847t294r2151b355],
5	system	NN	O	system	dobj	1	SENT_361	[p21l141t401r351b471],
6	reliably	RB	O	reliably	advmod	1	SENT_361	[p21l380t387r614b471],
7	deﬁne	JJ	O	deﬁne	amod	10	SENT_361	[p21l639t387r834b449],
8	sweat	NN	O	sweat	nn	10	SENT_361	[p21l864t401r1039b449],
9	chloride	NN	O	chloride	nn	10	SENT_361	[p21l1066t388r1321b449],
10	concentration	NN	O	concentration	tmod	1	SENT_361	[p21l1351t396r1785b449],
11	in	IN	O	in	_	0	SENT_361	[p21l1811t396r1871b448],
12	subjects	NNS	O	subject	prep_in	10	SENT_361	[p21l1900t388r2149b471],
13	with	IN	O	with	_	0	SENT_361	[p21l136t481r273b542],
14	intermediate	JJ	O	intermediate	amod	15	SENT_361	[p21l291t481r686b543],
15	results	NNS	O	result	prep_with	12	SENT_361	[p21l706t481r939b543],
16	?	.	O	?	_	0	SENT_361	[p21l706t481r939b543],

1	C	NN	O	c	nn	2	SENT_362	[p21l959t486r1008b542],
2	lm	NN	O	lm	_	0	SENT_362	[p21l1010t481r1088b542],
3	Biochem	NNP	ORGANIZATION	Biochem	dep	2	SENT_362	[p21l1107t481r1391b542],
4	.	.	O	.	_	0	SENT_362	[p21l1107t481r1391b542],

1	2009	CD	DATE	2009	_	0	SENT_363	[p21l1414t481r2139b554],
2	;	:	O	;	_	0	SENT_363	[p21l1414t481r2139b554],
3	42	CD	NUMBER	42	number	4	SENT_363	[p21l1414t481r2139b554],
4	(	CD	NUMBER	(	dep	1	SENT_363	[p21l1414t481r2139b554],
5	12	CD	NUMBER	12	num	6	SENT_363	[p21l1414t481r2139b554],
6	)	NN	O	)	dep	4	SENT_363	[p21l1414t481r2139b554],
7	:1260	CD	NUMBER	:1260	number	8	SENT_363	[p21l1414t481r2139b554],
8	—	CD	NUMBER	—	dep	4	SENT_363	[p21l1414t481r2139b554],
9	1264	CD	DATE	1264	dep	8	SENT_363	[p21l1414t481r2139b554],
10	.	.	O	.	_	0	SENT_363	[p21l1414t481r2139b554],

1	18	CD	NUMBER	18	_	0	SENT_364	[p21l7t580r95b635],
2	.	.	O	.	_	0	SENT_364	[p21l7t580r95b635],

1	Fuchs	NNP	PERSON	Fuchs	nn	3	SENT_365	[p21l141t574r344b635],
2	H	NNP	O	H	nn	3	SENT_365	[p21l398t580r508b658],
3	]	NN	O	]	_	0	SENT_365	[p21l398t580r508b658],
4	,	,	O	,	_	0	SENT_365	[p21l398t580r508b658],
5	Borowitz	NNP	PERSON	Borowitz	nn	6	SENT_365	[p21l563t580r869b636],
6	DS	NN	O	d	appos	3	SENT_365	[p21l920t580r1044b647],
7	,	,	O	,	_	0	SENT_365	[p21l920t580r1044b647],
8	Christiansen	NNP	PERSON	Christiansen	nn	9	SENT_365	[p21l1098t574r1528b635],
9	DH	NNP	O	DH	appos	3	SENT_365	[p21l1580t580r1726b647],
10	,	,	O	,	_	0	SENT_365	[p21l1580t580r1726b647],
11	et	FW	O	et	nn	12	SENT_365	[p21l1780t587r1842b635],
12	al	FW	O	al	appos	3	SENT_365	[p21l1892t574r1965b647],
13	;	:	O	;	_	0	SENT_365	[p21l1892t574r1965b647],
14	The	DT	O	the	det	17	SENT_365	[p21l2017t574r2149b635],
15	Pulmozyme	NNP	O	Pulmozyme	nn	17	SENT_365	[p21l140t667r520b750],
16	Study	NNP	O	Study	nn	17	SENT_365	[p21l555t666r739b750],
17	Group	NNP	O	Group	dep	3	SENT_365	[p21l769t672r992b750],
18	.	.	O	.	_	0	SENT_365	[p21l769t672r992b750],

1	Effect	NN	O	effect	_	0	SENT_366	[p21l1028t667r1228b728],
2	of	IN	O	of	_	0	SENT_366	[p21l1258t666r1327b728],
3	aerosolized	JJ	O	aerosolized	amod	6	SENT_366	[p21l1350t667r1711b728],
4	recombinant	JJ	O	recombinant	amod	6	SENT_366	[p21l1741t666r2152b728],
5	human	JJ	O	human	amod	6	SENT_366	[p21l138t760r362b821],
6	DNase	NN	MISC	dnase	prep_of	1	SENT_366	[p21l394t766r614b821],
7	on	IN	O	on	_	0	SENT_366	[p21l646t784r725b821],
8	exacerbations	NNS	O	exacerbation	prep_on	1	SENT_366	[p21l756t760r1184b821],
9	of	IN	O	of	_	0	SENT_366	[p21l1217t760r1286b821],
10	respiratory	JJ	O	respiratory	amod	11	SENT_366	[p21l1308t769r1654b843],
11	symptoms	NNS	O	symptom	prep_of	8	SENT_366	[p21l1682t773r2002b844],
12	and	CC	O	and	_	0	SENT_366	[p21l2035t760r2151b821],
13	on	IN	O	on	_	0	SENT_366	[p21l140t878r218b914],
14	pulmonary	JJ	O	pulmonary	amod	15	SENT_366	[p21l246t853r592b937],
15	function	NN	O	function	prep_on	1	SENT_366	[p21l619t853r881b914],
16	in	IN	O	in	_	0	SENT_366	[p21l911t862r971b913],
17	patients	NNS	O	patient	prep_in	15	SENT_366	[p21l999t862r1246b937],
18	with	IN	O	with	_	0	SENT_366	[p21l1275t853r1414b915],
19	cystic	JJ	O	cystic	amod	20	SENT_366	[p21l1445t862r1616b937],
20	fibrosis	NN	O	fibrosis	prep_with	17	SENT_366	[p21l1647t853r1884b915],
21	.	.	O	.	_	0	SENT_366	[p21l1647t853r1884b915],

1	N	NN	O	n	_	0	SENT_367	[p21l1917t859r1975b914],
2	Engl	NNP	O	Engl	nn	4	SENT_367	[p21l2002t853r2151b937],
3	]	NNP	O	]	nn	4	SENT_367	[p21l129t954r167b1031],
4	Med	NNP	O	Med	dep	1	SENT_367	[p21l187t947r349b1009],
5	.	.	O	.	_	0	SENT_367	[p21l187t947r349b1009],

1	1994	CD	DATE	1994	_	0	SENT_368	[p21l381t948r1112b1021],
2	;	:	O	;	_	0	SENT_368	[p21l381t948r1112b1021],
3	331	CD	NUMBER	331	number	4	SENT_368	[p21l381t948r1112b1021],
4	(	CD	NUMBER	(	dep	1	SENT_368	[p21l381t948r1112b1021],
5	10	CD	NUMBER	10	num	6	SENT_368	[p21l381t948r1112b1021],
6	)	NN	O	)	dep	4	SENT_368	[p21l381t948r1112b1021],
7	:637	CD	NUMBER	:637	num	8	SENT_368	[p21l381t948r1112b1021],
8	—	NN	O	—	dep	4	SENT_368	[p21l381t948r1112b1021],
9	642	CD	NUMBER	642	dep	8	SENT_368	[p21l381t948r1112b1021],
10	.	.	O	.	_	0	SENT_368	[p21l381t948r1112b1021],

1	Original	NNP	O	Original	nn	2	SENT_369	[p21l1631t1201r1851b1263],
2	Research	NNP	O	Research	_	0	SENT_369	[p21l1878t1202r2148b1250],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_370	[p21l302t1339r479b1363],
2	From	IN	O	from	dep	1	SENT_370	[p21l488t1339r576b1362],
3	:	:	O	:	_	0	SENT_370	[p21l488t1339r576b1362],
4	http://journal.puhlications.chestnet.org/	NN	O	http://journal.puhlications.chestnet.org/	dep	1	SENT_370	[p21l587t1338r1156b1369],
5	by	IN	O	by	dep	4	SENT_370	[p21l1163t1339r1198b1369],
6	a	DT	O	a	det	10	SENT_370	[p21l1207t1346r1223b1362],
7	University	NNP	ORGANIZATION	University	dep	10	SENT_370	[p21l1232t1338r1379b1369],
8	of	IN	ORGANIZATION	of	_	0	SENT_370	[p21l1389t1338r1418b1362],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_370	[p21l1425t1338r1570b1363],
10	User	NN	ORGANIZATION	user	pobj	5	SENT_370	[p21l1579t1339r1645b1363],
11	on	IN	O	on	_	0	SENT_370	[p21l1663t1346r1697b1362],
12	01/05/2014	CD	DATE	01/05/2014	prep_on	10	SENT_370	[p21l1706t1338r1857b1363],

